,INCHI,chemical,title,index,MolecularFormula,Mass,M+H
0,"InChI=1S/C10H10N4O3/c11-4-6-3-7(5-15)17-9(6)14-2-1-8(12)13-10(14)16/h1-3,7,9,15H,5H2,(H2,12,13,16)/t7-,9+/m0/s1","2'-C-cyano-2',3'-didehydro-2',3'-dideoxycytidine",2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.,101271,C10H10N4O3,234.21,235.21
1,"InChI=1S/C10H10N6O5/c11-1-4-2-16(10(20)13-8(4)19)9-6(14-15-12)7(18)5(3-17)21-9/h2,5-7,9,17-18H,3H2,(H,13,19,20)/t5-,6-,7-,9-/m1/s1",2'-azido-5-cyano-2'-deoxyuridine,A direct comparison of azide and nitrile vibrational probes.,50500,C10H10N6O5,294.22,295.22
2,"InChI=1S/C10H11BrN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1","8-bromoadenosine 3',5'-cyclic monophosphate",Formation of 8-S-L-Cysteinyladenosine from 8-Bromoadenosine and Cysteine.,15272,C10H11BrN5O6P,408.1,409.1
3,"InChI=1S/C10H11BrN5O6PS/c11-9-14-3-1-13-10(12)15-7(3)16(9)8-6(18)5(17)4(22-8)2-21-23(19,20)24/h1,4,8,17-18H,2H2,(H2,12,13,15)(H2,19,20,24)/t4-,8-/m1/s1","Rp-8-bromoguanosine 3',5'-cyclic monophosphorothioate","Synthesis and Characterization of 8-Nitroguanosine 3',5'-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α.",20238,C10H11BrN5O6PS,440.17,441.17
4,"InChI=1S/C10H11BrN5O7P/c11-9-13-3-6(14-10(12)15-7(3)18)16(9)8-4(17)5-2(22-8)1-21-24(19,20)23-5/h2,4-5,8,17H,1H2,(H,19,20)(H3,12,14,15,18)/t2-,4-,5-,8-/m1/s1","8-bromoguanosine 3',5'-cyclic monophosphate",cGMP-mediated inhibition of cardiac L-type Ca(2+) current by a monoclonal antibody against the M(2) ACh receptor.,99020,C10H11BrN5O7P,424.1,425.1
5,"InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1",2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine,"Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.",114589,C10H11ClFN5O3,303.68,304.68
6,"InChI=1S/C10H11ClN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1","8-Chloroadenosine 3',5'-monophosphate",The mechanism of 8-Cl-cAMP action.,109868,C10H11ClN5O6P,363.65,364.65
7,"InChI=1S/C10H11ClN8O2/c11-10-15-8(12)7-9(16-10)19(3-14-7)6-1-4(17-18-13)5(2-20)21-6/h3-6,20H,1-2H2,(H2,12,15,16)/t4-,5+,6+/m1/s1","3'-azido-2-chloro-2',3'-dideoxyadenosine","Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.",72632,C10H11ClN8O2,310.7,311.7
8,"InChI=1S/C10H11F2N5O3/c11-1-4-6(18)7(19)10(12,20-4)17-3-16-5-8(13)14-2-15-9(5)17/h2-4,6-7,18-19H,1H2,(H2,13,14,15)/t4-,6-,7-,10+/m1/s1",5'-fluoro-5'-deoxyfluoroadenosine,Biochemistry: biosynthesis of an organofluorine molecule.,96503,C10H11F2N5O3,287.22,288.22
9,"InChI=1S/C10H11F2N5O3/c11-7(12)6-4(18)5(19)10(20-6)17-2-16-3-8(13)14-1-15-9(3)17/h1-2,4-7,10,18-19H,(H2,13,14,15)/t4-,5+,6-,10+/m0/s1","5',5'-Difluoro-5'-deoxyadenosine",Exploration of a potential difluoromethyl-nucleoside substrate with the fluorinase enzyme.,25224,C10H11F2N5O3,287.22,288.22
10,"InChI=1S/C10H11F2N5O4/c11-10(12)5(19)3(1-18)21-8(10)17-2-14-4-6(17)15-9(13)16-7(4)20/h2-3,5,8,18-19H,1H2,(H3,13,15,16,20)/t3-,5-,8-/m1/s1","2',2'-difluorodeoxyguanosine",Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.,73356,C10H11F2N5O4,303.22,304.22
11,"InChI=1S/C10H11F2N5O4/c11-17(12)10-14-8-7(9(20)15-10)13-3-16(8)6-1-4(19)5(2-18)21-6/h3-6,18-19H,1-2H2,(H,14,15,20)/t4-,5+,6+/m0/s1",difluorodeoxyguanosine,Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line.,106458,C10H11F2N5O4,303.22,304.22
12,"InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1",2'-deoxy-5-trifluoromethyluridine,Triplex- and Duplex-Forming Abilities of Oligonucleotides Containing 2'-Deoxy-5-trifluoromethyluridine and 2'-Deoxy-5-trifluoromethylcytidine.,16674,C10H11F3N2O5,296.2,297.2
13,"InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1
InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)
InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6-,7-/m1/s1",2'-deoxy-5-(trifluoromethyl)uridine,Incorporation of 2'-deoxy-5-(trifluoromethyl)uridine and 5-cyano-2'-deoxyuridine into DNA.,99001,C10H11F3N2O5,296.2,297.2
14,"InChI=1S/C10H11FIN5O3/c11-10-15-7(13)4-8(16-10)17(2-14-4)9-6(19)5(18)3(1-12)20-9/h2-3,5-6,9,18-19H,1H2,(H2,13,15,16)/t3-,5-,6-,9-/m1/s1",5'-deoxy-5'-iodo-2-fluoroadenosine,Isolation and substrate specificity of an adenine nucleoside phosphorylase from adult Schistosoma mansoni.,42640,C10H11FIN5O3,395.13,396.13
15,"InChI=1S/C10H11FN2O5/c11-3-5-8(16)6(4-14)18-9(5)13-2-1-7(15)12-10(13)17/h1-3,6,8-9,14,16H,4H2,(H,12,15,17)/b5-3+/t6-,8+,9-/m1/s1",(E)-2'-deoxy-2'-(fluoromethylene)uridine,"Metabolism and ribonucleotide reductase inhibition of (E)-2'-deoxy-2'-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S3 cells.",112922,C10H11FN2O5,258.2,259.2
16,"InChI=1S/C10H11N3O5/c11-2-5-3-13(10(17)12-9(5)16)8-1-6(15)7(4-14)18-8/h3,6-8,14-15H,1,4H2,(H,12,16,17)/t6-,7+,8+/m0/s1",5-cyano-2'-deoxyuridine,A vibrational probe for local nucleic acid environments: 5-cyano-2'-deoxyuridine.,62983,C10H11N3O5,253.21,254.21
17,"InChI=1S/C10H11N3O5S/c11-4-19-7-2-13(10(17)12-9(7)16)8-1-5(15)6(3-14)18-8/h2,5-6,8,14-15H,1,3H2,(H,12,16,17)/t5-,6+,8+/m0/s1",5-thiocyanato-2'-deoxyuridine,5-Thiocyanato-2'-deoxyuridine as a possible radiosensitizer: electron-induced formation of uracil-C5-thiyl radical and its dimerization.,27680,C10H11N3O5S,285.28,286.28
18,"InChI=1S/C10H11N3O5Se/c11-4-19-7-2-13(10(17)12-9(7)16)8-1-5(15)6(3-14)18-8/h2,5-6,8,14-15H,1,3H2,(H,12,16,17)/t5-,6+,8+/m0/s1",5-Selenocyanato-2'-deoxyuridine,Electron-Induced Dissociation of the Potential Radiosensitizer 5-Selenocyanato-2'-deoxyuridine.,11282,C10H11N3O5Se,332.17,333.17
19,"InChI=1S/C10H11N3O6/c11-2-4-1-6(15)12-10(18)13(4)9-8(17)7(16)5(3-14)19-9/h1,5,7-9,14,16-17H,3H2,(H,12,15,18)/t5-,7-,8-,9-/m1/s1",6-cyanouridine,Synthesis of 6-alkyluridines from 6-cyanouridine via zinc(II) chloride-catalyzed nucleophilic substitution with alkyl Grignard reagents.,36715,C10H11N3O6,269.21,270.21
20,"InChI=1S/C10H11N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h1-2,4-7,16H,3H2,(H2,11,12,13)/t6-,7+/m0/s1","2',3'-didehydro-2',3'-dideoxyadenosine",Structural and energetic properties of the potential HIV-1 reverse transcriptase inhibitors d4A and d4G: a comprehensive theoretical investigation.,34626,C10H11N5O2,233.23,234.23
21,"InChI=1S/C10H11N5O3/c11-10-13-8-7(9(17)14-10)12-4-15(8)6-2-1-5(3-16)18-6/h1-2,4-6,16H,3H2,(H3,11,13,14,17)/t5-,6+/m0/s1","2',3'-didehydro-2',3'-dideoxyguanosine",Microsolvated Model for the Kinetics and Thermodynamics of Glycosidic Bond Dissociative Cleavage of Nucleoside D4G.,15500,C10H11N5O3,249.23,250.23
22,"InChI=1S/C10H11N5O3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7-6(18-7)4(1-16)17-10/h2-4,6-7,10,16H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1","2',3'-anhydroadenosine","A simple and efficient synthesis of puromycin, 2,2'-anhydro-pyrimidine nucleosides, cytidines and 2',3'-anhydroadenosine from 3',5'-O-sulfinyl xylo-nucleosides.",74409,C10H11N5O3,249.23,250.23
23,"InChI=1S/C10H11N5O3/c11-8-5-9(13-2-12-8)15-4-1-3(16)7(18-4)6(17)10(15)14-5/h2-4,6-7,16-17H,1H2,(H2,11,12,13)/t3-,4+,6+,7-/m0/s1
InChI=1S/C10H11N5O3/c11-8-5-9(13-2-12-8)15-4-1-3(16)7(18-4)6(17)10(15)14-5/h2-4,6-7,16-17H,1H2,(H2,11,12,13)/t3-,4+,6?,7-/m0/s1","5',8-Cyclo-2'-deoxyadenosine","Diastereomeric Recognition of 5',8-cyclo-2'-Deoxyadenosine Lesions by Human Poly(ADP-ribose) Polymerase 1 in a Biomimetic Model.",11056,C10H11N5O3,249.23,250.23
24,"InChI=1S/C10H11N5O3/c11-8-5-9(13-2-12-8)15-4-1-3(16)7(18-4)6(17)10(15)14-5/h2-4,6-7,16-17H,1H2,(H2,11,12,13)/t3-,4+,6+,7?/m0/s1","(5'S)-5',8-cyclo-2'-deoxyadenosine","A 5', 8-cyclo-2'-deoxypurine lesion induces trinucleotide repeat deletion via a unique lesion bypass by DNA polymerase β.",30662,C10H11N5O3,249.23,250.23
25,"InChI=1S/C10H11N5O3/c11-8-5-9(13-2-12-8)15-4-1-3(16)7(18-4)6(17)10(15)14-5/h2-4,6-7,16-17H,1H2,(H2,11,12,13)/t3-,4+,6-,7-/m0/s1","8,5'-Cyclo-2'-deoxyadenosine","8,5'-Cyclopurine-2'-deoxynucleosides in DNA: mechanisms of formation, measurement, repair and biological effects.",64222,C10H11N5O3,249.23,250.23
26,"InChI=1S/C10H11N5O4/c11-10-13-7-4(9(18)14-10)12-8-5(17)6-2(16)1-3(19-6)15(7)8/h2-3,5-6,16-17H,1H2,(H3,11,13,14,18)/t2-,3+,5+,6-/m0/s1","(5'S)-5',8-cyclo-2'-deoxyguanosine","A lipophilic ""fully-anti"" dodecamer from a (5'S)-5',8-cyclo-2'-deoxyguanosine.",32167,C10H11N5O4,265.23,266.23
27,"InChI=1S/C10H11N5O4/c11-10-13-7-4(9(18)14-10)12-8-5(17)6-2(16)1-3(19-6)15(7)8/h2-3,5-6,16-17H,1H2,(H3,11,13,14,18)/t2-,3+,5-,6-/m0/s1","(5'R)-5',8-cyclo-2'-deoxyguanosine","Synthesis and characterization of oligonucleotides containing 5',8-cyclopurine 2'-deoxyribonucleosides: (5'R)-5',8-cyclo-2'-deoxyadenosine, (5'S)-5',8-cyclo-2'-deoxyguanosine, and (5'R)-5',8-cyclo-2'-deoxyguanosine.",108743,C10H11N5O4,265.23,266.23
28,"InChI=1S/C10H11N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,7,10,16,18H,1H2,(H2,11,12,13)/t4-,7-,10-/m1/s1",3'-ketoadenosine,"The mechanism of inactivation of human placental S-adenosylhomocysteine hydrolase by (E)-4',5'-didehydro-5'-methoxyadenosine and adenosine 5'-carboxaldehyde oxime.",114390,C10H11N5O4,265.23,266.23
29,"InChI=1S/C10H11N5O4/c11-9-8-10(13-4-12-9)15(5-14-8)7(3-18)19-6(1-16)2-17/h1,3-7,17H,2H2,(H2,11,12,13)",adenosine-dialdehyde,Elimination of high amounts of extracellular homocysteine in human cell lines.,81064,C10H11N5O4,265.23,266.23
30,"InChI=1S/C10H11N5O5/c11-7-3-8(13-1-12-7)15(2-14-3)9-5(17)4(16)6(20-9)10(18)19/h1-2,4-6,9,16-17H,(H,18,19)(H2,11,12,13)/t4-,5+,6-,9+/m0/s1
InChI=1S/C10H11N5O5/c11-7-3-8(13-1-12-7)15(2-14-3)9-5(17)4(16)6(20-9)10(18)19/h1-2,4-6,9,16-17H,(H,18,19)(H2,11,12,13)",adenosine-5'-carboxylic acid,Conjugation of adenosine and hexa-(D-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases.,72915,C10H11N5O5,281.23,282.23
31,"InChI=1S/C10H11N6O9P/c11-9-13-6-3(7(18)14-9)12-10(16(19)20)15(6)8-4(17)5-2(24-8)1-23-26(21,22)25-5/h2,4-5,8,17H,1H2,(H,21,22)(H3,11,13,14,18)/t2-,4-,5-,8-/m1/s1
InChI=1S/C10H11N6O9P/c11-9-13-6-3(7(18)14-9)12-10(16(19)20)15(6)8-4(17)5-2(24-8)1-23-26(21,22)25-5/h2,4-5,8,17H,1H2,(H,21,22)(H3,11,13,14,18)/p-1/t2-,4-,5-,8-/m1/s1","8-Nitroguanosine 3',5'-cyclic monophosphate","Synthesis and Characterization of 8-Nitroguanosine 3',5'-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α.",20238,C10H11N6O9P,390.2,391.2
32,"InChI=1S/C10H12BrN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",2-bromo-2'-deoxyadenosine,"Reaction mechanism in the photochemistry of the antileukaemic agents 2-chloro- and 2-bromo-2'-deoxyadenosine, studied by nanosecond laser flash photolysis.",107824,C10H12BrN5O3,330.14,331.14
33,"InChI=1S/C10H12BrN5O3/c11-10-15-7-8(12)13-3-14-9(7)16(10)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,13,14)/t4-,5+,6+/m0/s1",8-bromo-2'-deoxyadenosine,Formation of 8-S-L-Cysteinyladenosine from 8-Bromoadenosine and Cysteine.,15272,C10H12BrN5O3,330.14,331.14
34,"InChI=1S/C10H12BrN5O4/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,13,14)/t3-,5-,6-,9-/m1/s1",8-bromo-adenosine,Induction of meiotic maturation in mouse oocytes by adenosine analogs.,74989,C10H12BrN5O4,346.14,347.14
35,"InChI=1S/C10H12BrN5O4/c11-9-13-6-7(14-10(12)15-8(6)19)16(9)5-1-3(18)4(2-17)20-5/h3-5,17-18H,1-2H2,(H3,12,14,15,19)/t3-,4+,5+/m0/s1",8-bromo-2'-deoxyguanosine,Recognition Interface of the Thrombin Binding Aptamer Requires Antiparallel Topology of the Quadruplex Core.,442,C10H12BrN5O4,346.14,347.14
36,"InChI=1S/C10H12BrN5O5/c11-10(6(19)5(18)3(1-17)21-10)16-2-13-4-7(16)14-9(12)15-8(4)20/h2-3,5-6,17-19H,1H2,(H3,12,14,15,20)/t3-,5-,6-,10+/m1/s1",bromoguanosine,Self-Assembly of a Guanosine Derivative To Form Nanostructures and Transmembrane Channels.,15068,C10H12BrN5O5,362.14,363.14
37,"InChI=1S/C10H12BrN5O5/c11-9-13-3-6(14-10(12)15-7(3)20)16(9)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H3,12,14,15,20)/t2-,4-,5-,8-/m1/s1",8-Bromoguanosine,Singlet O,55,C10H12BrN5O5,362.14,363.14
38,"InChI=1S/C10H12ClN5O2/c11-10-14-8(12)7-9(15-10)16(4-13-7)6-2-1-5(3-17)18-6/h4-6,17H,1-3H2,(H2,12,14,15)/t5-,6+/m0/s1",2-chlorodideoxyadenosine,Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation.,89659,C10H12ClN5O2,269.69,270.69
39,"InChI=1S/C10H12ClN5O3/c11-1-4-6(17)7(18)10(19-4)16-3-15-5-8(12)13-2-14-9(5)16/h2-4,6-7,10,17-18H,1H2,(H2,12,13,14)/t4-,6-,7-,10-/m1/s1",5'-chloro-5'-deoxyadenosine,S-Adenosyl Methionine Cofactor Modifications Enhance the Biocatalytic Repertoire of Small Molecule C-Alkylation.,8242,C10H12ClN5O3,285.69,286.69
40,"InChI=1S/C10H12ClN5O3/c11-10-14-7(12)6-8(15-10)16(3-13-6)9-5(18)1-4(2-17)19-9/h3-5,9,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,9+/m0/s1",2-chloro-3'-deoxyadenosine,Peliosis hepatis after treatment with 2-chloro-3'-deoxyadenosine.,104201,C10H12ClN5O3,285.69,286.69
41,"InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)",2-Chloro-2-Deoxyadenosine,Randomised Introduction of 2-CDA as Intensification during Consolidation for Children with High-risk AML--results from Study AML-BFM 2004.,27982,C10H12ClN5O3,285.69,286.69
42,"InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",2-Chloro-2'-deoxyadenosine,"Synthesis of New Potential Lipophilic Co-Drugs of 2-Chloro-2'-deoxyadenosine (Cladribine, 2-CdA, Mavenclad®, Leustatin®) and 6-Azauridine (z",11435,C10H12ClN5O3,285.69,286.69
43,"InChI=1S/C10H12ClN5O3/c11-10-15-7-8(12)13-3-14-9(7)16(10)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,13,14)/t4-,5+,6+/m0/s1",8-chloro-2'-deoxyadenosine,Ability of hypochlorous acid and N-chloramines to chlorinate DNA and its constituents.,53797,C10H12ClN5O3,285.69,286.69
44,"InChI=1S/C10H12ClN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1",2'-chlorodeoxyadenosine,CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia.,96448,C10H12ClN5O3,285.69,286.69
45,"InChI=1S/C10H12ClN5O4/c11-10(19)6(18)4(1-17)20-9(10)16-3-15-5-7(12)13-2-14-8(5)16/h2-4,6,9,17-19H,1H2,(H2,12,13,14)/t4-,6-,9-,10-/m1/s1",2'-chloroadenosine,Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.,48330,C10H12ClN5O4,301.69,302.69
46,"InChI=1S/C10H12ClN5O4/c11-10(7(19)6(18)4(1-17)20-10)16-3-15-5-8(12)13-2-14-9(5)16/h2-4,6-7,17-19H,1H2,(H2,12,13,14)/t4-,6-,7-,10+/m1/s1",Chloroadenosine,Adenosine action on interneurons and synaptic transmission onto interneurons in rat hippocampus in vitro.,102748,C10H12ClN5O4,301.69,302.69
47,"InChI=1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1",2-Chloroadenosine,Adenosine Attenuates Human Coronary Artery Smooth Muscle Cell Proliferation by Inhibiting Multiple Signaling Pathways That Converge on Cyclin D.,26150,C10H12ClN5O4,301.69,302.69
48,"InChI=1S/C10H12ClN5O4/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,13,14)/t3-,5-,6-,9-/m1/s1",8-Chloro-adenosine,8-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.,4184,C10H12ClN5O4,301.69,302.69
49,"InChI=1S/C10H12ClN5O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H12ClN5O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5+,6?,9-/m1/s1
InChI=1S/C10H12ClN5O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5?,6?,9-/m1/s1
InChI=1S/C10H12ClN5O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)",6-chloroguanosine,"Modular, Step-Efficient Palladium-Catalyzed Cross-Coupling Strategy To Access C6-Heteroaryl 2-Aminopurine Ribonucleosides.",17649,C10H12ClN5O4,301.69,302.69
50,"InChI=1S/C10H12ClN5O4/c11-9-13-6-7(14-10(12)15-8(6)19)16(9)5-1-3(18)4(2-17)20-5/h3-5,17-18H,1-2H2,(H3,12,14,15,19)/t3-,4+,5+/m0/s1",8-Chloro-2'-deoxyguanosine,"Miscoding properties of 8-chloro-2'-deoxyguanosine, a hypochlorous acid-induced DNA adduct, catalysed by human DNA polymerases.",39138,C10H12ClN5O4,301.69,302.69
51,"InChI=1S/C10H12ClN5O5/c11-9-13-3-6(14-10(12)15-7(3)20)16(9)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H3,12,14,15,20)/t2-,4-,5-,8-/m1/s1",8-Chloroguanosine,Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine.,99067,C10H12ClN5O5,317.69,318.69
52,"InChI=1S/C10H12F3N3O4/c11-10(12,13)4-2-16(9(19)15-8(4)14)7-1-5(18)6(3-17)20-7/h2,5-7,17-18H,1,3H2,(H2,14,15,19)/t5-,6+,7+/m0/s1",2'-deoxy-5-trifluoromethylcytidine,Triplex- and Duplex-Forming Abilities of Oligonucleotides Containing 2'-Deoxy-5-trifluoromethyluridine and 2'-Deoxy-5-trifluoromethylcytidine.,16674,C10H12F3N3O4,295.22,296.22
53,"InChI=1S/C10H12FN3O4/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17)/b5-3+/t6-,8+,9-/m1/s1
InChI=1S/C10H12FN3O4.H2O/c11-3-5-8(16)6(4-15)18-9(5)14-2-1-7(12)13-10(14)17;/h1-3,6,8-9,15-16H,4H2,(H2,12,13,17);1H2/b5-3+;/t6-,8+,9-;/m1./s1",(E)-2'-Deoxy-2'-(fluoromethylene)cytidine,"Metabolism and ribonucleotide reductase inhibition of (E)-2'-deoxy-2'-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S3 cells.",112922,C10H12FN3O4,257.22,258.22
54,"InChI=1S/C10H12FN5O2/c11-5-1-7(18-6(5)2-17)16-4-15-8-9(12)13-3-14-10(8)16/h3-7,17H,1-2H2,(H2,12,13,14)/t5-,6+,7+/m0/s1","2',3'-dideoxy-3'-fluoroadenosine","Phosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.",88602,C10H12FN5O2,253.23,254.23
55,"InChI=1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6+,10+/m0/s1","2'-fluoro-2',3'-dideoxyadenosine","Single dose and multiple dose pharmacokinetics of 2'-fluoro-2',3'-dideoxyadenosine and 2'-fluoro-2',3'-dideoxyinosine, anti-HIV agents, in rats.",104116,C10H12FN5O2,253.23,254.23
56,"InChI=1S/C10H12FN5O2/c11-6-1-5(2-17)18-10(6)16-4-15-7-8(12)13-3-14-9(7)16/h3-6,10,17H,1-2H2,(H2,12,13,14)/t5-,6-,10+/m0/s1","2'-beta-Fluoro-2',3'-dideoxyadenosine","2'-beta-fluoro-2',3'-dideoxyadenosine, lodenosine, in rhesus monkeys: plasma and cerebrospinal fluid pharmacokinetics and urinary disposition.",107333,C10H12FN5O2,253.23,254.23
57,"InChI=1S/C10H12FN5O3/c11-1-4-6(17)7(18)10(19-4)16-3-15-5-8(12)13-2-14-9(5)16/h2-4,6-7,10,17-18H,1H2,(H2,12,13,14)/t4-,6-,7-,10-/m1/s1",5'-fluoro-5'-deoxyadenosine,Enzymatic Fluorination of Biotin and Tetrazine Conjugates for Pretargeting Approaches to Positron Emission Tomography Imaging.,13634,C10H12FN5O3,269.23,270.23
58,"InChI=1S/C10H12FN5O3/c11-10-14-7(12)6-8(15-10)16(3-13-6)9-5(18)1-4(2-17)19-9/h3-5,9,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,9+/m0/s1",2-fluoro-3'-deoxyadenosine,Structure-activity relationships of synthetic cordycepin analogues as experimental therapeutics for African trypanosomiasis.,33141,C10H12FN5O3,269.23,270.23
59,"InChI=1S/C10H12FN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",2'-deoxy-2-fluoroadenosine,"Synthesis of 2',5'-dideoxy-2-fluoroadenosine and 2',5'-dideoxy-2,5'-difluoroadenosine: potent P-site inhibitors of adenylyl cyclase.",87356,C10H12FN5O3,269.23,270.23
60,"InChI=1S/C10H12FN5O3/c11-4-1-6(19-5(4)2-17)16-3-13-7-8(16)14-10(12)15-9(7)18/h3-6,17H,1-2H2,(H3,12,14,15,18)/t4-,5+,6+/m0/s1","2',3'-dideoxy-3'-fluoroguanosine","In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.",76727,C10H12FN5O3,269.23,270.23
61,"InChI=1S/C10H12FN5O3/c11-5-4(1-17)19-10(7(5)18)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1",3'-deoxy-3'-fluoroadenosine,Broad-Spectrum Antiviral Activity of 3'-Deoxy-3'-Fluoroadenosine against Emerging Flaviviruses.,3319,C10H12FN5O3,269.23,270.23
62,"InChI=1S/C10H12FN5O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1",2'-deoxy-2'-fluoroadenosine,"Recombinant purine nucleoside phosphorylases from thermophiles: preparation, properties and activity towards purine and pyrimidine nucleosides.",37727,C10H12FN5O3,269.23,270.23
63,"InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5+,6-,9-/m1/s1",2-fluoradenosine,Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors.,62988,C10H12FN5O4,285.23,286.23
64,"InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1",2-fluoroadenosine,Radical Dehalogenation and Purine Nucleoside Phosphorylase ,1686,C10H12FN5O4,285.23,286.23
65,"InChI=1S/C10H12FN5O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(12)14-10(19)15-8(5)16/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4-,6-,9-/m1/s1",2'-deoxy-2'-fluoroisoguanosine,"Duplex DNA and DNA-RNA hybrids with parallel strand orientation: 2'-deoxy-2'-fluoroisocytidine, 2'-deoxy-2'-fluoroisoguanosine, and canonical nucleosides with 2'-fluoro substituents cause unexpected changes on the double helix stability.",29151,C10H12FN5O4,285.23,286.23
66,"InChI=1S/C10H12FN5O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4-,6-,9-/m1/s1",2'-Fluoro-2'-deoxyguanosine,Synthesis and biological evaluation of purine 2'-fluoro-2'-deoxyriboside ProTides as anti-influenza virus agents.,37459,C10H12FN5O4,285.23,286.23
67,"InChI=1S/C10H12FNO6/c11-6-4(14)1-2-12(9(6)17)10-8(16)7(15)5(3-13)18-10/h1-2,5,7-8,10,13-16H,3H2/t5-,7-,8-,10-/m1/s1",3-fluoro-3-deazauridine,"Synthesis and biological evaluation of 3,3-difluoropyridine-2,4(1H,3H)-dione and 3-deaza-3-fluorouracil base and nucleoside derivatives.",60193,C10H12FNO6,261.2,262.2
68,"InChI=1S/C10H12IN5O4/c11-9-13-6-7(14-10(12)15-8(6)19)16(9)5-1-3(18)4(2-17)20-5/h3-5,17-18H,1-2H2,(H3,12,14,15,19)/t3-,4+,5+/m0/s1",8-iodo-2'-deoxyguanosine,Base pair stability of 8-chloro- and 8-iodo-2'-deoxyguanosine opposite 2'-deoxycytidine: implications regarding the bioactivity of 8-oxo-2'-deoxyguanosine.,79349,C10H12IN5O4,393.14,394.14
69,"InChI=1S/C10H12IN5O5/c11-9-13-3-6(14-10(12)15-7(3)20)16(9)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H3,12,14,15,20)/t2-,4-,5-,8-/m1/s1",8-iodoguanosine,Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.,106504,C10H12IN5O5,409.14,410.14
70,"InChI=1S/C10H12N2O5/c1-5-8(15)6(4-13)17-9(5)12-3-2-7(14)11-10(12)16/h2-3,6,8-9,13,15H,1,4H2,(H,11,14,16)/t6-,8+,9-/m1/s1",2'-deoxy-2'-methylideneuridine,"Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agent.",104167,C10H12N2O5,240.21,241.21
71,"InChI=1S/C10H12N2O6/c13-3-5-2-12(10(17)11-9(5)16)8-1-6(15)7(4-14)18-8/h2-3,6-8,14-15H,1,4H2,(H,11,16,17)/t6-,7+,8+/m0/s1",2'-deoxy-5-formyluridine,X-ray analyses of DNA dodecamers containing 2'-deoxy-5-formyluridine.,90657,C10H12N2O6,256.21,257.21
72,"InChI=1S/C10H12N2O7/c13-2-4-1-12(10(18)11-8(4)17)9-7(16)6(15)5(3-14)19-9/h1-2,5-7,9,14-16H,3H2,(H,11,17,18)/t5-,6-,7-,9-/m1/s1",5-formyluridine,Pre-steady-state kinetic analysis of damage recognition by human single-strand selective monofunctional uracil-DNA glycosylase SMUG1.,16448,C10H12N2O7,272.21,273.21
73,"InChI=1S/C10H12N2O7/c13-3-6-5(14)1-7(19-6)12-2-4(9(16)17)8(15)11-10(12)18/h2,5-7,13-14H,1,3H2,(H,16,17)(H,11,15,18)/t5-,6+,7+/m0/s1",5-Carboxy-2'-deoxyuridine,Prediction of AChE-ligand affinity using the umbrella sampling simulation.,8583,C10H12N2O7,272.21,273.21
74,"InChI=1S/C10H12N2O8/c13-2-4-5(14)6(15)8(20-4)12-1-3(9(17)18)7(16)11-10(12)19/h1,4-6,8,13-15H,2H2,(H,17,18)(H,11,16,19)/t4-,5-,6-,8-/m1/s1",5-carboxyuridine,Biochemical characterization of a Naegleria TET-like oxygenase and its application in single molecule sequencing of 5-methylcytosine.,28707,C10H12N2O8,288.21,289.21
75,"InChI=1S/C10H12N2O8/c13-3-1-2-12(10(19)11-3)8-5(15)4(14)7(20-8)6(16)9(17)18/h1-2,4-8,14-16H,(H,17,18)(H,11,13,19)/t4-,5+,6?,7-,8+/m0/s1",uridine-5'-carboxylic acid,"Synthesis and preliminary biological assay of uridine glycoconjugate derivatives containing amide and/or 1,2,3-triazole linkers.",18768,C10H12N2O8,288.21,289.21
76,"InChI=1S/C10H12N4O6S/c11-9-12-6-5(7(18)13-9)21-10(19)14(6)8-4(17)3(16)2(1-15)20-8/h2-4,8,15-17H,1H2,(H3,11,12,13,18)/t2-,3-,4-,8-/m1/s1",7-Thia-8-oxoguanosine,Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7.,91379,C10H12N4O6S,316.29,317.29
77,"InChI=1S/C10H12N5O3Se/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H2,11,13,14)/t4-,5+,6+/m0/s1",6-seleno-2'-deoxyguanosine,Synthesis and optical behaviors of 6-seleno-deoxyguanosine.,44042,C10H12N5O3Se,329.19,330.19
78,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/p-1/t4-,6-,7-,10-/m1/s1","adenosine-3',5'-monophosphate",Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery.,84888,C10H11N5O6P,328.2,329.2
79,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1","adenosine 3',5'-cyclic monophosphate","Role of CNPase in the oligodendrocytic extracellular 2',3'-cAMP-adenosine pathway.",34732,C10H12N5O6P,329.21,330.21
80,"InChI=1S/C10H12N5O6PS/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(21-6)2-20-22(18,19)23/h1,3,5-6,16H,2H2,(H2,18,19,23)(H3,11,13,14,17)/t5-,6-/m1/s1","guanosine 3',5'-cyclic monophosphorothioate","Synthesis and Characterization of 8-Nitroguanosine 3',5'-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α.",20238,C10H12N5O6PS,361.27,362.27
81,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5+,6+,9+/m0/s1",guanosine 3'5'-monophosphate,Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.,80391,C10H12N5O7P,345.21,346.21
82,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1","3',5'-guanosine monophosphate",cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.,115293,C10H12N5O7P,345.21,346.21
83,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/p-1/t3-,5-,6-,9-/m1/s1","guanosine 3',5'-cyclic monophosphate","Discovery of Quality Markers of Nucleobases, Nucleosides, Nucleotides and Amino Acids for Chrysanthemi Flos From Different Geographical Origins Using UPLC-MS/MS Combined With Multivariate Statistical Analysis.",710,C10H12N5O7P,345.21,346.21
84,"InChI=1S/C10H12N6O6/c11-9-13-7-6(8(19)14-9)12-10(16(20)21)15(7)5-1-3(18)4(2-17)22-5/h3-5,17-18H,1-2H2,(H3,11,13,14,19)/t3-,4+,5+/m0/s1",8-Nitro-2'-deoxyguanosine,"Base-pairing preferences, physicochemical properties and mutational behaviour of the DNA lesion 8-nitroguanine.",39696,C10H12N6O6,312.24,313.24
85,"InChI=1S/C10H12N6O7/c11-9-13-6-3(7(20)14-9)12-10(16(21)22)15(6)8-5(19)4(18)2(1-17)23-8/h2,4-5,8,17-19H,1H2,(H3,11,13,14,20)/t2-,4-,5-,8-/m1/s1",8-Nitroguanosine,New NitroG-Grasp Molecules with Enhanced Capture Reactivity for 8-Nitroguanosine in the Aqueous Media.,25668,C10H12N6O7,328.24,329.24
86,"InChI=1S/C10H12N6O7/c11-9-13-7-4(8(20)14-9)12-2-15(7)10(16(21)22)6(19)5(18)3(1-17)23-10/h2-3,5-6,17-19H,1H2,(H3,11,13,14,20)/t3-,5-,6-,10-/m1/s1",Nitroguanosine,8-nitroguanosine formation in viral pneumonia and its implication for pathogenesis.,92885,C10H12N6O7,328.24,329.24
87,"InChI=1S/C10H12N8O2/c11-9-8-10(14-3-13-9)18(4-15-8)7-1-5(16-17-12)6(2-19)20-7/h3-7,19H,1-2H2,(H2,11,13,14)/t5-,6+,7+/m0/s1","3'-azido-2',3'-dideoxyadenosine","The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.",48947,C10H12N8O2,276.26,277.26
88,"InChI=1S/C10H12N8O3/c11-10-14-8-7(9(20)15-10)13-3-18(8)6-1-4(16-17-12)5(2-19)21-6/h3-6,19H,1-2H2,(H3,11,14,15,20)/t4-,5+,6+/m0/s1","3'-azido-2',3'-dideoxyguanosine","Molecular mechanism of HIV-1 resistance to 3'-azido-2',3'-dideoxyguanosine.",33391,C10H12N8O3,292.25,293.25
89,"InChI=1S/C10H12N8O3/c11-8-6-9(14-2-13-8)18(3-15-6)10-7(20)5(16-17-12)4(1-19)21-10/h2-5,7,10,19-20H,1H2,(H2,11,13,14)/t4-,5-,7-,10-/m1/s1",3'-azido-3'-deoxyadenosine,"Synthesis of aminoacylated N(6),N(6)-dimethyladenosine solid support for efficient access to hydrolysis-resistant 3'-charged tRNA mimics.",30509,C10H12N8O3,292.25,293.25
90,"InChI=1S/C10H12N8O3/c11-8-7-9(14-3-13-8)18(10(15-7)16-17-12)6-1-4(20)5(2-19)21-6/h3-6,19-20H,1-2H2,(H2,11,13,14)/t4-,5+,6+/m0/s1",8-Azido-2'-deoxyadenosine,Convenient synthesis of 8-amino-2'-deoxyadenosine.,91332,C10H12N8O3,292.25,293.25
91,"InChI=1S/C10H12N8O3/c11-8-7-9(15-10(14-8)16-17-12)18(3-13-7)6-1-4(20)5(2-19)21-6/h3-6,19-20H,1-2H2,(H2,11,14,15)/t4-,5+,6+/m0/s1",2-azidodeoxyadenosine,New photoreactive tRNA derivatives for probing the peptidyl transferase center of the ribosome.,71145,C10H12N8O3,292.25,293.25
92,"InChI=1S/C10H12N8O4/c11-10-15-7-4(8(21)16-10)13-2-18(7)9-6(20)5(19)3(22-9)1-14-17-12/h2-3,5-6,9,19-20H,1H2,(H3,11,15,16,21)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H12N8O4/c11-10-15-7-4(8(21)16-10)13-2-18(7)9-6(20)5(19)3(22-9)1-14-17-12/h2-3,5-6,9,19-20H,1H2,(H3,11,15,16,21)
InChI=1S/C10H12N8O4/c11-10-15-7-4(8(21)16-10)13-2-18(7)9-6(20)5(19)3(22-9)1-14-17-12/h2-3,5-6,9,19-20H,1H2,(H3,11,15,16,21)/t3-,5+,6?,9-/m1/s1",5'-azido-5'-deoxyguanosine,Simple and efficient synthesis of 5'-aryl-5'-deoxyguanosine analogs by azide-alkyne click reaction and their antileishmanial activities.,24737,C10H12N8O4,308.25,309.25
93,"InChI=1S/C10H12N8O4/c11-7-4-8(14-2-13-7)18(10(15-4)16-17-12)9-6(21)5(20)3(1-19)22-9/h2-3,5-6,9,19-21H,1H2,(H2,11,13,14)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H12N8O4/c11-7-4-8(14-2-13-7)18(10(15-4)16-17-12)9-6(21)5(20)3(1-19)22-9/h2-3,5-6,9,19-21H,1H2,(H2,11,13,14)
InChI=1S/C10H12N8O4/c11-7-4-8(14-2-13-7)18(10(15-4)16-17-12)9-6(21)5(20)3(1-19)22-9/h2-3,5-6,9,19-21H,1H2,(H2,11,13,14)/t3-,5-,6-,9-/m0/s1
InChI=1S/C10H12N8O4/c11-7-4-8(14-2-13-7)18(10(15-4)16-17-12)9-6(21)5(20)3(1-19)22-9/h2-3,5-6,9,19-21H,1H2,(H2,11,13,14)/t3-,5+,6?,9-/m1/s1",8-azidoadenosine,Photoaffinity labeling with 8-azidoadenosine and its derivatives: chemistry of closed and opened adenosine diazaquinodimethanes.,79549,C10H12N8O4,308.25,309.25
94,"InChI=1S/C10H12N8O4/c11-7-4-8(14-2-13-7)18(3-15-4)9-5(20)6(21)10(1-19,22-9)16-17-12/h2-3,5-6,9,19-21H,1H2,(H2,11,13,14)/t5-,6+,9-,10-/m1/s1",4'-azidoadenosine,First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine): conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virus.,68359,C10H12N8O4,308.25,309.25
95,"InChI=1S/C10H12N8O5/c11-10-14-7(22)4-8(18(10)16-15-12)17(2-13-4)9-6(21)5(20)3(1-19)23-9/h2-3,5-6,9,19-21H,1H2,(H2,11,14,22)",guanosine azide,Bis-triazolyl diguanosine derivatives as synthetic transmembrane ion channels.,23162,C10H12N8O5,324.25,325.25
96,"InChI=1S/C10H12N8O5/c11-9-14-6-3(7(22)15-9)13-10(16-17-12)18(6)8-5(21)4(20)2(1-19)23-8/h2,4-5,8,19-21H,1H2,(H3,11,14,15,22)/t2-,4-,5-,8-/m1/s1",8-azidoguanosine,Synthesis and in vitro evaluation of antiviral and cytostatic properties of novel 8-triazolyl acyclovir derivatives.,11995,C10H12N8O5,324.25,325.25
97,"InChI=1S/C10H13BrN2O6/c1-10(18)6(15)5(3-14)19-8(10)13-2-4(11)7(16)12-9(13)17/h2,5-6,8,14-15,18H,3H2,1H3,(H,12,16,17)/t5-,6-,8-,10-/m1/s1",5-bromo-2'-C-methyluridine,Conformational states of 2'-C-methylpyrimidine nucleosides in single and double nucleic acid stranded structures.,38258,C10H13BrN2O6,337.12,338.12
98,"InChI=1S/C10H13BrN6O4/c11-9-14-3-6(12)15-10(13)16-7(3)17(9)8-5(20)4(19)2(1-18)21-8/h2,4-5,8,18-20H,1H2,(H4,12,13,15,16)/t2-,4-,5-,8-/m1/s1",8-bromo-2-aminoadenosine,One-electron reduction of 8-bromo-2-aminoadenosine in the aqueous phase: radiation chemical and DFT studies of the mechanism.,65705,C10H13BrN6O4,361.15,362.15
99,"InChI=1S/C10H13ClFN3O4/c11-3-10(4-16)7(17)6(12)8(19-10)15-2-1-5(13)14-9(15)18/h1-2,6-8,16-17H,3-4H2,(H2,13,14,18)/t6-,7+,8-,10-/m1/s1",4'-chloromethyl-2'-deoxy-2'-fluorocytidine,Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virus.,7070,C10H13ClFN3O4,293.68,294.68
100,"InChI=1S/C10H13FN2O5/c1-10(11)7(16)5(4-14)18-8(10)13-3-2-6(15)12-9(13)17/h2-3,5,7-8,14,16H,4H2,1H3,(H,12,15,17)/t5-,7-,8-,10-/m1/s1",2'-deoxy-2'-fluoro-2'-C-methyluridine,Towards interference free HPLC-SERS for the trace analysis of drug metabolites in biological fluids.,19963,C10H13FN2O5,260.22,261.22
101,"InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-7(15)6(11)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6-,7-,9-/m1/s1",3'-deoxy-3'-fluoro-5-methyluridine,Influence of fluorine substitution on the molecular conformation of 3'-deoxy-3'-fluoro-5-methyluridine.,6157,C10H13FN2O5,260.22,261.22
102,"InChI=1S/C10H13FN4O6/c11-1-5(17)13-9-12-3-15(10(20)14-9)8-7(19)6(18)4(2-16)21-8/h3-4,6-8,16,18-19H,1-2H2,(H,13,14,17,20)/t4-,6-,7-,8-/m1/s1",N4-fluoroacetyl-5-azacytidine,Establishment and functional validation of a structural homology model for human DNA methyltransferase 1.,90933,C10H13FN4O6,304.23,305.23
103,"InChI=1S/C10H13N2O5Se/c1-10(16)7(15)5(4-13)17-8(10)12-3-2-6(14)11-9(12)18/h2-3,5,7-8,13,15-16H,4H2,1H3/t5-,7-,8-,10-/m1/s1",2'-methylseleno uridine,Selenium derivatization and crystallization of DNA and RNA oligonucleotides for X-ray crystallography using multiple anomalous dispersion.,87093,C10H13N2O5Se,320.18,321.18
104,"InChI=1S/C10H13N3O4/c1-5-8(15)6(4-14)17-9(5)13-3-2-7(11)12-10(13)16/h2-3,6,8-9,14-15H,1,4H2,(H2,11,12,16)/t6-,8+,9-/m1/s1",2'-Deoxy-2'-methylidenecytidine,"High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine.",112324,C10H13N3O4,239.23,240.23
105,"InChI=1S/C10H13N3O5/c11-9-5(3-14)2-13(10(17)12-9)8-1-6(16)7(4-15)18-8/h2-3,6-8,15-16H,1,4H2,(H2,11,12,17)",2'-Deoxy-5-formylcytidine,Solvent-Dependent Stabilization of a Charge Transfer State is the Key to Ultrafast Triplet State Formation in an Epigenetic DNA Nucleoside.,1808,C10H13N3O5,255.23,256.23
106,"InChI=1S/C10H13N3O5/c11-9-5(3-14)2-13(10(17)12-9)8-1-6(16)7(4-15)18-8/h2-3,6-8,15-16H,1,4H2,(H2,11,12,17)/t6-,7+,8+/m0/s1",5-formyl-2'-deoxycytidine,Unified Description of Ultrafast Excited State Decay Processes in Epigenetic Deoxycytidine Derivatives.,228,C10H13N3O5,255.23,256.23
107,"InChI=1S/C10H13N3O6/c1-11-4-2-13(10(18)12-8(4)17)9-7(16)6(15)5(3-14)19-9/h2,5-7,9,14-16H,1,3H2,(H,12,17,18)/t5-,6-,7-,9-/m1/s1",5-methyleneaminouridine,"[Escherichia coli ribosomes as the model to test new photoactivated tRNA analogues, containing 6-thioguanosine].",83485,C10H13N3O6,271.23,272.23
108,"InChI=1S/C10H13N3O6/c11-5-1-2-13(10(18)12-5)6-3-4(14)8(19-6)7(15)9(16)17/h1-2,4,6-8,14-15H,3H2,(H,16,17)(H2,11,12,18)",5-carboxyl-2'-deoxycytidine,Unified Description of Ultrafast Excited State Decay Processes in Epigenetic Deoxycytidine Derivatives.,228,C10H13N3O6,271.23,272.23
109,"InChI=1S/C10H13N3O6/c11-8-4(2-14)1-13(10(18)12-8)9-7(17)6(16)5(3-15)19-9/h1-2,5-7,9,15-17H,3H2,(H2,11,12,18)/t5-,6-,7-,9-/m1/s1",5-formylcytidine,Radical Transfer Dissociation for De Novo Characterization of Modified Ribonucleic Acids by Mass Spectrometry.,7279,C10H13N3O6,271.23,272.23
110,"InChI=1S/C10H13N3O6/c11-8-4(9(16)17)2-13(10(18)12-8)7-1-5(15)6(3-14)19-7/h2,5-7,14-15H,1,3H2,(H,16,17)(H2,11,12,18)/t5-,6+,7+/m0/s1",5-Carboxy-2'-deoxycytidine,Synthesis and properties of oligodeoxynucleotides containing 5-carboxy-2'-deoxycytidines.,67755,C10H13N3O6,271.23,272.23
111,"InChI=1S/C10H13N3O7/c11-7-3(9(17)18)1-13(10(19)12-7)8-6(16)5(15)4(2-14)20-8/h1,4-6,8,14-16H,2H2,(H,17,18)(H2,11,12,19)/t4-,5-,6-,8-/m1/s1",5-carboxycytidine,"Synthesis of RNA Containing 5-Hydroxymethyl-, 5-Formyl-, and 5-Carboxycytidine.",16876,C10H13N3O7,287.23,288.23
112,"InChI=1S/C10H13N3O7/c11-8(18)6(17)7-4(15)5(16)9(20-7)13-2-1-3(14)12-10(13)19/h1-2,4-7,9,15-17H,(H2,11,18)(H,12,14,19)/t4-,5+,6?,7-,9+/m0/s1",uridine-5'-carboxamide,"The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.",28601,C10H13N3O7,287.23,288.23
113,"InChI=1S/C10H13N3O7/c11-9(17)20-7-6(16)4(3-14)19-8(7)13-2-1-5(15)12-10(13)18/h1-2,4,6-8,14,16H,3H2,(H2,11,17)(H,12,15,18)/t4-,6-,7-,8-/m1/s1",2'-O-Carbamoyluridine,Synthesis and hybridization of 2'-O-methyl-RNAs incorporating 2'-O-carbamoyluridine and unique participation of the carbamoyl group in U-G base pair.,57865,C10H13N3O7,287.23,288.23
114,"InChI=1S/C10H13N5O2/c1-5-6(16)2-7(17-5)15-4-14-8-9(11)12-3-13-10(8)15/h3-7,16H,2H2,1H3,(H2,11,12,13)/t5-,6+,7-/m1/s1","2',5'-dideoxyadenosine",Soluble adenylyl cyclase is an acid-base sensor in epithelial base-secreting cells.,22547,C10H13N5O2,235.24,236.24
115,"InChI=1S/C10H13N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h4-7,16H,1-3H2,(H2,11,12,13)/t6-,7+/m0/s1","2',3'-Dideoxyadenosine",Helicobacter pylori induces pepsinogen secretion by rat gastric cells in culture via a cAMP signal pathway.,100590,C10H13N5O2,235.24,236.24
116,"InChI=1S/C10H13N5O3/c1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15/h2-4,6-7,10,16-17H,1H3,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",5'-deoxyadenosine,Williams-Beuren syndrome-related methyltransferase WBSCR27: cofactor binding and cleavage.,6081,C10H13N5O3,251.24,252.24
117,"InChI=1S/C10H13N5O3/c11-10-13-8-7(9(17)14-10)12-4-15(8)6-2-1-5(3-16)18-6/h4-6,16H,1-3H2,(H3,11,13,14,17)/t5-,6+/m0/s1","2',3'-dideoxyguanosine","In Vitro Anti-hepatitis B Virus Activity of 2',3'-Dideoxyguanosine.",12068,C10H13N5O3,251.24,252.24
118,"InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)",3-deoxyadenosine,Cordycepin reduces weight through regulating gut microbiota in high-fat diet-induced obese rats.,11715,C10H13N5O3,251.24,252.24
119,"InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1",3'-Deoxyadenosine,The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms ,569,C10H13N5O3,251.24,252.24
120,"InChI=1S/C10H13N5O3/c11-9-5-2-14-15(10(5)13-4-12-9)8-1-6(17)7(3-16)18-8/h2,4,6-8,16-17H,1,3H2,(H2,11,12,13)/t6-,7+,8+/m0/s1",8-Aza-7-deaza-2'-deoxyadenosine,A novel strategy of chemical modification for rate enhancement of 10-23 DNAzyme: a combination of A9 position and 8-aza-7-deaza-2'-deoxyadenosine analogs.,48581,C10H13N5O3,251.24,252.24
121,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)",2'deoxyadenosine,Can radical cations of the constituents of nucleic acids be formed in the gas phase using ternary transition metal complexes?,80519,C10H13N5O3,251.24,252.24
122,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1","2""-deoxyadenosine",Substrate recognition by Escherichia coli MutY using substrate analogs.,107727,C10H13N5O3,251.24,252.24
123,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1
InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)",2-deoxyadenosine,Molecularly Imprinted Composite Membranes for Selective Detection of 2-Deoxyadenosine in Urine Samples.,27557,C10H13N5O3,251.24,252.24
124,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m1/s1
InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7-/m1/s1",2'-deoxy-L-adenosine,Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and LC-MS/MS method for their characterization.,1830,C10H13N5O3,251.24,252.24
125,"InChI=1S/C10H13N5O3S/c11-10-13-7-6(8(17)14-10)12-3-15(7)9-5(19)1-4(2-16)18-9/h3-5,9,16,19H,1-2H2,(H3,11,13,14,17)/t4-,5+,9+/m0/s1
InChI=1S/C10H13N5O3S/c11-10-13-7-6(8(17)14-10)12-3-15(7)9-5(19)1-4(2-16)18-9/h3-5,9,16,19H,1-2H2,(H3,11,13,14,17)",deoxythioguanosine,Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone.,18501,C10H13N5O3S,283.31,284.31
126,"InChI=1S/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)/t4-,5+,6+/m0/s1",2'-Deoxy-6-thioguanosine,Site-specific modification of the 6-amino group of adenosine in RNA by an interstrand functionality-transfer reaction with an s-functionalized 4-thiothymidine.,28189,C10H13N5O3S,283.31,284.31
127,"InChI=1S/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)/t4-,5+,6+/m0/s1
InChI=1S/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)
InChI=1S/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)/t4-,5+,6-/m0/s1
InChI=1S/C10H13N5O3S/c11-10-13-8-7(9(19)14-10)12-3-15(8)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H3,11,13,14,19)/t4?,5-,6?/m1/s1",6-thio-2'-deoxyguanosine,Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity.,5033,C10H13N5O3S,283.31,284.31
128,"InChI=1S/C10H13N5O3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(1-19)18-10/h2-4,6-7,10,16-17,19H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",5'-mercapto-5'-deoxyadenosine,Protein residues that control the reaction trajectory in S-adenosylmethionine radical enzymes: mutagenesis of asparagine 153 and aspartate 155 in Escherichia coli biotin synthase.,61186,C10H13N5O3S,283.31,284.31
129,"InChI=1S/C10H13N5O3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",4'-thioadenosine,"Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.",52796,C10H13N5O3S,283.31,284.31
130,"InChI=1S/C10H13N5O3S/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(19)6(17)4(1-16)18-10/h2-4,6-7,10,16-17,19H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",thioadenosine,Synthesis and in vitro stability of nucleoside 5'-phosphonate derivatives.,40961,C10H13N5O3S,283.31,284.31
131,"InChI=1S/C10H13N5O3Se/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",4'-Selenoadenosine,"New RNA purine building blocks, 4'-selenopurine nucleosides: first synthesis and unusual mixture of sugar puckerings.",36614,C10H13N5O3Se,330.2,331.2
132,"InChI=1S/C10H13N5O4.C5H4N4O2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;10-4-2-3(7-1-6-2)8-5(11)9-4/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H,(H3,6,7,8,9,10,11)/t4-,6-,7-,10-;/m1./s1",xanthine adenosine,"Effects of adenosine analogs on inositol 1,4,5-trisphosphate production in porcine coronary artery.",92261,C15H17N9O6,419.35,420.35
133,"InChI=1S/C10H13N5O4.K/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);/t4-,6-,7-,10-;/m1./s1",potassium adenosine,Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.,114880,C10H13KN5O4,306.34,307.34
134,"InChI=1S/C10H13N5O4/c11-10-13-7-6(8(18)14-10)12-3-15(7)9-5(17)1-4(2-16)19-9/h3-5,9,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,9+/m0/s1",3'-deoxyguanosine,Structure of human PNP complexed with ligands.,80260,C10H13N5O4,267.24,268.24
135,"InChI=1S/C10H13N5O4/c11-10-13-8-4(9(18)14-10)2-12-15(8)7-1-5(17)6(3-16)19-7/h2,5-7,16-17H,1,3H2,(H3,11,13,14,18)/t5-,6+,7+/m0/s1",8-aza-7-deaza-2'-deoxyguanosine,Oligonucleotide duplexes containing N8-glycosylated 8-aza-7-deazaguanine and self-assembly of 8-aza-7-deazapurines on the nucleoside and the oligomeric level.,88201,C10H13N5O4,267.24,268.24
136,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1",2'-Deoxyguanosine,Gas-Phase Conformations and N-Glycosidic Bond Stabilities of Sodium Cationized 2'-Deoxyguanosine and Guanosine: Sodium Cations Preferentially Bind to the Guanine Residue.,18879,C10H13N5O4,267.24,268.24
137,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-7,16-17H,1-2H2,(H2,11,14,18)/t4-,5+,6+,7?/m0/s1",2' deoxyguanosine,Tobacco Use Increases Oxidative DNA Damage in Sperm - Possible Etiology of Childhood Cancer.,25708,C10H13N5O4,267.24,268.24
138,"InChI=1S/C10H13N5O4/c11-7-6-8(14-10(18)13-7)15(3-12-6)9-5(17)1-4(2-16)19-9/h3-5,9,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,9+/m0/s1",3'-deoxyisoguanosine,Chemo-enzymatic synthesis of 3-deoxy-beta-D-ribofuranosyl purines and study of their biological properties.,89129,C10H13N5O4,267.24,268.24
139,"InChI=1S/C10H13N5O4/c11-8-12-9-14(1-2-15(9)10(18)13-8)7-3-5(17)6(4-16)19-7/h1-2,5-7,16-17H,3-4H2,(H2,11,13,18)/t5-,6+,7+/m0/s1",5-Aza-7-deaza-2'-deoxyguanosine,5-Aza-7-deaza-2'-deoxyguanosine and 2'-Deoxycytidine Form Programmable Silver-Mediated Base Pairs with Metal Ions in the Core of the DNA Double Helix.,14613,C10H13N5O4,267.24,268.24
140,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m0/s1",L-adenosine,Development of dried blood spot quality control materials for adenosine deaminase severe combined immunodeficiency and LC-MS/MS method for their characterization.,1830,C10H13N5O4,267.24,268.24
141,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",3H-adenosine,Early changes in adenosine A1 receptors in cerebral cortex slices submitted to in vitro ischemia.,108221,C10H13N5O4,267.24,268.24
142,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10?/m1/s1",riboadenosine,Solid phase synthesis and binding affinity of peptidyl transferase transition state mimics containing 2'-OH at P-site position A76.,87147,C10H13N5O4,267.24,268.24
143,"InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)/t4-,5+,6+/m0/s1",8-hydroxy-2'-deoxyadenosine,"The oxidatively induced DNA lesions 8,5'-cyclo-2'-deoxyadenosine and 8-hydroxy-2'-deoxyadenosine are strongly resistant to acid-induced hydrolysis of the glycosidic bond.",69140,C10H13N5O4,267.24,268.24
144,"InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)/t4-,5+,6+/m0/s1
InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)/t4-,5+,6?/m0/s1","8-Oxo-7,8-dihydro-2'-deoxyadenosine",DNA damage reduces Taq DNA polymerase fidelity and PCR amplification efficiency.,71688,C10H13N5O4,267.24,268.24
145,"InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)/t4-,5+,6+/m0/s1
InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)/t4-,5+,6?/m0/s1
InChI=1S/C10H13N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H,14,18)(H2,11,12,13)",8-oxo-2'-deoxyadenosine,"Purine 5',8-cyclo-2'-deoxynucleoside lesions: formation by radical stress and repair in human breast epithelial cancer cells.",18460,C10H13N5O4,267.24,268.24
146,"InChI=1S/C10H13N5O4/c11-8-7-9(14-10(18)13-8)15(3-12-7)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1",2'-Deoxyisoguanosine,"Preparation of the 2'-deoxynucleosides of 2,6-diaminopurine and isoguanine by direct glycosylation.",55934,C10H13N5O4,267.24,268.24
147,"InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-5(17)6(20)3(1-16)19-9/h2-3,5-6,9,16-17,20H,1H2,(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",3'-thioguanosine,Synthesis of 3'-thioribonucleosides and their incorporation into oligoribonucleotides via phosphoramidite chemistry.,113418,C10H13N5O4S,299.31,300.31
148,"InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)/t3-,5-,6-,9-/m0/s1",L-thioguanosine,L-nucleoside analogues as potential antimalarials that selectively target Plasmodium falciparum adenosine deaminase.,106108,C10H13N5O4S,299.31,300.31
149,"InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)/t3-,5-,6-,9-/m1/s1",6-Thioguanosine,Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.,52425,C10H13N5O4S,299.31,300.31
150,"InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H13N5O4S.H2O/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9;/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20);1H2/t3-,5-,6-,9-;/m1./s1",Thioguanosine,Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?,60279,C10H13N5O4S,299.31,300.31
151,"InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H13N5O4S/c11-10-13-7-4(8(20)14-10)12-2-15(7)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,20)",6-mercaptoguanosine,Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.,105122,C10H13N5O4S,299.31,300.31
152,"InChI=1S/C10H13N5O5.2H2O/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9;;/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19);2*1H2/t3-,5-,6-,9-;;/m1../s1",guanosine dihydrate,"Crystal water dynamics of guanosine dihydrate: analysis of atomic displacement parameters, time profile of hydrogen-bonding probability, and translocation of water by MD simulation.",74667,C10H17N5O7,319.27,320.27
153,"InChI=1S/C10H13N5O5.C10H12N4O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9;15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19);2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t3-,5-,6-,9-;4-,6-,7-,10-/m11/s1",guanosine-inosine,Calcium-stimulated guanosine--inosine nucleosidase from yellow lupin (Lupinus luteus).,74883,C20H25N9O10,551.47,552.47
154,"InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m0/s1",L-guanosine,Chirality from D-guanosine to L-guanosine shapes a stable gel for three-dimensional cell culture.,248,C10H13N5O5,283.24,284.24
155,"InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1",3H-guanosine,Anoxia inhibits guanosine salvage in cardiac myocytes.,113059,C10H13N5O5,283.24,284.24
156,"InChI=1S/C10H13N5O5/c11-14-12-2-5-3-15(10(19)13-9(5)18)8-1-6(17)7(4-16)20-8/h3,6-8,16-17H,1-2,4H2,(H,13,18,19)/t6-,7+,8+/m0/s1",5-azidomethyl-2'-deoxyuridine,Electron-Mediated Aminyl and Iminyl Radicals from C5 Azido-Modified Pyrimidine Nucleosides Augment Radiation Damage to Cancer Cells.,11958,C10H13N5O5,283.24,284.24
157,"InChI=1S/C10H13N5O5/c11-7-4-8(13-2-12-7)15(10(19)14-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H,14,19)(H2,11,12,13)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H13N5O5/c11-7-4-8(13-2-12-7)15(10(19)14-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H,14,19)(H2,11,12,13)/t3-,5?,6+,9-/m1/s1",8-oxoadenosine,Syntheses and properties of low-polarity shape mimics of 8-oxopurines.,67687,C10H13N5O5,283.24,284.24
158,"InChI=1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1",2-hydroxyadenosine,Identification and quantification of isoguanosine in humans and mice.,10525,C10H13N5O5,283.24,284.24
159,"InChI=1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)
InChI=1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5+,6-,9-/m1/s1",isoguanosine,Dual-functional guanosine-based hydrogel integrating localized delivery and anticancer activities for cancer therapy.,7746,C10H13N5O5,283.24,284.24
160,"InChI=1S/C10H13N5O5/c11-8-5-9(13-2-12-8)14(3-15(5)19)10-7(18)6(17)4(1-16)20-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
InChI=1S/C10H13N5O5/c11-8-5-9(13-2-12-8)14(3-15(5)19)10-7(18)6(17)4(1-16)20-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)",adenosine-N1-oxide,Synthesis and antiviral evaluation of analogs of adenosine-N1-oxide and 1-(Benzyloxy)adenosine.,111535,C10H13N5O5,283.24,284.24
161,"InChI=1S/C10H13N5O5/c11-8-5-9(13-3-15(8)19)14(2-12-5)10-7(18)6(17)4(1-16)20-10/h2-4,6-7,10-11,16-19H,1H2/t4-,6-,7-,10-/m1/s1",adenosine N1-oxide,Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation.,9651,C10H13N5O5,283.24,284.24
162,"InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)",8-Hydroxy 2'-deoxyguanosine,Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.,96182,C10H13N5O5,283.24,284.24
163,"InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)
InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)/t3-,4-,5-/m1/s1",8-Hydroxy-2-desoxyguanosine,"Dietary supplementation of potassium sorbate, hydrated sodium calcium almuniosilicate and methionine enhances growth, antioxidant status and immunity in growing rabbits exposed to aflatoxin B1 in the diet.",7799,C10H13N5O5,283.24,284.24
164,"InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-10(19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17H,1-2H2,(H,12,19)(H3,11,13,14,18)/t3-,4+,5+/m0/s1","2'-deoxy-7,8-dihydro-8-oxoguanosine",Lesion (in)tolerance reveals insights into DNA replication fidelity.,86680,C10H13N5O5,283.24,284.24
165,"InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-3-15(7)10(19)1-4(17)5(2-16)20-10/h3-5,16-17,19H,1-2H2,(H3,11,13,14,18)/t4-,5+,10+/m0/s1
InChI=1S/C10H13N5O5/c11-9-13-7-6(8(18)14-9)12-3-15(7)10(19)1-4(17)5(2-16)20-10/h3-5,16-17,19H,1-2H2,(H3,11,13,14,18)",hydroxydeoxyguanosine,Association of gene polymorphism in detoxification enzymes and urinary 8-OHdG levels in traffic policemen exposed to vehicular exhaust.,37933,C10H13N5O5,283.24,284.24
166,"InChI=1S/C10H13N5O5/c16-1-4-6(17)7(18)10(20-4)15-3-13-5-8(14-19)11-2-12-9(5)15/h2-4,6-7,10,16-19H,1H2,(H,11,12,14)/t4-,6-,7-,10-/m1/s1",N-hydroxyadenosine,The pivotal role of the mitochondrial amidoxime reducing component 2 in protecting human cells against apoptotic effects of the base analog N6-hydroxylaminopurine.,29320,C10H13N5O5,283.24,284.24
167,"InChI=1S/C10H13N5O5S/c11-9-13-6-3(7(19)14-9)12-10(21)15(6)8-5(18)4(17)2(1-16)20-8/h2,4-5,8,16-18H,1H2,(H,12,21)(H3,11,13,14,19)/t2-,4-,5-,8-/m1/s1",8-mercaptoguanosine,Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.,61431,C10H13N5O5S,315.31,316.31
168,"InChI=1S/C10H13N5O6/c11-10-13-7(19)4-8(15(10)20)14(2-12-4)9-6(18)5(17)3(1-16)21-9/h2-3,5-6,9,16-18,20H,1H2,(H2,11,13,19)",Oxyguanosine,Rubratoxin B elicits antioxidative and DNA repair responses in mouse brain.,85641,C10H13N5O6,299.24,300.24
169,"InChI=1S/C10H13N5O6/c11-14-12-1-4-2-15(10(20)13-8(4)19)9-7(18)6(17)5(3-16)21-9/h2,5-7,9,16-18H,1,3H2,(H,13,19,20)/t5-,6-,7-,9-/m1/s1",5-azidomethyluridine,"Synthesis and antiviral evaluation of 5-(1,2,3-triazol-1-ylmethyl)uridine derivatives.",59359,C10H13N5O6,299.24,300.24
170,"InChI=1S/C10H13N5O6/c11-8-13-7(18)6-10(20,14-8)15(9(19)12-6)5-1-3(17)4(2-16)21-5/h3-5,16-17,20H,1-2H2,(H3,11,13,14,18)/t3-,4+,5+,10-/m0/s1","(4S)-4,8-dihydro-4-hydroxy-8-oxo-2'-deoxyguanosine",Type II guanine oxidation photoinduced by the antibacterial fluoroquinolone Rufloxacin in isolated DNA and in 2'-deoxyguanosine.,94357,C10H13N5O6,299.24,300.24
171,"InChI=1S/C10H13N5O6/c11-8-13-7(18)6-10(20,14-8)15(9(19)12-6)5-1-3(17)4(2-16)21-5/h3-5,16-17,20H,1-2H2,(H3,11,13,14,18)/t3-,4+,5+,10?/m0/s1","4,8-dihydro-4-hydroxy-8-oxo-2'-deoxyguanosine",Spiroiminodihydantoin is a major product in the photooxidation of 2'-deoxyguanosine by the triplet states and oxyl radicals generated from hydroxyacetophenone photolysis and dioxetane thermolysis.,96952,C10H13N5O6,299.24,300.24
172,"InChI=1S/C10H13N5O6/c11-9-12-7-6(8(18)13-9)15(20)10(19)14(7)5-1-3(17)4(2-16)21-5/h3-5,16-17,20H,1-2H2,(H3,11,12,13,18)/t3-,4+,5+/m0/s1",7-hydroxy-8-oxo-2'-deoxyguanosine,Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies.,94950,C10H13N5O6,299.24,300.24
173,"InChI=1S/C10H13N5O6/c11-9-13-6-3(7(19)14-9)12-10(20)15(6)8-5(18)4(17)2(1-16)21-8/h2,4-5,8,16-18H,1H2,(H,12,20)(H3,11,13,14,19)",8-hydroxy-2-deoxy-guanosine,"Association between human exposure to heavy metals/metalloid and occurrences of respiratory diseases, lipid peroxidation and DNA damage in Kumasi, Ghana.",15602,C10H13N5O6,299.24,300.24
174,"InChI=1S/C10H13N5O6/c11-9-13-6-3(7(19)14-9)12-10(20)15(6)8-5(18)4(17)2(1-16)21-8/h2,4-5,8,16-18H,1H2,(H,12,20)(H3,11,13,14,19)/t2-,4-,5-,8-/m1/s1","7,8-dihydro-8-oxoguanosine","7,8-Dihydro-8-oxoguanosine Lesions Inhibit the Theophylline Aptamer or Change Its Selectivity.",7353,C10H13N5O6,299.24,300.24
175,"InChI=1S/C10H13N5O6/c11-9-13-6-3(7(19)14-9)12-10(20)15(6)8-5(18)4(17)2(1-16)21-8/h2,4-5,8,16-18H,1H2,(H,12,20)(H3,11,13,14,19)/t2-,4-,5-,8-/m1/s1/i/hD",8-hydroxy-D-guanosine,Oxidative Modification of Biomolecules in the Nonstimulated and Stimulated Saliva of Patients with Morbid Obesity Treated with Bariatric Surgery.,15002,C10H13N5O6,299.24,300.24
176,"InChI=1S/C10H13N5O6/c11-9-13-7-6(8(18)14-9)12-10(21-19)15(7)5-1-3(17)4(2-16)20-5/h3-5,16-17,19H,1-2H2,(H3,11,13,14,18)/t3-,4+,5+/m0/s1",8-hydroperoxy-2'-deoxyguanosine,A novel method using 8-hydroperoxy-2'-deoxyguanosine formation for evaluating antioxidative potency.,95445,C10H13N5O6,299.24,300.24
177,"InChI=1S/C10H13N5O7/c11-8-12-6-10(21,7(19)13-8)14-9(20)15(6)5-4(18)3(17)2(1-16)22-5/h2-5,16-18,21H,1H2,(H,14,20)(H2,11,13,19)/t2-,3-,4-,5-,10?/m1/s1","5-hydroxy-8-oxo-7,8-dihydroguanosine","Characterization of 5-hydroxy-8-oxo-7,8-dihydroguanosine in the photosensitized oxidation of 8-oxo-7,8-dihydroguanosine and its rearrangement to spiroiminodihydantoin.",82942,C10H13N5O7,315.24,316.24
178,"InChI=1S/C10H13N9O2/c11-8-7-9(16-10(12)15-8)19(3-14-7)6-1-4(17-18-13)5(2-20)21-6/h3-6,20H,1-2H2,(H4,11,12,15,16)/t4-,5+,6+/m0/s1","3'-azido-2',3'-dideoxy-2-aminoadenosine","3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.",68186,C10H13N9O2,291.27,292.27
179,"InChI=1S/C10H13NO6/c12-4-6-8(15)9(16)10(17-6)11-2-1-5(13)3-7(11)14/h1-3,6,8-10,12-13,15-16H,4H2/t6-,8-,9-,10-/m1/s1",3-deazauridine,The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma.,22843,C10H13NO6,243.21,244.21
180,"InChI=1S/C10H14BrN5O9P2/c11-10-15-7-8(12)13-3-14-9(7)16(10)6-1-4(25-27(20,21)22)5(24-6)2-23-26(17,18)19/h3-6H,1-2H2,(H2,12,13,14)(H2,17,18,19)(H2,20,21,22)/t4-,5+,6+/m0/s1","8-bromo-2'-deoxyadenosine 3',5'-diphosphate","Electron-induced degradation of 8-bromo-2'-deoxyadenosine 3',5'-diphosphate, a DNA radiosensitizing nucleotide.",35360,C10H14BrN5O9P2,490.1,491.1
181,"InChI=1S/C10H14ClN5O3/c11-10(18)7-8(14-9(12)15-10)16(4-13-7)6-2-1-5(3-17)19-6/h4-6,17-18H,1-3H2,(H3,12,14,15)/t5-,6+,10?/m0/s1
InChI=1S/C10H14ClN5O3/c11-10(18)7-8(14-9(12)15-10)16(4-13-7)6-2-1-5(3-17)19-6/h4-6,17-18H,1-3H2,(H3,12,14,15)","6-chloro-2',3'-dideoxyguanosine",Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.,21277,C10H14ClN5O3,287.7,288.7
182,"InChI=1S/C10H14ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-6,8-9,17-19H,1H2,(H2,12,14,15)/t3-,4?,5+,6-,8?,9-/m1/s1",2-chloradenosine,Acetate metabolism in brain mechanisms of adaptation to ethanol.,91219,C10H14ClN5O4,303.7,304.7
183,"InChI=1S/C10H14FN3O4/c1-10(11)7(16)5(4-15)18-8(10)14-3-2-6(12)13-9(14)17/h2-3,5,7-8,15-16H,4H2,1H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1",2'-deoxy-2'-fluoro-2'-C-methylcytidine,One-electron oxidation of gemcitabine and analogs: mechanism of formation of C3' and C2' sugar radicals.,31229,C10H14FN3O4,259.23,260.23
184,"InChI=1S/C10H14N2O4/c11-6-1-2-12(9(15)3-6)10-4-7(14)8(5-13)16-10/h1-3,7-8,10,13-14H,4-5,11H2/t7-,8+,10-/m0/s1",3-deaza-2'-deoxycytidine,Nucleoside analogue substitutions in the trinucleotide DNA template recognition sequence 3'-(CTG)-5' and their effects on the activity of bacteriophage T7 primase.,105216,C10H14N2O4,226.23,227.23
185,"InChI=1S/C10H14N2O5/c1-11-8(15)2-3-12(10(11)16)9-4-6(14)7(5-13)17-9/h2-3,6-7,9,13-14H,4-5H2,1H3/t6-,7+,9+/m0/s1",3-methyl-2'-deoxyuridine,Deoxyuridines from the marine sponge associated actinomycete Streptomyces microflavus.,48819,C10H14N2O5,242.23,243.23
186,"InChI=1S/C10H14N2O5/c1-5-2-8(15)11-10(16)12(5)9-3-6(14)7(4-13)17-9/h2,6-7,9,13-14H,3-4H2,1H3,(H,11,15,16)/t6-,7+,9+/m0/s1",6-methyl-2'-deoxyuridine,Synthesis of 6-methyl[11C]-2'-deoxyuridine and evaluation of its in vivo distribution in Wistar rats.,113318,C10H14N2O5,242.23,243.23
187,"InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1",2'-deoxy-5-methyluridine,"Metal ion-binding properties of (N3)-deprotonated uridine, thymidine, and related pyrimidine nucleosides in aqueous solution.",80869,C10H14N2O5,242.23,243.23
188,"InChI=1S/C10H14N2O5/c1-5-8(15)6(4-13)17-9(5)12-3-2-7(14)11-10(12)16/h2-3,5-6,8-9,13,15H,4H2,1H3,(H,11,14,16)/t5-,6+,8-,9+/m0/s1",(2'S)-2'-Deoxy-2'-C-methyluridine,siRNA Modified with 2'-Deoxy-2'-C-methylpyrimidine Nucleosides.,14350,C10H14N2O5,242.23,243.23
189,"InChI=1S/C10H14N2O5S/c1-16-8-7(15)5(4-13)17-9(8)12-3-2-6(14)11-10(12)18/h2-3,5,7-9,13,15H,4H2,1H3,(H,11,14,18)/t5-,7-,8-,9-/m1/s1",2'-O-methyl-2-thiouridine,Chemical synthesis of LNA-2-thiouridine and its influence on stability and selectivity of oligonucleotide binding to RNA.,57588,C10H14N2O5S,274.3,275.3
190,"InChI=1S/C10H14N2O5S/c1-4-2-12(10(18)11-8(4)16)9-7(15)6(14)5(3-13)17-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,18)/t5-,6-,7-,9-/m1/s1",5-methyl-2-thiouridine,Stabilizing contributions of sulfur-modified nucleotides: crystal structure of a DNA duplex with 2'-O-[2-(methoxy)ethyl]-2-thiothymidines.,79081,C10H14N2O5S,274.3,275.3
191,"InChI=1S/C10H14N2O6/c1-10(17)5(4-13)18-8(7(10)15)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)/t5-,7+,8-,10-/m1/s1",3'-C-methyluridine,Synthesis of some derivatives of 3'-C-methyl pyrimidine nucleosides.,63268,C10H14N2O6,258.23,259.23
192,"InChI=1S/C10H14N2O6/c1-10(17)7(15)5(4-13)18-8(10)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)/t5-,7-,8-,10-/m1/s1
InChI=1S/C10H14N2O6/c1-10(17)7(15)5(4-13)18-8(10)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)/t5-,7+,8-,10-/m1/s1
InChI=1S/C10H14N2O6/c1-10(17)7(15)5(4-13)18-8(10)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)/t5-,7-,8-,10-/m0/s1
InChI=1S/C10H14N2O6/c1-10(17)7(15)5(4-13)18-8(10)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)
InChI=1S/C10H14N2O6/c1-10(17)7(15)5(4-13)18-8(10)12-3-2-6(14)11-9(12)16/h2-3,5,7-8,13,15,17H,4H2,1H3,(H,11,14,16)/t5-,7+,8-,10?/m1/s1",2'-C-Methyluridine,DNAzymes and ribozymes carrying 2'-C-methyl nucleotides.,63274,C10H14N2O6,258.23,259.23
193,"InChI=1S/C10H14N2O6/c1-10(8(16)7(15)5(4-13)18-10)12-3-2-6(14)11-9(12)17/h2-3,5,7-8,13,15-16H,4H2,1H3,(H,11,14,17)/t5-,7-,8-,10-/m1/s1",methyluridine,Discrimination of common isomerides of methyl nucleosides by collision-induced dissociation tandem mass spectrometry.,4974,C10H14N2O6,258.23,259.23
194,"InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3/t5-,7-,8-,9-/m1/s1
InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3
InChI=1S/C10H14N2O6/c1-11-6(14)2-3-12(10(11)17)9-8(16)7(15)5(4-13)18-9/h2-3,5,7-9,13,15-16H,4H2,1H3/t5-,7-,8-,9-/m0/s1",3-Methyluridine,Solution conformations of two naturally occurring RNA nucleosides: 3-methyluridine and 3-methylpseudouridine.,79387,C10H14N2O6,258.23,259.23
195,"InChI=1S/C10H14N2O6/c1-12-2-4(9(16)11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,8+/m1/s1",1-methyl-pseudouridine,Machine Learning for Designing Next-Generation mRNA Therapeutics.,77,C10H14N2O6,258.23,259.23
196,"InChI=1S/C10H14N2O6/c1-12-2-4(9(16)11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,8+/m1/s1
InChI=1S/C10H14N2O6/c1-12-2-4(9(16)11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,16,17)",N1-methylpseudouridine,N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells.,6575,C10H14N2O6,258.23,259.23
197,"InChI=1S/C10H14N2O6/c1-12-9(16)4(2-11-10(12)17)8-7(15)6(14)5(3-13)18-8/h2,5-8,13-15H,3H2,1H3,(H,11,17)/t5-,6-,7-,8+/m1/s1",3-methylpseudouridine,Solution conformations of two naturally occurring RNA nucleosides: 3-methyluridine and 3-methylpseudouridine.,79387,C10H14N2O6,258.23,259.23
198,"InChI=1S/C10H14N2O6/c1-17-8-5(4-13)18-9(7(8)15)12-3-2-6(14)11-10(12)16/h2-3,5,7-9,13,15H,4H2,1H3,(H,11,14,16)/t5-,7-,8-,9-/m1/s1",3'-O-methyluridine,Differentiation of 2'-O- and 3'-O-methylated ribonucleosides by tandem mass spectrometry.,75367,C10H14N2O6,258.23,259.23
199,"InChI=1S/C10H14N2O6/c1-17-8-7(15)5(4-13)18-9(8)12-3-2-6(14)11-10(12)16/h2-3,5,7-9,13,15H,4H2,1H3,(H,11,14,16)/t5-,7-,8-,9-/m1/s1",2'-O-methyluridine,New nucleoside hydrolase with transribosylation activity from Agromyces sp. MM-1 and its application for enzymatic synthesis of 2'-O-methylribonucleosides.,17140,C10H14N2O6,258.23,259.23
200,"InChI=1S/C10H14N2O6/c1-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)18-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,9-/m1/s1",5-Methyluridine,Two-step efficient synthesis of 5-methyluridine via two thermostable nucleoside phosphorylase from Aeropyrum pernix.,45123,C10H14N2O6,258.23,259.23
201,"InChI=1S/C10H14N2O6/c1-4-2-6(14)11-10(17)12(4)9-8(16)7(15)5(3-13)18-9/h2,5,7-9,13,15-16H,3H2,1H3,(H,11,14,17)/t5-,7-,8-,9-/m1/s1",6-Methyluridine,Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.,66752,C10H14N2O6,258.23,259.23
202,"InChI=1S/C10H14N2O6/c13-3-5-2-12(10(17)11-9(5)16)8-1-6(15)7(4-14)18-8/h2,6-8,13-15H,1,3-4H2,(H,11,16,17)/t6-,7+,8+/m0/s1",2'-deoxy-5-(hydroxymethyl)uridine,Replacement of Thymidine by a Modified Base in the Escherichia coli Genome.,22946,C10H14N2O6,258.23,259.23
203,"InChI=1S/C10H14N2O6/c13-4-6(15)9-5(14)3-8(18-9)12-2-1-7(16)11-10(12)17/h1-2,5-6,8-9,13-15H,3-4H2,(H,11,16,17)/t5-,6?,8+,9-/m0/s1",5'-hydroxymethyl-2'-deoxyuridine,Replacement of 2'-Deoxycytidine by 2'-Deoxycytidine Analogues in the E. coli Genome.,20853,C10H14N2O6,258.23,259.23
204,"InChI=1S/C10H14N2O6/c13-4-7-6(15)3-10(5-14,18-7)12-2-1-8(16)11-9(12)17/h1-2,6-7,13-15H,3-5H2,(H,11,16,17)/t6-,7+,10-/m0/s1",hydroxymethyldeoxyuridine,Biosynthesis and function of the modified DNA base beta-D-glucosyl-hydroxymethyluracil in Trypanosoma brucei.,110968,C10H14N2O6,258.23,259.23
205,"InChI=1S/C10H14N2O7/c1-18-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)19-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,9-/m1/s1",5-Methoxyuridine,A single uridine modification at the wobble position of an artificial tRNA enhances wobbling in an Escherichia coli cell-free translation system.,108934,C10H14N2O7,274.23,275.23
206,"InChI=1S/C10H14N2O7/c13-2-4-1-12(10(18)11-8(4)17)9-7(16)6(15)5(3-14)19-9/h1,5-7,9,13-16H,2-3H2,(H,11,17,18)/t5-,6-,7-,9-/m1/s1",5-hydroxymethyluridine,Pre-steady-state kinetic analysis of damage recognition by human single-strand selective monofunctional uracil-DNA glycosylase SMUG1.,16448,C10H14N2O7,274.23,275.23
207,"InChI=1S/C10H14N2O7/c13-3-7-6(14)1-8(19-7)12-2-5(4-18-17)9(15)11-10(12)16/h2,6-8,13-14,17H,1,3-4H2,(H,11,15,16)/t6-,7+,8+/m0/s1",5-(hydroperoxymethyl)-2'-deoxyuridine,A formation mechanism for 8-hydroxy-2'-deoxyguanosine mediated by peroxidized 2'-deoxythymidine.,63354,C10H14N2O7,274.23,275.23
208,"InChI=1S/C10H14N4O5/c11-9(17)12-7-1-2-14(10(18)13-7)8-3-5(16)6(4-15)19-8/h1-2,5-6,8,15-16H,3-4H2,(H3,11,12,13,17,18)/t5-,6+,8+/m0/s1",4-N-carbamoyldeoxycytidine,Synthesis and properties of a new fluorescent bicyclic 4-N-carbamoyldeoxycytidine derivative.,76099,C10H14N4O5,270.24,271.24
209,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",2'-Deoxyadenosine 5'-monophosphate,Mutual role of ecto-5'-nucleotidase/CD73 and concentrative nucleoside transporter 3 in the intestinal uptake of dAMP.,8011,C10H14N5O6P,331.22,332.22
210,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(6(2-16)20-7)21-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",2'-deoxyadenosine-3'-monophosphate,Lys-Ala mutations of type I adenylyl cyclase result in altered susceptibility to inhibition by adenine nucleoside 3'-polyphosphates.,105916,C10H14N5O6P,331.22,332.22
211,"InChI=1S/C10H14N5O7P.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20;/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20);1H2/t4-,6-,7-,10-;/m1./s1
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",adenosine-5-monophosphate,CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function.,35608,C10H16N5O8P,365.24,366.24
212,"InChI=1S/C10H14N5O7P.H3N/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20;/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17);1H3/t4-,5+,6?;/m0./s1",2'-deoxyguanosine monophosphate,"Miscoding properties of 8-chloro-2'-deoxyguanosine, a hypochlorous acid-induced DNA adduct, catalysed by human DNA polymerases.",39138,C10H17N6O7P,364.25,365.25
213,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",2'-deoxyguanosine-5'-monophosphate,Protonation induces base rotation of purine nucleotides pdGuo and pGuo.,22988,C10H14N5O7P,347.22,348.22
214,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1
InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/p-1/t4-,5+,6+/m0/s1
InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/p-2/t4-,5+,6+/m0/s1",2'-deoxyguanosine 5'-monophosphate,The solvent effect and identification of a weakly emissive state in nonradiative dynamics of guanine nucleosides and nucleotides--a combined femtosecond broadband time-resolved fluorescence and transient absorption study.,36693,C10H14N5O7P,347.22,348.22
215,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(5(2-16)21-6)22-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",2'-deoxyguanosine 3'-monophosphate,Oxidation of guanosine derivatives by a platinum(IV) complex: internal electron transfer through cyclization.,82318,C10H14N5O7P,347.22,348.22
216,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(17)7(4(1-16)21-10)22-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",3'-adenosine monophosphate,"A novel adenosine precursor 2',3'-cyclic adenosine monophosphate inhibits formation of post-surgical adhesions.",43029,C10H14N5O7P,347.22,348.22
217,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",5'-adenosine monophosphate,Adenosine accumulation causes metabolic disorders in testes and associates with lower testosterone level in obese mice.,6800,C10H14N5O7P,347.22,348.22
218,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(22-23(18,19)20)6(17)4(1-16)21-10/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",adenosine 2'-monophosphate,"Adenosine 2'-monophosphate, 5'-O-[S-(4-succinimidylbenzophenone)-thiophosphate]: a new photoaffinity label for the coenzyme site of porcine NADP-specific isocitrate dehydrogenase.",80863,C10H14N5O7P,347.22,348.22
219,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(22-23(18,19)20)6(17)4(1-16)21-10/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(22-23(18,19)20)6(17)4(1-16)21-10/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(22-23(18,19)20)6(17)4(1-16)21-10/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10?/m1/s1",adenosine 2'-phosphate,"Adenophostin A can stimulate Ca2+ influx without depleting the inositol 1,4,5-trisphosphate-sensitive Ca2+ stores in the Xenopus oocyte.",115020,C10H14N5O7P,347.22,348.22
220,"InChI=1S/C10H14N5O7PS/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-6(24)5(16)3(22-9)1-21-23(18,19)20/h2-3,5-6,9,16,24H,1H2,(H2,18,19,20)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",thioguanosine monophosphate,Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?,60279,C10H14N5O7PS,379.29,380.29
221,"InChI=1S/C10H14N5O7PS/c11-10-13-7-4(8(24)14-10)12-2-15(7)9-6(17)5(16)3(22-9)1-21-23(18,19)20/h2-3,5-6,9,16-17H,1H2,(H2,18,19,20)(H3,11,13,14,24)/t3-,5-,6-,9-/m1/s1",6-thioguanosine monophosphate,The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease.,50633,C10H14N5O7PS,379.29,380.29
222,"InChI=1S/C10H14N5O8P.2Na/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21;;/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18);;/q;2*+1/p-2/t3-,5-,6-,9-;;/m1../s1",disodium guanosine-5'-monophosphate,Single atom modification leads to enhanced nucleotide self-assembly: the role of cation bridging.,50501,C10H12N5Na2O8P,407.18,408.18
223,"InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",5'-guanosine monophosphate,"A review on the nucleic acid constituents in mushrooms: nucleobases, nucleosides and nucleotides.",16164,C10H14N5O8P,363.22,364.22
224,"InChI=1S/C10H14N5O9P/c16-5-3(1-23-25(20,21)22)24-9(6(5)17)15-2-11-4-7(15)12-10(14-19)13-8(4)18/h2-3,5-6,9,16-17,19H,1H2,(H2,20,21,22)(H2,12,13,14,18)/p-2/t3-,5-,6-,9-/m1/s1",N2-hydroxyguanosine 5'-monophosphate,N2-hydroxyguanosine 5'-monophosphate is a time-dependent inhibitor of Escherichia coli guanosine monophosphate synthetase.,109909,C10H12N5O9P,377.2,378.2
225,"InChI=1S/C10H14N6O3/c1-5-3-16(10(18)13-9(5)11)8-2-6(14-15-12)7(4-17)19-8/h3,6-8,17H,2,4H2,1H3,(H2,11,13,18)/t6-,7+,8+/m0/s1","3'-azido-2',3'-dideoxy-5-methylcytidine",Early detection of mixed mutations selected by antiretroviral agents in HIV-infected primary human lymphocytes.,98403,C10H14N6O3,266.26,267.26
226,"InChI=1S/C10H14N6O3/c11-1-4-6(17)7(18)10(19-4)16-3-15-5-8(12)13-2-14-9(5)16/h2-4,6-7,10,17-18H,1,11H2,(H2,12,13,14)",5'-deoxy-5'-aminoadenosine,"Adenosine kinase inhibitors. 4. 6,8-Disubstituted purine nucleoside derivatives. Synthesis, conformation, and enzyme inhibition.",81162,C10H14N6O3,266.26,267.26
227,"InChI=1S/C10H14N6O3/c11-1-4-6(17)7(18)10(19-4)16-3-15-5-8(12)13-2-14-9(5)16/h2-4,6-7,10,17-18H,1,11H2,(H2,12,13,14)/t4-,6-,7-,10-/m1/s1",5'-amino 5'-deoxyadenosine,Adenosine-mediated killing of cultured epithelial cancer cells.,105152,C10H14N6O3,266.26,267.26
228,"InChI=1S/C10H14N6O3/c11-5-4(1-17)19-10(7(5)18)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1,11H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1",3'-Amino-3'-deoxyadenosine,Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides.,97970,C10H14N6O3,266.26,267.26
229,"InChI=1S/C10H14N6O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1,11H2,(H2,12,13,14)/t4-,5+,7-,10+/m0/s1",2-amino-adenosine,Synthesis and biological activity of 4'-thio-2'-deoxy purine nucleosides.,107894,C10H14N6O3,266.26,267.26
230,"InChI=1S/C10H14N6O3/c11-5-7(18)4(1-17)19-10(5)16-3-15-6-8(12)13-2-14-9(6)16/h2-5,7,10,17-18H,1,11H2,(H2,12,13,14)/t4-,5-,7-,10-/m1/s1",2'-amino-2'-deoxyadenosine,[Simultaneous determination of pentostatin and 2'-amino-2'-deoxyadenosine in fermentation broth by high performance liquid chromatography-tandem mass spectrometry].,1051,C10H14N6O3,266.26,267.26
231,"InChI=1S/C10H14N6O3/c11-8-7-9(14-3-13-8)16(10(12)15-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,15)(H2,11,13,14)/t4-,5+,6+/m0/s1",8-amino-2'-deoxyadenosine,Convenient synthesis of 8-amino-2'-deoxyadenosine.,91332,C10H14N6O3,266.26,267.26
232,"InChI=1S/C10H14N6O3/c11-8-7-9(15-10(12)14-8)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H4,11,12,14,15)/t4-,5+,6+/m0/s1",2-amino-2'-deoxyadenosine,Bright fluorescent purine analogues as promising probes.,175,C10H14N6O3,266.26,267.26
233,"InChI=1S/C10H14N6O4/c1-5-7(18)10(4-17,14-15-12)20-8(5)16-3-2-6(11)13-9(16)19/h2-3,5,7-8,17-18H,4H2,1H3,(H2,11,13,19)/t5-,7-,8+,10+/m0/s1",4'-Azido-2'-deoxy-2'-methylcytidine,Discovery of 4'-azido-2'-deoxy-2'-C-methyl cytidine and prodrugs thereof: a potent inhibitor of Hepatitis C virus replication.,44321,C10H14N6O4,282.26,283.26
234,"InChI=1S/C10H14N6O4/c11-15-8-5-9(13-2-12-8)16(3-14-5)10-7(19)6(18)4(1-17)20-10/h2-4,6-7,10,17-19H,1,11H2,(H,12,13,15)/t4-,6-,7-,10-/m1/s1",N6-aminoadenosine,Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig.,111409,C10H14N6O4,282.26,283.26
235,"InChI=1S/C10H14N6O4/c11-4-3(1-17)20-9(6(4)18)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1,11H2,(H3,12,14,15,19)/t3-,4-,6-,9-/m1/s1",3'-amino-3'-deoxyguanosine,Synthesis of 3'-amino-3'-deoxyguanosine and 3'-amino-3'-deoxyxyloguanosine monophosphate HepDirect prodrugs from guanosine.,55711,C10H14N6O4,282.26,283.26
236,"InChI=1S/C10H14N6O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1,11H2,(H3,12,14,15,19)/t3-,4-,6-,9-/m1/s1",2'-Amino-2'-deoxyguanosine,Syntheses of (2')3'-15N-amino-(2')3'-deoxyguanosine and determination of their pKa values by 15N NMR spectroscopy.,69528,C10H14N6O4,282.26,283.26
237,"InChI=1S/C10H14N6O4/c11-7-4-8(14-2-13-7)16(10(12)15-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,15)(H2,11,13,14)/t3-,5-,6-,9-/m1/s1",8-Aminoadenosine,8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.,52689,C10H14N6O4,282.26,283.26
238,"InChI=1S/C10H14N6O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H4,11,12,14,15)/t3-,5-,6-,9-/m1/s1",2-aminoadenosine,Intrinsic Contributions of 2'-Hydroxyl to the Hydration of Nucleosides at the Monomeric Level.,4530,C10H14N6O4,282.26,283.26
239,"InChI=1S/C10H14N6O4/c11-7-5-8(14-2-13-7)16(3-15-5)9-6(18)10(12,19)4(1-17)20-9/h2-4,6,9,17-19H,1,12H2,(H2,11,13,14)/t4-,6+,9-,10-/m1/s1",3'-aminoadenosine,Synthesis of 3'-acetamidoadenosine derivatives as potential A3 adenosine receptor agonists.,65492,C10H14N6O4,282.26,283.26
240,"InChI=1S/C10H14N6O4/c11-8-5-9(14-2-13-8)16(3-15-5)10(12)7(19)6(18)4(1-17)20-10/h2-4,6-7,17-19H,1,12H2,(H2,11,13,14)/t4-,6-,7-,10+/m1/s1",adenosine amine,Purinergic Signaling and Aminoglycoside Ototoxicity: The Opposing Roles of P1 (Adenosine) and P2 (ATP) Receptors on Cochlear Hair Cell Survival.,9650,C10H14N6O4,282.26,283.26
241,"InChI=1S/C10H14N6O4/c11-9-14-7-6(8(19)15-9)13-10(12)16(7)5-1-3(18)4(2-17)20-5/h3-5,17-18H,1-2H2,(H2,12,13)(H3,11,14,15,19)/t3-,4+,5+/m0/s1",8-Amino-2'-deoxyguanosine,Site-specifically located 8-amino-2'-deoxyguanosine: thermodynamic stability and mutagenic properties in Escherichia coli.,101224,C10H14N6O4,282.26,283.26
242,"InChI=1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1",8-Aminoguanosine,"8-Aminoguanosine Exerts Diuretic, Natriuretic, and Glucosuric Activity via Conversion to 8-Aminoguanine, Yet Has Direct Antikaliuretic Effects.",16809,C10H14N6O5,298.26,299.26
243,"InChI=1S/C10H15ClN5O12P3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(17)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,17H,1-2H2,(H,21,22)(H,23,24)(H2,12,14,15)(H2,18,19,20)",2-chloro-2'-deoxyadenosine triphosphate,Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.,97992,C10H15ClN5O12P3,525.63,526.63
244,"InChI=1S/C10H15ClN5O12P3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(17)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,17H,1-2H2,(H,21,22)(H,23,24)(H2,12,14,15)(H2,18,19,20)/t4-,5+,6+/m0/s1",2-chlorodeoxyadenosine triphosphate,The antileukemia drug 2-chloro-2'-deoxyadenosine: an intrinsic transcriptional antagonist.,87798,C10H15ClN5O12P3,525.63,526.63
245,"InChI=1S/C10H15FN5O13P3/c11-4-6(17)3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(4)16-2-13-5-7(16)14-10(12)15-8(5)18/h2-4,6,9,17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,12,14,15,18)/t3-,4-,6-,9-/m1/s1",2'-deoxy-2'-fluoroguanosine triphosphate,AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase.,10984,C10H15FN5O13P3,525.17,526.17
246,"InChI=1S/C10H15N2O15P3/c13-3-5-2-12(10(16)11-9(5)15)8-1-6(14)7(25-8)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h2-3,6-8,14H,1,4H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t6-,7+,8+/m0/s1",5-formyl-2'-deoxyuridine 5'-triphosphate,"The mutations induced by oxidatively damaged nucleotides, 5-formyl-dUTP and 5-hydroxy-dCTP,in Escherichia coli.",110879,C10H15N2O15P3,496.15,497.15
247,"InChI=1S/C10H15N3O3/c1-6-4-13(10(15)12-9(6)11)8-3-2-7(5-14)16-8/h4,7-8,14H,2-3,5H2,1H3,(H2,11,12,15)/t7-,8+/m0/s1","5-methyl-2',3'-dideoxycytidine","Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.",69099,C10H15N3O3,225.24,226.24
248,"InChI=1S/C10H15N3O4/c1-12-8(11)2-3-13(10(12)16)9-4-6(15)7(5-14)17-9/h2-3,6-7,9,11,14-15H,4-5H2,1H3/t6-,7+,9+/m0/s1",3-methyl-2'-deoxycytidine,The selectivity and inhibition of AlkB.,92910,C10H15N3O4,241.24,242.24
249,"InChI=1S/C10H15N3O4/c1-5-3-13(10(11)12-9(5)16)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6-,7+,8+/m0/s1",2'-deoxy-5-methylisocytidine,"2'-deoxy-1-methylpseudocytidine, a stable analog of 2'-deoxy-5-methylisocytidine.",60105,C10H15N3O4,241.24,242.24
250,"InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6-,7+,8+/m0/s1",2'-deoxy-5-methylcytidine,Excited State Decay Pathways of 2'-Deoxy-5-methylcytidine and Deoxycytidine Revisited in Solution: A Comprehensive Kinetic Study by Femtosecond Transient Absorption.,13724,C10H15N3O4,241.24,242.24
251,"InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6-,7+,8+/m0/s1
InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)
InChI=1S/C10H15N3O4/c1-5-3-13(10(16)12-9(5)11)8-2-6(15)7(4-14)17-8/h3,6-8,14-15H,2,4H2,1H3,(H2,11,12,16)/t6?,7-,8-/m1/s1",5-methyldeoxycytidine,Adenosine Kinase Expression Determines DNA Methylation in Cancer Cell Lines.,1809,C10H15N3O4,241.24,242.24
252,"InChI=1S/C10H15N3O4/c1-5-8(15)6(4-14)17-9(5)13-3-2-7(11)12-10(13)16/h2-3,5-6,8-9,14-15H,4H2,1H3,(H2,11,12,16)/t5-,6+,8-,9+/m0/s1",(2'S)-2'-deoxy-2'-C-methylcytidine,siRNA Modified with 2'-Deoxy-2'-C-methylpyrimidine Nucleosides.,14350,C10H15N3O4,241.24,242.24
253,"InChI=1S/C10H15N3O4/c1-5-8(15)6(4-14)17-9(5)13-3-2-7(11)12-10(13)16/h2-3,5-6,8-9,14-15H,4H2,1H3,(H2,11,12,16)/t5-,6-,8+,9-/m1/s1",2'-deoxy-2'-C-methylcytidine,Core modified 8-17 DNAzymes with 2'-deoxy-2'-C-methylpyrimidine nucleosides.,3546,C10H15N3O4,241.24,242.24
254,"InChI=1S/C10H15N3O4S/c1-4-2-13(10(18)12-8(4)11)9-7(16)6(15)5(3-14)17-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,18)/t5-,6-,7-,9-/m1/s1",5-methyl-2-thiocytidine,Formation of new base pairs between inosine and 5-methyl-2-thiocytidine derivatives.,45349,C10H15N3O4S,273.31,274.31
255,"InChI=1S/C10H15N3O5/c1-10(17)7(15)5(4-14)18-8(10)13-3-2-6(11)12-9(13)16/h2-3,5,7-8,14-15,17H,4H2,1H3,(H2,11,12,16)",2-C-methylcytidine,"Nm 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine.",78510,C10H15N3O5,257.24,258.24
256,"InChI=1S/C10H15N3O5/c1-10(17)7(15)5(4-14)18-8(10)13-3-2-6(11)12-9(13)16/h2-3,5,7-8,14-15,17H,4H2,1H3,(H2,11,12,16)/t5-,7-,8-,10-/m1/s1",2'-C-Methylcytidine,Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs.,34198,C10H15N3O5,257.24,258.24
257,"InChI=1S/C10H15N3O5/c1-10(8(16)7(15)5(4-14)18-10)13-3-2-6(11)12-9(13)17/h2-3,5,7-8,14-16H,4H2,1H3,(H2,11,12,17)/t5-,7-,8-,10-/m1/s1",methylcytidine,Discrimination of common isomerides of methyl nucleosides by collision-induced dissociation tandem mass spectrometry.,4974,C10H15N3O5,257.24,258.24
258,"InChI=1S/C10H15N3O5/c1-11-6-2-3-13(10(17)12-6)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,14-16H,4H2,1H3,(H,11,12,17)/t5-,7-,8-,9-/m1/s1",N(4)-methylcytidine,Properties of N(4)-methylated cytidines in miRNA mimics.,44840,C10H15N3O5,257.24,258.24
259,"InChI=1S/C10H15N3O5/c1-12-6(11)2-3-13(10(12)17)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,11,14-16H,4H2,1H3/t5-,7-,8-,9-/m1/s1
InChI=1S/C10H15N3O5/c1-12-6(11)2-3-13(10(12)17)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,11,14-16H,4H2,1H3/t5-,7-,8-,9+/m1/s1
InChI=1S/C10H15N3O5/c1-12-6(11)2-3-13(10(12)17)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,11,14-16H,4H2,1H3
InChI=1S/C10H15N3O5/c1-12-6(11)2-3-13(10(12)17)9-8(16)7(15)5(4-14)18-9/h2-3,5,7-9,11,14-16H,4H2,1H3/t5-,7?,8?,9-/m1/s1",3-Methylcytidine,Nucleotide resolution profiling of m3C RNA modification by HAC-seq.,3089,C10H15N3O5,257.24,258.24
260,"InChI=1S/C10H15N3O5/c1-17-8-6(15)5(3-14)18-7(8)4-2-12-10(11)13-9(4)16/h2,5-8,14-15H,3H2,1H3,(H3,11,12,13,16)/t5-,6-,7+,8-/m1/s1",2'-O-methylpseudoisocytidine,Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.,76970,C10H15N3O5,257.24,258.24
261,"InChI=1S/C10H15N3O5/c1-17-8-7(15)5(4-14)18-9(8)13-3-2-6(11)12-10(13)16/h2-3,5,7-9,14-15H,4H2,1H3,(H2,11,12,16)/t5-,7-,8-,9-/m1/s1",2'-O-methyl-cytidine,Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.,81169,C10H15N3O5,257.24,258.24
262,"InChI=1S/C10H15N3O5/c1-4(14)8-6(15)7(16)9(18-8)13-3-2-5(11)12-10(13)17/h2-4,6-9,14-16H,1H3,(H2,11,12,17)/t4?,6-,7+,8+,9+/m0/s1",5'-methylcytidine,Kilo-scale synthesis process for 2'-O-(2-methoxyethyl)-pyrimidine derivatives.,78501,C10H15N3O5,257.24,258.24
263,"InChI=1S/C10H15N3O5/c1-4-2-13(10(11)12-8(4)17)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1",5-methylisocytidine,"2'-O-Methyl- and 2'-O-propargyl-5-methylisocytidine: synthesis, properties and impact on the isoCd-dG and the isoCd-isoGd base pairing in nucleic acids with parallel and antiparallel strand orientation.",22917,C10H15N3O5,257.24,258.24
264,"InChI=1S/C10H15N3O5/c1-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1",5-methyl-cytidine,"Quantum dynamics of the ππ*/nπ* decay of the epigenetic nucleobase 1,5-dimethyl-cytosine in the gas phase.",3421,C10H15N3O5,257.24,258.24
265,"InChI=1S/C10H15N3O5/c1-4-2-6(11)12-10(17)13(4)9-8(16)7(15)5(3-14)18-9/h2,5,7-9,14-16H,3H2,1H3,(H2,11,12,17)",6-methylcytidine,Thiosugars. X. Novel nucleoside analogues derived from 4-thio-L-lyxofuranose.,88608,C10H15N3O5,257.24,258.24
266,"InChI=1S/C10H15N3O5/c11-9-5(3-14)2-13(10(17)12-9)8-1-6(16)7(4-15)18-8/h2,6-8,14-16H,1,3-4H2,(H2,11,12,17)/t6-,7+,8+/m0/s1",5-(Hydroxymethyl)-2'-deoxycytidine,"Enrichment and Quantitative Determination of 5-(Hydroxymethyl)-2'-deoxycytidine, 5-(Formyl)-2'-deoxycytidine, and 5-(Carboxyl)-2'-deoxycytidine in Human Urine of Breast Cancer Patients by Magnetic Hyper-Cross-Linked Microporous Polymers Based on Polyionic Liquid.",15501,C10H15N3O5,257.24,258.24
267,"InChI=1S/C10H15N3O5/c11-9-5(3-14)2-13(10(17)12-9)8-1-6(16)7(4-15)18-8/h2,6-8,14-16H,1,3-4H2,(H2,11,12,17)/t6-,7+,8+/m0/s1
InChI=1S/C10H15N3O5/c11-9-5(3-14)2-13(10(17)12-9)8-1-6(16)7(4-15)18-8/h2,6-8,14-16H,1,3-4H2,(H2,11,12,17)/t6-,7-,8-/m1/s1",5-hydroxymethyl-2'-deoxycytidine,Unified Description of Ultrafast Excited State Decay Processes in Epigenetic Deoxycytidine Derivatives.,228,C10H15N3O5,257.24,258.24
268,"InChI=1S/C10H15N3O6/c1-18-12-6-2-3-13(10(17)11-6)9-8(16)7(15)5(4-14)19-9/h2-3,5,7-9,14-16H,4H2,1H3,(H,11,12,17)/t5-,7-,8-,9-/m1/s1",N4-methoxycytidine,Template properties of mutagenic cytosine analogues in reverse transcription.,72882,C10H15N3O6,273.24,274.24
269,"InChI=1S/C10H15N3O6/c11-1-4-2-13(10(18)12-8(4)17)9-7(16)6(15)5(3-14)19-9/h2,5-7,9,14-16H,1,3,11H2,(H,12,17,18)/t5-,6-,7-,9-/m1/s1",5-aminomethyluridine,Characterization and structure of the Aquifex aeolicus protein DUF752: a bacterial tRNA-methyltransferase (MnmC2) functioning without the usually fused oxidase domain (MnmC1).,39050,C10H15N3O6,273.24,274.24
270,"InChI=1S/C10H15N3O6/c11-8-4(2-14)1-13(10(18)12-8)9-7(17)6(16)5(3-15)19-9/h1,5-7,9,14-17H,2-3H2,(H2,11,12,18)/t5-,6-,7-,9-/m1/s1",5-Hydroxymethylcytidine,2'-O-Methyl-5-hydroxymethylcytidine: A Second Oxidative Derivative of 5-Methylcytidine in RNA.,19782,C10H15N3O6,273.24,274.24
271,"InChI=1S/C10H15N3O6/c11-9-5(4-18-17)2-13(10(16)12-9)8-1-6(15)7(3-14)19-8/h2,6-8,14-15,17H,1,3-4H2,(H2,11,12,16)/t6-,7+,8+/m0/s1",5-(hydroperoxymethyl)-2'-deoxycytidine,Potent methyl oxidation of 5-methyl-2'-deoxycytidine by halogenated quinoid carcinogens and hydrogen peroxide via a metal-independent mechanism.,37517,C10H15N3O6,273.24,274.24
272,"InChI=1S/C10H15N3O7/c11-19-4-18-8-7(16)5(3-14)20-9(8)13-2-1-6(15)12-10(13)17/h1-2,5,7-9,14,16H,3-4,11H2,(H,12,15,17)/t5-,7-,8-,9-/m1/s1",2'-O-(aminooxymethyl)uridine,Convenient and efficient approach to the permanent or reversible conjugation of RNA and DNA sequences with functional groups.,39747,C10H15N3O7,289.24,290.24
273,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(16)14-10)12-3-15(8)6-1-4(25-27(20,21)22)5(24-6)2-23-26(17,18)19/h3-6H,1-2H2,(H2,17,18,19)(H2,20,21,22)(H3,11,13,14,16)/t4-,5+,6+/m0/s1","2'-deoxyguanosine-3',5'-diphosphate",Electron attachment to DNA single strands: gas phase and aqueous solution.,69347,C10H15N5O10P2,427.2,428.2
274,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1
InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)
InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6?/m0/s1",deoxyguanosine diphosphate,Mechanism of Deoxyguanosine Diphosphate Insertion by Human DNA Polymerase β.,2710,C10H15N5O10P2,427.2,428.2
275,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",adenosine 5'-diphosphate,Clinical overview of promising nonthienopyridine antiplatelet agents.,63876,C10H15N5O10P2,427.2,428.2
276,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",adenosine-diphosphate,[Systemic inflammatory response syndrome associated with use of ticagrelor].,352,C10H15N5O10P2,427.2,428.2
277,"InChI=1S/C10H15N5O10P2S/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-6(28)5(16)3(24-9)1-23-27(21,22)25-26(18,19)20/h2-3,5-6,9,16,28H,1H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",thioguanosine diphosphate,Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?,60279,C10H15N5O10P2S,459.27,460.27
278,"InChI=1S/C10H15N5O10P2S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(24-9)1-23-27(22,28)25-26(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,28)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-,27?/m1/s1",guanosine 5'-O-(1-thiodiphosphate,Synthesis and characterization of mRNA cap analogs containing phosphorothioate substitutions that bind tightly to eIF4E and are resistant to the decapping pyrophosphatase DcpS.,65273,C10H15N5O10P2S,459.27,460.27
279,"InChI=1S/C10H15N5O10P2S/c11-10-13-7-4(8(28)14-10)12-2-15(7)9-6(17)5(16)3(24-9)1-23-27(21,22)25-26(18,19)20/h2-3,5-6,9,16-17H,1H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,28)/t3-,5-,6-,9-/m1/s1",6-thioguanosine diphosphate,Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function.,23011,C10H15N5O10P2S,459.27,460.27
280,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(26-28(21,22)23)3(25-9)1-24-27(18,19)20/h2-3,5-6,9,16H,1H2,(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1","guanosine 3',5'-diphosphate",Comprehensive analysis of DNA strand breaks at the guanosine site induced by low-energy electron attachment.,57028,C10H15N5O11P2,443.2,444.2
281,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",guanosine 5'-diphosphate,Hair cell specific NTPDase6 immunolocalisation in vestibular end organs: potential role of purinergic signaling in vestibular sensory transduction.,37859,C10H15N5O11P2,443.2,444.2
282,"InChI=1S/C10H15N5O13P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/t4-,6-,7-,10-/m1/s1",3'-phosphoadenosine 5'-phosphosulfate,Synthesis of nucleoside phosphosulfates.,41532,C10H15N5O13P2S,507.27,508.27
283,"InChI=1S/C10H15N5O4/c11-10-12-1-4-8(14-10)15(3-13-4)9-7(18)6(17)5(2-16)19-9/h3,5-7,9,16-18H,1-2H2,(H3,11,12,14)",(deoxy)guanosine,Mechanism of formation of (deoxy)guanosine adducts derived from peroxidase-catalyzed oxidation of the carcinogenic nonaminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I).,57714,C10H15N5O4,269.26,270.26
284,"InChI=1S/C10H15N5O4/c11-8-7-9(13-3-12-8)15(10(18)14-7)6-1-4(17)5(2-16)19-6/h4-6,13,16-17H,1-3H2,(H2,11,12)(H,14,18)/t4-,5+,6+/m1/s1",8-oxodeoxyadenosine,Recognition of oxidatively modified bases within the biotin-binding site of avidin.,77316,C10H15N5O4,269.26,270.26
285,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",2'-deoxyadenosine 5'-diphosphate,Effect of the ribose versus 2'-deoxyribose residue on the metal ion-binding properties of purine nucleotides.,62901,C10H15N5O9P2,411.2,412.2
286,"InChI=1S/C10H15N6O6P/c11-8-5-9(14-2-13-8)16(3-15-5)10-7(18)6(17)4(22-10)1-21-23(12,19)20/h2-4,6-7,10,17-18H,1H2,(H2,11,13,14)(H3,12,19,20)/t4-,6-,7-,10-/m1/s1",adenosine 5'-monophosphoramidate,31P NMR and genetic analysis establish hinT as the only Escherchia coli purine nucleoside phosphoramidase and as essential for growth under high salt conditions.,82304,C10H15N6O6P,346.24,347.24
287,"InChI=1S/C10H16N3O7P/c1-5-3-13(10(15)12-9(5)11)8-2-6(14)7(20-8)4-19-21(16,17)18/h3,6-8,14H,2,4H2,1H3,(H2,11,12,15)(H2,16,17,18)/t6-,7+,8+/m0/s1",5-methyl-2'-deoxycytidine monophosphate,Formation and Determination of Endogenous Methylated Nucleotides in Mammals by Chemical Labeling Coupled with Mass Spectrometry Analysis.,19180,C10H16N3O7P,321.22,322.22
288,"InChI=1S/C10H16N3O8P/c1-4-2-13(10(16)12-8(4)11)9-7(15)6(14)5(21-9)3-20-22(17,18)19/h2,5-7,9,14-15H,3H2,1H3,(H2,11,12,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1",5-methylcytidine monophosphate,Formation and Determination of Endogenous Methylated Nucleotides in Mammals by Chemical Labeling Coupled with Mass Spectrometry Analysis.,19180,C10H16N3O8P,337.22,338.22
289,"InChI=1S/C10H16N5O11P3/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h4-7H,1-3H2,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1","2',3'-dideoxyadenosine triphosphate",A strategy for liquid chromatography/tandem mass spectrometric assays of intracellular drugs: application to the validation of the triphosphorylated anabolite of antiretrovirals in peripheral blood mononuclear cells.,89894,C10H16N5O11P3,475.18,476.18
290,"InChI=1S/C10H16N5O11P3/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h4-7H,1-3H2,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m1/s1","2',3'-dideoxyadenosine-5'-triphosphate","Simultaneous determination of 2',3'-dideoxyinosine and the active metabolite, 2',3'-dideoxyadenosine-5'-triphosphate in human peripheral-blood mononuclear cell by HPLC-MS/MS and the application to cell pharmacokinetics.",26437,C10H16N5O11P3,475.18,476.18
291,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",2'-deoxyadenosine 5'-triphosphate,Effect of the ribose versus 2'-deoxyribose residue on the metal ion-binding properties of purine nucleotides.,62901,C10H16N5O12P3,491.18,492.18
292,"InChI=1S/C10H16N5O13P3.2Na/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;/t4-,6-,7-,10-;;/m1../s1
InChI=1S/C10H16N5O13P3.2Na.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;1H2/q;2*+1;/p-2/t4-,6-,7-,10?;;;/m1.../s1",adenosine disodium triphosphate,[Optimization of high-cell-density fermentation process for S-adenosyl-L-methionine production].,58741,C10H16N5Na2O13P3,553.16,554.16
293,"InChI=1S/C10H16N5O13P3.4K/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;;;;/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);;;;/q;4*+1/p-4/t4-,6-,7-,10-;;;;/m1..../s1",potassium-adenosine triphosphate,Donor heart preservation with pinacidil: the role of the mitochondrial K ATP channel.,85089,C10H12K4N5O13P3,659.54,660.54
294,"InChI=1S/C10H16N5O13P3.C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20;11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20);2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t2*4-,6-,7-,10-/m11/s1",ATP-adenosine,Targeting adenosine in cancer immunotherapy: a review of recent progress.,18709,C20H29N10O17P3,774.42,775.42
295,"InChI=1S/C10H16N5O13P3/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",2'-deoxyguanosine 5'-triphosphate,Misincorporation of 2'-deoxyoxanosine 5'-triphosphate by DNA polymerases and its implication for mutagenesis.,111221,C10H16N5O13P3,507.18,508.18
296,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",adenosine triphosphate,Purinergic signaling in the modulation of redox biology.,455,C10H16N5O13P3,507.18,508.18
297,"InChI=1S/C10H16N5O13P3/c11-8-7-9(14-10(17)13-8)15(3-12-7)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",2'-deoxy-2-hydroxyadenosine triphosphate,"MTH1, an oxidized purine nucleoside triphosphatase, prevents the cytotoxicity and neurotoxicity of oxidized purine nucleotides.",75937,C10H16N5O13P3,507.18,508.18
298,"InChI=1S/C10H16N5O13P3/c11-8-7-9(14-10(17)13-8)15(3-12-7)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1
InChI=1S/C10H16N5O13P3/c11-8-7-9(14-10(17)13-8)15(3-12-7)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/p-4/t4-,5+,6+/m0/s1",2-hydroxy-2'-deoxyadenosine 5'-triphosphate,"Mutagenicity of oxidized DNA precursors in living cells: Roles of nucleotide pool sanitization and DNA repair enzymes, and translesion synthesis DNA polymerases.",54164,C10H16N5O13P3,507.18,508.18
299,"InChI=1S/C10H16N5O13P3S/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-6(32)5(16)3(26-9)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-3,5-6,9,16,32H,1H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",thioguanosine triphosphate,Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.,31500,C10H16N5O13P3S,539.25,540.25
300,"InChI=1S/C10H16N5O13P3S/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(26-9)1-25-29(19,20)27-30(21,22)28-31(23,24)32/h2-3,5-6,9,16-17H,1H2,(H,19,20)(H,21,22)(H2,23,24,32)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",guanosine 5'-[gamma-thio]triphosphate,High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor.,61386,C10H16N5O13P3S,539.25,540.25
301,"InChI=1S/C10H16N5O13P3S/c11-10-13-7-4(8(32)14-10)12-2-15(7)9-6(17)5(16)3(26-9)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-3,5-6,9,16-17H,1H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,32)/t3-,5-,6-,9-/m1/s1",6-thioguanosine triphosphate,NUDT15: A bench to bedside success story.,2227,C10H16N5O13P3S,539.25,540.25
302,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-4/t3-,5-,6-,9-/m1/s1",guanosine-triphosphate,Azathioprine and 6-mercaptopurine alter the nucleotide balance in endothelial cells.,108836,C10H12N5O14P3,519.15,520.15
303,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",guanosine triphosphate,"Guanosine, a guanine-based nucleoside relaxed isolated corpus cavernosum from mice through cGMP accumulation.",5494,C10H16N5O14P3,523.18,524.18
304,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-4/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-3/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H16N5O14P3.4Li/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21;;;;/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18);;;;/q;4*+1/p-4/t3-,5-,6-,9-;;;;/m1..../s1",guanosine 5'-triphosphate,A novel Escherichia coli strain allows functional analysis of guanylate kinase drug resistance and sensitivity.,87916,C10H16N5O14P3,523.18,524.18
305,"InChI=1S/C10H16N5O14P3/c11-9-13-7-6(8(17)14-9)12-10(18)15(7)5-1-3(16)4(27-5)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-5,16H,1-2H2,(H,12,18)(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,17)/t3-,4+,5+/m0/s1",8-oxo-2'-deoxyguanosine triphosphate,Development of Damaged Nucleoside Mimics for Inhibition of Their Repair Enzymes.,19256,C10H16N5O14P3,523.18,524.18
306,"InChI=1S/C10H16N5O14P3/c11-9-13-7-6(8(17)14-9)12-10(18)15(7)5-1-3(16)4(27-5)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-5,16H,1-2H2,(H,12,18)(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,17)/t3-,4?,5?/m0/s1",8-Hydroxy-2'-deoxyguanosine 5'-triphosphate,"Mutagenicity of oxidized DNA precursors in living cells: Roles of nucleotide pool sanitization and DNA repair enzymes, and translesion synthesis DNA polymerases.",54164,C10H16N5O14P3,523.18,524.18
307,"InChI=1S/C10H16N5O15P3/c11-9-13-6-3(7(18)14-9)12-10(19)15(6)8-5(17)4(16)2(28-8)1-27-32(23,24)30-33(25,26)29-31(20,21)22/h2,4-5,8,16-17H,1H2,(H,12,19)(H,23,24)(H,25,26)(H2,20,21,22)(H3,11,13,14,18)/t2-,4-,5-,8-/m1/s1",8-hydroxyguanosine triphosphate,Anti-inflammatory effects of 8-hydroxy-2'-deoxyguanosine on lipopolysaccharide-induced inflammation via Rac suppression in Balb/c mice.,67617,C10H16N5O15P3,539.18,540.18
308,"InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1
InChI=1S/C10H17N5O17P4/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6(30-36(26,27)32-34(21,22)23)3(29-9)1-28-35(24,25)31-33(18,19)20/h2-3,5-6,9,16H,1H2,(H,24,25)(H,26,27)(H2,18,19,20)(H2,21,22,23)(H3,11,13,14,17)/p-6/t3-,5-,6-,9-/m1/s1","guanosine 3',5'-bispyrophosphate","Crystal structure of Escherichia coli MazG, the regulator of nutritional stress response.",65822,C10H17N5O17P4,603.16,604.16
309,"InChI=1S/C10H17N6O13P3/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(18)5(17)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,17-18H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H4,11,12,14,15)/t3-,5-,6-,9-/m1/s1",2-aminoadenosine triphosphate,Quantitative assessment of the use of modified nucleoside triphosphates in expression profiling: differential effects on signal intensities and impacts on expression ratios.,94901,C10H17N6O13P3,522.2,523.2
310,"InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)11)8-2-6(14)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,14H,2,4H2,1H3,(H,19,20)(H,21,22)(H2,11,12,15)(H2,16,17,18)/t6-,7+,8+/m0/s1
InChI=1S/C10H18N3O13P3/c1-5-3-13(10(15)12-9(5)11)8-2-6(14)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,14H,2,4H2,1H3,(H,19,20)(H,21,22)(H2,11,12,15)(H2,16,17,18)/p-4/t6-,7+,8+/m0/s1",5-methyl-2'-deoxycytidine-5'-triphosphate,Alteration of the DNA methylation status of donor cells impairs the developmental competence of porcine cloned embryos.,25601,C10H18N3O13P3,481.18,482.18
311,"InChI=1S/C10H18N3O14P3/c1-10(16)7(14)5(25-8(10)13-3-2-6(11)12-9(13)15)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h2-3,5,7-8,14,16H,4H2,1H3,(H,20,21)(H,22,23)(H2,11,12,15)(H2,17,18,19)/t5-,7-,8-,10-/m1/s1",2'-C-methylcytidine triphosphate,Antiviral efficacy upon administration of a HepDirect prodrug of 2'-C-methylcytidine to hepatitis C virus-infected chimpanzees.,49023,C10H18N3O14P3,497.18,498.18
312,"InChI=1S/C10H18N3O14P3/c1-4-2-13(10(16)12-8(4)11)9-7(15)6(14)5(25-9)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h2,5-7,9,14-15H,3H2,1H3,(H,20,21)(H,22,23)(H2,11,12,16)(H2,17,18,19)/t5-,6-,7-,9-/m1/s1",5-methylcytidine-5'-triphosphate,An Efficient Protection-Free One-Pot Chemical Synthesis of Modified Nucleoside-5'-Triphosphates.,23113,C10H18N3O14P3,497.18,498.18
313,"InChI=1S/C10H6N5O17P3S/c16-1-7-8(18)9(19,27-34(21,25-7)26-8)10(24-7)13-4-2-3(17)12-5(15-30-35(22,28-10)31-15)14(4)29-33(20,32-36)23-6(13)11-2/h16,18-19,36H,1H2",guanosine-5'-O-(3-thio)triphosphate,The heat shock cognate protein hsc73 assembles with A(1) adenosine receptors to form functional modules in the cell membrane.,104322,C10H6N5O17P3S,593.17,594.17
314,"InChI=1S/C11H10F2N2O5/c1-2-5-3-15(10(19)14-8(5)18)9-11(12,13)7(17)6(4-16)20-9/h1,3,6-7,9,16-17H,4H2,(H,14,18,19)/t6-,7-,9-/m1/s1","2'-deoxy-2',2'-difluoro-5-ethynyluridine",A Bioorthogonal Chemical Reporter of Viral Infection.,28022,C11H10F2N2O5,288.2,289.2
315,"InChI=1S/C11H11BrFN5O3/c12-5(13)1-4-7(19)8(20)11(21-4)18-3-17-6-9(14)15-2-16-10(6)18/h1-4,7-8,11,19-20H,(H2,14,15,16)/b5-1+/t4-,7-,8-,11-/m1/s1",5'-(bromofluoromethylene)-5'-deoxyadenosine,Synthesis of 5'-functionalized nucleosides: S-Adenosylhomocysteine analogues with the carbon-5' and sulfur atoms replaced by a vinyl or halovinyl unit.,65092,C11H11BrFN5O3,360.14,361.14
316,"InChI=1S/C11H11FN2O5/c1-2-5-3-14(11(18)13-9(5)17)10-7(12)8(16)6(4-15)19-10/h1,3,6-8,10,15-16H,4H2,(H,13,17,18)/t6-,7+,8-,10-/m1/s1",(2'S)-2'-deoxy-2'-fluoro-5-ethynyluridine,Dynamic metabolic labeling of DNA in vivo with arabinosyl nucleosides.,46167,C11H11FN2O5,270.21,271.21
317,"InChI=1S/C11H12FIN2O5/c12-7-8(17)6(4-16)20-10(7)15-3-5(1-2-13)9(18)14-11(15)19/h1-3,6-8,10,16-17H,4H2,(H,14,18,19)/b2-1+/t6-,7-,8-,10-/m1/s1",(E)-5-(2-Iodovinyl)-2'-fluoro-2'-deoxyuridine,A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.,80267,C11H12FIN2O5,398.13,399.13
318,"InChI=1S/C11H12N2O4/c1-2-7-5-13(11(16)12-10(7)15)9-4-3-8(6-14)17-9/h1,5,8-9,14H,3-4,6H2,(H,12,15,16)/t8-,9+/m0/s1","5-ethynyl-2',3'-dideoxyuridine",Nucleotide and nucleoside analogues as inhibitors of cytosolic 5'-nucleotidase I from heart.,111828,C11H12N2O4,236.22,237.22
319,"InChI=1S/C11H12N2O5/c1-2-11(5-7(15)8(6-14)18-11)13-4-3-9(16)12-10(13)17/h1,3-4,7-8,14-15H,5-6H2,(H,12,16,17)/t7-,8+,11+/m0/s1",ethynyl deoxyuridine,Utilization of macrophage extracellular trap nucleotides by Mycoplasma hyopneumoniae.,12216,C11H12N2O5,252.22,253.22
320,"InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)
InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)/t7?,8-,9-/m1/s1",5-ethynyl-2-deoxyuridine,Kinetics of Label Retaining Cells in the Developing Rat Kidneys.,25186,C11H12N2O5,252.22,253.22
321,"InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)/t7-,8+,9+/m0/s1",2'-Deoxy-5-ethynyluridine,A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity.,29528,C11H12N2O5,252.22,253.22
322,"InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)/t7-,8+,9+/m0/s1
InChI=1S/C11H12N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h1,4,7-9,14-15H,3,5H2,(H,12,16,17)/t7-,8+,9+/m1/s1",5'-Ethynyl-2'-deoxyuridine,Cell-Based High Content Analysis of Cell Proliferation and Apoptosis.,16339,C11H12N2O5,252.22,253.22
323,"InChI=1S/C11H12N2O6/c1-2-11(18)6(5-14)19-9(8(11)16)13-4-3-7(15)12-10(13)17/h1,3-4,6,8-9,14,16,18H,5H2,(H,12,15,17)/t6-,8+,9-,11-/m1/s1",3'-C-ethynyluridine,Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).,82510,C11H12N2O6,268.22,269.22
324,"InChI=1S/C11H12N2O6/c1-2-11(18)8(16)6(5-14)19-9(11)13-4-3-7(15)12-10(13)17/h1,3-4,6,8-9,14,16,18H,5H2,(H,12,15,17)/t6-,8-,9-,11-/m1/s1",2'-ethynyluridine,Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk.,21477,C11H12N2O6,268.22,269.22
325,"InChI=1S/C11H12N2O6/c1-2-11(9(17)8(16)6(5-14)19-11)13-4-3-7(15)12-10(13)18/h1,3-4,6,8-9,14,16-17H,5H2,(H,12,15,18)/t6-,8-,9-,11-/m1/s1",ethynyl-uridine,Labeling and Purification of Temporally Expressed RNAs During the S-Phase of the Cell Cycle in Living Cells.,3057,C11H12N2O6,268.22,269.22
326,"InChI=1S/C11H12N2O6/c1-2-5-3-13(11(18)12-9(5)17)10-8(16)7(15)6(4-14)19-10/h1,3,6-8,10,14-16H,4H2,(H,12,17,18)/t6-,7-,8-,10-/m1/s1",5-ethynyl uridine,Metabolic Labeling of RNAs Uncovers Hidden Features and Dynamics of the Arabidopsis Transcriptome.,6674,C11H12N2O6,268.22,269.22
327,"InChI=1S/C11H12N6O3S/c12-2-21-1-5-7(18)8(19)11(20-5)17-4-16-6-9(13)14-3-15-10(6)17/h3-5,7-8,11,18-19H,1H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1",5'-S-cyano-5'-thioadenosine,Inactivation of S-adenosyl-L-homocysteine hydrolase with novel 5'-thioadenosine derivatives. Antiviral effects.,91453,C11H12N6O3S,308.32,309.32
328,"InChI=1S/C11H13BrN2O4S/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+
InChI=1S/C11H13BrN2O4S/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9-/m0/s1
InChI=1S/C11H13BrN2O4S/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1",(E)-5-(2-Bromovinyl)-2'-deoxy-4'-thiouridine,Efficient syntheses of (E)-5-(2-bromovinyl)-2'-deoxy-4'-thiouridine; a nucleoside analogue with potent biological activity.,111255,C11H13BrN2O4S,349.2,350.2
329,"InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1",(E)-5-(2-Bromovinyl)-2'-deoxyuridine,Determination of (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma and urine by capillary electrophoresis.,108634,C11H13BrN2O5,333.14,334.14
330,"InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1
InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8-,10-/m1/s1",(E)-5-(2-bromovinyl)uridine,Novel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2.,103270,C11H13BrN2O6,349.13,350.13
331,"InChI=1S/C11H13F2N5O3S/c12-11(13)22-1-4-6(19)7(20)10(21-4)18-3-17-5-8(14)15-2-16-9(5)18/h2-4,6-7,10-11,19-20H,1H2,(H2,14,15,16)/t4-,6-,7-,10-/m1/s1",5'-Deoxy-5'-difluoromethylthioadenosine,The mechanism of inactivation of S-adenosylhomocysteine hydrolase by fluorinated analogs of 5'-methylthioadenosine.,110396,C11H13F2N5O3S,333.32,334.32
332,"InChI=1S/C11H13FN2O4/c1-2-6-4-14(11(17)13-9(6)16)10-8(12)3-7(5-15)18-10/h3-4,7,10,15H,2,5H2,1H3,(H,13,16,17)/t7-,10+/m0/s1","2',3'-dideoxy-2',3'-didehydro-2'-fluoro-5-ethyluridine","Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.",52614,C11H13FN2O4,256.23,257.23
333,"InChI=1S/C11H13IN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1",(E)-5-(2-Iodovinyl)-2'-deoxyuridine,In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats.,88055,C11H13IN2O5,380.14,381.14
334,"InChI=1S/C11H13IN2O5/c12-3-2-11(5-7(16)8(6-15)19-11)14-4-1-9(17)13-10(14)18/h1-4,7-8,15-16H,5-6H2,(H,13,17,18)/t7-,8+,11+/m0/s1",iodovinyldeoxyuridine,Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.,88028,C11H13IN2O5,380.14,381.14
335,"InChI=1S/C11H13IN2O6/c12-3-2-11(19)6(5-15)20-9(8(11)17)14-4-1-7(16)13-10(14)18/h1-4,6,8-9,15,17,19H,5H2,(H,13,16,18)/b3-2+/t6-,8+,9-,11-/m1/s1",3'-(E)-(2-iodovinyl)uridine,"Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualization.",57577,C11H13IN2O6,396.14,397.14
336,"InChI=1S/C11H13N3O4/c1-2-11(6-15)7(16)5-9(18-11)14-4-3-8(12)13-10(14)17/h1,3-4,7,9,15-16H,5-6H2,(H2,12,13,17)/t7-,9+,11+/m0/s1",4'-C-ethynyl-2'-deoxycytidine,"A 4'-C-ethynyl-2',3'-dideoxynucleoside analogue highlights the role of the 3'-OH in anti-HIV active 4'-C-ethynyl-2'-deoxy nucleosides.",84211,C11H13N3O4,251.24,252.24
337,"InChI=1S/C11H13N3O4/c1-2-6-4-14(11(17)13-10(6)12)9-3-7(16)8(5-15)18-9/h1,4,7-9,15-16H,3,5H2,(H2,12,13,17)/t7-,8+,9+/m0/s1",5-ethynyl-2'-deoxycytidine,Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2'-deoxyuridine and 5-ethynyl-2'-deoxycytidine.,24800,C11H13N3O4,251.24,252.24
338,"InChI=1S/C11H13N3O4/c12-8-2-4-14(10(17)13-8)11-3-1-6(11)9(16)7(5-15)18-11/h1-4,6-7,9,15-16H,5H2,(H2,12,13,17)/t6-,7-,9+,11-/m1/s1",ethenodeoxycytidine,Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA.,99519,C11H13N3O4,251.24,252.24
339,"InChI=1S/C11H13N3O4/c15-6-8-7(16)5-10(18-8)14-3-1-9-12-2-4-13(9)11(14)17/h1-4,7-8,10,15-16H,5-6H2/t7-,8+,10+/m0/s1","3,N(4)-etheno-2'-deoxycytidine",Ultrasensitive UPLC-MS/MS method for analysis of etheno-DNA adducts in human white blood cells.,28054,C11H13N3O4,251.24,252.24
340,"InChI=1S/C11H13N3O5/c1-2-11(18)6(5-15)19-9(8(11)16)14-4-3-7(12)13-10(14)17/h1,3-4,6,8-9,15-16,18H,5H2,(H2,12,13,17)/t6-,8+,9-,11-/m1/s1",3'-C-ethynylcytidine,Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro.,13450,C11H13N3O5,267.24,268.24
341,"InChI=1S/C11H13N3O5/c1-2-5-3-14(11(18)13-9(5)12)10-8(17)7(16)6(4-15)19-10/h1,3,6-8,10,15-17H,4H2,(H2,12,13,18)/t6-,7-,8-,10-/m1/s1",5-ethynylcytidine,"5-Ethynylcytidine as a new agent for detecting RNA synthesis in live cells by ""click"" chemistry.",38376,C11H13N3O5,267.24,268.24
342,"InChI=1S/C11H13N3O5/c1-2-5-3-14(11(18)13-9(5)12)10-8(17)7(16)6(4-15)19-10/h1,3,6-8,10,15-17H,4H2,(H2,12,13,18)/t6-,7-,8-,10?/m1/s1",ethinylcytidine,Liposome Formulations of Hydrophobic Drugs.,20700,C11H13N3O5,267.24,268.24
343,"InChI=1S/C11H13N3O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h3,6-8,10,15-17H,1,4H2,(H,13,18,19)/t6-,7-,8-,10-/m1/s1",5-Cyanomethyluridine,Cyano Modification on Uridine Decreases Base-Pairing Stability and Specificity through Neighboring Disruption in RNA Duplex.,12535,C11H13N3O6,283.24,284.24
344,"InChI=1S/C11H13N5O3/c1-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h2-5,7-8,11,17-18H,1H2,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",5'-deoxy-5'-methyleneadenosine,Synthesis of 5'-functionalized nucleosides: S-Adenosylhomocysteine analogues with the carbon-5' and sulfur atoms replaced by a vinyl or halovinyl unit.,65092,C11H13N5O3,263.25,264.25
345,"InChI=1S/C11H13N5O3/c12-9-8-10(14-4-13-9)16(5-15-8)7-1-6-11(2-17,19-7)3-18-6/h4-7,17H,1-3H2,(H2,12,13,14)/t6-,7+,11-/m0/s1",Isoadenosine,Carbocyclic isoadenosine analogues of neplanocin A.,88666,C11H13N5O3,263.25,264.25
346,"InChI=1S/C11H13N5O4/c12-8-5-9(14-3-13-8)16(4-15-5)10-6-7(18)11(1-17,20-10)2-19-6/h3-4,6-7,10,17-18H,1-2H2,(H2,12,13,14)/t6-,7+,10-,11+/m1/s1",LNA-adenosine,"A chemical synthesis of LNA-2,6-diaminopurine riboside, and the influence of 2'-O-methyl-2,6-diaminopurine and LNA-2,6-diaminopurine ribosides on the thermodynamic properties of 2'-O-methyl RNA/RNA heteroduplexes.",69955,C11H13N5O4,279.25,280.25
347,"InChI=1S/C11H13N5O4/c12-9-6-10(14-2-13-9)16(3-15-6)11-8-7(18-4-19-8)5(1-17)20-11/h2-3,5,7-8,11,17H,1,4H2,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1","2',3'-O-methyleneadenosine","Hydrolysis of 2',3'-O-methyleneadenos-5'-yl bis(2',5'-di-O-methylurid-3'-yl) phosphate, a sugar O-alkylated trinucleoside 3',3',5'-monophosphate: implications for the mechanism of large ribozymes.",87600,C11H13N5O4,279.25,280.25
348,"InChI=1S/C11H13N5O5/c1-5(14-15-12)6-3-16(11(20)13-10(6)19)9-2-7(18)8(4-17)21-9/h3,7-9,17-18H,1-2,4H2,(H,13,19,20)/t7-,8+,9+/m0/s1",5-(1-azidovinyl)-2'-deoxyuridine,Electron-Mediated Aminyl and Iminyl Radicals from C5 Azido-Modified Pyrimidine Nucleosides Augment Radiation Damage to Cancer Cells.,11958,C11H13N5O5,295.25,296.25
349,"InChI=1S/C11H13N7O3/c12-2-11(3-19)5(20)1-6(21-11)18-4-15-7-8(13)16-10(14)17-9(7)18/h4-6,19-20H,1,3H2,(H4,13,14,16,17)/t5-,6+,11+/m0/s1",4'-C-cyano-2-amino-2'-deoxyadenosine,4'-modified nucleoside analogs: potent inhibitors active against entecavir-resistant hepatitis B virus.,27394,C11H13N7O3,291.27,292.27
350,"InChI=1S/C11H14BrN3O4/c12-2-1-6-4-15(11(18)14-10(6)13)9-3-7(17)8(5-16)19-9/h1-2,4,7-9,16-17H,3,5H2,(H2,13,14,18)/b2-1+/t7?,8-,9-/m1/s1",(E)-5-(2-bromovinyl)-2'-deoxycytidine,"Synthesis, molecular conformation and activity against herpes simplex virus of (E)-5-(2-bromovinyl)-2'-deoxycytidine analogs.",44464,C11H14BrN3O4,332.15,333.15
351,"InChI=1S/C11H14BrN5O5/c12-2-6(15-16-13)5-3-17(11(21)14-10(5)20)9-1-7(19)8(4-18)22-9/h3,6-9,18-19H,1-2,4H2,(H,14,20,21)/t6?,7-,8+,9+/m0/s1",5-(1-azido-2-bromoethyl)-2'-deoxyuridine,Synthesis and antiviral activity of novel 5-(1-cyanamido-2-haloethyl) and 5-(1-hydroxy(or methoxy)-2-azidoethyl) analogues of uracil nucleosides.,98491,C11H14BrN5O5,376.16,377.16
352,"InChI=1S/C11H14N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h2,4,7-9,14-15H,1,3,5H2,(H,12,16,17)/t7-,8+,9+/m0/s1",5-Vinyl-2'-deoxyuridine,Alkene-tetrazine ligation for imaging cellular DNA.,41763,C11H14N2O5,254.24,255.24
353,"InChI=1S/C11H14N2O5/c1-5-3-13(11(17)12-9(5)16)10-6(2)8(15)7(4-14)18-10/h3,7-8,10,14-15H,2,4H2,1H3,(H,12,16,17)/t7-,8+,10-/m1/s1",2'-Deoxy-2'-methylene-6-azauridine,"Synthesis of 2'-methylene-substituted 5-azapyrimidine, 6-azapyrimidine, and 3-deazaguanine nucleoside analogues as potential antitumor/antiviral agents.",109524,C11H14N2O5,254.24,255.24
354,"InChI=1S/C11H14N2O6/c1-2-5-3-13(11(18)12-9(5)17)10-8(16)7(15)6(4-14)19-10/h2-3,6-8,10,14-16H,1,4H2,(H,12,17,18)/t6-,7-,8-,10-/m1/s1",5-vinyluridine,Mutually Orthogonal Bioconjugation of Vinyl Nucleosides for RNA Metabolic Labeling.,574,C11H14N2O6,270.24,271.24
355,"InChI=1S/C11H14N2O6/c1-6(15)13-9(17)2-3-12(11(13)18)10-4-7(16)8(5-14)19-10/h2-3,7-8,10,14,16H,4-5H2,1H3/t7-,8+,10+/m0/s1",3-acetyl-2'-deoxyuridine,New Cerebroside and Nucleoside Derivatives from a Red Sea Strain of the Marine Cyanobacterium Moorea producens.,23736,C11H14N2O6,270.24,271.24
356,"InChI=1S/C11H14N2O7/c14-3-4-19-9-8(17)6(5-15)20-10(9)13-2-1-7(16)12-11(13)18/h1-3,6,8-10,15,17H,4-5H2,(H,12,16,18)/t6-,8-,9-,10-/m1/s1",2'-O-(2-oxoethyl)uridine,"[Synthesis and characteristics of modified oligodeoxyribonucleotides containing 2'-O-(2,3-dihydroxypropyl)uridine and 2'-O-(2-exoethyl)uridine].",101302,C11H14N2O7,286.24,287.24
357,"InChI=1S/C11H14N2O9/c14-2-5-7(17)8(18)10(22-5)13-1-4(21-3-6(15)16)9(19)12-11(13)20/h1,5,7-8,10,14,17-18H,2-3H2,(H,15,16)(H,12,19,20)",uridine 5-oxyacetic acid,Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines.,70377,C11H14N2O9,318.24,319.24
358,"InChI=1S/C11H14N2O9/c14-2-5-7(17)8(18)10(22-5)13-1-4(21-3-6(15)16)9(19)12-11(13)20/h1,5,7-8,10,14,17-18H,2-3H2,(H,15,16)(H,12,19,20)/t5-,7-,8-,10-/m1/s1",5-oxyacetyluridine,Identification of a novel tRNA wobble uridine modifying activity in the biosynthesis of 5-methoxyuridine.,13573,C11H14N2O9,318.24,319.24
359,"InChI=1S/C11H14N4O3/c12-10-6-1-2-15(11(6)14-5-13-10)9-3-7(17)8(4-16)18-9/h1-2,5,7-9,16-17H,3-4H2,(H2,12,13,14)/t7-,8+,9+/m0/s1",7-Deaza-2'-deoxyadenosine,Probing DNA interstrand cross-link formation by an oxidized abasic site using nonnative nucleotides.,47540,C11H14N4O3,250.25,251.25
360,"InChI=1S/C11H14N4O3/c12-11-10-6(1-2-13-11)15(5-14-10)9-3-7(17)8(4-16)18-9/h1-2,5,7-9,16-17H,3-4H2,(H2,12,13)/t7-,8+,9+/m0/s1",3-deaza-2'-deoxyadenosine,"Design and synthesis of a novel fluorescent benzo[g]imidazo[4,5-c]quinoline nucleoside for monitoring base-pair-induced protonation with cytosine: distinguishing cytosine via changes in the intensity and wavelength of fluorescence.",23577,C11H14N4O3,250.25,251.25
361,"InChI=1S/C11H14N4O4.H2O/c12-9-5-1-2-15(10(5)14-11(18)13-9)8-3-6(17)7(4-16)19-8;/h1-2,6-8,16-17H,3-4H2,(H3,12,13,14,18);1H2/t6-,7+,8+;/m0./s1",7-deaza-2'-deoxyisoguanosine,Mismatch discrimination of base-modified nucleic acids and their constituents: non-Watson-Crick base pairing induced by tautomerization.,67303,C11H16N4O5,284.27,285.27
362,"InChI=1S/C11H14N4O4/c12-10-7-5(1-2-13-10)15(4-14-7)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1",3-Deaza-adenosine,"S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor.",81254,C11H14N4O4,266.25,267.25
363,"InChI=1S/C11H14N4O4/c12-11-13-5-1-2-15(9(5)10(18)14-11)8-3-6(17)7(4-16)19-8/h1-2,6-8,16-17H,3-4H2,(H3,12,13,14,18)/t6-,7+,8+/m0/s1",9-Deaza-2'-deoxyguanosine,"Oligonucleotide incorporation and base pair stability of 9-deaza-2'-deoxyguanosine, an analogue of 8-oxo-2'-deoxyguanosine.",53380,C11H14N4O4,266.25,267.25
364,"InChI=1S/C11H14N4O4/c12-11-13-9-5(10(18)14-11)1-2-15(9)8-3-6(17)7(4-16)19-8/h1-2,6-8,16-17H,3-4H2,(H3,12,13,14,18)/t6-,7+,8+/m0/s1",7-deaza-2'-deoxyguanosine,Enhancement of exon skipping activity by reduction in the secondary structure content of LNA-based splice-switching oligonucleotides.,9783,C11H14N4O4,266.25,267.25
365,"InChI=1S/C11H14N4O4/c12-11-7-6(14-3-15-11)4(1-13-7)10-9(18)8(17)5(2-16)19-10/h1,3,5,8-10,13,16-18H,2H2,(H2,12,14,15)/t5-,8-,9-,10+/m1/s1
InChI=1S/C11H14N4O4/c12-11-7-6(14-3-15-11)4(1-13-7)10-9(18)8(17)5(2-16)19-10/h1,3,5,8-10,13,16-18H,2H2,(H2,12,14,15)",9-deazaadenosine,4-Thiofuranoid Glycal: Versatile Glycosyl Donor for the Selective Synthesis of β-anomer of 4’-thionucleoside and its biological activities,193,C11H14N4O4,266.25,267.25
366,"InChI=1S/C11H14N4O4/c12-5-1-2-13-10-7(5)14-4-15(10)11-9(18)8(17)6(3-16)19-11/h1-2,4,6,8-9,11,16-18H,3H2,(H2,12,13)/t6-,8-,9-,11-/m1/s1",1-deazaadenosine,[Conformation of adenosine deaminase in complexes with inhibitors: application of selective quenching of fluorescence emission].,64629,C11H14N4O4,266.25,267.25
367,"InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)",7-deazadenosine,"7-deazainosine derivatives: synthesis and characterization of 7- and 7,8-substituted pyrrolo [2,3-d]pyrimidine ribonucleosides.",64462,C11H14N4O4,266.25,267.25
368,"InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1",7-deazaadenosine,Tricyclic Nucleobase Analogs and Their Ribosides as Substrates and Inhibitors of Purine-Nucleoside Phosphorylases III. Aminopurine Derivatives.,6772,C11H14N4O4,266.25,267.25
369,"InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7-,8-,11-/m1/s1
InChI=1S/C11H14N4O4/c12-9-5-1-2-15(10(5)14-4-13-9)11-8(18)7(17)6(3-16)19-11/h1-2,4,6-8,11,16-18H,3H2,(H2,12,13,14)/t6-,7+,8?,11-/m1/s1",7-deaza-adenosine,Optochemical control of transcription by the use of 7-deaza-adenosine-based diarylethenes.,1269,C11H14N4O4,266.25,267.25
370,"InChI=1S/C11H14N4O5/c12-11-13-8-4(9(19)14-11)1-2-15(8)10-7(18)6(17)5(3-16)20-10/h1-2,5-7,10,16-18H,3H2,(H3,12,13,14,19)/t5-,6-,7-,10-/m1/s1",7-Deazaguanosine,Evidence for higher-order structure formation by the c-myb 18-mer phosphorothioate antisense (codons 2-7) oligodeoxynucleotide: potential relationship to antisense c-myb inhibition.,100711,C11H14N4O5,282.25,283.25
371,"InChI=1S/C11H14N4O5/c12-11-14-5-3(1-13-6(5)10(19)15-11)9-8(18)7(17)4(2-16)20-9/h1,4,7-9,13,16-18H,2H2,(H3,12,14,15,19)/t4-,7-,8-,9+/m1/s1",9-Deazaguanosine,Synthesis and study of 9-deazaguanosine derivatives as potential inhibitors of RNA virus replication.,63249,C11H14N4O5,282.25,283.25
372,"InChI=1S/C11H14N4O5/c12-6-1-4-7(10(19)14-6)13-3-15(4)11-9(18)8(17)5(2-16)20-11/h1,3,5,8-9,11,16-18H,2H2,(H3,12,14,19)/t5-,8-,9-,11-/m1/s1",3-Deazaguanosine,Access to 3-Deazaguanosine Building Blocks for RNA Solid-Phase Synthesis Involving Hartwig-Buchwald C-N Cross-Coupling.,9917,C11H14N4O5,282.25,283.25
373,"InChI=1S/C11H14N6O4/c1-13-10(20)7-5(18)6(19)11(21-7)17-3-16-4-8(12)14-2-15-9(4)17/h2-3,5-7,11,18-19H,1H3,(H,13,20)(H2,12,14,15)/t5-,6+,7-,11+/m0/s1",5'-N-methylcarboxamidoadenosine,Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A(2B) receptors.,79539,C11H14N6O4,294.27,295.27
374,"InChI=1S/C11H15BrN4O3/c12-2-1-6-5-16(11(18)15-10(6)17)9-3-7(14)8(4-13)19-9/h1-2,5,7-9H,3-4,13-14H2,(H,15,17,18)/t7-,8+,9+/m0/s1
InChI=1S/C11H15BrN4O3/c12-2-1-6-5-16(11(18)15-10(6)17)9-3-7(14)8(4-13)19-9/h1-2,5,7-9H,3-4,13-14H2,(H,15,17,18)/b2-1+/t7-,8+,9+/m0/s1","(E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine","Synthesis and antiviral activity assay of novel (E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine.",89112,C11H15BrN4O3,331.17,332.17
375,"InChI=1S/C11H15ClN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h4,7-9,15-16H,1-3,5H2,(H,13,17,18)/t7-,8+,9+/m0/s1",5-(2-Chloroethyl)-2'-deoxyuridine,"Induction of in vivo Pig-a gene mutation but not micronuclei by 5-(2-chloroethyl)-2'-deoxyuridine, an antiviral pyrimidine nucleoside analogue.",12708,C11H15ClN2O5,290.7,291.7
376,"InChI=1S/C11H15N2O5Se/c1-5-3-13(10(17)12-9(5)16)11(2)8(19)7(15)6(4-14)18-11/h3,6-8,14-15H,4H2,1-2H3,(H,12,16,17)/t6-,7-,8-,11-/m1/s1",5-methylselenyl-methyl-2'-deoxyuridine,p38 mitogen-activated protein kinase is a key regulator of 5-phenylselenyl- and 5-methylselenyl-methyl-2'-deoxyuridine-induced apoptosis in human HL-60 cells.,46171,C11H15N2O5Se,334.21,335.21
377,"InChI=1S/C11H15N3O4/c1-3-6-4-14(11(17)13-9(6)12)10-8(16)7(15)5(2)18-10/h3-5,7-8,10,15-16H,1H2,2H3,(H2,12,13,17)/t5-,7-,8-,10-/m1/s1",5'-deoxy-5-vinylcytidine,"Single ascending dose tolerability, pharmacokinetic-pharmacodynamic study of dihydropyrimidine dehydrogenase inhibitor Ro 09-4889.",86575,C11H15N3O4,253.26,254.26
378,"InChI=1S/C11H15N3O6/c1-5(16)12-7-2-3-14(11(19)13-7)10-9(18)8(17)6(4-15)20-10/h2-3,6,8-10,15,17-18H,4H2,1H3,(H,12,13,16,19)/t6-,8-,9-,10-/m1/s1",N(4)-acetylcytidine,Profiling of cis-diol-containing nucleosides and ribosylated metabolites by boronate-affinity organic-silica hybrid monolithic capillary liquid chromatography/mass spectrometry.,29915,C11H15N3O6,285.25,286.25
379,"InChI=1S/C11H15N3O6/c1-5(16)12-7-2-3-14(11(19)13-7)10-9(18)8(17)6(4-15)20-10/h2-3,6,8-10,15,17-18H,4H2,1H3,(H,12,13,16,19)/t6-,8-,9-,10-/m1/s1
InChI=1S/C11H15N3O6/c1-5(16)12-7-2-3-14(11(19)13-7)10-9(18)8(17)6(4-15)20-10/h2-3,6,8-10,15,17-18H,4H2,1H3,(H,12,13,16,19)",acetylcytidine,Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.,77825,C11H15N3O6,285.25,286.25
380,"InChI=1S/C11H15N3O7/c12-3-4(15)6(17)9-7(18)8(19)10(21-9)14-2-1-5(16)13-11(14)20/h1-2,6-10,17-19H,3,12H2,(H,13,16,20)/t6?,7-,8+,9+,10+/m0/s1",5'-C-glycyluridine,"The Biosynthesis of Capuramycin-type Antibiotics: IDENTIFICATION OF THE A-102395 BIOSYNTHETIC GENE CLUSTER, MECHANISM OF SELF-RESISTANCE, AND FORMATION OF URIDINE-5'-CARBOXAMIDE.",28601,C11H15N3O7,301.25,302.25
381,"InChI=1S/C11H15N3O7/c12-6(16)1-4-2-14(11(20)13-9(4)19)10-8(18)7(17)5(3-15)21-10/h2,5,7-8,10,15,17-18H,1,3H2,(H2,12,16)(H,13,19,20)/t5-,7-,8-,10-/m1/s1",5-carbamoylmethyluridine,Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS.,2417,C11H15N3O7,301.25,302.25
382,"InChI=1S/C11H15N5O3/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(18)7(3-17)19-8/h4-8,17-18H,2-3H2,1H3,(H,12,13,14)/t6-,7+,8+/m0/s1",N6-methyl-2'-deoxyadenosine,Mass spectrometric profiling of DNA adducts in the human stomach associated with damage from environmental factors.,1859,C11H15N5O3,265.27,266.27
383,"InChI=1S/C11H15N5O3/c1-15-4-14-10(12)9-11(15)16(5-13-9)8-2-6(18)7(3-17)19-8/h4-8,12,17-18H,2-3H2,1H3/t6-,7+,8+/m0/s1",3-methyl-2'-deoxyadenosine,The impact of protonation and deprotonation of 3-methyl-2'-deoxyadenosine on N-glycosidic bond cleavage.,50866,C11H15N5O3,265.27,266.27
384,"InChI=1S/C11H15N5O3/c1-15-4-14-11-9(10(15)12)13-5-16(11)8-2-6(18)7(3-17)19-8/h4-8,12,17-18H,2-3H2,1H3/t6-,7+,8+/m0/s1",N1-methyl-deoxyadenosine,Mechanism of error-free DNA synthesis across N1-methyl-deoxyadenosine by human DNA polymerase-ι.,19175,C11H15N5O3,265.27,266.27
385,"InChI=1S/C11H15N5O3/c1-5-15-9-10(12)13-4-14-11(9)16(5)8-2-6(18)7(3-17)19-8/h4,6-8,17-18H,2-3H2,1H3,(H2,12,13,14)/t6-,7+,8+/m0/s1",2'-deoxy-8-methyladenosine,Synthesis and structural study of quadruplex structures containing 2'-deoxy-8-methyladenosine.,78556,C11H15N5O3,265.27,266.27
386,"InChI=1S/C11H15N5O3/c12-11-14-9-8(10(19)15-11)13-4-16(9)6-1-5(3-17)7(18)2-6/h4-7,17-18H,1-3H2,(H3,12,14,15,19)/t5-,6-,7+/m1/s1",2'-deoxycarbaguanosine,The conformational study of two carbocyclic nucleosides: why carbocyclic nucleic acids (CarNAs) form more stable duplexes with RNA than DNA does.,93564,C11H15N5O3,265.27,266.27
387,"InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",5'-Deoxy-5'-(methylthio)adenosine,Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine.,81820,C11H15N5O3S,297.34,298.34
388,"InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1
InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8+,11+/m0/s1
InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5?,7-,8?,11?/m1/s1",5'-Deoxy-5'-methylthioadenosine,The Oncometabolite 5'-Deoxy-5'-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation.,3591,C11H15N5O3S,297.34,298.34
389,"InChI=1S/C11H15N5O4/c1-11(19)5(2-17)20-10(7(11)18)16-4-15-6-8(12)13-3-14-9(6)16/h3-5,7,10,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7+,10-,11-/m1/s1",3'-C-Methyladenosine,"Development of C-Methyl Branched Purine Ribonucleoside Analogs: Chemistry, Biological Activity and Therapeutic Potential.",22443,C11H15N5O4,281.27,282.27
390,"InChI=1S/C11H15N5O4/c1-11(19)7(18)5(2-17)20-10(11)16-4-15-6-8(12)13-3-14-9(6)16/h3-5,7,10,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7-,10-,11-/m1/s1",2'-C-Methyladenosine,Liver-targeted prodrugs of 2'-C-methyladenosine for therapy of hepatitis C virus infection.,69480,C11H15N5O4,281.27,282.27
391,"InChI=1S/C11H15N5O4/c1-11(8(19)7(18)5(2-17)20-11)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",methyladenosine,Discrimination of common isomerides of methyl nucleosides by collision-induced dissociation tandem mass spectrometry.,4974,C11H15N5O4,281.27,282.27
392,"InChI=1S/C11H15N5O4/c1-12-11-14-9-8(10(19)15-11)13-4-16(9)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15,19)/t5-,6+,7+/m0/s1",N2-methyl-2'-deoxyguanosine,Translesional synthesis on a DNA template containing N2-methyl-2'-deoxyguanosine catalyzed by the Klenow fragment of Escherichia coli DNA polymerase I.,100668,C11H15N5O4,281.27,282.27
393,"InChI=1S/C11H15N5O4/c1-12-9-6-10(14-3-13-9)16(4-15-6)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11,17-19H,2H2,1H3,(H,12,13,14)/t5-,7-,8-,11-/m1/s1",6-methyladenosine,Long Non-Coding RNA Epigenetics.,1096,C11H15N5O4,281.27,282.27
394,"InChI=1S/C11H15N5O4/c1-15-10(19)8-9(14-11(15)12)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14)/t5-,6+,7+/m0/s1",1-methyl-2'-deoxyguanosine,Inhibitory effects of the guanine moiety on Suzuki couplings of unprotected halonucleosides in aqueous media.,79779,C11H15N5O4,281.27,282.27
395,"InChI=1S/C11H15N5O4/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3/t5-,7-,8-,11-/m1/s1",1-methyladenosine,Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.,74,C11H15N5O4,281.27,282.27
396,"InChI=1S/C11H15N5O4/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3/t5-,7-,8-,11-/m1/s1
InChI=1S/C11H15N5O4/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3
InChI=1S/C11H15N5O4/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3/t5-,7+,8?,11-/m1/s1
InChI=1S/C11H15N5O4/c1-15-3-14-10-6(9(15)12)13-4-16(10)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3/t5-,7?,8?,11-/m1/s1",N1-methyladenosine,Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.,201,C11H15N5O4,281.27,282.27
397,"InChI=1S/C11H15N5O4/c1-15-3-14-9(12)6-10(15)16(4-13-6)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11-12,17-19H,2H2,1H3/t5-,7-,8-,11-/m1/s1",3-methyladenosine,Oxymatrine Inhibits Homocysteine-Mediated Autophagy via MIF/mTOR Signaling in Human Umbilical Vein Endothelial Cells.,14813,C11H15N5O4,281.27,282.27
398,"InChI=1S/C11H15N5O4/c1-15-4-16(7-2-5(18)6(3-17)20-7)9-8(15)10(19)14-11(12)13-9/h4-7,17-18H,2-3H2,1H3,(H2-,12,13,14,19)/p+1/t5-,6+,7+/m0/s1",N7-Methyldeoxyguanosine,Development and application of a sensitive and rapid immunoassay for the quantitation of N7-methyldeoxyguanosine in DNA samples.,101281,C11H16N5O4+,283.28,284.28
399,"InChI=1S/C11H15N5O4/c1-19-10-8-9(14-11(12)15-10)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15)/t5-,6+,7+/m0/s1",O(6)-Methyl-2'-deoxyguanosine,An efficient and simple method for site-selective modification of O6-methyl-2'-deoxyguanosine in DNA.,44585,C11H15N5O4,281.27,282.27
400,"InChI=1S/C11H15N5O4/c1-19-11-14-9(12)8-10(15-11)16(4-13-8)7-2-5(18)6(3-17)20-7/h4-7,17-18H,2-3H2,1H3,(H2,12,14,15)/t5-,6+,7+/m0/s1",2-methoxy-2'-deoxyadenosine,Hoogsteen vs. Watson-Crick base pairing: incorporation of 2-substituted adenine- and 7-deazaadenine 2'-deoxy-beta-D-ribonucleosides into oligonucleotides.,67132,C11H15N5O4,281.27,282.27
401,"InChI=1S/C11H15N5O4/c1-19-15-10-9-11(13-4-12-10)16(5-14-9)8-2-6(18)7(3-17)20-8/h4-8,17-18H,2-3H2,1H3,(H,12,13,15)/t6-,7+,8+/m0/s1",2'-deoxy-N6-methoxyadenosine,Crystallization and preliminary analysis of a DNA dodecamer of d(CGCGmo6AATCCGCG) containing 2'-deoxy-N6-methoxyadenosine: change in crystal packing with different humidity.,109271,C11H15N5O4,281.27,282.27
402,"InChI=1S/C11H15N5O4/c1-19-8-5(2-17)20-11(7(8)18)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",3'-O-methyladenosine,"Acidity of secondary hydroxyls in ATP and adenosine analogues and the question of a 2',3'-hydrogen bond in ribonucleosides.",83633,C11H15N5O4,281.27,282.27
403,"InChI=1S/C11H15N5O4/c1-19-8-7(18)5(2-17)20-11(8)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",2'-O-methyladenosine,A comprehensive review of m6A/m6Am RNA methyltransferase structures.,1473,C11H15N5O4,281.27,282.27
404,"InChI=1S/C11H15N5O4/c1-2-6-4-16(11(19)13-10(6)18)9-3-7(14-15-12)8(5-17)20-9/h4,7-9,17H,2-3,5H2,1H3,(H,13,18,19)/t7-,8+,9+/m0/s1","3'-Azido-2',3'-dideoxy-5-ethyluridine","Simultaneous determination of 3'-azido-2',3'-dideoxyuridine and novel prodrugs in rat plasma by liquid chromatography.",89376,C11H15N5O4,281.27,282.27
405,"InChI=1S/C11H15N5O4/c1-4-13-8-9(14-11(12)15-10(8)19)16(4)7-2-5(18)6(3-17)20-7/h5-7,17-18H,2-3H2,1H3,(H3,12,14,15,19)/t5-,6+,7+/m0/s1",8-methyl-2'-deoxyguanosine,"Stability of N-glycosidic bond of (5'S)-8,5'-cyclo-2'-deoxyguanosine.",39416,C11H15N5O4,281.27,282.27
406,"InChI=1S/C11H15N5O4/c1-4-14-9(12)6-10(15-4)16(3-13-6)11-8(19)7(18)5(2-17)20-11/h3,5,7-8,11,17-19H,2H2,1H3,(H2,12,14,15)/t5-,7-,8-,11-/m1/s1",2-Methyladenosine,Metabolism of 2-methyladenosine in Mycobacterium tuberculosis.,85583,C11H15N5O4,281.27,282.27
407,"InChI=1S/C11H15N5O4/c1-4-15-6-9(12)13-3-14-10(6)16(4)11-8(19)7(18)5(2-17)20-11/h3,5,7-8,11,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",8-methyladenosine,Doxifluridine-conjugated 2-5A analog shows strong RNase L activation ability and tumor suppressive effect.,22427,C11H15N5O4,281.27,282.27
408,"InChI=1S/C11H15N5O4/c12-10-14-8-7(9(19)15-10)13-11(20)16(8)5-1-4(3-17)6(18)2-5/h4-6,17-18H,1-3H2,(H,13,20)(H3,12,14,15,19)/t4-,5-,6+/m1/s1","8-oxo-7,8-dihydro-2'-deoxycarbaguanosine",Synthesis of enzymatically noncleavable carbocyclic nucleosides for DNA-N-glycosylase studies.,112555,C11H15N5O4,281.27,282.27
409,"InChI=1S/C11H15N5O4/c12-9-6-10(14-3-13-9)16(4-15-6)11-8(19)7(18)5(20-11)1-2-17/h3-5,7-8,11,17-19H,1-2H2,(H2,12,13,14)",homoadenosine,S-homoadenosyl-L-cysteine and S-homoadenosyl-L-homocysteine. Synthesis and binding studies of hon-hydrolyzed substrate analogues with S-adenosyl-L-homocysteine hydrolase.,93673,C11H15N5O4,281.27,282.27
410,"InChI=1S/C11H15N5O4S/c1-15-3-16(8-5(15)9(21)14-11(12)13-8)10-7(19)6(18)4(2-17)20-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,21)",7-methyl-6-thioguanosine,Synthetic Capped mRNAs for Cap-Specific Photo-Cross-Linking Experiments.,22856,C11H15N5O4S,313.33,314.33
411,"InChI=1S/C11H15N5O4S/c1-15-3-16(8-5(15)9(21)14-11(12)13-8)10-7(19)6(18)4(2-17)20-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,21)/t4-,6-,7-,10-/m1/s1",7-methylthioguanosine,Measurement of Nonribosomal Peptide Synthetase Adenylation Domain Activity Using a Continuous Hydroxylamine Release Assay.,24405,C11H15N5O4S,313.33,314.33
412,"InChI=1S/C11H15N5O4S/c1-21-11-14-8(12)5-9(15-11)16(3-13-5)10-7(19)6(18)4(2-17)20-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7-,10-/m1/s1",2-methylthioadenosine,"Biosynthesis of Sulfur-Containing tRNA Modifications: A Comparison of Bacterial, Archaeal, and Eukaryotic Pathways.",19098,C11H15N5O4S,313.33,314.33
413,"InChI=1S/C11H15N5O5/c1-11(20)6(18)4(2-17)21-9(11)16-3-13-5-7(16)14-10(12)15-8(5)19/h3-4,6,9,17-18,20H,2H2,1H3,(H3,12,14,15,19)/t4-,6-,9-,11-/m1/s1",2'-C-methyl-guanosine,Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.,47094,C11H15N5O5,297.27,298.27
414,"InChI=1S/C11H15N5O5/c1-11(20)6(18)4(2-17)21-9(11)16-3-13-5-7(16)14-10(12)15-8(5)19/h3-4,6,9,17-18,20H,2H2,1H3,(H3,12,14,15,19)/t4-,6-,9-,11-/m1/s1
InChI=1S/C11H15N5O5/c1-11(20)6(18)4(2-17)21-9(11)16-3-13-5-7(16)14-10(12)15-8(5)19/h3-4,6,9,17-18,20H,2H2,1H3,(H3,12,14,15,19)/t4?,6?,9?,11-/m1/s1
InChI=1S/C11H15N5O5/c1-11(20)6(18)4(2-17)21-9(11)16-3-13-5-7(16)14-10(12)15-8(5)19/h3-4,6,9,17-18,20H,2H2,1H3,(H3,12,14,15,19)
InChI=1S/C11H15N5O5/c1-11(20)6(18)4(2-17)21-9(11)16-3-13-5-7(16)14-10(12)15-8(5)19/h3-4,6,9,17-18,20H,2H2,1H3,(H3,12,14,15,19)/t4-,6+,9-,11?/m1/s1",2'-C-Methylguanosine,Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication.,84208,C11H15N5O5,297.27,298.27
415,"InChI=1S/C11H15N5O5/c1-12-11-14-8-5(9(20)15-11)13-3-16(8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15,20)/t4-,6-,7-,10-/m1/s1",2-methylguanosine,Efficient recovery of electrophoretic profiles of nucleoside metabolites from urine samples by multivariate curve resolution.,57962,C11H15N5O5,297.27,298.27
416,"InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/p+1/t4-,6-,7-,10-/m1/s1",N(7)-methylguanosine,Dynamic m(6)A mRNA methylation directs translational control of heat shock response.,25976,C11H16N5O5+,299.28,300.28
417,"InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/p+1/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/p+1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/p+1/t4-,6-,7+,10+/m0/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/t4-,6?,7?,10-/m0/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/t4-,6?,7?,10-/m1/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,18-19H,2H2,1H3,(H3,12,13,14,20)/t4-,6-,7-,10-/m1/s1",7-Methylguanosine,On the reactivity of mRNA Cap0: C-H oxidative addition of 7-methylguanosine to Pt,3842,C11H16N5O5+,299.28,300.28
418,"InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H15N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2-,12,13,14,20)/p+1/t4-,6-,7-,10-/m1/s1",N7-methylguanosine,N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis.,17,C11H15N5O5,297.27,298.27
419,"InChI=1S/C11H15N5O5/c1-15-9(20)5-8(14-11(15)12)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14)/t4-,6-,7-,10-/m1/s1",1-methylguanosine,Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.,74,C11H15N5O5,297.27,298.27
420,"InChI=1S/C11H15N5O5/c1-20-11(8(19)7(18)5(2-17)21-11)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",methoxyadenosine,Spongosine production by a Vibrio harveyi strain associated with the sponge Tectitethya crypta.,29536,C11H15N5O5,297.27,298.27
421,"InChI=1S/C11H15N5O5/c1-20-11-13-7-8(14-10(12)15-9(7)19)16(11)6-2-4(18)5(3-17)21-6/h4-6,17-18H,2-3H2,1H3,(H3,12,14,15,19)/t4-,5+,6+/m0/s1",8-methoxy-2'-deoxyguanosine,Identification of the main oxidation products of 8-methoxy-2'-deoxyguanosine by singlet molecular oxygen.,80926,C11H15N5O5,297.27,298.27
422,"InChI=1S/C11H15N5O5/c1-20-7-4(2-17)21-10(6(7)18)16-3-13-5-8(16)14-11(12)15-9(5)19/h3-4,6-7,10,17-18H,2H2,1H3,(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1",3'-O-methylguanosine,An efficient process for synthesis of 2'-O-methyl and 3'-O-methyl guanosine from 2-aminoadenosine using diazomethane and the catalyst stannous chloride.,75884,C11H15N5O5,297.27,298.27
423,"InChI=1S/C11H15N5O5/c1-20-7-6(18)4(2-17)21-10(7)16-3-13-5-8(16)14-11(12)15-9(5)19/h3-4,6-7,10,17-18H,2H2,1H3,(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1",2'-O-methyl-guanosine,MDPSCL2: a new protecting group for chemoselective synthesis of 2'-O-alkylated guanosines.,89166,C11H15N5O5,297.27,298.27
424,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7-,10-/m1/s1",6-O-methyl guanosine,Sustainable Flow-Synthesis of (Bulky) Nucleoside Drugs by a Novel and Highly Stable Nucleoside Phosphorylase Immobilized on Reusable Supports.,258,C11H15N5O5,297.27,298.27
425,"InChI=1S/C11H15N5O5/c1-3-13-5-8(14-11(12)15-9(5)20)16(3)10-7(19)6(18)4(2-17)21-10/h4,6-7,10,17-19H,2H2,1H3,(H3,12,14,15,20)/t4-,6-,7-,10-/m1/s1",8-methylguanosine,8-Methylguanosine: a powerful Z-DNA stabilizer.,88781,C11H15N5O5,297.27,298.27
426,"InChI=1S/C11H15N5O5/c12-8-6-9(14-3-13-8)16(4-15-6)10-11(20,2-18)7(19)5(1-17)21-10/h3-5,7,10,17-20H,1-2H2,(H2,12,13,14)/t5-,7-,10-,11-/m1/s1",2'-C-hydroxymethyladenosine,Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides.,53628,C11H15N5O5,297.27,298.27
427,"InChI=1S/C11H15N5O5/c17-1-5-7(19)8(20)11(21-5)16-3-14-6-9(15-4-18)12-2-13-10(6)16/h2-3,5,7-8,11,17-20H,1,4H2,(H,12,13,15)/t5-,7-,8-,11-/m1/s1",N(6)-hydroxymethyladenosine,FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA.,36071,C11H15N5O5,297.27,298.27
428,"InChI=1S/C11H15N5O5S/c1-22(20)11(8(19)7(18)5(2-17)21-11)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,17-19H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11+,22?/m1/s1",methylsulfinyladenosine,Epimeric methylsulfinyladenosine derivatives from the marine ascidian Herdmania momus.,35321,C11H15N5O5S,329.33,330.33
429,"InChI=1S/C11H15N5O6/c1-15-4-7(13-10(12)14-8(4)20)16(11(15)21)9-6(19)5(18)3(2-17)22-9/h3,5-6,9,17-19H,2H2,1H3,(H3,12,13,14,20)/t3-,5-,6-,9-/m1/s1",7-methyl-8-oxoguanosine,Facile method for the preparation of 7-methyl-8-oxoguanosines as an immunomodulator.,111252,C11H15N5O6,313.27,314.27
430,"InChI=1S/C11H15N5O6/c1-21-11-13-4-7(14-10(12)15-8(4)20)16(11)9-6(19)5(18)3(2-17)22-9/h3,5-6,9,17-19H,2H2,1H3,(H3,12,14,15,20)/t3-,5-,6-,9-/m1/s1",8-methoxyguanosine,Hybridization Properties of RNA Containing 8-Methoxyguanosine and 8-Benzyloxyguanosine.,26428,C11H15N5O6,313.27,314.27
431,"InChI=1S/C11H15N7O4/c12-8-5-9(16-2-15-8)18(3-17-5)10-7(20)6(19)4(22-10)1-14-11(13)21/h2-4,6-7,10,19-20H,1H2,(H2,12,15,16)(H3,13,14,21)/t4-,6-,7-,10-/m1/s1",5'-Deoxy-5'-ureidoadenosine,"Design, synthesis, and molecular modeling studies of 5'-deoxy-5'-ureidoadenosine: 5'-ureido group as multiple hydrogen bonding donor in the active site of S-adenosylhomocysteine hydrolase.",69820,C11H15N7O4,309.28,310.28
432,"InChI=1S/C11H15N7O6/c12-9-15-7-4(8(22)16-9)14-2-18(7)11(17-10(13)23)6(21)5(20)3(1-19)24-11/h2-3,5-6,19-21H,1H2,(H3,13,17,23)(H3,12,15,16,22)/t3-,5-,6-,11+/m1/s1",ureidoguanosine,"Supramolecular ABC triblock copolymers via one-pot, orthogonal self-assembly.",56304,C11H15N7O6,341.28,342.28
433,"InChI=1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1",5-ethyl-2'-deoxyuridine,Enzymatic synthesis of nucleoside analogues using immobilized 2'-deoxyribosyltransferase from Lactobacillus reuteri.,49819,C11H16N2O5,256.26,257.26
434,"InChI=1S/C11H16N2O6/c1-10(5-14)7(16)8(17)11(2,19-10)13-4-3-6(15)12-9(13)18/h3-4,7-8,14,16-17H,5H2,1-2H3,(H,12,15,18)/t7-,8+,10+,11+/m0/s1","1',4'-dimethyluridine","Diastereoselective synthesis of (+/-)-1',4'-dimethyluridine.",56380,C11H16N2O6,272.26,273.26
435,"InChI=1S/C11H16N2O6/c1-17-5-6-8(15)9(18-2)10(19-6)13-4-3-7(14)12-11(13)16/h3-4,6,8-10,15H,5H2,1-2H3,(H,12,14,16)/t6-,8-,9-,10-/m1/s1","2',5'-di-O-methyluridine","Hydrolysis of 2',3'-O-methyleneadenos-5'-yl bis(2',5'-di-O-methylurid-3'-yl) phosphate, a sugar O-alkylated trinucleoside 3',3',5'-monophosphate: implications for the mechanism of large ribozymes.",87600,C11H16N2O6,272.26,273.26
436,"InChI=1S/C11H16N2O6/c1-2-5-3-13(11(18)12-9(5)17)10-8(16)7(15)6(4-14)19-10/h3,6-8,10,14-16H,2,4H2,1H3,(H,12,17,18)/t6-,7-,8-,10-/m1/s1",5-ethyluridine,Synthesis and properties of small interfering RNA duplexes carrying 5-ethyluridine residues.,51822,C11H16N2O6,272.26,273.26
437,"InChI=1S/C11H16N2O6/c1-4-5(2)13(11(18)12-9(4)17)10-8(16)7(15)6(3-14)19-10/h6-8,10,14-16H,3H2,1-2H3,(H,12,17,18)/t6-,7-,8-,10-/m1/s1","5,6-dimethyluridine","Synthesis and properties of uniquely modified oligoribonucleotides: yeast tRNA(Phe) fragments with 6-methyluridine and 5,6-dimethyluridine at site-specific positions.",104521,C11H16N2O6,272.26,273.26
438,"InChI=1S/C11H16N3O5Se/c1-12-2-5-3-14(11(20)13-9(5)18)10-8(17)7(16)6(4-15)19-10/h3,6-8,10,12,15-17H,2,4H2,1H3/t6-,7-,8-,10-/m1/s1",5-Methylaminomethyl-2-selenouridine,Selenomodification of tRNA in archaea requires a bipartite rhodanese enzyme.,45298,C11H16N3O5Se,349.22,350.22
439,"InChI=1S/C11H16N5O7PS/c1-25-9-5-8(14-11(12)15-9)16(3-13-5)10-7(18)6(17)4(23-10)2-22-24(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1",6-methylthioguanosine 5'-monophosphate,The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.,63607,C11H16N5O7PS,393.31,394.31
440,"InChI=1S/C11H16N5O8P/c1-11(19)6(17)4(2-23-25(20,21)22)24-9(11)16-3-13-5-7(16)14-10(12)15-8(5)18/h3-4,6,9,17,19H,2H2,1H3,(H2,20,21,22)(H3,12,14,15,18)/t4-,6-,9-,11-/m1/s1",2'-methylguanosine-5'-monophosphate,"Pharmacokinetics of IDX184, a liver-targeted oral prodrug of 2'-methylguanosine-5'-monophosphate, in the monkey and formulation optimization for human exposure.",28399,C11H16N5O8P,377.25,378.25
441,"InChI=1S/C11H16N6O4/c1-20-7-6(19)4(2-18)21-10(7)17-3-14-5-8(12)15-11(13)16-9(5)17/h3-4,6-7,10,18-19H,2H2,1H3,(H4,12,13,15,16)/t4-,6-,7-,10-/m1/s1",2'-O-methyl-2-aminoadenosine,An efficient process for synthesis of 2'-O-methyl and 3'-O-methyl guanosine from 2-aminoadenosine using diazomethane and the catalyst stannous chloride.,75884,C11H16N6O4,296.28,297.28
442,"InChI=1S/C11H17N3O4/c1-2-12-9-3-4-14(11(17)13-9)10-5-7(16)8(6-15)18-10/h3-4,7-8,10,15-16H,2,5-6H2,1H3,(H,12,13,17)/t7-,8+,10+/m0/s1",N4-ethyl-2'-deoxycytidine,Self-Avoiding Molecular Recognition Systems (SAMRS).,63333,C11H17N3O4,255.27,256.27
443,"InChI=1S/C11H17N3O4/c1-2-6-5-14(11(17)13-10(6)16)9-3-7(15)8(4-12)18-9/h5,7-9,15H,2-4,12H2,1H3,(H,13,16,17)/t7-,8+,9+/m0/s1","5'-amino-2',5'-dideoxy-5-ethyluridine",Nucleoside analogues as highly potent and selective inhibitors of herpes simplex virus thymidine kinase.,99869,C11H17N3O4,255.27,256.27
444,"InChI=1S/C11H17N3O4/c1-6-13-8(12)3-4-14(6)10-11(2,17)9(16)7(5-15)18-10/h3-4,7,9-10,15-17H,1,5H2,2H3,(H2,12,13)/t7-,9-,10-,11-/m1/s1",2'-methyl-cytidine,Enhancement of intestinal absorption of 2-methyl cytidine prodrugs.,55353,C11H17N3O4,255.27,256.27
445,"InChI=1S/C11H17N3O5/c1-5-3-14(11(17)13-9(5)12)10-8(18-2)7(16)6(4-15)19-10/h3,6-8,10,15-16H,4H2,1-2H3,(H2,12,13,17)/t6-,7-,8-,10-/m1/s1",2'-O-methyl-5-methylcytidine,Chemical labeling - Assisted mass spectrometry analysis for sensitive detection of cytidine dual modifications in RNA of mammals.,7028,C11H17N3O5,271.27,272.27
446,"InChI=1S/C11H17N3O5S/c1-12-2-5-3-14(11(20)13-9(5)18)10-8(17)7(16)6(4-15)19-10/h3,6-8,10,12,15-17H,2,4H2,1H3,(H,13,18,20)/t6-,7-,8-,10-/m1/s1",2-thio-5-methylaminomethyluridine,E. coli glutamyl-tRNA synthetase is inhibited by anticodon stem-loop domains and a minihelix.,69266,C11H17N3O5S,303.34,304.34
447,"InChI=1S/C11H17N3O6/c1-12-2-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h3,6-8,10,12,15-17H,2,4H2,1H3,(H,13,18,19)/t6-,7-,8-,10-/m1/s1",5-methylaminomethyluridine,Characterization and structure of the Aquifex aeolicus protein DUF752: a bacterial tRNA-methyltransferase (MnmC2) functioning without the usually fused oxidase domain (MnmC1).,39050,C11H17N3O6,287.27,288.27
448,"InChI=1S/C11H17N3O6/c1-19-8-7(17)6(4-16)20-10(8)14-2-5(3-15)9(12)13-11(14)18/h2,6-8,10,15-17H,3-4H2,1H3,(H2,12,13,18)/t6-,7-,8-,10-/m1/s1",2'-O-methyl-5-hydroxymethylcytidine,"Synthesis and Multiple Incorporations of 2'-O-Methyl-5-hydroxymethylcytidine, 5-Hydroxymethylcytidine and 5-Formylcytidine Monomers into RNA Oligonucleotides.",16890,C11H17N3O6,287.27,288.27
449,"InChI=1S/C11H17N3O6/c1-5(16)11(12)2-3-14(10(19)13-11)9-8(18)7(17)6(4-15)20-9/h2-3,6-9,15,17-18H,4,12H2,1H3,(H,13,19)/t6-,7-,8-,9-,11?/m1/s1",4-acetylcytidine,Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.,74,C11H17N3O6,287.27,288.27
450,"InChI=1S/C11H17N4O12P3/c12-10-6-1-2-15(11(6)14-5-13-10)9-3-7(16)8(25-9)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,5,7-9,16H,3-4H2,(H,20,21)(H,22,23)(H2,12,13,14)(H2,17,18,19)/t7-,8+,9+/m0/s1",7-deaza-2'-deoxyadenosine triphosphate,Triazine-Modified 7-Deaza-2'-deoxyadenosines: Better Suited for Bioorthogonal Labeling of DNA by PCR than 2'-Deoxyuridines.,9811,C11H17N4O12P3,490.19,491.19
451,"InChI=1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1",2-methylthio-adenosine 5'-diphosphate,Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.,64685,C11H17N5O10P2S,473.29,474.29
452,"InChI=1S/C11H17N5O10P2S/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H17N5O10P2S.3Na/c1-29-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(25-10)2-24-28(22,23)26-27(19,20)21;;;/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H2,12,14,15)(H2,19,20,21);;;/q;3*+1/p-3/t4-,6-,7-,10-;;;/m1.../s1",2-(methylthio)adenosine 5'-diphosphate,Characterization of purine receptors in mouse thoracic aorta.,85338,C11H17N5O10P2S,473.29,474.29
453,"InChI=1S/C11H17N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H5-,12,13,14,19,20,21,22,23,24)/p+1/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H17N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H5-,12,13,14,19,20,21,22,23,24)/t4-,6-,7-,10-/m1/s1",7-methylguanosine 5'-diphosphate,Solid-supported synthesis of 5'-mRNA CAP-4 from Trypanosomatids.,67353,C11H18N5O11P2+,459.24,460.24
454,"InChI=1S/C11H17N5O5/c1-15-3-16(8-5(15)9(20)14-11(12)13-8)10-7(19)6(18)4(2-17)21-10/h4,6-7,10,17-19H,2-3H2,1H3,(H3,12,13,14,20)/t4-,6-,7-,10-/m1/s1",7-Methyl-guanosine,"Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.",26576,C11H17N5O5,299.28,300.28
455,"InChI=1S/C11H17N5O9P2/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(25-27(20,21)22)7(24-8)3-23-26(17,18)19/h4-8H,2-3H2,1H3,(H,12,13,14)(H2,17,18,19)(H2,20,21,22)/t6-,7+,8+/m0/s1","N6-methyl-2'-deoxyadenosine-3',5'-bisphosphate",Extracellular adenine nucleotides regulate Na+/H+ exchanger NHE3 activity in A6-NHE3 transfectants by a cAMP/PKA-dependent mechanism.,94676,C11H17N5O9P2,425.23,426.23
456,"InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1","alpha,beta-methyleneadenosine 5'-diphosphate",ATP as a source of interstitial adenosine in the rat heart.,106958,C11H17N5O9P2,425.23,426.23
457,"InChI=1S/C11H18N4O6/c12-13-2-4-20-9-8(18)6(5-16)21-10(9)15-3-1-7(17)14-11(15)19/h1,3,6,8-10,13,16,18H,2,4-5,12H2,(H,14,17,19)/t6-,8-,9-,10-/m1/s1",2'-O-(2-hydrazinoethyl)uridine,"Preparation of 2'-hydrazino oligonucleotides and their reaction with aldehydes and 1,3-diketones.",67230,C11H18N4O6,302.28,303.28
458,"InChI=1S/C11H18N5O13P3/c1-11(18)7(17)5(2-26-31(22,23)29-32(24,25)28-30(19,20)21)27-10(11)16-4-15-6-8(12)13-3-14-9(6)16/h3-5,7,10,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H2,12,13,14)(H2,19,20,21)/t5-,7-,10-,11-/m1/s1",2'-C-methyladenosine triphosphate,Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.,73053,C11H18N5O13P3,521.21,522.21
459,"InChI=1S/C11H18N5O13P3/c1-12-9-6-10(14-3-13-9)16(4-15-6)11-8(18)7(17)5(27-11)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-5,7-8,11,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H,12,13,14)(H2,19,20,21)/t5-,7-,8-,11-/m1/s1",N6-methyladenosine-5'-triphosphate,Electrochemical immunosensor for N6-methyladenosine detection in human cell lines based on biotin-streptavidin system and silver-SiO,20746,C11H18N5O13P3,521.21,522.21
460,"InChI=1S/C11H18N5O13P3S/c1-33-11-14-8(12)5-9(15-11)16(3-13-5)10-7(18)6(17)4(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h3-4,6-7,10,17-18H,2H2,1H3,(H,22,23)(H,24,25)(H2,12,14,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1",2-methylthioadenosine 5'-triphosphate,Endothelial-mediated dilations of rat middle cerebral arteries by ATP and ADP.,113895,C11H18N5O13P3S,553.27,554.27
461,"InChI=1S/C11H18N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H6-,12,13,14,19,20,21,22,23,24,25,26)/t4-,6-,7-,10-/m1/s1
InChI=1S/C11H18N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H6-,12,13,14,19,20,21,22,23,24,25,26)/t4-,6-,7-,10-/m1/s1",7-methylguanosine 5'-triphosphate,Charge distribution in 7-methylguanine regarding cation-pi interaction with protein factor eIF4E.,89837,C11H18N5O14P3,537.21,538.21
462,"InChI=1S/C12H12ClN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1",2'-deoxy-4'-C-ethynyl-2-chloroadenosine,Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants.,50087,C12H12ClN5O3,309.71,310.71
463,"InChI=1S/C12H12FN5O3/c1-2-12(4-19)6(20)3-7(21-12)18-5-15-8-9(14)16-11(13)17-10(8)18/h1,5-7,19-20H,3-4H2,(H2,14,16,17)/t6-,7+,12+/m0/s1",2'-deoxy-4'-C-ethynyl-2-fluoroadenosine,Development of modified nucleosides that have supremely high anti-HIV activity and low toxicity and prevent the emergence of resistant HIV mutants.,50087,C12H12FN5O3,293.25,294.25
464,"InChI=1S/C12H13N5O3/c1-2-12(4-18)7(19)3-8(20-12)17-6-16-9-10(13)14-5-15-11(9)17/h1,5-8,18-19H,3-4H2,(H2,13,14,15)/t7-,8+,12+/m0/s1
InChI=1S/C12H13N5O3/c1-2-12(4-18)7(19)3-8(20-12)17-6-16-9-10(13)14-5-15-11(9)17/h1,5-8,18-19H,3-4H2,(H2,13,14,15)/t7?,8?,12-/m1/s1
InChI=1S/C12H13N5O3/c1-2-12(4-18)7(19)3-8(20-12)17-6-16-9-10(13)14-5-15-11(9)17/h1,5-8,18-19H,3-4H2,(H2,13,14,15)",4'-ethynyl-2'-deoxyadenosine,"Synthesis of nucleotide analogues, EFdA, EdA and EdAP, and the effect of EdAP on hepatitis B virus replication.",8177,C12H13N5O3,275.26,276.26
465,"InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2",N6-etheno-2'-deoxyadenosine,"Formation of 1,N6-etheno-2'-deoxyadenosine adducts by trans,trans-2, 4-Decadienal.",110835,C12H13N5O3,275.26,276.26
466,"InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9+/m0/s1",ethenodeoxyadenosine,Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA.,99519,C12H13N5O3,275.26,276.26
467,"InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9?/m0/s1","1,N2-etheno-2'-deoxyguanosine","Secondary oxidation of cyclic 1,N2-propano and 1,N2-etheno-2'-deoxyguanosine DNA adducts. Consequences in oxidative stress biomarker development.",54189,C12H13N5O3,275.26,276.26
468,"InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9?/m0/s1
InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2
InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9+/m0/s1","1,N6-Etheno-2'-deoxyadenosine","Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA.",106244,C12H13N5O3,275.26,276.26
469,"InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9?/m0/s1
InChI=1S/C12H13N5O3/c18-4-8-7(19)3-9(20-8)17-6-14-10-11-13-1-2-16(11)5-15-12(10)17/h1-2,5-9,18-19H,3-4H2/t7-,8+,9+/m0/s1","1,N(6)-Ethenodeoxyadenosine","Translesion DNA synthesis catalyzed by human pol eta and pol kappa across 1,N6-ethenodeoxyadenosine.",100213,C12H13N5O3,275.26,276.26
470,"InChI=1S/C12H13N5O4/c1-2-12(3-18)8(20)7(19)11(21-12)17-5-16-6-9(13)14-4-15-10(6)17/h1,4-5,7-8,11,18-20H,3H2,(H2,13,14,15)/t7-,8+,11-,12?/m1/s1",4'-ethynyladenosine,"Design, Synthesis, and Biological Evaluation of EdAP, a 4'-Ethynyl-2'-Deoxyadenosine 5'-Monophosphate Analog, as a Potent Influenza a Inhibitor.",9099,C12H13N5O4,291.26,292.26
471,"InChI=1S/C12H13N5O4/c1-2-7-14-9-10(15-12(13)16-11(9)20)17(7)8-3-5(19)6(4-18)21-8/h1,5-6,8,18-19H,3-4H2,(H3,13,15,16,20)/t5-,6+,8+/m0/s1",8-ethynyl-2'-deoxyguanosine,Conformation of G-quadruplex Controlled by Click Reaction.,4007,C12H13N5O4,291.26,292.26
472,"InChI=1S/C12H13N5O4/c13-9-7-10(15-4-14-9)17(5-16-7)12-2-1-11(12,20)8(19)6(3-18)21-12/h1-2,4-6,8,18-20H,3H2,(H2,13,14,15)/t6-,8-,11-,12-/m1/s1
InChI=1S/C12H13N5O4/c13-9-7-10(15-4-14-9)17(5-16-7)12-2-1-11(12,20)8(19)6(3-18)21-12/h1-2,4-6,8,18-20H,3H2,(H2,13,14,15)",ethenoadenosine,Adenosine stimulates connexin 43 expression and gap junctional communication in pituitary folliculostellate cells.,73296,C12H13N5O4,291.26,292.26
473,"InChI=1S/C12H13N5O4/c18-3-6-8(19)9(20)12(21-6)17-5-14-7-10-13-1-2-16(10)4-15-11(7)17/h1-2,4-6,8-9,12,18-20H,3H2/t6-,8-,9-,12-/m1/s1","1,N(6)-Ethenoadenosine","Sequence selective formation of 1,N(6)-ethenoadenine in DNA by furan-conjugated probe.",59680,C12H13N5O4,291.26,292.26
474,"InChI=1S/C12H13N5O4/c18-4-7-6(19)3-8(21-7)17-5-14-9-10(17)15-12-13-1-2-16(12)11(9)20/h1-2,5-8,18-19H,3-4H2,(H,13,15)/t6-,7+,8-/m0/s1","1,N(2)-ethenodeoxyguanosine","Structure of the 1,N(2)-etheno-2'-deoxyguanosine lesion in the 3'-G(epsilon dG)T-5' sequence opposite a one-base deletion.",55532,C12H13N5O4,291.26,292.26
475,"InChI=1S/C12H13N5O5/c13-1-4-2-17(9-6(4)10(21)16-12(14)15-9)11-8(20)7(19)5(3-18)22-11/h2,5,7-8,11,18-20H,3H2,(H3,14,15,16,21)/t5-,7-,8-,11-/m1/s1
InChI=1S/C12H13N5O5/c13-1-4-2-17(9-6(4)10(21)16-12(14)15-9)11-8(20)7(19)5(3-18)22-11/h2,5,7-8,11,18-20H,3H2,(H3,14,15,16,21)",7-cyano-7-deazaguanosine,"Efficient synthesis of the tRNA nucleoside preQ0, 7-cyano-7-deazaguanosine, via microwave-assisted iodo→carbonitrile exchange.",52170,C12H13N5O5,307.26,308.26
476,"InChI=1S/C12H13N5O5/c18-3-5-7(19)8(20)11(22-5)17-4-14-6-9(17)15-12-13-1-2-16(12)10(6)21/h1-2,4-5,7-8,11,18-20H,3H2,(H,13,15)/t5-,7-,8-,11-/m1/s1","1,N2-ethenoguanosine",Determination of new types of DNA lesions in human sperm.,66552,C12H13N5O5,307.26,308.26
477,"InChI=1S/C12H13N5O5/c18-3-5-7(19)8(20)11(22-5)17-4-14-6-9(17)15-12-13-1-2-16(12)10(6)21/h1-2,4-5,7-8,11,18-20H,3H2,(H,13,15)/t5-,7-,8-,11?/m1/s1","1,N(2)-ethenoguanosine",Base-Modified Nucleosides: Etheno Derivatives.,22974,C12H13N5O5,307.26,308.26
478,"InChI=1S/C12H13N5O6/c13-10-7-11(17(4-20)6(2-19)15-10)16(3-14-7)12-9(22)8(21)5(1-18)23-12/h2-5,8-9,12-13,18,21-22H,1H2/t5-,8-,9-,12-/m1/s1","adenosine-2,3-dialdehyde",Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells.,37331,C12H13N5O6,323.26,324.26
479,"InChI=1S/C12H13N5O6/c13-8-7-9(15-4-14-8)17(5-16-7)10-12(22,3-20)11(21,2-19)6(1-18)23-10/h2-6,10,18,21-22H,1H2,(H2,13,14,15)/t6-,10-,11-,12+/m1/s1","adenosine-2',3'-dialdehyde","Induction of human fetal hemoglobin expression by adenosine-2',3'-dialdehyde.",37812,C12H13N5O6,323.26,324.26
480,"InChI=1S/C12H14N2O5/c1-2-3-7-5-14(12(18)13-11(7)17)10-4-8(16)9(6-15)19-10/h5,8-10,15-16H,4,6H2,1H3,(H,13,17,18)/t8-,9+,10+/m0/s1",5-(1-propynyl)-2'-deoxyuridine,Synthesis of 5-(1-propynyl)-2'-deoxyuridine 5'-(alpha-P-borano)triphosphate and kinetic characterization as a substrate for mmlv reverse transcriptase.,78476,C12H14N2O5,266.25,267.25
481,"InChI=1S/C12H14N2O7S/c1-12(9(18)7(17)8(21-12)5(16)4-15)14-3-6(20-2)10(19)13-11(14)22/h3-4,7-9,17-18H,1-2H3,(H,13,19,22)/t7-,8-,9-,12-/m1/s1",5-methoxy-carbonyl-methyl-2-thio-uridine,Elongator Subunit 3 (Elp3) Is Required for Zebrafish Trunk Development.,6803,C12H14N2O7S,330.32,331.32
482,"InChI=1S/C12H15FN2O6/c1-11(2)19-7-8(20-11)12(13,5-16)21-9(7)15-4-3-6(17)14-10(15)18/h3-4,7-9,16H,5H2,1-2H3,(H,14,17,18)/t7-,8+,9-,12-/m1/s1","4'-fluoro-2',3'-O-isopropylideneuridine",[Synthesis and biological properties of pyrimidine 4'-fluoro nucleosides and 4'-fluoro uridine 5'-O-triphospate].,52812,C12H15FN2O6,302.26,303.26
483,"InChI=1S/C12H15IN4O5/c13-2-7(15-5-14)6-3-17(12(21)16-11(6)20)10-1-8(19)9(4-18)22-10/h3,7-10,15,18-19H,1-2,4H2,(H,16,20,21)/t7?,8-,9+,10+/m0/s1",5-(1-cyanamido-2-iodoethyl)-2'-deoxyuridine,Synthesis and antiviral activity of novel 5-(1-cyanamido-2-haloethyl) and 5-(1-hydroxy(or methoxy)-2-azidoethyl) analogues of uracil nucleosides.,98491,C12H15IN4O5,422.18,423.18
484,"InChI=1S/C12H15N3O4/c1-2-3-7-5-15(12(18)14-11(7)13)10-4-8(17)9(6-16)19-10/h5,8-10,16-17H,4,6H2,1H3,(H2,13,14,18)/t8-,9+,10+/m0/s1
InChI=1S/2C12H15N3O4/c2*1-2-3-7-5-15(12(18)14-11(7)13)10-4-8(17)9(6-16)19-10/h2*5,8-10,16-17H,4,6H2,1H3,(H2,13,14,18)/t2*8-,9+,10+/m00/s1",2'-deoxy-5-propynylcytidine,Oligonucleotides forming an i-motif: the pH-dependent assembly of individual strands and branched structures containing 2'-deoxy-5-propynylcytidine.,70056,C12H15N3O4,265.27,266.27
485,"InChI=1S/C12H15N5O3/c1-2-8-16-10-11(13)14-5-15-12(10)17(8)9-3-6(19)7(4-18)20-9/h2,5-7,9,18-19H,1,3-4H2,(H2,13,14,15)/t6-,7+,9+/m0/s1",8-Vinyl-2'-deoxyadenosine,Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain.,70485,C12H15N5O3,277.28,278.28
486,"InChI=1S/C12H15N5O4/c1-2-13-12-15-10-9(11(20)16-12)14-5-17(10)8-3-6(19)7(4-18)21-8/h2,5-8,18-19H,3-4H2,1H3,(H,15,16,20)/t6-,7+,8+/m0/s1",N2-ethylidenedeoxyguanosine,N2-ethyldeoxyguanosine as a potential biomarker for assessing effects of alcohol consumption on DNA.,62422,C12H15N5O4,293.28,294.28
487,"InChI=1S/C12H15N5O4/c1-2-6-15-10(13)7-11(16-6)17(4-14-7)12-9(20)8(19)5(3-18)21-12/h2,4-5,8-9,12,18-20H,1,3H2,(H2,13,15,16)/t5-,8-,9-,12-/m1/s1",2-vinyladenosine,Mutually Orthogonal Bioconjugation of Vinyl Nucleosides for RNA Metabolic Labeling.,574,C12H15N5O4,293.28,294.28
488,"InChI=1S/C12H15N5O4/c1-2-6-16-7-10(13)14-4-15-11(7)17(6)12-9(20)8(19)5(3-18)21-12/h2,4-5,8-9,12,18-20H,1,3H2,(H2,13,14,15)/t5-,8-,9-,12-/m1/s1",8-Vinyladenosine,Change in electronic structure upon optical excitation of 8-vinyladenosine: an experimental and theoretical study.,57022,C12H15N5O4,293.28,294.28
489,"InChI=1S/C12H15N5O4/c1-2-7-14-9-10(15-12(13)16-11(9)20)17(7)8-3-5(19)6(4-18)21-8/h2,5-6,8,18-19H,1,3-4H2,(H3,13,15,16,20)/t5-,6+,8+/m0/s1",8-vinyl-2'-deoxyguanosine,Enzymatic synthesis of 8-vinyl- and 8-styryl-2'-deoxyguanosine modified DNA--novel fluorescent molecular probes.,44271,C12H15N5O4,293.28,294.28
490,"InChI=1S/C12H15N5O7/c18-2-4-7(21)8(22)11(24-4)17-3-14-6-9(17)15-12(16-10(6)23)13-1-5(19)20/h3-4,7-8,11,18,21-22H,1-2H2,(H,19,20)(H2,13,15,16,23)/t4-,7-,8-,11-/m1/s1",N2-carboxymethylguanosine,DNA-glycation leads to depurination by the loss of N2-carboxyethylguanine in vitro.,110258,C12H15N5O7,341.28,342.28
491,"InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8-,9-,10-/m1/s1
InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)","2',3'-isopropylideneuridine",[New nucleoside conjugates with phospholipids: synthesis of anti-HIV activity of rac-1-hexadecyl-2-acyl-sn-glycero-3-phosphonucleosides].,114171,C12H16N2O6,284.27,285.27
492,"InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8-,9-,10-/m1/s1
InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)
InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8?,9?,10-/m1/s1
InChI=1S/C12H16N2O6/c1-12(2)19-8-6(5-15)18-10(9(8)20-12)14-4-3-7(16)13-11(14)17/h3-4,6,8-10,15H,5H2,1-2H3,(H,13,16,17)/t6-,8+,9?,10-/m1/s1","2',3'-O-isopropylideneuridine",Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice.,81964,C12H16N2O6,284.27,285.27
493,"InChI=1S/C12H16N2O6/c1-5(2)7(16)10-8(17)9(18)11(20-10)14-4-3-6(15)13-12(14)19/h3-4,8-11,16-18H,1-2H3,(H,13,15,19)/t8-,9+,10+,11+/m0/s1",isopropylideneuridine,Inhibition of UDP-glucuronosyltransferase by 5'-O-amino acid and oligopeptide derivatives of uridine: structure-activity relationships.,111441,C12H16N2O6,284.27,285.27
494,"InChI=1S/C12H16N2O6/c1-6-4-13(10-3-8(17)9(5-15)20-10)12(19)14(7(2)16)11(6)18/h4,8-10,15,17H,3,5H2,1-2H3/t8-,9+,10+/m0/s1",3-acetyl-5-methyl-2'-deoxyuridine,Deoxyuridines from the marine sponge associated actinomycete Streptomyces microflavus.,48819,C12H16N2O6,284.27,285.27
495,"InChI=1S/C12H16N2O6S/c1-5(16)2-6-3-14(12(21)13-10(6)19)11-9(18)8(17)7(4-15)20-11/h3,7-9,11,15,17-18H,2,4H2,1H3,(H,13,19,21)/t7-,8-,9-,11-/m1/s1",5-methylcarbonylmethyl-2-thiouridine,Novel methyltransferase for modified uridine residues at the wobble position of tRNA.,88311,C12H16N2O6S,316.33,317.33
496,"InChI=1S/C12H16N2O7S/c1-11(20)9(19)6(5-15)21-12(11,4-8(17)18)14-3-2-7(16)13-10(14)22/h2-3,6,9,15,19-20H,4-5H2,1H3,(H,17,18)(H,13,16,22)/t6-,9-,11-,12-/m1/s1",methylcarboxymethyl-2-thiouridine,Introduction of hypermodified nucleotides in RNA.,84702,C12H16N2O7S,332.33,333.33
497,"InChI=1S/C12H16N2O7S/c1-20-7(16)2-5-3-14(12(22)13-10(5)19)11-9(18)8(17)6(4-15)21-11/h3,6,8-9,11,15,17-18H,2,4H2,1H3,(H,13,19,22)/t6-,8-,9-,11-/m1/s1",5-methoxycarbonylmethyl-2-thiouridine,Monitoring the 5-Methoxycarbonylmethyl-2-Thiouridine (mcm5s2U) Modification Utilizing the Gamma-Toxin Endonuclease.,1332,C12H16N2O7S,332.33,333.33
498,"InChI=1S/C12H16N2O7S/c1-5-3-14(11(22)13-10(5)20)12(2-7(16)17)9(19)8(18)6(4-15)21-12/h3,6,8-9,15,18-19H,2,4H2,1H3,(H,16,17)(H,13,20,22)/t6-,8-,9-,12-/m1/s1",5-methylcarboxymethyl-2-thiouridine,"An unmodified wobble uridine in tRNAs specific for Glutamine, Lysine, and Glutamic acid from Salmonella enterica Serovar Typhimurium results in nonviability-Due to increased missense errors?",18584,C12H16N2O7S,332.33,333.33
499,"InChI=1S/C12H16N2O8/c1-21-7(16)2-5-3-14(12(20)13-10(5)19)11-9(18)8(17)6(4-15)22-11/h3,6,8-9,11,15,17-18H,2,4H2,1H3,(H,13,19,20)/t6-,8-,9-,11-/m1/s1",5-methoxycarbonylmethyluridine,Protein Phosphatase Sit4 Affects Lipid Droplet Synthesis and Soraphen A Resistance Independent of Its Role in Regulating Elongator Dependent tRNA Modification.,13525,C12H16N2O8,316.26,317.26
500,"InChI=1S/C12H16N2O9/c1-21-7(16)4-22-5-2-14(12(20)13-10(5)19)11-9(18)8(17)6(3-15)23-11/h2,6,8-9,11,15,17-18H,3-4H2,1H3,(H,13,19,20)/t6-,8-,9-,11-/m1/s1",5-methoxycarbonylmethoxyuridine,Biogenesis and growth phase-dependent alteration of 5-methoxycarbonylmethoxyuridine in tRNA anticodons.,25045,C12H16N2O9,332.26,333.26
501,"InChI=1S/C12H16N2O9/c1-22-10(20)5-2-14(11(21)13-9(5)19)12(4-16)8(18)7(17)6(3-15)23-12/h2,6-8,15-18H,3-4H2,1H3,(H,13,19,21)/t6-,7-,8-,12+/m1/s1",(S)-5-methoxycarbonylhydroxymethyluridine,"ALKB-8, a 2-Oxoglutarate-Dependent Dioxygenase and S-Adenosine Methionine-Dependent Methyltransferase Modulates Metabolic Events Linked to Lysosome-Related Organelles and Aging in C. elegans.",12389,C12H16N2O9,332.26,333.26
502,"InChI=1S/C12H16N2O9/c1-22-10(20)5-2-14(11(21)13-9(5)19)12(4-16)8(18)7(17)6(3-15)23-12/h2,6-8,15-18H,3-4H2,1H3,(H,13,19,21)/t6-,7-,8-,12-/m1/s1",5-methoxycarbonylhydroxymethyluridine,ALKBH8-mediated formation of a novel diastereomeric pair of wobble nucleosides in mammalian tRNA.,50756,C12H16N2O9,332.26,333.26
503,"InChI=1S/C12H16N4O4/c1-12(19)8(18)7(4-17)20-11(12)16-3-2-6-9(13)14-5-15-10(6)16/h2-3,5,7-8,11,17-19H,4H2,1H3,(H2,13,14,15)/t7-,8-,11-,12-/m1/s1",7-Deaza-2'-C-methyl-adenosine,A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.,84300,C12H16N4O4,280.28,281.28
504,"InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1",5'-(N-Ethylcarboxamido)adenosine,Pharmacological characterization of adenosine receptors on isolated human bronchi.,48667,C12H16N6O4,308.29,309.29
505,"InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7+,8-,12+/m0/s1
InChI=1S/C12H16N6O4/c1-2-14-11(21)8-6(19)7(20)12(22-8)18-4-17-5-9(13)15-3-16-10(5)18/h3-4,6-8,12,19-20H,2H2,1H3,(H,14,21)(H2,13,15,16)/t6-,7?,8+,12-/m1/s1",5'-ethylcarboxamidoadenosine,Adenosine A(2A) receptors in portal hypertension: their role in the abnormal response to adenosine of the cranial mesenteric artery in rabbits.,96717,C12H16N6O4,308.29,309.29
506,"InChI=1S/C12H16N6O5/c13-8(14)3-1-18(9-5(3)10(22)17-12(15)16-9)11-7(21)6(20)4(2-19)23-11/h1,4,6-7,11,19-21H,2H2,(H3,13,14)(H3,15,16,17,22)/t4-,6-,7-,11-/m1/s1",7-formamidino-7-deazaguanosine,Crystal structure of archaeosine tRNA-guanine transglycosylase.,95575,C12H16N6O5,324.29,325.29
507,"InChI=1S/C12H17N3O6/c1-2-3-5-9(13)14-12(20)15(10(5)19)11-8(18)7(17)6(4-16)21-11/h2,6-8,11,16-18H,1,3-4,13H2,(H,14,20)/t6-,7-,8-,11-/m1/s1",5-allyl-6-oxocytidine,pH-independent triple-helix formation with 6-oxocytidine as cytidine analogue.,103749,C12H17N3O6,299.28,300.28
508,"InChI=1S/C12H17N3O7/c1-21-9-8(18)6(4-16)22-11(9)15-3-5(2-7(13)17)10(19)14-12(15)20/h3,6,8-9,11,16,18H,2,4H2,1H3,(H2,13,17)(H,14,19,20)/t6-,8-,9-,11-/m1/s1
InChI=1S/C12H17N3O7/c1-21-9-8(18)6(4-16)22-11(9)15-3-5(2-7(13)17)10(19)14-12(15)20/h3,6,8-9,11,16,18H,2,4H2,1H3,(H2,13,17)(H,14,19,20)",5-carbamoylmethyl-2'-O-methyluridine,The role of wobble uridine modifications in +1 translational frameshifting in eukaryotes.,26723,C12H17N3O7,315.28,316.28
509,"InChI=1S/C12H17N3O7S/c16-4-6-8(19)9(20)11(22-6)15-3-5(1-13-2-7(17)18)10(21)14-12(15)23/h3,6,8-9,11,13,16,19-20H,1-2,4H2,(H,17,18)(H,14,21,23)/t6-,8-,9-,11-/m1/s1",5-carboxymethylaminomethyl-2-thiouridine,S-Geranyl-2-thiouridine wobble nucleosides of bacterial tRNAs; chemical and enzymatic synthesis of S-geranylated-RNAs and their physicochemical characterization.,21744,C12H17N3O7S,347.35,348.35
510,"InChI=1S/C12H17N3O8/c16-4-6-8(19)9(20)11(23-6)15-3-5(1-13-2-7(17)18)10(21)14-12(15)22/h3,6,8-9,11,13,16,19-20H,1-2,4H2,(H,17,18)(H,14,21,22)/t6-,8-,9-,11-/m1/s1",5-carboxymethylaminomethyluridine,Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease.,15259,C12H17N3O8,331.28,332.28
511,"InChI=1S/C12H17N3O8/c16-4-6-9(20)10(21)12(23-6,5-13-3-8(18)19)15-2-1-7(17)14-11(15)22/h1-2,6,9-10,13,16,20-21H,3-5H2,(H,18,19)(H,14,17,22)/t6-,9-,10-,12-/m1/s1",carboxymethylaminomethyl uridine,Structural basis for hypermodification of the wobble uridine in tRNA by bifunctional enzyme MnmC.,36273,C12H17N3O8,331.28,332.28
512,"InChI=1S/C12H17N5O4/c1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20-2)8(19)6(3-18)21-12/h4-6,8-9,12,18-19H,3H2,1-2H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1","N6,2'-O-dimethyladenosine",The comprehensive interactomes of human adenosine RNA methyltransferases and demethylases reveal distinct functional and regulatory features.,349,C12H17N5O4,295.3,296.3
513,"InChI=1S/C12H17N5O4/c1-16(2)10-7-11(14-4-13-10)17(5-15-7)12-9(20)8(19)6(3-18)21-12/h4-6,8-9,12,18-20H,3H2,1-2H3/t6-,8-,9-,12-/m1/s1","N(6),N(6)-dimethyladenosine",Control of substrate specificity by a single active site residue of the KsgA methyltransferase.,46176,C12H17N5O4,295.3,296.3
514,"InChI=1S/C12H17N5O4/c1-2-13-12-15-10-9(11(20)16-12)14-5-17(10)8-3-6(19)7(4-18)21-8/h5-8,18-19H,2-4H2,1H3,(H2,13,15,16,20)/t6-,7+,8+/m0/s1",N2-ethyl-2'-deoxyguanosine,Increased formation of hepatic N2-ethylidene-2'-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol.,71269,C12H17N5O4,295.3,296.3
515,"InChI=1S/C12H17N5O4/c1-2-20-11-9-10(15-12(13)16-11)17(5-14-9)8-3-6(19)7(4-18)21-8/h5-8,18-19H,2-4H2,1H3,(H2,13,15,16)/t6-,7+,8+/m0/s1",O(6)-ethyl-2'-deoxyguanosine,Quantification of O6-methyl and O6-ethyl deoxyguanosine adducts in C57BL/6N/Tk+/- mice using LC/MS/MS.,74159,C12H17N5O4,295.3,296.3
516,"InChI=1S/C12H17N5O4/c1-4-14-10(13)7-11(15-4)17(5(2)16-7)12-9(20)8(19)6(3-18)21-12/h6,8-9,12,18-20H,3H2,1-2H3,(H2,13,14,15)/t6-,8-,9-,12-/m1/s1","2,8-dimethyladenosine",Identification of 8-methyladenosine as the modification catalyzed by the radical SAM methyltransferase Cfr that confers antibiotic resistance in bacteria.,61513,C12H17N5O4,295.3,296.3
517,"InChI=1S/C12H17N5O4/c18-2-1-13-11-10-12(15-5-14-11)17(6-16-10)9-3-7(20)8(4-19)21-9/h5-9,18-20H,1-4H2,(H,13,14,15)",N6-(2-hydroxyethyl)-2'-deoxyadenosine,"LC-MS/MS simultaneous quantitation of 2-hydroxyethylated, oxidative, and unmodified DNA nucleosides in DNA isolated from tissues of mice after exposure to ethylene oxide.",30158,C12H17N5O4,295.3,296.3
518,"InChI=1S/C12H17N5O4S/c1-13-9-6-10(16-12(15-9)22-2)17(4-14-6)11-8(20)7(19)5(3-18)21-11/h4-5,7-8,11,18-20H,3H2,1-2H3,(H,13,15,16)
InChI=1S/C12H17N5O4S/c1-13-9-6-10(16-12(15-9)22-2)17(4-14-6)11-8(20)7(19)5(3-18)21-11/h4-5,7-8,11,18-20H,3H2,1-2H3,(H,13,15,16)/t5-,7-,8-,11-/m1/s1",2-methylthio-N6-methyladenosine,The thermodynamic stability of RNA duplexes and hairpins containing N6-alkyladenosines and 2-methylthio-N6-alkyladenosines.,90289,C12H17N5O4S,327.36,328.36
519,"InChI=1S/C12H17N5O4S/c13-10-6-11(15-3-14-10)17(4-16-6)12-9(22)7(20)8(21-12)5(19)1-2-18/h3-5,7-9,12,18-20,22H,1-2H2,(H2,13,14,15)/t5?,7-,8-,9-,12-/m1/s1",5'-hydroxyethylthio-adenosine,Leishmania infantum 5'-Methylthioadenosine Phosphorylase presents relevant structural divergence to constitute a potential drug target.,15706,C12H17N5O4S,327.36,328.36
520,"InChI=1S/C12H17N5O5/c1-16(2)12-14-9-6(10(21)15-12)13-4-17(9)11-8(20)7(19)5(3-18)22-11/h4-5,7-8,11,18-20H,3H2,1-2H3,(H,14,15,21)/t5-,7-,8-,11-/m1/s1","N(2),N(2)-dimethylguanosine",Structural and functional analyses of the archaeal tRNA m2G/m22G10 methyltransferase aTrm11 provide mechanistic insights into site specificity of a tRNA methyltransferase that contains common RNA-binding modules.,22572,C12H17N5O5,311.29,312.29
521,"InChI=1S/C12H17N5O5/c1-16-10(20)6-9(15-12(16)13)17(4-14-6)11-8(21-2)7(19)5(3-18)22-11/h4-5,7-8,11,18-19H,3H2,1-2H3,(H2,13,15)/t5-,7-,8-,11-/m1/s1","1,2'-O-dimethylguanosine",Posttranscriptional modification of transfer RNA in the submarine hyperthermophile Pyrolobus fumarii.,90122,C12H17N5O5,311.29,312.29
522,"InChI=1S/C12H17N5O5/c13-12-15-10-9(11(16-12)21-2-1-18)14-5-17(10)8-3-6(20)7(4-19)22-8/h5-8,18-20H,1-4H2,(H2,13,15,16)/t6?,7-,8-/m1/s1",O6-(2-hydroxyethyl)-2'-deoxyguanosine,"LC-MS/MS simultaneous quantitation of 2-hydroxyethylated, oxidative, and unmodified DNA nucleosides in DNA isolated from tissues of mice after exposure to ethylene oxide.",30158,C12H17N5O5,311.29,312.29
523,"InChI=1S/C12H18AsN5O4/c1-13(2,21)3-6-8(19)9(20)12(22-6)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19-20H,3H2,1-2H3,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1",5'-dimethylarsinoyladenosine,Application of selected reaction monitoring tandem mass spectrometry to the quantitative determination of an arsenic-containing nucleoside in a crude biological extract.,86280,C12H18AsN5O4,371.22,372.22
524,"InChI=1S/C12H18N2O4S/c1-2-3-7-5-14(12(19)13-11(7)17)10-4-8(16)9(6-15)18-10/h5,8-10,15-16H,2-4,6H2,1H3,(H,13,17,19)/t8-,9+,10+/m0/s1",2'-deoxy-5-propyl-2-thiouridine,Synthesis and antiherpesvirus activities of 5-alkyl-2-thiopyrimidine nucleoside analogues.,94290,C12H18N2O4S,286.35,287.35
525,"InChI=1S/C12H18N2O7/c1-19-11(20-2)6-4-14(12(18)13-10(6)17)9-3-7(16)8(5-15)21-9/h4,7-9,11,15-16H,3,5H2,1-2H3,(H,13,17,18)/t7-,8+,9+/m0/s1",5-(dimethoxymethyl)-2'-deoxyuridine,5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.,75473,C12H18N2O7,302.28,303.28
526,"InChI=1S/C12H18N2O8/c15-3-6(17)5-21-10-9(19)7(4-16)22-11(10)14-2-1-8(18)13-12(14)20/h1-2,6-7,9-11,15-17,19H,3-5H2,(H,13,18,20)/t6?,7-,9-,10-,11-/m1/s1","2'-O-(2,3-dihydroxypropyl)uridine","[Synthesis and characteristics of modified oligodeoxyribonucleotides containing 2'-O-(2,3-dihydroxypropyl)uridine and 2'-O-(2-exoethyl)uridine].",101302,C12H18N2O8,318.28,319.28
527,"InChI=1S/C12H18N6O3/c1-17(2)10-8-11(15-4-14-10)18(5-16-8)12-9(20)7(13)6(3-19)21-12/h4-7,9,12,19-20H,3,13H2,1-2H3/t6-,7-,9-,12-/m1/s1","3'-amino-3'-deoxy-N6,N6-dimethyladenosine","A simple and efficient synthesis of puromycin, 2,2'-anhydro-pyrimidine nucleosides, cytidines and 2',3'-anhydroadenosine from 3',5'-O-sulfinyl xylo-nucleosides.",74409,C12H18N6O3,294.31,295.31
528,"InChI=1S/C12H19N3O5/c13-3-1-2-7-5-15(12(19)14-11(7)18)10-4-8(17)9(6-16)20-10/h5,8-10,16-17H,1-4,6,13H2,(H,14,18,19)/t8-,9+,10+/m0/s1",5-(3-aminopropyl)-2'-deoxyuridine,A bridging water anchors the tethered 5-(3-aminopropyl)-2'-deoxyuridine amine in the DNA major groove proximate to the N+2 C.G base pair: implications for formation of interstrand 5'-GNC-3' cross-links by nitrogen mustards.,64606,C12H19N3O5,285.3,286.3
529,"InChI=1S/C12H19N3O8S2/c16-5-7-8(17)9(18)11(23-7)15-4-6(10(19)14-12(15)24)3-13-1-2-25(20,21)22/h4,7-9,11,13,16-18H,1-3,5H2,(H,14,19,24)(H,20,21,22)/t7-,8?,9?,11-/m1/s1
InChI=1S/C12H19N3O8S2/c16-5-7-8(17)9(18)11(23-7)15-4-6(10(19)14-12(15)24)3-13-1-2-25(20,21)22/h4,7-9,11,13,16-18H,1-3,5H2,(H,14,19,24)(H,20,21,22)/p-1/t7-,8-,9-,11-/m1/s1",5-taurinomethyl-2-thiouridine,"Preferences of AAA/AAG codon recognition by modified nucleosides, τm",15744,C12H19N3O8S2,397.43,398.43
530,"InChI=1S/C13H15N5O3/c1-2-3-9-17-11-12(14)15-6-16-13(11)18(9)10-4-7(20)8(5-19)21-10/h6-8,10,19-20H,4-5H2,1H3,(H2,14,15,16)/t7-,8+,10+/m0/s1",2'-Deoxy-8-(propyn-1-yl)adenosine,2'-Deoxy-8-(propyn-1-yl)adenosine-containing oligonucleotides: effects on stability of duplex and quadruplex structures.,103356,C13H15N5O3,289.29,290.29
531,"InChI=1S/C13H15N5O3S/c1-2-3-22-4-7-9(19)10(20)13(21-7)18-6-17-8-11(14)15-5-16-12(8)18/h5-7,9-10,13,19-20H,4H2,1H3,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1",5'-S-propynyl-5'-thioadenosine,"Synthesis, mechanism of action, and antiviral activity of a new series of covalent mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase.",99339,C13H15N5O3S,321.36,322.36
532,"InChI=1S/C13H16N2O6/c1-3-4-7-5-15(13(19)14-11(7)18)12-10(20-2)9(17)8(6-16)21-12/h5,8-10,12,16-17H,6H2,1-2H3,(H,14,18,19)/t8-,9+,10-,12-/m1/s1",2'-O-methyl-5-propynyluridine,Selectivity and affinity of DNA triplex forming oligonucleotides containing the nucleoside analogues 2'-O-methyl-5-(3-amino-1-propynyl)uridine and 2'-O-methyl-5-propynyluridine.,62542,C13H16N2O6,296.28,297.28
533,"InChI=1S/C13H16N2O8/c1-6(17)21-10-8(5-16)23-12(11(10)22-7(2)18)15-4-3-9(19)14-13(15)20/h3-4,8,10-12,16H,5H2,1-2H3,(H,14,19,20)/t8-,10-,11-,12-/m1/s1","2',3'-di-O-acetyluridine","A rational approach to the regioselective deacetylation of 2',3',5'-tri-O-acetyluridine by Novozym 435 catalysed alcoholysis.",45220,C13H16N2O8,328.28,329.28
534,"InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)",5'-(N-cyclopropyl)-carboxamidoadenosine,Involvement of guanylate cyclase in the cardiovascular response induced by adenosine A2B receptor stimulation in the posterior hypothalamus of the anesthetized rats.,71260,C13H16N6O4,320.3,321.3
535,"InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)/t7-,8+,9-,13+/m0/s1
InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)
InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)/t7-,8?,9+,13-/m1/s1
InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)/t7-,8+,9-,13?/m0/s1
InChI=1S/C13H16N6O4/c14-10-6-11(16-3-15-10)19(4-17-6)13-8(21)7(20)9(23-13)12(22)18-5-1-2-5/h3-5,7-9,13,20-21H,1-2H2,(H,18,22)(H2,14,15,16)/t7-,8-,9+,13-/m1/s1",5'-(N-cyclopropyl)carboxamidoadenosine,Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells.,77654,C13H16N6O4,320.3,321.3
536,"InChI=1S/C13H17N3O6/c1-21-10-9(18)8(6-17)22-12(10)16-5-7(3-2-4-14)11(19)15-13(16)20/h5,8-10,12,17-18H,4,6,14H2,1H3,(H,15,19,20)/t8-,9-,10-,12-/m1/s1",2'-O-methyl-5-(3-amino-1-propynyl)uridine,Selectivity and affinity of DNA triplex forming oligonucleotides containing the nucleoside analogues 2'-O-methyl-5-(3-amino-1-propynyl)uridine and 2'-O-methyl-5-propynyluridine.,62542,C13H17N3O6,311.29,312.29
537,"InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)
InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1
InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)/t6-,8?,9-,12-/m1/s1
InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)/t6-,8+,9?,12-/m1/s1","2',3'-isopropylideneadenosine",Efficient synthesis of azide-bearing cofactor mimics.,87406,C13H17N5O4,307.31,308.31
538,"InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)/t6-,8-,9-,12-/m1/s1","2',3'-O-isopropylideneadenosine",Unzipping nucleoside channels by means of alcohol disassembly.,33728,C13H17N5O4,307.31,308.31
539,"InChI=1S/C13H17N5O4/c14-12-16-10-8(11(21)17-12)15-5-18(10)13-3-1-2-6(13)9(20)7(4-19)22-13/h5-7,9,19-20H,1-4H2,(H3,14,16,17,21)/t6-,7-,9+,13-/m1/s1",Propanodeoxyguanosine,Replication of template-primers containing propanodeoxyguanosine by DNA polymerase beta. Induction of base pair substitution and frameshift mutations by template slippage and deoxynucleoside triphosphate stabilization.,114153,C13H17N5O4,307.31,308.31
540,"InChI=1S/C13H17N5O4/c19-5-8-7(20)4-9(22-8)18-6-15-10-11(18)16-13-14-2-1-3-17(13)12(10)21/h6-9,19-20H,1-5H2,(H,14,16)/t7-,8+,9+/m0/s1","1,N(2)-Propanodeoxyguanosine","Structure of an oligodeoxynucleotide containing a 1,N(2)-propanodeoxyguanosine adduct positioned in a palindrome derived from the Salmonella typhimurium hisD3052 gene: Hoogsteen pairing at pH 5.2.",96919,C13H17N5O4,307.31,308.31
541,"InChI=1S/C13H17N5O6/c1-2-3-17-6-9(15-12(14)16-10(6)22)18(13(17)23)11-8(21)7(20)5(4-19)24-11/h2,5,7-8,11,19-21H,1,3-4H2,(H3,14,15,16,22)/t5-,7-,8-,11-/m1/s1","7-allyl-7,8-dihydro-8-oxo-guanosine","Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.",52848,C13H17N5O6,339.3,340.3
542,"InChI=1S/C13H17N5O6/c1-5(12(22)23)15-13-16-10-9(11(21)17-13)14-4-18(10)8-2-6(20)7(3-19)24-8/h4-8,19-20H,2-3H2,1H3,(H,22,23)(H2,15,16,17,21)/t5?,6-,7+,8+/m0/s1",N(2)-(1-carboxyethyl)-2'-deoxyguanosine,The roles of DNA polymerases κ and ι in the error-free bypass of N2-carboxyalkyl-2'-deoxyguanosine lesions in mammalian cells.,49911,C13H17N5O6,339.3,340.3
543,"InChI=1S/C13H17N5O7/c1-4(12(23)24)15-13-16-9-6(10(22)17-13)14-3-18(9)11-8(21)7(20)5(2-19)25-11/h3-5,7-8,11,19-21H,2H2,1H3,(H,23,24)(H2,15,16,17,22)/t4?,5-,7-,8-,11-/m1/s1",N(2)-carboxyethylguanosine,Detection of DNA-bound advanced glycation end-products by immunoaffinity chromatography coupled to HPLC-diode array detection.,76093,C13H17N5O7,355.3,356.3
544,"InChI=1S/C13H18N2O8/c1-21-8(17)3-6-4-15(13(20)14-11(6)19)12-10(22-2)9(18)7(5-16)23-12/h4,7,9-10,12,16,18H,3,5H2,1-2H3,(H,14,19,20)/t7-,9-,10-,12-/m1/s1",5-methoxycarbonylmethyl-2'-O-methyluridine,Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS.,2417,C13H18N2O8,330.29,331.29
545,"InChI=1S/C13H18N2O8/c1-6-4-15(12(21)14-11(6)20)13(3-8(17)18)10(22-2)9(19)7(5-16)23-13/h4,7,9-10,16,19H,3,5H2,1-2H3,(H,17,18)(H,14,20,21)/t7-,9-,10-,13-/m1/s1",5-methylcarboxymethyl-2'-O-methyluridine,Selenium metabolism in Drosophila. Characterization of the selenocysteine tRNA population.,108430,C13H18N2O8,330.29,331.29
546,"InChI=1S/C13H18N2O9/c1-21-8(17)5-23-6-3-15(13(20)14-11(6)19)12-10(22-2)9(18)7(4-16)24-12/h3,7,9-10,12,16,18H,4-5H2,1-2H3,(H,14,19,20)/t7-,9-,10-,12-/m1/s1",5-methoxycarbonylmethoxy-2'-O-methyluridine,Biogenesis and growth phase-dependent alteration of 5-methoxycarbonylmethoxyuridine in tRNA anticodons.,25045,C13H18N2O9,346.29,347.29
547,"InChI=1S/C13H19N3O8/c1-23-10-9(20)7(5-17)24-12(10)16-4-6(2-14-3-8(18)19)11(21)15-13(16)22/h4,7,9-10,12,14,17,20H,2-3,5H2,1H3,(H,18,19)(H,15,21,22)
InChI=1S/C13H19N3O8/c1-23-10-9(20)7(5-17)24-12(10)16-4-6(2-14-3-8(18)19)11(21)15-13(16)22/h4,7,9-10,12,14,17,20H,2-3,5H2,1H3,(H,18,19)(H,15,21,22)/t7-,9-,10-,12-/m1/s1",5-carboxymethylaminomethyl-2'-O-methyluridine,Modified nucleosides in the first positions of the anticodons of tRNA(Leu)4 and tRNA(Leu)5 from Escherichia coli.,109910,C13H19N3O8,345.31,346.31
548,"InChI=1S/C13H19N3O8/c14-6(12(21)22)1-3-15-8(18)2-4-16(13(15)23)11-10(20)9(19)7(5-17)24-11/h2,4,6-7,9-11,17,19-20H,1,3,5,14H2,(H,21,22)/t6?,7-,9-,10-,11-/m1/s1",3-(3-amino-3-carboxypropyl)uridine,Biogenesis and functions of aminocarboxypropyluridine in tRNA.,7494,C13H19N3O8,345.31,346.31
549,"InChI=1S/C13H19N5O5/c1-11(21)6(4-19)23-13(3,12(11,2)22)18-5-15-7-8(18)16-10(14)17-9(7)20/h5-6,19,21-22H,4H2,1-3H3,(H3,14,16,17,20)/t6-,11-,12-,13-/m1/s1",Trimethylguanosine,Self-association of Trimethylguanosine Synthase Tgs1 is required for efficient snRNA/snoRNA trimethylation and pre-rRNA processing.,27618,C13H19N5O5,325.32,326.32
550,"InChI=1S/C13H19N5O5/c1-16(2)13-14-10-7(11(22)15-13)17(3)5-18(10)12-9(21)8(20)6(4-19)23-12/h5-6,8-9,12,19-21H,4H2,1-3H3/p+1/t6-,8-,9-,12-/m1/s1","2,2,7-trimethylguanosine",Loss of the RNA trimethylguanosine cap is compatible with nuclear accumulation of spliceosomal snRNAs but not pre-mRNA splicing or snRNA processing during animal development.,3700,C13H20N5O5+,327.34,328.34
551,"InChI=1S/C13H19N5O5/c1-5(2)22-11-7-10(16-13(14)17-11)18(4-15-7)12-9(21)8(20)6(3-19)23-12/h4-6,8-9,12,19-21H,3H2,1-2H3,(H2,14,16,17)
InChI=1S/C13H19N5O5/c1-5(2)22-11-7-10(16-13(14)17-11)18(4-15-7)12-9(21)8(20)6(3-19)23-12/h4-6,8-9,12,19-21H,3H2,1-2H3,(H2,14,16,17)/t6-,8?,9+,12-/m1/s1",O6-isopropylguanosine,"Determinants of selectivity in alkylation of nucleosides and DNA by secondary diazonium ions: evidence for, and consequences of, a preassociation mechanism.",83591,C13H19N5O5,325.32,326.32
552,"InChI=1S/C13H21N3O8/c14-6(12(21)22)1-3-15-8(18)2-4-16(13(15)23)11-10(20)9(19)7(5-17)24-11/h6-7,9-11,17,19-20H,1-5,14H2,(H,21,22)/t6?,7-,9-,10-,11-/m1/s1","3-(3-amino-3-carboxypropyl)-5,6-dihydrouridine","3-(3-amino-3-carboxypropyl)-5,6-dihydrouridine is one of two novel post-transcriptional modifications in tRNALys(UUU) from Trypanosoma brucei.",46760,C13H21N3O8,347.32,348.32
553,"InChI=1S/C14H15N5O5/c1-2-14(23)9(21)7(4-20)24-13(14)19-3-6(11(16)22)8-10(15)17-5-18-12(8)19/h1,3,5,7,9,13,20-21,23H,4H2,(H2,16,22)(H2,15,17,18)/t7-,9-,13-,14-/m1/s1",2'-C-acetylene-7-deaza-7-carbamoyladenosine,Inhibition of dengue virus by an ester prodrug of an adenosine analog.,54308,C14H15N5O5,333.3,334.3
554,"InChI=1S/C14H16N2O4/c17-6-7-20-10-16-9-12(13(18)15-14(16)19)8-11-4-2-1-3-5-11/h1-5,9,17H,6-8,10H2,(H,15,18,19)",5-benzylacyclouridine,"Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.",79264,C14H16N2O4,276.29,277.29
555,"InChI=1S/C14H16N4O3/c1-2-3-8-5-18(11-4-9(20)10(6-19)21-11)14-12(8)13(15)16-7-17-14/h5,7,9-11,19-20H,4,6H2,1H3,(H2,15,16,17)/t9-,10+,11+/m0/s1",2'-deoxy-7-propynyl-7-deazaadenosine,2'-Deoxy-7-propynyl-7-deazaadenosine: a DNA duplex-stabilizing nucleoside.,75672,C14H16N4O3,288.3,289.3
556,"InChI=1S/C14H16N4O6/c1-7(19)22-4-10-9(23-8(2)20)3-11(24-10)18-6-17-12-13(18)15-5-16-14(12)21/h5-6,9-11H,3-4H2,1-2H3,(H,15,16,21)/t9-,10+,11+/m0/s1","3',5'-di-O-acetyl-2'-deoxyadenosine",Regioselective 1-N-Alkylation and Rearrangement of Adenosine Derivatives.,27263,C14H16N4O6,336.3,337.3
557,"InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)",6-azauridine triacetate,Identification of active antiviral compounds against a New York isolate of West Nile virus.,95411,C14H17N3O9,371.3,372.3
558,"InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)/t9-,11-,12-,13-/m1/s1
InChI=1S/C14H17N3O9/c1-6(18)23-5-9-11(24-7(2)19)12(25-8(3)20)13(26-9)17-14(22)16-10(21)4-15-17/h4,9,11-13H,5H2,1-3H3,(H,16,21,22)","2',3',5'-triacetyl-6-azauridine","In vitro metabolism studies of the prodrug, 2',3',5'-triacetyl-6-azauridine, utilizing an automated analytical system.",98361,C14H17N3O9,371.3,372.3
559,"InChI=1S/C14H17N5O6/c1-6(20)23-4-9-8(24-7(2)21)3-10(25-9)19-5-16-11-12(19)17-14(15)18-13(11)22/h5,8-10H,3-4H2,1-2H3,(H3,15,17,18,22)/t8-,9+,10+/m0/s1","3',5'-di-O-acetyl-2'-deoxyguanosine","Identification of products formed by reaction of 3',5'-di-O-acetyl-2'-deoxyguanosine with hypochlorous acid or a myeloperoxidase-H2O2-Cl- system.",92099,C14H17N5O6,351.32,352.32
560,"InChI=1S/C14H17N5O8/c20-2-6-9(23)10(24)13(27-6)19-4-17-8-11(15-3-16-12(8)19)18-5(14(25)26)1-7(21)22/h3-6,9-10,13,20,23-24H,1-2H2,(H,21,22)(H,25,26)(H,15,16,18)/t5-,6+,9+,10+,13+/m0/s1",Succinyladenosine,Identification and determination of succinyladenosine in human cerebrospinal fluid.,108636,C14H17N5O8,383.31,384.31
561,"InChI=1S/C14H18N5O11P/c20-7(21)1-5(14(24)25)18-11-8-12(16-3-15-11)19(4-17-8)13-10(23)9(22)6(30-13)2-29-31(26,27)28/h3-6,9-10,13,22-23H,1-2H2,(H,20,21)(H,24,25)(H,15,16,18)(H2,26,27,28)/t5-,6+,9+,10+,13+/m0/s1",succinyladenosine 5'-monophosphate,"Preparation of 5-amino-4-imidazole-N-succinocarboxamide ribotide, 5-amino-4-imidazole-N-succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency.",80836,C14H18N5O11P,463.29,464.29
562,"InChI=1S/C14H18N7O7P/c1-6-16-2-3-21(6)29(25,26)27-4-7-9(22)10(23)13(28-7)20-5-17-8-11(20)18-14(15)19-12(8)24/h2-3,5,7,9-10,13,22-23H,4H2,1H3,(H,25,26)(H3,15,18,19,24)/t7-,9-,10-,13-/m1/s1",guanosine 5'-phospho-2-methylimidazolide,"Montmorillonite, oligonucleotides, RNA and origin of life.",83335,C14H18N7O7P,427.31,428.31
563,"InChI=1S/C14H19N5O4/c20-4-8-10(21)11(22)14(23-8)19-6-17-9-12(15-5-16-13(9)19)18-7-2-1-3-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t8-,10-,11-,14-/m1/s1",N6-cyclobutyladenosine,Processing of adenosine receptor agonists in rat and human whole blood.,109679,C14H19N5O4,321.33,322.33
564,"InChI=1S/C14H19N5O5/c1-6-2-9(22)19-13(23)11-12(17-14(19)16-6)18(5-15-11)10-3-7(21)8(4-20)24-10/h5-11,20-22H,2-4H2,1H3/t6?,7?,8-,9?,10-,11?/m1/s1","alpha-methyl-gamma-hydroxy-1,N2-propano-2'-deoxyguanosine",Increased formation of hepatic N2-ethylidene-2'-deoxyguanosine DNA adducts in aldehyde dehydrogenase 2-knockout mice treated with ethanol.,71269,C14H19N5O5,337.33,338.33
565,"InChI=1S/C14H20N2O10/c17-3-6-9(21)11(23)14(26-6,16-2-1-7(19)15-13(16)24)12-10(22)8(20)5(18)4-25-12/h1-2,5-6,8-12,17-18,20-23H,3-4H2,(H,15,19,24)/t5-,6-,8-,9-,10+,11-,12?,14+/m1/s1",arabinosyl uridine,"Study of [18F]FLT and [123I]IaraU for cellular imaging in HSV1 tk-transfected murine fibrosarcoma cells: evaluation of the tracer uptake using 5-fluoro, 5-iodo and 5-iodovinyl arabinosyl uridines as competitive probes.",46280,C14H20N2O10,376.32,377.32
566,"InChI=1S/C14H20N2O6/c1-13(2,3)11(20)14(6-8(18)9(7-17)22-14)16-5-4-10(19)15-12(16)21/h4-5,8-9,17-18H,6-7H2,1-3H3,(H,15,19,21)/t8-,9+,14-/m0/s1",1'-pivaloyl-2'-deoxyuridine,Reactivity of 2'-deoxyuridin-1'-yl radical in various DNA structures.,72681,C14H20N2O6,312.32,313.32
567,"InChI=1S/C14H20N4O6/c15-3-1-2-8-6-18(14(22)17-12(8)21)13-11(23-5-4-16)10(20)9(7-19)24-13/h6,9-11,13,19-20H,3-5,7,15-16H2,(H,17,21,22)/t9-,10-,11-,13-/m1/s1",2'-O-(2-aminoethyl)-5-(3-amino-1-propynyl)uridine,Kinetic studies on the formation of DNA triplexes containing the nucleoside analogue 2'-O-(2-aminoethyl)-5-(3-amino-1-propynyl)uridine.,67170,C14H20N4O6,340.33,341.33
568,"InChI=1S/C14H20N6O4/c15-11-8-12(17-6-16-11)20(14(18-8)19-3-1-2-4-19)13-10(23)9(22)7(5-21)24-13/h6-7,9-10,13,21-23H,1-5H2,(H2,15,16,17)/t7-,9-,10-,13-/m1/s1",8-(pyrrolidin-1-yl)adenosine,Crystal structure and conformation of 8-(2-hydroxyethylamino) and 8-(pyrrolidin-1-yl) adenosines.,78283,C14H20N6O4,336.35,337.35
569,"InChI=1S/C14H21N3O10/c15-11-4(14(25)10(23)8(21)6(3-19)27-14)1-17(13(24)16-11)12-9(22)7(20)5(2-18)26-12/h1,5-10,12,18-23,25H,2-3H2,(H2,15,16,24)/t5-,6-,7?,8-,9-,10+,12?,14+/m1/s1",1-beta-D-arabinofuranosyl cytidine,Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.,84107,C14H21N3O10,391.33,392.33
570,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)",cytidine-5'-diphosphocholine,Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury.,44436,C14H26N4O11P2,488.32,489.32
571,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1",cytidine 5'-diphosphocholine,Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats.,82289,C14H26N4O11P2,488.32,489.32
572,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1
InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/p+1/t9-,11-,12-,13-/m1/s1",cytidine 5'-diphosphate choline,Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine.,109305,C14H26N4O11P2,488.32,489.32
573,"InChI=1S/C15H16N2O5/c18-8-12-11(19)6-13(22-12)17-7-10(14(20)16-15(17)21)9-4-2-1-3-5-9/h1-5,7,11-13,18-19H,6,8H2,(H,16,20,21)/t11-,12+,13+/m0/s1",5-phenyl-2'-deoxyuridine,High-affinity RNA targeting by oligonucleotides displaying aromatic stacking and amino groups in the major groove. Comparison of triazoles and phenyl substituents.,43490,C15H16N2O5,304.3,305.3
574,"InChI=1S/C15H16N6O4/c16-14-10(8-1-3-9(4-2-8)19-20-17)6-21(15(24)18-14)13-5-11(23)12(7-22)25-13/h1-4,6,11-13,22-23H,5,7H2,(H2,16,18,24)/t11-,12+,13+/m0/s1",5-(4-Azidophenyl)-2'-deoxycytidine,Azidophenyl as a click-transformable redox label of DNA suitable for electrochemical detection of DNA-protein interactions.,30069,C15H16N6O4,344.33,345.33
575,"InChI=1S/C15H16N6O4/c16-15-19-13-11(14(24)20-15)18-12(7-3-1-2-4-17-7)21(13)10-5-8(23)9(6-22)25-10/h1-4,8-10,22-23H,5-6H2,(H3,16,19,20,24)/t8-,9+,10+/m0/s1",8-(2-Pyridyl)-2'-deoxyguanosine,Cation-mediated energy transfer in G-quadruplexes revealed by an internal fluorescent probe.,51594,C15H16N6O4,344.33,345.33
576,"InChI=1S/C15H17N5O5/c21-5-9-11(22)12(23)15(25-9)20-7-19-10-13(17-6-18-14(10)20)16-4-8-2-1-3-24-8/h1-3,6-7,9,11-12,15,21-23H,4-5H2,(H,16,17,18)/t9-,11-,12-,15-/m1/s1",N6-furfuryladenosine,Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin riboside.,4054,C15H17N5O5,347.33,348.33
577,"InChI=1S/C15H18N2O8S/c1-7(18)22-6-10-12(23-8(2)19)13(24-9(3)20)14(25-10)17-5-4-11(26)16-15(17)21/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,26)/t10-,12-,13-,14-/m1/s1","2',3',5'-tri-O-acetyl-4-thiouridine",Generation of thiyl radicals by the photolysis of 5-iodo-4-thiouridine.,82471,C15H18N2O8S,386.38,387.38
578,"InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1",tri-O-acetyluridine,Synthesis and hypnotic activities of 4-thio analogues of N3-substituted uridines.,98915,C15H18N2O9,370.31,371.31
579,"InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1
InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)
InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13?,14-/m1/s1
InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13+,14+/m1/s1
InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12+,13?,14-/m1/s1","2',3',5'-tri-O-acetyluridine","A rational approach to the regioselective deacetylation of 2',3',5'-tri-O-acetyluridine by Novozym 435 catalysed alcoholysis.",45220,C15H18N2O9,370.31,371.31
580,"InChI=1S/C15H20ClN5O4/c16-14(24)11(23)9(5-22)25-15(14,8-3-1-2-4-8)21-7-20-10-12(17)18-6-19-13(10)21/h6-9,11,22-24H,1-5H2,(H2,17,18,19)/t9-,11-,14-,15-/m1/s1",Chlorocyclopentyl-adenosine,Adenosine A2a receptors increase arterial endothelial cell nitric oxide.,109975,C15H20ClN5O4,369.8,370.8
581,"InChI=1S/C15H20ClN5O4/c16-15-19-12(18-7-3-1-2-4-7)9-13(20-15)21(6-17-9)14-11(24)10(23)8(5-22)25-14/h6-8,10-11,14,22-24H,1-5H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1",2-Chloro-N6-cyclopentyladenosine,Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.,1951,C15H20ClN5O4,369.8,370.8
582,"InChI=1S/C15H20ClN5O4/c16-8-3-1-2-7(8)15(12(24)11(23)9(4-22)25-15)21-6-20-10-13(17)18-5-19-14(10)21/h5-9,11-12,22-24H,1-4H2,(H2,17,18,19)/t7?,8?,9-,11-,12-,15-/m1/s1",2-chlorocyclopentyladenosine,Activated cardiac adenosine A(1) receptors translocate out of caveolae.,105952,C15H20ClN5O4,369.8,370.8
583,"InChI=1S/C15H20N2O10/c1-3-23-14(21)26-10-8(7-18)25-12(11(10)27-15(22)24-4-2)17-6-5-9(19)16-13(17)20/h5-6,8,10-12,18H,3-4,7H2,1-2H3,(H,16,19,20)/t8-,10-,11-,12-/m1/s1","2',3'-di-O-ethoxycarbonyluridine",Two new dialkoxycarbonylated nucleosides obtained through a regioselective enzymatic alcoholysis.,70185,C15H20N2O10,388.33,389.33
584,"InChI=1S/C15H20N6O8/c1-5(23)7(14(26)27)19-15(28)20-11-8-12(17-3-16-11)21(4-18-8)13-10(25)9(24)6(2-22)29-13/h3-7,9-10,13,22-25H,2H2,1H3,(H,26,27)(H2,16,17,19,20,28)/t5-,6-,7+,9-,10-,13-/m1/s1",N6-Threonylcarbamoyladenosine,A hydantoin isoform of cyclic N6-threonylcarbamoyladenosine (ct6A) is present in tRNAs.,20416,C15H20N6O8,412.36,413.36
585,"InChI=1S/C15H21BrN2O11/c16-4-1-18(15(26)17-12(4)25)13-10(24)11(6(3-20)27-13)29-14-9(23)8(22)7(21)5(2-19)28-14/h1,5-11,13-14,19-24H,2-3H2,(H,17,25,26)",3'-O-(beta-D-galactopyranosyl)-5-bromouridine,Formation of 3'-O-beta-galactosyl compounds of 5-bromouridine by Sporobolomyces singularis.,91478,C15H21BrN2O11,485.24,486.24
586,"InChI=1S/C15H21ClN6O4/c16-15-18-12(20-21-4-2-1-3-5-21)9-13(19-15)22(7-17-9)14-11(25)10(24)8(6-23)26-14/h7-8,10-11,14,23-25H,1-6H2,(H,18,19,20)/t8-,10-,11-,14-/m1/s1",2-chloro-N-(1-piperidinyl)adenosine,N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.,107479,C15H21ClN6O4,384.82,385.82
587,"InChI=1S/C15H21N5O4/c1-8(2)3-4-16-13-10-14(18-6-17-13)20(7-19-10)15-12(23)11(22)9(5-21)24-15/h3,6-7,9,11-12,15,21-23H,4-5H2,1-2H3,(H,16,17,18)/t9-,11-,12-,15-/m1/s1",Isopentenyladenosine,"Novel isopentenyladenosine analogues: synthesis, characterization, and evaluation of antiproliferative activity on bladder carcinoma cells.",55666,C15H21N5O4,335.36,336.36
588,"InChI=1S/C15H21N5O4/c1-8(2)3-4-16-13-10-14(18-6-17-13)20(7-19-10)15-12(23)11(22)9(5-21)24-15/h6-7,9,11-12,15,21-23H,1,3-5H2,2H3,(H,16,17,18)/t9-,11-,12-,15-/m1/s1",N(6)-Isopentenyladenosine,Antiproliferative activity of N(6)-isopentenyladenosine on HCT-15 colon carcinoma cell line.,46976,C15H21N5O4,335.36,336.36
589,"InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1",Cyclopentyladenosine,3-mercaptopropionic acid-induced seizures decrease NR2B expression in Purkinje cells: cyclopentyladenosine effect.,53639,C15H21N5O4,335.36,336.36
590,"InChI=1S/C15H21N5O5/c16-14-18-12-9(13(24)19-14)17-6-20(12)15(7-3-1-2-4-7)11(23)10(22)8(5-21)25-15/h6-8,10-11,21-23H,1-5H2,(H3,16,18,19,24)/t8-,10-,11-,15-/m1/s1",cyclopentyl guanosine,New drugs for chronic hepatitis B: a review.,65811,C15H21N5O5,351.36,352.36
591,"InChI=1S/C15H21N5O5/c21-4-9-11(23)12(24)15(25-9)20-6-18-10-13(16-5-17-14(10)20)19-7-2-1-3-8(7)22/h5-9,11-12,15,21-24H,1-4H2,(H,16,17,19)/t7-,8-,9+,11+,12+,15+/m0/s1","N-[(1S, trans)-2-hydroxycyclopentyl]adenosine","The time course of cardioprotection induced by GR79236, a selective adenosine A1-receptor agonist, in myocardial ischaemia-reperfusion injury in the pig.",109568,C15H21N5O5,351.36,352.36
592,"InChI=1S/C15H21N5O8/c16-12-7-13(18-3-17-12)20(4-19-7)14-11(9(24)6(2-22)26-14)28-15-10(25)8(23)5(1-21)27-15/h3-6,8-11,14-15,21-25H,1-2H2,(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1",2'-O-beta-D-ribofuranosyladenosine,Interaction of HIV-1 reverse transcriptase with modified oligonucleotide primers containing 2'-O-beta-D-ribofuranosyladenosine.,87130,C15H21N5O8,399.36,400.36
593,"InChI=1S/C15H21N6O6P/c16-12-9-13(18-7-17-12)21(15(19-9)20-4-2-1-3-5-20)14-10(22)11-8(26-14)6-25-28(23,24)27-11/h7-8,10-11,14,22H,1-6H2,(H,23,24)(H2,16,17,18)/t8-,10-,11-,14-/m1/s1","8-piperidinoadenosine-3',5'-cyclic monophosphate",The cAMP analogs have potent anti-proliferative effects on medullary thyroid cancer cell lines.,28571,C15H21N6O6P,412.34,413.34
594,"InChI=1S/C15H21N7O7/c1-5(24)7(16)13(27)21-14(28)15(10(26)9(25)6(2-23)29-15)22-4-20-8-11(17)18-3-19-12(8)22/h3-7,9-10,23-26H,2,16H2,1H3,(H2,17,18,19)(H,21,27,28)/t5-,6-,7+,9-,10-,15+/m1/s1",Threonylcarbamoyladenosine,"Essentiality of threonylcarbamoyladenosine (t(6)A), a universal tRNA modification, in bacteria.",26497,C15H21N7O7,411.37,412.37
595,"InChI=1S/C15H21N7O9S/c16-6(1-2-8(23)24)14(27)21-32(28,29)30-3-7-10(25)11(26)15(31-7)22-5-20-9-12(17)18-4-19-13(9)22/h4-7,10-11,15,25-26H,1-3,16H2,(H,21,27)(H,23,24)(H2,17,18,19)/p-2/t6-,7+,10+,11+,15+/m0/s1",5'-O-[N-(L-glutamyl)-sulfamoyl] adenosine,Glutamylsulfamoyladenosine and pyroglutamylsulfamoyladenosine are competitive inhibitors of E. coli glutamyl-tRNA synthetase.,80881,C15H19N7O9S,473.42,474.42
596,"InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1",N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine,Differential expression of uridine phosphorylase in tumors contributes to an improved fluoropyrimidine therapeutic activity.,47254,C15H22FN3O6,359.35,360.35
597,"InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1",uridine diphosphate glucuronic acid,Human placental glucuronidation and transport of 3'azido-3'-deoxythymidine and uridine diphosphate glucuronic acid.,85217,C15H22N2O18P2,580.29,581.29
598,"InChI=1S/C15H22N5O7P/c1-8(2)3-4-16-13-10-14(18-6-17-13)20(7-19-10)15-12(22)11(21)9(27-15)5-26-28(23,24)25/h3,6-7,9,11-12,15,21-22H,4-5H2,1-2H3,(H,16,17,18)(H2,23,24,25)/t9-,11-,12-,15-/m1/s1
InChI=1S/C15H22N5O7P/c1-8(2)3-4-16-13-10-14(18-6-17-13)20(7-19-10)15-12(22)11(21)9(27-15)5-26-28(23,24)25/h3,6-7,9,11-12,15,21-22H,4-5H2,1-2H3,(H,16,17,18)(H2,23,24,25)/p-2/t9-,11-,12-,15-/m1/s1",isopentenyladenosine-5'-monophosphate,The Arabidopsis AtIPT8/PGA22 gene encodes an isopentenyl transferase that is involved in de novo cytokinin biosynthesis.,92847,C15H22N5O7P,415.34,416.34
599,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1",adenosine-5-diphosphoribose,Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: An in silico study.,3003,C15H23N5O14P2,559.32,560.32
600,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15?/m1/s1
InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)
InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1
InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1
InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14+,15?/m1/s1",adenosine 5'-diphosphoribose,Designer small molecules to target calcium signalling.,27889,C15H23N5O14P2,559.32,560.32
601,"InChI=1S/C15H23N5O14P2/c16-13-9-14(18-4-17-13)20(5-19-9)15-12(26)11(25)8(33-15)3-32-36(29,30)34-35(27,28)31-2-7(23)10(24)6(22)1-21/h1,4-8,10-12,15,22-26H,2-3H2,(H,27,28)(H,29,30)(H2,16,17,18)/t6-,7+,8+,10-,11+,12+,15+/m0/s1",adenosine diphosphoribose,Arachidonic acid mobilizes Ca2+ from the endoplasmic reticulum and an acidic store in rat pancreatic β cells.,45857,C15H23N5O14P2,559.32,560.32
602,"InChI=1S/C15H23N5O4/c1-8(2)3-4-16-13-10-14(18-6-17-13)20(7-19-10)15-12(23)11(22)9(5-21)24-15/h6-9,11-12,15,21-23H,3-5H2,1-2H3,(H,16,17,18)/t9-,11-,12-,15-/m1/s1",N6-isopentyladenosine,The modified nucleoside 2-methylthio-N6-isopentenyladenosine in tRNA of Shigella flexneri is required for expression of virulence genes.,114028,C15H23N5O4,337.38,338.38
603,"InChI=1S/C15H23N5O4/c16-15(8-3-1-2-4-8)12-13(17-6-19-15)20(7-18-12)14-11(23)10(22)9(5-21)24-14/h6,8-11,14,21-23H,1-5,7,16H2/t9-,10-,11-,14-,15?/m1/s1",6-cyclopentyladenosine,Neuromuscular transmission modulation by adenosine upon aging.,44884,C15H23N5O4,337.38,338.38
604,"InChI=1S/C15H23N7O3/c1-21(5-3-2-4-16)6-9-11(23)12(24)15(25-9)22-8-20-10-13(17)18-7-19-14(10)22/h2-3,7-9,11-12,15,23-24H,4-6,16H2,1H3,(H2,17,18,19)/b3-2-/t9-,11-,12-,15-/m1/s1",5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine,"Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.",17207,C15H23N7O3,349.39,350.39
605,"InChI=1S/C15H23N7O7/c1-5(24)7(16)12(27)21-14(28)15(17)10-11(18-3-20-15)22(4-19-10)13-9(26)8(25)6(2-23)29-13/h3,5-9,13,23-26H,2,4,16-17H2,1H3,(H,21,27,28)/t5-,6-,7+,8-,9-,13-,15?/m1/s1",6-threonylcarbamoyladenosine,Accurate translation of the genetic code depends on tRNA modified nucleosides.,96835,C15H23N7O7,413.39,414.39
606,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1",uridine 5'-diphosphate-glucose,A mutation in an Arabidopsis ribose 5-phosphate isomerase reduces cellulose synthesis and is rescued by exogenous uridine.,73404,C15H24N2O17P2,566.3,567.3
607,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1
InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1/i14T",uridine 5'-diphosphoglucose,"Identification, Heterologous Expression, and Functional Characterization of Bacillus subtilis YutF, a HAD Superfamily 5'-Nucleotidase with Broad Substrate Specificity.",20444,C15H24N2O17P2,566.3,567.3
608,"InChI=1S/C15H24N2O5/c1-2-3-4-5-6-10-8-17(15(21)16-14(10)20)13-7-11(19)12(9-18)22-13/h8,11-13,18-19H,2-7,9H2,1H3,(H,16,20,21)/t11-,12+,13+/m0/s1
InChI=1S/C15H24N2O5/c1-2-3-4-5-6-10-8-17(15(21)16-14(10)20)13-7-11(19)12(9-18)22-13/h8,11-13,18-19H,2-7,9H2,1H3,(H,16,20,21)/t11-,12+,13?/m0/s1
InChI=1S/C15H24N2O5/c1-2-3-4-5-6-10-8-17(15(21)16-14(10)20)13-7-11(19)12(9-18)22-13/h8,11-13,18-19H,2-7,9H2,1H3,(H,16,20,21)/t11-,12+,13+/m1/s1
InChI=1S/C15H24N2O5/c1-2-3-4-5-6-10-8-17(15(21)16-14(10)20)13-7-11(19)12(9-18)22-13/h8,11-13,18-19H,2-7,9H2,1H3,(H,16,20,21)",5-hexyl-2'-deoxyuridine,Differential inhibition of single and cluster type tumor cell migration.,58595,C15H24N2O5,312.36,313.36
609,"InChI=1S/C15H24N2O5/c1-2-3-4-5-7-15(9-11(19)12(10-18)22-15)17-8-6-13(20)16-14(17)21/h6,8,11-12,18-19H,2-5,7,9-10H2,1H3,(H,16,20,21)/t11-,12+,15+/m0/s1",hexyldeoxyuridine,[Study of drugs against neoplastic metastasis].,74465,C15H24N2O5,312.36,313.36
610,"InChI=1S/C15H25N3O5/c16-6-4-2-1-3-5-10-8-18(15(22)17-14(10)21)13-7-11(20)12(9-19)23-13/h8,11-13,19-20H,1-7,9,16H2,(H,17,21,22)/t11-,12+,13+/m0/s1",5-(6-aminohexyl)-2'-deoxyuridine,Regioselective effect of zwitterionic DNA substitutions on DNA alkylation: evidence for a strong side chain orientational preference.,114724,C15H25N3O5,327.38,328.38
611,"InChI=1S/C15H25N5O6/c16-8(14(24)25)3-1-2-5-18-15-19-10(17)4-6-20(15)13-12(23)11(22)9(7-21)26-13/h4,6,8-9,11-13,21-23H,1-3,5,7,16H2,(H,24,25)(H2,17,18,19)/t8-,9+,11+,12+,13+/m0/s1",2-lysylcytidine,Convergent evolution of AUA decoding in bacteria and archaea.,29711,C15H25N5O6,371.39,372.39
612,"InChI=1S/C15H26N2O6Si/c1-15(2,3)24(4,5)22-8-9-11(19)12(20)13(23-9)17-7-6-10(18)16-14(17)21/h6-7,9,11-13,19-20H,8H2,1-5H3,(H,16,18,21)/t9-,11-,12-,13-/m1/s1",5'-O-(tert-butyldimethylsilyl)uridine,Synthesis of 2'- or 3'-O-heteroaryl substituted nucleic acid derivatives and their biological properties.,72693,C15H26N2O6Si,358.46,359.46
613,"InChI=1S/C15H26N4O4/c16-6-4-2-1-3-5-10-8-19(15(22)18-14(10)17)13-7-11(21)12(9-20)23-13/h8,11-13,20-21H,1-7,9,16H2,(H2,17,18,22)/t11-,12+,13+/m0/s1",5-(6-aminohexyl)-2'-deoxycytidine,Regioselective effect of zwitterionic DNA substitutions on DNA alkylation: evidence for a strong side chain orientational preference.,114724,C15H26N4O4,326.39,327.39
614,"InChI=1S/C16H16N4O4/c17-15-10(4-5-11-3-1-2-6-18-11)8-20(16(23)19-15)14-7-12(22)13(9-21)24-14/h1-3,6,8,12-14,21-22H,7,9H2,(H2,17,19,23)/t12-,13+,14+/m0/s1",5-(2-pyridylethynyl)-2'-deoxycytidine,Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.,53098,C16H16N4O4,328.32,329.32
615,"InChI=1S/C16H17N2O5Se/c1-16(13(24)12(20)11(8-19)23-16)18-7-10(14(21)17-15(18)22)9-5-3-2-4-6-9/h2-7,11-13,19-20H,8H2,1H3,(H,17,21,22)/t11-,12-,13-,16-/m1/s1",5-phenylselenyl-methyl-2'-deoxyuridine,p38 mitogen-activated protein kinase is a key regulator of 5-phenylselenyl- and 5-methylselenyl-methyl-2'-deoxyuridine-induced apoptosis in human HL-60 cells.,46171,C16H17N2O5Se,396.28,397.28
616,"InChI=1S/C16H17N3O7/c1-25-11-5-3-2-4-9(11)15(23)18-13(22)7-17-19(16(18)24)14-6-10(21)12(8-20)26-14/h2-5,7,10,12,14,20-21H,6,8H2,1H3/t10-,12+,14+/m0/s1",N(3)-anisoyl-6-aza-2'-deoxyuridine,6-Aza-2'-deoxyuridine and N(3)-anisoyl-6-aza-2'-deoxyuridine.,71413,C16H17N3O7,363.32,364.32
617,"InChI=1S/C16H17N5O3S/c17-14-11-15(19-7-18-14)21(8-20-11)16-13(23)12(22)10(24-16)6-25-9-4-2-1-3-5-9/h1-5,7-8,10,12-13,16,22-23H,6H2,(H2,17,18,19)/t10-,12-,13-,16-/m1/s1",5'-phenylthio-5'-deoxyadenosine,The 5'-nor aristeromycin analogues of 5'-deoxy-5'-methylthioadenosine and 5'-deoxy-5'-thiophenyladenosine.,31567,C16H17N5O3S,359.4,360.4
618,"InChI=1S/C16H17N5O4/c17-16-19-14-12(15(24)20-16)18-13(8-4-2-1-3-5-8)21(14)11-6-9(23)10(7-22)25-11/h1-5,9-11,22-23H,6-7H2,(H3,17,19,20,24)/t9-,10+,11+/m0/s1",8-Phenyl-2'-deoxyguanosine,Synthesis and miscoding specificity of oligodeoxynucleotide containing 8-phenyl-2'-deoxyguanosine.,113277,C16H17N5O4,343.34,344.34
619,"InChI=1S/C16H17N5O7S/c22-5-10-12(23)13(24)16(28-10)21-7-19-11-14(17-6-18-15(11)21)20-8-1-3-9(4-2-8)29(25,26)27/h1-4,6-7,10,12-13,16,22-24H,5H2,(H,17,18,20)(H,25,26,27)/t10-,12-,13-,16-/m1/s1",N6-(p-sulfophenyl)adenosine,Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action.,110806,C16H17N5O7S,423.4,424.4
620,"InChI=1S/C16H17N5O7S/c22-6-10-12(23)13(24)16(28-10,9-4-2-1-3-5-9)21-8-19-11-14(20-29(25,26)27)17-7-18-15(11)21/h1-5,7-8,10,12-13,22-24H,6H2,(H,17,18,20)(H,25,26,27)/t10-,12-,13-,16-/m1/s1",N6-sulfophenyladenosine,Processing of adenosine receptor agonists in rat and human whole blood.,109679,C16H17N5O7S,423.4,424.4
621,"InChI=1S/C16H18N2O5S/c19-8-13-12(20)6-14(23-13)18-7-10(15(21)17-16(18)22)9-24-11-4-2-1-3-5-11/h1-5,7,12-14,19-20H,6,8-9H2,(H,17,21,22)/t12-,13+,14+/m0/s1",5-(Phenylthiomethyl)-2'-deoxyuridine,5-(phenylthiomethyl)-2'-deoxyuridine as an efficient photoreactive precursor to generate single and multiple lesions within DNA fragments.,98675,C16H18N2O5S,350.39,351.39
622,"InChI=1S/C16H18N2O6/c19-9-11-13(21)14(22)15(24-11)17-7-6-12(20)18(16(17)23)8-10-4-2-1-3-5-10/h1-7,11,13-15,19,21-22H,8-9H2/t11-,13-,14-,15-/m1/s1",N3-Benzyluridine,Uridine receptor: discovery and its involvement in sleep mechanism.,100803,C16H18N2O6,334.32,335.32
623,"InChI=1S/C16H18N6O4/c17-13-10-14(21-16(20-13)19-8-4-2-1-3-5-8)22(7-18-10)15-12(25)11(24)9(6-23)26-15/h1-5,7,9,11-12,15,23-25H,6H2,(H3,17,19,20,21)/t9-,11-,12-,15-/m1/s1",2-phenylaminoadenosine,The stimulation of adenosine 2A receptor reduces inflammatory response in mouse articular chondrocytes treated with hyaluronan oligosaccharides.,40527,C16H18N6O4,358.35,359.35
624,"InChI=1S/C16H18N6O5/c1-16(13(26)12(25)9(5-23)27-16)22-7-20-11-14(18-6-19-15(11)22)21-10-3-2-8(24)4-17-10/h2-4,6-7,9,12-13,23-26H,5H2,1H3,(H,17,18,19,21)/t9-,12-,13-,16-/m1/s1",N6-(5-hydroxy-2-pyridyl)-methyl-adenosine,[The A1- and non A1-effects of N6-(5-hydroxy-2-pyridyl)-methyl-adenosine on rat vas deferens].,96323,C16H18N6O5,374.35,375.35
625,"InChI=1S/C16H19ClN2O9/c1-7(20)25-6-11-13(26-8(2)21)14(27-9(3)22)15(28-11)19-10(5-17)4-12(23)18-16(19)24/h4,11,13-15H,5-6H2,1-3H3,(H,18,23,24)/t11-,13-,14-,15-/m1/s1","6-chloromethyl-2',3',5'-tri-O-acetyluridine","Synthesis and antitumor evaluation of cis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and -uridine analogues.",110014,C16H19ClN2O9,418.78,419.78
626,"InChI=1S/C16H19N5O7/c1-7(22)25-4-10-12(26-8(2)23)13(27-9(3)24)16(28-10)21-6-20-11-14(17)18-5-19-15(11)21/h5-6,10,12-13,16H,4H2,1-3H3,(H2,17,18,19)/t10-,12-,13-,16-/m1/s1","2',3',5'-tri-O-acetyladenosine",Regioselective 1-N-Alkylation and Rearrangement of Adenosine Derivatives.,27263,C16H19N5O7,393.35,394.35
627,"InChI=1S/C16H19N5O7S/c1-6(22)25-4-9-11(26-7(2)23)12(27-8(3)24)15(28-9)21-5-18-10-13(21)19-16(17)20-14(10)29/h5,9,11-12,15H,4H2,1-3H3,(H3,17,19,20,29)/t9-,11-,12-,15-/m1/s1","2',3',5'-tri-O-acetyl-6-thioguanosine",Absorption Characteristics and Quantum Yields of Singlet Oxygen Generation of Thioguanosine Derivatives.,15149,C16H19N5O7S,425.42,426.42
628,"InChI=1S/C16H19N5O8/c1-6(22)26-4-9-11(27-7(2)23)12(28-8(3)24)15(29-9)21-5-18-10-13(21)19-16(17)20-14(10)25/h5,9,11-12,15H,4H2,1-3H3,(H3,17,19,20,25)/t9-,11-,12-,15-/m1/s1","2',3',5'-tri-O-acetyl-guanosine","A novel nitroimidazole compound formed during the reaction of peroxynitrite with 2',3',5'-tri-O-acetyl-guanosine.",97774,C16H19N5O8,409.35,410.35
629,"InChI=1S/C16H19N5O8/c1-6(22)26-4-9-11(27-7(2)23)12(28-8(3)24)15(29-9)21-5-18-10-13(21)19-16(17)20-14(10)25/h5,9,11-12,15H,4H2,1-3H3,(H3,17,19,20,25)/t9-,11-,12-,15-/m1/s1
InChI=1S/C16H19N5O8/c1-6(22)26-4-9-11(27-7(2)23)12(28-8(3)24)15(29-9)21-5-18-10-13(21)19-16(17)20-14(10)25/h5,9,11-12,15H,4H2,1-3H3,(H3,17,19,20,25)
InChI=1S/C16H19N5O8/c1-6(22)26-4-9-11(27-7(2)23)12(28-8(3)24)15(29-9)21-5-18-10-13(21)19-16(17)20-14(10)25/h5,9,11-12,15H,4H2,1-3H3,(H3,17,19,20,25)/t9-,11+,12+,15+/m0/s1","2',3',5'-tri-O-acetylguanosine",Structure and gelation mechanism of tunable guanosine-based supramolecular hydrogels.,54988,C16H19N5O8,409.35,410.35
630,"InChI=1S/C16H21N5O4/c1-2-3-4-5-6-10-19-14(17)11-15(20-10)21(8-18-11)16-13(24)12(23)9(7-22)25-16/h8-9,12-13,16,22-24H,2-4,7H2,1H3,(H2,17,19,20)/t9-,12-,13-,16-/m1/s1",2-(1-Hexynyl)adenosine,"2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.",91555,C16H21N5O4,347.37,348.37
631,"InChI=1S/C16H21N5O4/c1-2-3-4-5-6-24-7-10-12(22)13(23)16(25-10)21-9-20-11-14(17)18-8-19-15(11)21/h8-10,12-13,16,22-23H,2-3,6-7H2,1H3,(H2,17,18,19)/t10-,12-,13-,16-/m1/s1",2-hexynyladenosine,Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors.,81343,C16H21N5O4,347.37,348.37
632,"InChI=1S/C16H21N9O7S/c17-8(1-7-2-19-4-20-7)15(28)24-33(29,30)31-3-9-11(26)12(27)16(32-9)25-6-23-10-13(18)21-5-22-14(10)25/h2,4-6,8-9,11-12,16,26-27H,1,3,17H2,(H,19,20)(H,24,28)(H2,18,21,22)/t8-,9+,11+,12+,16+/m0/s1",5'-O-[N-(L-histidyl)sulfamoyl]adenosine,tRNA discrimination at the binding step by a class II aminoacyl-tRNA synthetase.,107109,C16H21N9O7S,483.46,484.46
633,"InChI=1S/C16H23N5O3S/c1-8(2)4-5-17-14-11-15(20-9(3)19-14)21(7-18-11)16-13(25)12(23)10(6-22)24-16/h4,7,10,12-13,16,22-23,25H,5-6H2,1-3H3,(H,17,19,20)/t10-,12-,13-,16-/m1/s1",6-N-dimethylallyl-2-methylthioadenosine,Requirement for IscS in biosynthesis of all thionucleosides in Escherichia coli.,93474,C16H23N5O3S,365.45,366.45
634,"InChI=1S/C16H23N5O4/c1-2-3-4-5-6-10-19-14(17)11-15(20-10)21(8-18-11)16-13(24)12(23)9(7-22)25-16/h5-6,8-9,12-13,16,22-24H,2-4,7H2,1H3,(H2,17,19,20)/b6-5+/t9-,12-,13-,16-/m1/s1",2-[(E)-1-hexenyl]adenosine,"2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A2A receptor.",91555,C16H23N5O4,349.39,350.39
635,"InChI=1S/C16H23N5O4/c17-14-11-15(19-7-18-14)21(8-20-11)16(9-4-2-1-3-5-9)13(24)12(23)10(6-22)25-16/h7-10,12-13,22-24H,1-6H2,(H2,17,18,19)/t10-,12-,13-,16-/m1/s1",Cyclohexyladenosine,Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors.,98008,C16H23N5O4,349.39,350.39
636,"InChI=1S/C16H23N5O4/c22-6-10-12(23)13(24)16(25-10)21-8-19-11-14(17-7-18-15(11)21)20-9-4-2-1-3-5-9/h7-10,12-13,16,22-24H,1-6H2,(H,17,18,20)/t10-,12-,13-,16-/m1/s1",N(6)-Cyclohexyladenosine,N6-cyclohexyladenosine and 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid enhance the effect of antiepileptic drugs against induced seizures in mice.,100963,C16H23N5O4,349.39,350.39
637,"InChI=1S/C16H23N5O4S/c1-8(2)4-5-17-13-10-14(20-16(19-13)26-3)21(7-18-10)15-12(24)11(23)9(6-22)25-15/h4,7,9,11-12,15,22-24H,5-6H2,1-3H3,(H,17,19,20)/t9-,11-,12-,15-/m1/s1",2-methylthio-N(6)-isopentenyladenosine,Radical S-Adenosylmethionine Enzymes in Human Health and Disease.,23177,C16H23N5O4S,381.45,382.45
638,"InChI=1S/C16H23N5O5S/c1-8(5-22)3-4-17-13-10-14(20-16(19-13)27-2)21(7-18-10)15-12(25)11(24)9(6-23)26-15/h3,7,9,11-12,15,22-25H,4-6H2,1-2H3,(H,17,19,20)/b8-3+/t9-,11-,12-,15-/m1/s1",N(6)-(4-hydroxyisopentenyl)-2-methylthioadenosine,Structural alterations of the cysteine desulfurase IscS of Salmonella enterica serovar Typhimurium reveal substrate specificity of IscS in tRNA thiolation.,76125,C16H23N5O5S,397.45,398.45
639,"InChI=1S/C16H23N7O7/c1-6(25)8(17)14(28)21-16(29)22(2)12-9-13(19-4-18-12)23(5-20-9)15-11(27)10(26)7(3-24)30-15/h4-8,10-11,15,24-27H,3,17H2,1-2H3,(H,21,28,29)/t6-,7-,8+,10-,11-,15-/m1/s1",N6-methyl-N6-threonylcarbamoyladenosine,Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS.,2417,C16H23N7O7,425.4,426.4
640,"InChI=1S/C16H23N7O7S/c1-5(25)7(17)13(28)22-15(29)19-11-8-12(21-16(20-11)31-2)23(4-18-8)14-10(27)9(26)6(3-24)30-14/h4-7,9-10,14,24-27H,3,17H2,1-2H3,(H2,19,20,21,22,28,29)/t5-,6-,7+,9-,10-,14-/m1/s1",2-methylthio-N6-threonylcarbamoyladenosine,"New efficient synthesis of tRNA related adenosines bearing the hydantoin ring (ct6A, ms2ct6A) by intramolecular cyclization of N6-(N-Boc-α-aminoacyl)-adenosine derivatives.",15,C16H23N7O7S,457.46,458.46
641,"InChI=1S/C17H16FN5O7S.ClH/c18-31(27,28)9-3-1-8(2-4-9)17(26)29-5-10-12(24)13(25)16(30-10)23-7-22-11-14(19)20-6-21-15(11)23;/h1-4,6-7,10,12-13,16,24-25H,5H2,(H2,19,20,21);1H/t10-,12-,13-,16-;/m1./s1",5'-p-fluorosulfonylbenzoyladenosine,"A new functional, chemical proteomics technology to identify purine nucleotide binding sites in complex proteomes.",72837,C17H17ClFN5O7S,489.86,490.86
642,"InChI=1S/C17H16FN5O7S/c18-31(28,29)16(27)11-10(24)13(26)17(30-11,12(25)8-4-2-1-3-5-8)23-7-22-9-14(19)20-6-21-15(9)23/h1-7,10-11,13,16,24,26-27H,(H2,19,20,21)/t10-,11+,13-,16?,17-/m1/s1",5'-fluorosulfonylbenzoyladenosine,A 5'-fluorosulfonylbenzoyladenosine-based method to identify physiological substrates of a Drosophila p21-activated kinase.,69717,C17H16FN5O7S,453.4,454.4
643,"InChI=1S/C17H16FN5O7S/c18-31(28,29)8-3-1-7(2-4-8)10(24)11(25)14-12(26)13(27)17(30-14)23-6-22-9-15(19)20-5-21-16(9)23/h1-6,11-14,17,25-27H,(H2,19,20,21)/t11?,12-,13+,14+,17+/m0/s1",5'-(p-fluorosulfonylbenzoyl)adenosine,Kinetic mechanism and ATP-binding site reactivity of p38gamma MAP kinase.,106788,C17H16FN5O7S,453.4,454.4
644,"InChI=1S/C17H16FN5O8S/c18-32(29,30)7-3-1-6(2-4-7)9(24)10(25)13-11(26)12(27)16(31-13)23-5-20-8-14(23)21-17(19)22-15(8)28/h1-5,10-13,16,25-27H,(H3,19,21,22,28)/t10?,11-,12+,13+,16+/m0/s1",5'-[p-(Fluorosulfonyl)benzoyl] guanosine,Use of 5'-[p-(fluorosulfonyl)benzoyl] guanosine as an affinity probe for the guanine nucleotide-binding site of transducin.,71994,C17H16FN5O8S,469.4,470.4
645,"InChI=1S/C17H16N2O5/c20-10-14-13(21)8-15(24-14)19-9-12(16(22)18-17(19)23)7-6-11-4-2-1-3-5-11/h1-5,9,13-15,20-21H,8,10H2,(H,18,22,23)/t13-,14+,15+/m0/s1",5-phenylethynyl-2'-deoxyuridine,"5-Arylethynyl-2'-deoxyuridines, compounds active against HSV-1.",76499,C17H16N2O5,328.32,329.32
646,"InChI=1S/C17H17Br2N5O6/c18-10-6(1-8(26)12(27)11(10)19)2-20-17-21-3-7-15(23-17)24(5-22-7)16-14(29)13(28)9(4-25)30-16/h1,3,5,9,13-14,16,25-29H,2,4H2,(H,20,21,23)/t9-,13-,14-,16-/m1/s1","2-N-(2,3-dibromo-4,5-dihydroxybenzylamino)deoxyguanosine",Bromophenols coupled with derivatives of amino acids and nucleosides from the red alga Rhodomela confervoides.,80696,C17H17Br2N5O6,547.15,548.15
647,"InChI=1S/C17H17N5O5/c18-16-20-14-12(15(26)21-16)19-8-22(14)17(6-10(24)11(7-23)27-17)13(25)9-4-2-1-3-5-9/h1-5,8,10-11,23-24H,6-7H2,(H3,18,20,21,26)/t10-,11+,17-/m0/s1",benzoyl-2'-deoxyguanosine,Efficient syntheses of 2-chloro-2'-deoxyadenosine (cladribine) from 2'-deoxyguanosine(1).,92681,C17H17N5O5,371.35,372.35
648,"InChI=1S/C17H17N5O5/c23-9-14-13(24)6-15(27-14)21-8-12(16(25)18-17(21)26)22-7-11(19-20-22)10-4-2-1-3-5-10/h1-5,7-8,13-15,23-24H,6,9H2,(H,18,25,26)/t13-,14+,15+/m0/s1","5-(4-phenyl-1,2,3-triazol-1-yl)-2'-deoxyuridine",High-affinity RNA targeting by oligonucleotides displaying aromatic stacking and amino groups in the major groove. Comparison of triazoles and phenyl substituents.,43490,C17H17N5O5,371.35,372.35
649,"InChI=1S/C17H18IN5O4/c18-10-3-1-2-9(4-10)5-19-15-12-16(21-7-20-15)23(8-22-12)17-14(26)13(25)11(6-24)27-17/h1-4,7-8,11,13-14,17,24-26H,5-6H2,(H,19,20,21)/t11-,13-,14-,17-/m1/s1",N6-(3-iodobenzyl)adenosine,"N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.",108983,C17H18IN5O4,483.26,484.26
650,"InChI=1S/C17H18N2O7/c20-9-12-14(23)15(24)16(26-12)18-7-6-13(22)19(17(18)25)8-11(21)10-4-2-1-3-5-10/h1-7,12,14-16,20,23-24H,8-9H2/t12-,14-,15-,16-/m1/s1",N(3)-phenacyluridine,Synthesis of N3-substituted uridine and related pyrimidine nucleosides and their antinociceptive effects in mice.,81964,C17H18N2O7,362.33,363.33
651,"InChI=1S/C17H18N6O5/c18-9-4-2-1-3-8(9)17(26)28-13-10(5-24)27-16(12(13)25)23-7-22-11-14(19)20-6-21-15(11)23/h1-4,6-7,10,12-13,16,24-25H,5,18H2,(H2,19,20,21)/t10-,12-,13-,16-/m1/s1",3'-O-Anthraniloyladenosine,"The structure of 3'-O-anthraniloyladenosine, an analogue of the 3'-end of aminoacyl-tRNA.",115496,C17H18N6O5,386.36,387.36
652,"InChI=1S/C17H18N6O6S/c18-16-20-14-11(15(26)21-16)19-7-22(14)17(13(30)12(25)10(6-24)29-17)5-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,24-25,30H,5-6H2,(H3,18,20,21,26)/t10-,12-,13-,17-/m1/s1",p-nitrobenzylthioguanosine,Identification of nucleoside transport binding sites in the human myocardium.,112537,C17H18N6O6S,434.43,435.43
653,"InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12+,13?,16-/m1/s1
InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12-,13-,16-/m1/s1
InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12+,13-,16-/m1/s1
InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12?,13-,16-/m1/s1",S-(4-nitrobenzyl)-6-thioguanosine,Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.,28103,C17H18N6O6S,434.43,435.43
654,"InChI=1S/C17H18N6O6S/c18-17-20-14-11(19-7-22(14)16-13(26)12(25)10(5-24)29-16)15(21-17)30-6-8-1-3-9(4-2-8)23(27)28/h1-4,7,10,12-13,16,24-26H,5-6H2,(H2,18,20,21)/t10-,12-,13-,16-/m1/s1",S-(p-nitrobenzyl)-6-thioguanosine,Indirect activation of adenosine A1 receptors in cultured rat hippocampal neurons by volatile anaesthetics.,79129,C17H18N6O6S,434.43,435.43
655,"InChI=1S/C17H18N8O4/c18-24-23-10-3-1-9(2-4-10)5-19-15-12-16(21-7-20-15)25(8-22-12)17-14(28)13(27)11(6-26)29-17/h1-4,7-8,11,13-14,17,26-28H,5-6H2,(H,19,20,21)/t11-,13-,14-,17-/m1/s1",N(6)-(p-azidobenzyl)adenosine,Metabolism and selective toxicity of 6-nitrobenzylthioinosine in Toxoplasma gondii.,107228,C17H18N8O4,398.38,399.38
656,"InChI=1S/C17H19IN6O4/c18-9-3-8(1-2-10(9)19)4-20-15-12-16(22-6-21-15)24(7-23-12)17-14(27)13(26)11(5-25)28-17/h1-3,6-7,11,13-14,17,25-27H,4-5,19H2,(H,20,21,22)/t11-,13-,14-,17-/m1/s1",N6-(4-amino-3-iodobenzyl)adenosine,Adenosine A3 receptor expression and function in eosinophils.,114893,C17H19IN6O4,498.28,499.28
657,"InChI=1S/C17H19N5O3/c23-8-13-12(24)6-14(25-13)22-10-21-15-16(19-9-20-17(15)22)18-7-11-4-2-1-3-5-11/h1-5,9-10,12-14,23-24H,6-8H2,(H,18,19,20)/t12-,13+,14+/m0/s1",N6-benzyl-2'-deoxyadenosine,Site-Specific Mutagenesis in Escherichia coli by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives in Double-Stranded or Gapped Plasmids.,92687,C17H19N5O3,341.37,342.37
658,"InChI=1S/C17H19N5O4/c18-17-20-15-14(16(21-17)25-8-10-4-2-1-3-5-10)19-9-22(15)13-6-11(24)12(7-23)26-13/h1-5,9,11-13,23-24H,6-8H2,(H2,18,20,21)/t11-,12+,13+/m0/s1",O(6)-benzyl-2'-deoxyguanosine,Beta-glucuronidase-cleavable prodrugs of O6-benzylguanine and O6-benzyl-2'-deoxyguanosine.,82804,C17H19N5O4,357.36,358.36
659,"InChI=1S/C17H19N5O4/c18-17-20-15-14(16(21-17)25-8-10-4-2-1-3-5-10)19-9-22(15)13-6-11(24)12(7-23)26-13/h1-5,9,11-13,23-24H,6-8H2,(H2,18,20,21)/t11?,12-,13-/m1/s1",O6-Benzyl-2'-deoxyguanosine,"Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.",106604,C17H19N5O4,357.36,358.36
660,"InChI=1S/C17H19N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-25H,6-7H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1",N(6)-benzyladenosine,Modification of the length and structure of the linker of N(6)-benzyladenosine modulates its selective antiviral activity against enterovirus 71.,24314,C17H19N5O4,357.36,358.36
661,"InChI=1S/C17H19N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-25H,6-7H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1
InChI=1S/C17H19N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-25H,6-7H2,(H,18,19,20)",6-benzyladenosine,"Preparation, biological activity and endogenous occurrence of N6-benzyladenosines.",70891,C17H19N5O4,357.36,358.36
662,"InChI=1S/C17H19N5O4/c23-8-12-11(24)6-13(26-12)22-9-19-14-15(22)20-17(21-16(14)25)18-7-10-4-2-1-3-5-10/h1-5,9,11-13,23-24H,6-8H2,(H2,18,20,21,25)/t11-,12+,13+/m0/s1",N2-benzyl-2'-deoxyguanosine,Site-Specific Mutagenesis in Escherichia coli by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives in Double-Stranded or Gapped Plasmids.,92687,C17H19N5O4,357.36,358.36
663,"InChI=1S/C17H19N5O6/c18-16-20-13-10(14(26)21-16)19-17(27-7-8-4-2-1-3-5-8)22(13)15-12(25)11(24)9(6-23)28-15/h1-5,9,11-12,15,23-25H,6-7H2,(H3,18,20,21,26)/t9-,11-,12-,15-/m1/s1",8-benzyloxyguanosine,Hybridization Properties of RNA Containing 8-Methoxyguanosine and 8-Benzyloxyguanosine.,26428,C17H19N5O6,389.36,390.36
664,"InChI=1S/C17H20N2O5/c20-11-14-13(21)10-16(24-14)19-9-7-15(22)18(17(19)23)8-6-12-4-2-1-3-5-12/h1-5,7,9,13-14,16,20-21H,6,8,10-11H2/t13-,14+,16+/m0/s1",3-phenylethyl-2'-deoxyuridine,New Cerebroside and Nucleoside Derivatives from a Red Sea Strain of the Marine Cyanobacterium Moorea producens.,23736,C17H20N2O5,332.35,333.35
665,"InChI=1S/C17H20N6O4/c18-14-12-15(21-8-20-14)23(9-22-12)16(6-10-4-2-1-3-5-10)17(19,26)13(25)11(7-24)27-16/h1-5,8-9,11,13,24-26H,6-7,19H2,(H2,18,20,21)/t11-,13-,16-,17-/m1/s1",aminobenzyladenosine,Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors.,107724,C17H20N6O4,372.38,373.38
666,"InChI=1S/C17H20N6O4/c18-7-5-3-1-2-4-6-11-21-15(19)12-16(22-11)23(9-20-12)17-14(26)13(25)10(8-24)27-17/h9-10,13-14,17,24-26H,1-3,5,8H2,(H2,19,21,22)/t10-,13-,14-,17-/m1/s1",2-(6-cyano-1-hexyn-1-yl)adenosine,Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on ocular blood flow in rabbits.,72064,C17H20N6O4,372.38,373.38
667,"InChI=1S/C17H21N6O14P3/c18-9-4-2-1-3-8(9)13(24)17(26)5-11(23-7-20-12-14(23)21-16(19)22-15(12)25)35-10(17)6-34-39(30,31)37-40(32,33)36-38(27,28)29/h1-4,7,10-11,26H,5-6,18H2,(H,30,31)(H,32,33)(H2,27,28,29)(H3,19,21,22,25)/t10-,11-,17+/m1/s1",3'-anthraniloyl-2'-deoxyguanosine-5'-triphosphate,UMP kinase from the Gram-positive bacterium Bacillus subtilis is strongly dependent on GTP for optimal activity.,90440,C17H21N6O14P3,626.3,627.3
668,"InChI=1S/C17H25N5O4/c1-25-14-13(24)11(7-23)26-17(14)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-2-4-6-10/h8-11,13-14,17,23-24H,2-7H2,1H3,(H,18,19,21)/t11-,13-,14-,17-/m1/s1",N-cyclohexyl-2'-O-methyladenosine,N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.,107479,C17H25N5O4,363.41,364.41
669,"InChI=1S/C17H25N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-20-12-15(18-8-19-16(12)22)21-10-5-3-1-2-4-6-10/h8-11,13-14,17,23-25H,1-7H2,(H,18,19,21)/t11-,13-,14-,17-/m1/s1",N6-cycloheptyladenosine,Processing of adenosine receptor agonists in rat and human whole blood.,109679,C17H25N5O4,363.41,364.41
670,"InChI=1S/C17H27N3O5/c1-2-3-4-5-6-7-15(23)18-14-8-9-20(17(24)19-14)16-10-12(22)13(11-21)25-16/h8-9,12-13,16,21-22H,2-7,10-11H2,1H3,(H,18,19,23,24)/t12-,13+,16+/m0/s1",N4-octanoyl-2'-deoxycytidine,Low Molecular Weight Nucleoside Gelators: A Platform for Protein Aggregation Inhibition.,11868,C17H27N3O5,353.41,354.41
671,"InChI=1S/C17H27N5O4/c1-25-13-12(24)11(7-23)26-16(13)22-9-20-14-15(22)19-8-21-17(14,18)10-5-3-2-4-6-10/h8,10-13,16,23-24H,2-7,9,18H2,1H3/t11-,12-,13-,16-,17?/m1/s1",6-cyclohexyl-2'-O-methyl-adenosine,"Hypoglycemic and hypotensive effects of 6-cyclohexyl-2'-O-methyl-adenosine, an adenosine A1 receptor agonist, in spontaneously hypertensive rat complicated with hyperglycemia.",112167,C17H27N5O4,365.43,366.43
672,"InChI=1S/C18H17N5O4/c19-16-13-17(21-9-20-16)23(10-22-13)18(7-6-11-4-2-1-3-5-11)15(26)14(25)12(8-24)27-18/h1-5,9-10,12,14-15,24-26H,8H2,(H2,19,20,21)/t12-,14-,15-,18-/m1/s1",2-Phenylethynyladenosine,Synthetic procedure for the preparation of novel potent and selective A3 adenosine receptor radioligands.,98716,C18H17N5O4,367.36,368.36
673,"InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-2-4-9(20)5-3-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1",2-chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide,Cl-IB-MECA inhibits human erythropoiesis.,70980,C18H18ClIN6O4,544.73,545.73
674,"InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1",2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide,"Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury.",68307,C18H18ClIN6O4,544.73,545.73
675,"InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)",N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide,Homeostatic action of adenosine A3 and A1 receptor agonists on proliferation of hematopoietic precursor cells.,65177,C18H19IN6O4,510.29,511.29
676,"InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1",N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,Purinergic receptors in ocular inflammation.,31934,C18H19IN6O4,510.29,511.29
677,"InChI=1S/C18H19N5O4/c19-17-12(13-6-7-23(21-13)11-4-2-1-3-5-11)9-22(18(26)20-17)16-8-14(25)15(10-24)27-16/h1-7,9,14-16,24-25H,8,10H2,(H2,19,20,26)/t14-,15+,16+/m0/s1",5-(1-phenyl-1H-pyrazol-3-yl)-2'-deoxycytidine,Photophysical investigation of two emissive nucleosides exhibiting gigantic stokes shifts.,9407,C18H19N5O4,369.38,370.38
678,"InChI=1S/C18H19N5O4/c19-18-21-16-15(17(26)22-18)20-13(7-6-10-4-2-1-3-5-10)23(16)14-8-11(25)12(9-24)27-14/h1-7,11-12,14,24-25H,8-9H2,(H3,19,21,22,26)/t11-,12+,14+/m0/s1",8-styryl-2'-deoxyguanosine,Enzymatic synthesis of 8-vinyl- and 8-styryl-2'-deoxyguanosine modified DNA--novel fluorescent molecular probes.,44271,C18H19N5O4,369.38,370.38
679,"InChI=1S/C18H20ClN5O5/c19-10-3-1-9(2-4-10)5-6-28-18-22-15(20)12-16(23-18)24(8-21-12)17-14(27)13(26)11(7-25)29-17/h1-4,8,11,13-14,17,25-27H,5-7H2,(H2,20,22,23)/t11-,13-,14-,17-/m1/s1",2-[2-(4-chlorophenyl)ethoxy]adenosine,Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.,82492,C18H20ClN5O5,421.84,422.84
680,"InChI=1S/C18H20IN7O4/c1-21-17(29)14-12(27)13(28)18(30-14)26-7-25-11-15(23-6-24-16(11)26)22-5-8-2-3-10(20)9(19)4-8/h2-4,6-7,12-14,18,27-28H,5,20H2,1H3,(H,21,29)(H,22,23,24)/t12-,13+,14-,18+/m0/s1",N6-(4-amino-3-iodobenzyl)-5'-N-methylcarbamoyladenosine,"Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.",111313,C18H20IN7O4,525.3,526.3
681,"InChI=1S/C18H20IN7O4/c1-21-17(29)14-12(27)13(28)18(30-14)26-7-25-11-15(23-6-24-16(11)26)22-5-8-2-3-10(20)9(19)4-8/h2-4,6-7,12-14,18,27-28H,5,20H2,1H3,(H,21,29)(H,22,23,24)/t12-,13+,14-,18+/m0/s1/i19-2",[125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide,Differential allosteric modulation by amiloride analogues of agonist and antagonist binding at A(1) and A(3) adenosine receptors.,92630,C18H20IN7O4,525.3,526.3
682,"InChI=1S/C18H21IN6O4/c19-10-5-9(1-2-11(10)20)3-4-21-16-13-17(23-7-22-16)25(8-24-13)18-15(28)14(27)12(6-26)29-18/h1-2,5,7-8,12,14-15,18,26-28H,3-4,6,20H2,(H,21,22,23)/t12-,14-,15-,18+/m1/s1",N(6)-2-(4-amino-3-iodophenyl)ethyladenosine,Adenosine A(3) receptor-mediated potentiation of mucociliary transport and epithelial ciliary motility.,97015,C18H21IN6O4,512.3,513.3
683,"InChI=1S/C18H21N5O4/c1-10-4-2-3-5-11(10)6-19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)12(7-24)27-18/h2-5,8-9,12,14-15,18,24-26H,6-7H2,1H3,(H,19,20,21)/t12-,14-,15-,18-/m1/s1",N-[(2-methylphenyl)methyl]adenosine,N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.,107479,C18H21N5O4,371.39,372.39
684,"InChI=1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22)",N6-2-(4-Aminophenyl)ethyladenosine,Characterization of vasodilatory adenosine receptors in equine digital veins.,112778,C18H22N6O4,386.41,387.41
685,"InChI=1S/C18H22N6O4/c19-11-3-1-10(2-4-11)5-6-20-16-13-17(22-8-21-16)24(9-23-13)18-15(27)14(26)12(7-25)28-18/h1-4,8-9,12,14-15,18,25-27H,5-7,19H2,(H,20,21,22)/t12-,14-,15-,18-/m1/s1",N6-2-(4-Aminophenyl)ethyl-adenosine,N6-2-(4-aminophenyl)ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs.,114704,C18H22N6O4,386.41,387.41
686,"InChI=1S/C18H23N4O14P/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29/h1-4,7-8,11-16,23,26-28H,5-6H2,(H,31,32)(H,19,24,29)(H,20,25,30)/t7-,8-,11-,12-,13-,14-,15-,16-/m1/s1","uridylyl-(3',5')-uridine","Phosphodiester cleavage of guanylyl-(3',3')-(2'-amino-2'-deoxyuridine): rate acceleration by the 2'-amino function.",82317,C18H23N4O14P,550.37,551.37
687,"InChI=1S/C18H24N6O4/c1-3-5-6-7-8-10-22-15(19)11-16(23-10)24(9-21-11)18-13(26)12(25)14(28-18)17(27)20-4-2/h9,12-14,18,25-26H,3-6H2,1-2H3,(H,20,27)(H2,19,22,23)/t12-,13+,14-,18+/m0/s1",2-hexynyl-5'-ethylcarboxamidoadenosine,Comparison of different microscopy approaches to quantification of inhibitory effect on thrombus formation under flow conditions by the example of adenosine receptor agonist HE-NECA.,13411,C18H24N6O4,388.42,389.42
688,"InChI=1S/C18H24N6O4/c1-3-5-6-7-8-10-22-15(19)11-16(23-10)24(9-21-11)18-13(26)12(25)14(28-18)17(27)20-4-2/h9,12-14,18,25-26H,3-6H2,1-2H3,(H,20,27)(H2,19,22,23)/t12-,13+,14-,18+/m0/s1
InChI=1S/C18H24N6O4/c1-3-5-6-7-8-10-22-15(19)11-16(23-10)24(9-21-11)18-13(26)12(25)14(28-18)17(27)20-4-2/h9,12-14,18,25-26H,3-6H2,1-2H3,(H,20,27)(H2,19,22,23)
InChI=1S/C18H24N6O4/c1-3-5-6-7-8-10-22-15(19)11-16(23-10)24(9-21-11)18-13(26)12(25)14(28-18)17(27)20-4-2/h9,12-14,18,25-26H,3-6H2,1-2H3,(H,20,27)(H2,19,22,23)/t12?,13-,14-,18+/m0/s1",2-hexynyl-5'-N-ethylcarboxamidoadenosine,Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.,104041,C18H24N6O4,388.42,389.42
689,"InChI=1S/C18H25N5O4/c1-2-3-4-5-6-7-8-12-21-16(19)13-17(22-12)23(10-20-13)18-15(26)14(25)11(9-24)27-18/h10-11,14-15,18,24-26H,2-6,9H2,1H3,(H2,19,21,22)/t11-,14-,15-,18-/m1/s1",2-octynyladenosine,Effects of 2-Octynyladenosine (YT-146) on Mitochondrial Function in Ischemic/Reperfused Rat Hearts.,25264,C18H25N5O4,375.42,376.42
690,"InChI=1S/C18H25N5O6/c1-3-5-9(24)18(28,10(25)6-4-2)14-12(26)13(27)17(29-14)23-8-22-11-15(19)20-7-21-16(11)23/h7-8,12-14,17,26-28H,3-6H2,1-2H3,(H2,19,20,21)/t12-,13+,14-,17+/m0/s1
InChI=1S/C18H25N5O6/c1-3-5-9(24)18(28,10(25)6-4-2)14-12(26)13(27)17(29-14)23-8-22-11-15(19)20-7-21-16(11)23/h7-8,12-14,17,26-28H,3-6H2,1-2H3,(H2,19,20,21)",dibutyryl adenosine,"Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.",104643,C18H25N5O6,407.42,408.42
691,"InChI=1S/C18H26N4O9/c1-9(23)28-8-12-15(29-10(2)24)16(30-11(3)25)18(4,31-12)22-13(20-6-5-19)7-14(26)21-17(22)27/h7,12,15-16,20H,5-6,8,19H2,1-4H3,(H,21,26,27)/t12-,15-,16-,18-/m1/s1","6-[(aminoethyl)amino] methyl-2',3',5'-tri-O-acetyluridine","Synthesis and antitumor evaluation of cis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and -uridine analogues.",110014,C18H26N4O9,442.42,443.42
692,"InChI=1S/C18H26N4O9/c1-9(23)28-8-13-14(29-10(2)24)15(30-11(3)25)17(31-13)22-7-12(6-20-5-4-19)16(26)21-18(22)27/h7,13-15,17,20H,4-6,8,19H2,1-3H3,(H,21,26,27)/t13-,14-,15-,17-/m1/s1","5-[(amino-ethyl)amino]methyl-2',3',5'-tri-O-acetyluridine","Synthesis and antitumor evaluation of cis-(1,2-diaminoethane) dichloroplatinum (II) complexes linked to 5- and 6-methyleneuracil and -uridine analogues.",110014,C18H26N4O9,442.42,443.42
693,"InChI=1S/C19H18N2O6/c22-10-14-16(24)17(18(27-14)21-8-7-15(23)20-19(21)25)26-13-6-5-11-3-1-2-4-12(11)9-13/h1-9,14,16-18,22,24H,10H2,(H,20,23,25)/t14-,16-,17-,18-/m1/s1",2'-O-(2-naphthyl)uridine,Synthesis and hybridization properties of 2'-O-methylated oligoribonucleotides incorporating 2'-O-naphthyluridines.,52070,C19H18N2O6,370.36,371.36
694,"InChI=1S/C19H18N2O6/c22-10-14-16(24)17(18(27-14)21-9-8-15(23)20-19(21)25)26-13-7-3-5-11-4-1-2-6-12(11)13/h1-9,14,16-18,22,24H,10H2,(H,20,23,25)/t14-,16-,17-,18-/m1/s1",2'-O-(1-Naphthyl)uridine,Synthesis and hybridization properties of 2'-O-methylated oligoribonucleotides incorporating 2'-O-naphthyluridines.,52070,C19H18N2O6,370.36,371.36
695,"InChI=1S/C19H19N3O5/c20-18-12(15-7-6-14(26-15)11-4-2-1-3-5-11)9-22(19(25)21-18)17-8-13(24)16(10-23)27-17/h1-7,9,13,16-17,23-24H,8,10H2,(H2,20,21,25)/t13-,16+,17+/m0/s1",5-(5-phenylfuran-2-yl)-2'-deoxycytidine,Photophysical investigation of two emissive nucleosides exhibiting gigantic stokes shifts.,9407,C19H19N3O5,369.37,370.37
696,"InChI=1S/C19H19N5O4/c1-20-17-14-18(22-10-21-17)24(11-23-14)19(8-7-12-5-3-2-4-6-12)16(27)15(26)13(9-25)28-19/h2-6,10-11,13,15-16,25-27H,9H2,1H3,(H,20,21,22)/t13-,15-,16-,19-/m1/s1",N6-methyl-2-phenylethynyladenosine,Synthetic procedure for the preparation of novel potent and selective A3 adenosine receptor radioligands.,98716,C19H19N5O4,381.39,382.39
697,"InChI=1S/C19H20ClIN6O5/c1-26(6-8-3-2-4-9(21)5-8)16-10-17(25-19(20)24-16)27(7-23-10)18-12(29)11(28)14(32-18)13(30)15(22)31/h2-5,7,11-14,18,28-30H,6H2,1H3,(H2,22,31)/t11-,12+,13?,14-,18+/m0/s1",2-chloro-N6-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine,Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.,71354,C19H20ClIN6O5,574.76,575.76
698,"InChI=1S/C19H21IN6O5/c1-25(6-9-3-2-4-10(20)5-9)17-11-18(23-7-22-17)26(8-24-11)19-13(28)12(27)15(31-19)14(29)16(21)30/h2-5,7-8,12-15,19,27-29H,6H2,1H3,(H2,21,30)/t12-,13+,14?,15-,19+/m0/s1",N6-(3-iodobenzyl)-N-methyl-5'-carbamoyladenosine,Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.,112730,C19H21IN6O5,540.31,541.31
699,"InChI=1S/C19H22N6O4/c1-2-20-18(28)15-13(26)14(27)19(29-15)25-10-24-12-16(22-9-23-17(12)25)21-8-11-6-4-3-5-7-11/h3-7,9-10,13-15,19,26-27H,2,8H2,1H3,(H,20,28)(H,21,22,23)",N6-benzyl-5'-N-ethylcarboxamidoadenosine,Expression of CD73/ecto-5'-nucleotidase on human gingival fibroblasts and contribution to the inhibition of interleukin-1alpha-induced granulocyte-macrophage colony stimulating factor production.,88058,C19H22N6O4,398.42,399.42
700,"InChI=1S/C19H23N5O4/c1-11(2)19(16(27)15(26)13(8-25)28-19)24-10-22-14-17(20-9-21-18(14)24)23-12-6-4-3-5-7-12/h3-7,9-11,13,15-16,25-27H,8H2,1-2H3,(H,20,21,23)/t13-,15-,16-,19-/m1/s1
InChI=1S/C19H23N5O4/c1-11(2)19(16(27)15(26)13(8-25)28-19)24-10-22-14-17(20-9-21-18(14)24)23-12-6-4-3-5-7-12/h3-7,9-11,13,15-16,25-27H,8H2,1-2H3,(H,20,21,23)",N6-phenylisopropyladenosine,Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.,109042,C19H23N5O4,385.42,386.42
701,"InChI=1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11-,13-,15+,16?,19-/m1/s1",R(-)-N6-(2-phenylisopropyl)adenosine,The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal.,107418,C19H23N5O4,385.42,386.42
702,"InChI=1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11-,13-,15-,16-,19-/m1/s1",(-)-N6-(2-phenylisopropyl)-adenosine,Effects of urea pretreatment on the binding properties of adenosine A1 receptors.,78690,C19H23N5O4,385.42,386.42
703,"InChI=1S/C19H23N5O4/c1-11(7-12-5-3-2-4-6-12)23-17-14-18(21-9-20-17)24(10-22-14)19-16(27)15(26)13(8-25)28-19/h2-6,9-11,13,15-16,19,25-27H,7-8H2,1H3,(H,20,21,23)/t11?,13-,15-,16-,19-/m1/s1",N(6)-(2-phenylisopropyl)adenosine,Epidermal growth factor protects GH3 cells from adenosine induced growth arrest.,115235,C19H23N5O4,385.42,386.42
704,"InChI=1S/C19H23N5O4/c20-17-14-18(23-13(22-17)8-4-7-11-5-2-1-3-6-11)24(10-21-14)19-16(27)15(26)12(9-25)28-19/h1-3,5-6,10,12,15-16,19,25-27H,4,7-9H2,(H2,20,22,23)/t12-,15-,16-,19-/m1/s1",2-(3-phenylpropyl)adenosine,Characterization of two adenosine analogs as fluorescence probes in RNA.,63610,C19H23N5O4,385.42,386.42
705,"InChI=1S/C19H23N7O5S/c20-5-6-32-8-13-15(27)16(28)19(31-13)25-10-24-14-17(22-9-23-18(14)25)21-7-11-1-3-12(4-2-11)26(29)30/h1-4,9-10,13,15-16,19,27-28H,5-8,20H2,(H,21,22,23)/t13-,15-,16-,19-/m1/s1",5'-S-(2-aminoethyl)-N6-(4-nitrobenzyl)-5'-thioadenosine,Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.,96915,C19H23N7O5S,461.5,462.5
706,"InChI=1S/C19H24N7O13P/c20-18-23-14-9(15(32)24-18)21-5-26(14)17-12(31)13(6(3-27)37-17)39-40(34,35)36-4-7-10(29)11(30)16(38-7)25-2-1-8(28)22-19(25)33/h1-2,5-7,10-13,16-17,27,29-31H,3-4H2,(H,34,35)(H,22,28,33)(H3,20,23,24,32)/t6-,7-,10-,11-,12-,13-,16-,17-/m1/s1",guanylyl(3'-5')uridine,Three-dimensional structure of ribonuclease T1 complexed with an isosteric phosphonate substrate analogue of GpU: alternate substrate binding modes and catalysis.,109551,C19H24N7O13P,589.41,590.41
707,"InChI=1S/C19H24N8O7/c20-15-9(4-25(19(32)23-15)13-3-10(30)11(6-29)34-13)27-17-14(16(31)24-18(27)21)22-7-26(17)12-2-1-8(5-28)33-12/h4,7-8,10-13,28-30H,1-3,5-6H2,(H2,20,23,32)(H2,21,24,31)/t8-,10?,11?,12?,13?/m0/s1",deoxycytidyl-deoxyguanosine,Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics.,79547,C19H24N8O7,476.44,477.44
708,"InChI=1S/C20H21N5O5/c1-20(2)29-14-12(8-26)28-19(15(14)30-20)25-10-23-13-16(21-9-22-17(13)25)24-18(27)11-6-4-3-5-7-11/h3-7,9-10,12,14-15,19,26H,8H2,1-2H3,(H,21,22,24,27)/t12-,14-,15-,19-/m1/s1","6-N-benzoyl-2',3'-O-isopropylideneadenosine","Discovery of type II (covalent) inactivation of S-adenosyl-L-homocysteine hydrolase involving its ""hydrolytic activity"": synthesis and evaluation of dihalohomovinyl nucleoside analogues derived from adenosine.",111458,C20H21N5O5,411.41,412.41
709,"InChI=1S/C20H25N5O4/c21-18-15-19(25(11-22-15)20-17(28)16(27)13(10-26)29-20)24-14(23-18)9-5-4-8-12-6-2-1-3-7-12/h1-3,6-7,11,13,16-17,20,26-28H,4-5,8-10H2,(H2,21,23,24)/t13-,16-,17-,20-/m1/s1",2-(4-phenylbutyl)adenosine,Characterization of two adenosine analogs as fluorescence probes in RNA.,63610,C20H25N5O4,399.44,400.44
710,"InChI=1S/C20H26N10O13P2/c21-15-9-17(25-3-23-15)29(5-27-9)19-12(33)11(32)8(41-19)2-39-44(35,36)43-45(37,38)42-14-7(1-31)40-20(13(14)34)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20+/m1/s1",Diadenosine diphosphate,Diadenosine diphosphate (Ap₂A) delays neutrophil apoptosis via the adenosine A2A receptor and cAMP/PKA pathway.,31740,C20H26N10O13P2,676.43,677.43
711,"InChI=1S/C20H26N10O13P2/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(41-19)1-39-44(35,36)43-45(37,38)40-2-8-12(32)14(34)20(42-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",adenosine(5')diphospho(5')adenosine,"Poly(A) polymerase from Escherichia coli adenylylates the 3'-hydroxyl residue of nucleosides, nucleoside 5'-phosphates and nucleoside(5')oligophospho(5')nucleosides (NpnN).",99896,C20H26N10O13P2,676.43,677.43
712,"InChI=1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1
InChI=1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)/t7-,8+,11-,12+,13-,14+,19-,20+
InChI=1S/C20H27N10O16P3/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(43-19)1-41-47(35,36)45-49(39,40)46-48(37,38)42-2-8-12(32)14(34)20(44-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H2,21,23,25)(H2,22,24,26)",Diadenosine triphosphate,Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst.,55605,C20H27N10O16P3,756.41,757.41
713,"InChI=1S/C20H28N10O19P4/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(45-19)1-43-50(35,36)47-52(39,40)49-53(41,42)48-51(37,38)44-2-8-12(32)14(34)20(46-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",Diadenosine tetraphosphate,The IalA invasion gene of Bartonella bacilliformis encodes a (de)nucleoside polyphosphate hydrolase of the MutT motif family and has homologs in other invasive bacteria.,109315,C20H28N10O19P4,836.39,837.39
714,"InChI=1S/C20H28N10O21P4/c21-19-25-13-7(15(35)27-19)23-3-29(13)17-11(33)9(31)5(47-17)1-45-52(37,38)49-54(41,42)51-55(43,44)50-53(39,40)46-2-6-10(32)12(34)18(48-6)30-4-24-8-14(30)26-20(22)28-16(8)36/h3-6,9-12,17-18,31-34H,1-2H2,(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H3,21,25,27,35)(H3,22,26,28,36)/t5-,6-,9-,10-,11-,12-,17-,18-/m1/s1",diguanosine tetraphosphate,Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst.,55605,C20H28N10O21P4,868.39,869.39
715,"InChI=1S/C20H28N5O13P3/c1-2-3-4-12-5-7-13(8-6-12)22-20-23-18-17(19(27)24-20)21-11-25(18)16-9-14(26)15(36-16)10-35-40(31,32)38-41(33,34)37-39(28,29)30/h5-8,11,14-16,26H,2-4,9-10H2,1H3,(H,31,32)(H,33,34)(H2,28,29,30)(H2,22,23,24,27)/t14-,15+,16+/m0/s1",N2-(p-n-butylphenyl)-2'-deoxyguanosine 5'-triphosphate,Sensitivity of bacteriophage RB69 DNA polymerase to N2-(p-n-butylphenyl)-2'-deoxyguanosine nucleotides.,106314,C20H28N5O13P3,639.38,640.38
716,"InChI=1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-53(35,36)49-55(39,40)51-57(43,44)52-56(41,42)50-54(37,38)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H2,21,23,25)(H2,22,24,26)/p-5/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1","P1,P5-di(adenosine-5')-pentaphosphate",P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.,113633,C20H24N10O22P5,911.33,912.33
717,"InChI=1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-53(35,36)49-55(39,40)51-57(43,44)52-56(41,42)50-54(37,38)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",adenosine(5')pentaphospho(5')adenosine,"Poly(A) polymerase from Escherichia coli adenylylates the 3'-hydroxyl residue of nucleosides, nucleoside 5'-phosphates and nucleoside(5')oligophospho(5')nucleosides (NpnN).",99896,C20H29N10O22P5,916.37,917.37
718,"InChI=1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-53(35,36)49-55(39,40)51-57(43,44)52-56(41,42)50-54(37,38)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H2,21,23,25)(H2,22,24,26)/t7-,8?,11-,12-,13-,14-,19?,20-/m1/s1",diadenosine pentaphosphate,Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.,90267,C20H29N10O22P5,916.37,917.37
719,"InChI=1S/C20H29N10O22P5/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(47-19)1-45-53(35,36)49-55(39,40)51-57(43,44)52-56(41,42)50-54(37,38)46-2-8-12(32)14(34)20(48-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H2,21,23,25)(H2,22,24,26)/t7?,8?,11?,12?,13?,14?,19-,20-/m0/s1","P1,P5-di(adenosine-5')pentaphosphate",Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.,82668,C20H29N10O22P5,916.37,917.37
720,"InChI=1S/C20H30N10O25P6/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(49-19)1-47-56(35,36)51-58(39,40)53-60(43,44)55-61(45,46)54-59(41,42)52-57(37,38)48-2-8-12(32)14(34)20(50-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H,43,44)(H,45,46)(H2,21,23,25)(H2,22,24,26)/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",diadenosine hexaphosphate,Dinucleoside polyphosphates: newly detected uraemic compounds with an impact on leucocyte oxidative burst.,55605,C20H30N10O25P6,996.35,997.35
721,"InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1",cytidine-5'-monophospho-N-acetylneuraminic acid,Intestine specific regulation of pig cytidine-5'-monophospho-N-acetylneuraminic acid hydroxylase gene for N-glycolylneuraminic acid biosynthesis.,10621,C20H31N4O16P,614.45,615.45
722,"InChI=1S/C21H25BrN3O9P/c1-13(20(28)31-2)24-35(30,34-15-6-4-3-5-7-15)32-12-17-16(26)10-18(33-17)25-11-14(8-9-22)19(27)23-21(25)29/h3-9,11,13,16-18,26H,10,12H2,1-2H3,(H,24,30)(H,23,27,29)/b9-8+/t13-,16-,17+,18+,35?/m0/s1",E-5-(2-bromovinyl)-2'-deoxyuridine-5'-(L-methylalaninyl)-phenylphosphoramidate,"Cellular transformation of the investigational new anticancer drug NB1011, a phosphoramidate of 5-(2-bromovinyl)-2'-deoxyuridine, results in modification of cellular proteins not DNA.",92179,C21H25BrN3O9P,574.32,575.32
723,"InChI=1S/C21H31BrN2O16/c22-5-1-24(21(35)23-17(5)34)18-14(33)16(7(3-26)36-18)40-20-13(32)11(30)15(8(4-27)38-20)39-19-12(31)10(29)9(28)6(2-25)37-19/h1,6-16,18-20,25-33H,2-4H2,(H,23,34,35)",3'-O-[beta-D-galactopyranosyl-(1-->4)-beta-D-galactopyranosyl]-5-bromouridine,Formation of 3'-O-beta-galactosyl compounds of 5-bromouridine by Sporobolomyces singularis.,91478,C21H31BrN2O16,647.38,648.38
724,"InChI=1S/C21H35N5O4/c1-3-9-24-12-25(10-4-2)20-15(18(24)22)23-19(13-7-5-6-8-13)26(20)21-17(29)16(28)14(11-27)30-21/h13-14,16-17,21-22,27-29H,3-12H2,1-2H3/t14-,16-,17-,21-/m1/s1","1,3-dipropyl-8-cyclopentyladenosine",Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats.,89990,C21H35N5O4,421.53,422.53
725,"InChI=1S/C22H23N5O5/c23-19-16-20(27(11-24-16)21-18(30)17(29)15(10-28)32-21)26-22(25-19)31-8-7-12-5-6-13-3-1-2-4-14(13)9-12/h1-6,9,11,15,17-18,21,28-30H,7-8,10H2,(H2,23,25,26)/t15-,17-,18-,21-/m1/s1",2-[2-(2-naphthyl)ethyloxy]adenosine,2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.,84052,C22H23N5O5,437.45,438.45
726,"InChI=1S/C22H38N2O6/c1-2-3-4-5-6-7-8-9-10-11-12-29-16-17-14-24(22(28)23-21(17)27)20-13-18(26)19(15-25)30-20/h14,18-20,25-26H,2-13,15-16H2,1H3,(H,23,27,28)/t18-,19+,20+/m0/s1",5-Dodecyloxymethyl-2'-deoxyuridine,New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth.,55159,C22H38N2O6,426.55,427.55
727,"InChI=1S/C23H29N7O6.ClH/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32;/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29);1H/t16-,17+,18-,22+;/m0./s1",2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride hydrate,Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.,54723,C23H30ClN7O6,535.98,536.98
728,"InChI=1S/C23H29N7O6/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29)/t16-,17+,18-,22+/m0/s1
InChI=1S/C23H29N7O6.ClH/c1-2-25-21(35)18-16(33)17(34)22(36-18)30-11-27-15-19(24)28-23(29-20(15)30)26-10-9-13-5-3-12(4-6-13)7-8-14(31)32;/h3-6,11,16-18,22,33-34H,2,7-10H2,1H3,(H,25,35)(H,31,32)(H3,24,26,28,29);1H/t16-,17+,18-,22+;/m0./s1",2-p-(2-Carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride,Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation.,72436,C23H29N7O6,499.52,500.52
729,"InChI=1S/C24H19N3O6/c28-13-20-18(29)11-21(32-20)27-12-16(22(30)26-24(27)31)10-7-14-5-8-15(9-6-14)23-25-17-3-1-2-4-19(17)33-23/h1-6,8-9,12,18,20-21,28-29H,11,13H2,(H,26,30,31)/t18-,20+,21+/m0/s1",5-[4-(2-benzoxazolyl)phenylethynyl]-2'-deoxyuridine,[Antiviral activity of some 5-arylethynyl 2'-deoxyuridine derivatives].,90586,C24H19N3O6,445.43,446.43
730,"InChI=1S/C25H20N2O5/c28-12-20-19(29)10-21(32-20)27-11-18(24(30)26-25(27)31)16-8-6-15-5-4-13-2-1-3-14-7-9-17(16)23(15)22(13)14/h1-9,11,19-21,28-29H,10,12H2,(H,26,30,31)/t19-,20+,21+/m0/s1",5-(1-pyrenyl)-2'-deoxyuridine,"Comparison of Py*+/dU*- charge transfer state dynamics in 5-(1-pyrenyl)-2'-deoxyuridine nucleoside conjugates with amido-, ethylenyl-, and ethynyl linkers.",77823,C25H20N2O5,428.44,429.44
731,"InChI=1S/C25H37N5O4/c1-14(2)15-6-9-24(3)7-5-8-25(4,17(24)10-15)29-21-18-22(27-12-26-21)30(13-28-18)23-20(33)19(32)16(11-31)34-23/h12-13,15-17,19-20,23,31-33H,1,5-11H2,2-4H3,(H,26,27,29)/t15-,16-,17-,19-,20-,23-,24-,25-/m1/s1",Sorangiadenosine,2-Hydroxysorangiadenosine: Structure and Biosynthesis of a Myxobacterial Sesquiterpene-Nucleoside.,5299,C25H37N5O4,471.59,472.59
732,"InChI=1S/C25H37N5O5/c1-13(2)14-5-6-24(3)8-15(32)9-25(4,17(24)7-14)29-21-18-22(27-11-26-21)30(12-28-18)23-20(34)19(33)16(10-31)35-23/h11-12,14-17,19-20,23,31-34H,1,5-10H2,2-4H3,(H,26,27,29)/t14-,15-,16-,17-,19-,20-,23-,24+,25-/m1/s1",2-hydroxysorangiadenosine,2-Hydroxysorangiadenosine: Structure and Biosynthesis of a Myxobacterial Sesquiterpene-Nucleoside.,5299,C25H37N5O5,487.59,488.59
733,"InChI=1S/C25H45N5O4Si2/c1-12-13-31-22-20-21(28-23(26)29-22)30(16-27-20)19-14-17(34-36(10,11)25(5,6)7)18(33-19)15-32-35(8,9)24(2,3)4/h12,16-19H,1,13-15H2,2-11H3,(H2,26,28,29)/t17-,18+,19+/m0/s1","O6-allyl-3',5'-di-O-(tert-butyldimethylsilyl)-2'-deoxyguanosine","Fluorinated alcohol mediated displacement of the C10 acetoxy group of benzo[a]pyrene-7,8,9,10-tetrahydrotetraol tetraacetates: a new route to diol epoxide-deoxyguanosine adducts.",67556,C25H45N5O4Si2,535.82,536.82
734,"InChI=1S/C26H21N5O4/c27-26-29-24-22(25(34)30-26)28-23(31(24)19-10-17(33)18(11-32)35-19)16-9-7-14-5-4-12-2-1-3-13-6-8-15(16)21(14)20(12)13/h1-9,17-19,32-33H,10-11H2,(H3,27,29,30,34)/t17-,18+,19+/m0/s1",8-(Pyren-1-yl)-2'-deoxyguanosine,Pyrene-modified guanosine as fluorescent probe for DNA modulated by charge transfer.,70295,C26H21N5O4,467.48,468.48
735,"InChI=1S/C26H22N2O6/c29-12-19-23(31)24(25(34-19)28-11-10-20(30)27-26(28)32)33-13-17-7-6-16-5-4-14-2-1-3-15-8-9-18(17)22(16)21(14)15/h1-11,19,23-25,29,31H,12-13H2,(H,27,30,32)/t19-,23-,24-,25-/m1/s1",2'-O-(1-Pyrenylmethyl)uridine,Microenvironmental Effect of 2'-O-(1-Pyrenylmethyl)uridine Modified Fluorescent Oligonucleotide Probes on Sensitive and Selective Detection of Target RNA.,23678,C26H22N2O6,458.46,459.46
736,"InChI=1S/C27H24N2O4Si/c30-25-18-19-29(27(31)28-25)26-17-16-21(33-26)20-32-34(22-10-4-1-5-11-22,23-12-6-2-7-13-23)24-14-8-3-9-15-24/h1-19,21,26H,20H2,(H,28,30,31)/t21-,26+/m0/s1","5'-O-triphenylsilyl-2',3'-didehydro-2',3'-dideoxyuridine",Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target.,79151,C27H24N2O4Si,468.57,469.57
737,"InChI=1S/C27H31N5O6/c1-15-6-4-5-7-19(15)20(16-8-17(36-2)10-18(9-16)37-3)11-28-25-22-26(30-13-29-25)32(14-31-22)27-24(35)23(34)21(12-33)38-27/h4-10,13-14,20-21,23-24,27,33-35H,11-12H2,1-3H3,(H,28,29,30)/t20?,21-,23-,24-,27-/m1/s1","N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine",Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test.,68643,C27H31N5O6,521.57,522.57
738,"InChI=1S/C28H27N3O4/c32-23-18-26(31-17-16-25(33)30-27(31)34)35-24(23)19-29-28(20-10-4-1-5-11-20,21-12-6-2-7-13-21)22-14-8-3-9-15-22/h1-17,23-24,26,29,32H,18-19H2,(H,30,33,34)/t23-,24+,26+/m0/s1","5'-tritylamino-2',5'-dideoxyuridine",Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target.,79151,C28H27N3O4,469.53,470.53
739,"InChI=1S/C29H25N5O3/c35-14-25-24(36)12-26(37-25)34-16-33-27-28(31-15-32-29(27)34)30-13-23-20-8-4-2-6-18(20)11-22-19-7-3-1-5-17(19)9-10-21(22)23/h1-11,15-16,24-26,35-36H,12-14H2,(H,30,31,32)/t24-,25+,26+/m0/s1",N6-(benz[a]anthracen-7-ylmethyl)-2'-deoxyadenosine,Synthesis and characterization of oligonucleotides containing site-specific bulky N2-aralkylated guanines and N6-aralkylated adenines.,104575,C29H25N5O3,491.54,492.54
740,"InChI=1S/C29H25N5O4/c35-14-24-23(36)12-25(38-24)34-15-31-26-27(34)32-29(33-28(26)37)30-13-22-19-8-4-2-6-17(19)11-21-18-7-3-1-5-16(18)9-10-20(21)22/h1-11,15,23-25,35-36H,12-14H2,(H2,30,32,33,37)/t23-,24+,25+/m0/s1",N2-(benz[a]anthracen-7-ylmethyl)-2'-deoxyguanosine,Synthesis and characterization of oligonucleotides containing site-specific bulky N2-aralkylated guanines and N6-aralkylated adenines.,104575,C29H25N5O4,507.54,508.54
741,"InChI=1S/C29H37FN2O6/c1-18(11-12-21-20(3)10-7-13-29(21,4)5)8-6-9-19(2)14-26(34)38-23-15-25(37-24(23)17-33)32-16-22(30)27(35)31-28(32)36/h6,8-9,11-12,14,16,23-25,33H,7,10,13,15,17H2,1-5H3,(H,31,35,36)/b9-6+,12-11-,18-8+,19-14+/t23-,24+,25+/m0/s1",3'-O-Retinoyl-5-fluoro-2'-deoxyuridine,"Pharmacokinetics of 3'-O-retinoyl-5-fluoro-2'-deoxyuridine (RFUdR), a dual acting mutually masking prodrug, and its metabolites in tumor bearing mice.",35585,C29H37FN2O6,528.61,529.61
742,"InChI=1S/C30H32N2O8/c1-37-24-12-8-22(9-13-24)30(21-6-4-3-5-7-21,23-10-14-25(38-2)15-11-23)39-20-26(18-33)40-28(19-34)32-17-16-27(35)31-29(32)36/h3-17,26,28,33-34H,18-20H2,1-2H3,(H,31,35,36)/t26-,28+/m0/s1","5'-O-(4,4'-dimethoxytrityl)-2',3'-secouridine","Selective biocatalytic acylation studies on 5'-O-(4,4'-dimethoxytrityl)-2',3'-secouridine: an efficient synthesis of UNA monomer.",38393,C30H32N2O8,548.58,549.58
743,"InChI=1S/C30H45N5O4/c1-18(10-13-30(5)19(2)8-9-20-21(30)7-6-12-29(20,3)4)11-14-31-26-23-27(33-16-32-26)35(17-34-23)28-25(38)24(37)22(15-36)39-28/h9,11,16-17,19,21-22,24-25,28,36-38H,6-8,10,12-15H2,1-5H3,(H,31,32,33)/b18-11+/t19-,21+,22+,24+,25+,28+,30+/m0/s1",N6-tuberculosinyladenosine,Cytokinin Nucleosides - Natural Compounds with a Unique Spectrum of Biological Activities.,23394,C30H45N5O4,539.71,540.71
744,"InChI=1S/C30H45N5O4/c1-18(10-13-30(5)19(2)8-9-20-21(30)7-6-12-29(20,3)4)11-14-34-16-33-27-23(26(34)31)32-17-35(27)28-25(38)24(37)22(15-36)39-28/h9,11,16-17,19,21-22,24-25,28,31,36-38H,6-8,10,12-15H2,1-5H3/p+1/b18-11+/t19-,21+,22+,24+,25+,28+,30+/m0/s1",1-tuberculosinyladenosine,In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infection.,28348,C30H46N5O4+,541.73,542.73
745,"InChI=1S/C30H49N5O6/c1-3-5-7-9-11-13-15-17-21(36)25(38)26-30(40,22(37)18-16-14-12-10-8-6-4-2)19-23(41-26)35-20-32-24-27(35)33-29(31)34-28(24)39/h20,23,25-26,38,40H,3-19H2,1-2H3,(H3,31,33,34,39)/t23-,25?,26-,30-/m1/s1","3',5'-didecanoyl-2'-deoxyguanosine",The self-assembly of a lipophilic guanosine nucleoside into polymeric columnar aggregates: the nucleoside strucutre contains sufficient information to drive the process towards a strikingly regular polymer.,101193,C30H49N5O6,575.74,576.74
746,"InChI=1S/C31H22N2O5/c34-16-26-25(35)14-27(38-26)33-15-19(30(36)32-31(33)37)11-10-17-12-13-24-22-8-2-5-18-4-1-7-21(28(18)22)23-9-3-6-20(17)29(23)24/h1-9,12-13,15,25-27,34-35H,14,16H2,(H,32,36,37)/t25-,26+,27+/m0/s1",5-(3-Perylenylethynyl)-2'-deoxyuridine,[Antiviral activity of some 5-arylethynyl 2'-deoxyuridine derivatives].,90586,C31H22N2O5,502.52,503.52
747,"InChI=1S/C34H26N2O6/c37-18-27-31(39)32(33(42-27)36-17-16-28(38)35-34(36)40)41-19-21-6-4-20(5-7-21)8-9-22-10-11-25-13-12-23-2-1-3-24-14-15-26(22)30(25)29(23)24/h1-7,10-17,27,31-33,37,39H,18-19H2,(H,35,38,40)/t27-,31-,32-,33-/m1/s1",2'-O-[4-(pyren-1-ylethynyl)benzyl]uridine,Phenylethynylpyrene excimer forming hybridization probes for fluorescence SNP detection.,57964,C34H26N2O6,558.58,559.58
748,"InChI=1S/C6H7N5.C5H10O5/c1-7-5-4-6(10-2-8-4)11-3-9-5;6-2-1-10-5(9)4(8)3(2)7/h2-3H,1H3,(H2,7,8,9,10,11);2-9H,1H2/t;2-,3-,4+,5?/m.1/s1",N6-methyl-adenosine,Potential roles of N6-methyladenosine (m6A) in immune cells.,1295,C11H17N5O5,299.28,300.28
749,"InChI=1S/C7H11N5O4/c8-6-9-3-11(7(15)10-6)12-1-4(14)5(2-13)16-12/h3-5,13-14H,1-2H2,(H2,8,10,15)/t4-,5+/m0/s1",5-aza-2'-deoxyazacytidine,DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes.,66832,C7H11N5O4,229.19,230.19
750,"InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1",(-)-2'-deoxy-5-fluoro-3'-thiacytidine,"Reversion of the M184V mutation in simian immunodeficiency virus reverse transcriptase is selected by tenofovir, even in the presence of lamivudine.",93031,C8H10FN3O3S,247.25,248.25
751,"InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m0/s1
InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m1/s1","2',3'-dideoxy-5-fluoro-3'-thiacytidine",Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era.,11942,C8H10FN3O3S,247.25,248.25
752,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1",2'-deoxy-3'-oxa-4'-thiocytidine,Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC).,91436,C8H11N3O3S,229.26,230.26
753,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",(-)-2'-deoxy-3'-thiacytidine,"Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.",76583,C8H11N3O3S,229.26,230.26
754,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m1/s1
InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)",2'-deoxy-3'-thiacytidine,Pyrimidine deoxynucleoside and nucleoside reverse transcriptase inhibitor metabolism in the perfused heart and isolated mitochondria.,53841,C8H11N3O3S,229.26,230.26
755,"InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)
InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6?,7-/m1/s1
InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Beta-L-Dioxolane-cytidine,"Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.",113708,C8H11N3O4,213.19,214.19
756,"InChI=1S/C8H11N3O4S/c9-4-1-2-11(8(14)10-4)6-7(13)16-5(3-12)15-6/h1-2,5-7,12-13H,3H2,(H2,9,10,14)/t5-,6+,7+/m0/s1",3'-deoxy-3'-thiacytidine,"Intracellular nucleotides of (-)-2',3'-deoxy-3'-thiacytidine in peripheral blood mononuclear cells of a patient infected with human immunodeficiency virus.",110596,C8H11N3O4S,245.26,246.26
757,"InChI=1S/C8H11N3O4S/c9-4-1-2-11(8(14)10-4)6-7(13)16-5(3-12)15-6/h1-2,5-7,12-13H,3H2,(H2,9,10,14)/t5-,6+,7+/m0/s1
InChI=1S/C8H11N3O4S/c9-4-1-2-11(8(14)10-4)6-7(13)16-5(3-12)15-6/h1-2,5-7,12-13H,3H2,(H2,9,10,14)",3'-thiacytidine,Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC.,71288,C8H11N3O4S,245.26,246.26
758,"InChI=1S/C8H11N3O5/c12-3-5-4(13)1-7(16-5)11-8(15)10-6(14)2-9-11/h2,4-5,7,12-13H,1,3H2,(H,10,14,15)/t4-,5+,7+/m0/s1",6-aza-2'-deoxyuridine,6-Aza-2'-deoxyuridine and N(3)-anisoyl-6-aza-2'-deoxyuridine.,71413,C8H11N3O5,229.19,230.19
759,"InChI=1S/C8H11N3O5S/c12-2-3-5(14)6(15)7(16-3)11-8(17)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,17)/t3-,5-,6-,7-/m1/s1",2-thio-6-azauridine,2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation.,24006,C8H11N3O5S,261.26,262.26
760,"InChI=1S/C8H11N3O6/c12-2-3-5(14)6(15)7(17-3)11-8(16)10-4(13)1-9-11/h1,3,5-7,12,14-15H,2H2,(H,10,13,16)/t3-,5-,6-,7-/m1/s1",6-Azauridine,6-Azauridine Induces Autophagy-Mediated Cell Death via a p53- and AMPK-Dependent Pathway.,1944,C8H11N3O6,245.19,246.19
761,"InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)",acycloguanosine,A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase.,29072,C8H11N5O3,225.21,226.21
762,"InChI=1S/C8H12N4O3S/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1",5-aza-4'-thio-2'-deoxycytidine,"5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic ""Best-in-Class"": DNA Methyltransferase 1-Depleting Agent in Clinical Development.",555,C8H12N4O3S,244.27,245.27
763,"InChI=1S/C8H12N4O4/c9-5-1-2-12(8(14)10-5)6-3-4(13)7(11-15)16-6/h1-2,4,6-7,11,13,15H,3H2,(H2,9,10,14)/t4-,6+,7-/m0/s1",5' aza-2'-deoxycytidine,Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.,60022,C8H12N4O4,228.21,229.21
764,"InChI=1S/C8H12N4O4/c9-7-1-2-11(8(15)10-7)12-3-5(14)6(4-13)16-12/h1-2,5-6,13-14H,3-4H2,(H2,9,10,15)/t5-,6+/m0/s1",azadeoxycytidine,Inhibition of chromatin condensation prevents transgene silencing in a neural progenitor cell line transplanted to the rat brain.,80988,C8H12N4O4,228.21,229.21
765,"InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1",2'-deoxy-5-azacytidine,Comparative analysis of epigenetic inhibitors reveals different degrees of interference with transcriptional gene silencing and induction of DNA damage.,7709,C8H12N4O4,228.21,229.21
766,"InChI=1S/C8H12N4O5/c9-3-1-2-12(8(15)10-3)7-5(14)4(13)6(11-16)17-7/h1-2,4-7,11,13-14,16H,(H2,9,10,15)/t4-,5+,6-,7+/m0/s1",5' azacytidine,Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5' Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile Analysis.,5799,C8H12N4O5,244.21,245.21
767,"InChI=1S/C8H12N4O5/c9-4-1-10-12(8(16)11-4)7-6(15)5(14)3(2-13)17-7/h1,3,5-7,13-15H,2H2,(H2,9,11,16)/t3-,5-,6-,7-/m1/s1",6-azacytidine,Synthesis and Comparative Study of Anti-Adenoviral Activity of 6-Azacytidine and Its Analogues.,27217,C8H12N4O5,244.21,245.21
768,"InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1",5-Azacytidine,5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.,662,C8H12N4O5,244.21,245.21
769,"InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4?,5-,6?/m1/s1",5-azcytidine,Haloperidol induces demethylation and expression of the dual specificity phosphatase 6 gene in MIA PaCa-2 human pancreatic cancer cells.,39204,C8H12N4O5,244.21,245.21
770,"InChI=1S/C8H14N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h4-6,13-14H,1-3H2,(H3,9,10,11,15)/t4-,5+,6+/m0/s1","5,6-dihydro-5-aza-2'-deoxycytidine",Two-dimensional IR spectroscopy of the anti-HIV agent KP1212 reveals protonated and neutral tautomers that influence pH-dependent mutagenicity.,29193,C8H14N4O4,230.22,231.22
771,"InChI=1S/C8H14N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h4-6,13-14H,1-3H2,(H3,9,10,11,15)/t4-,5+,6+/m0/s1
InChI=1S/C8H14N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h4-6,13-14H,1-3H2,(H3,9,10,11,15)/t4-,5+,6-/m0/s1","2'-deoxy-5,6-dihydro-5-azacytidine","2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine: a comparative study of hypomethylating potential.",49312,C8H14N4O4,230.22,231.22
772,"InChI=1S/C8H14N4O4/c9-8-10-2-12(3-11-8)7-6(15)5(14)4(1-13)16-7/h2,4-7,13-15H,1,3H2,(H2,9,11)/t4-,5?,6-,7?/m1/s1",2-Deoxy-5-azacytidine,Frequent aberrant methylation of p16INK4a in primary rat lung tumors.,115494,C8H14N4O4,230.22,231.22
773,"InChI=1S/C8H14N4O5/c9-3-1-2-12(8(15)10-3)7-5(14)4(13)6(11-16)17-7/h4-7,11,13-14,16H,1-2H2,(H2,9,10,15)/t4-,5+,6-,7+/m0/s1","5,6-dihydro-5'-azacytidine","5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells.",108464,C8H14N4O5,246.22,247.22
774,"InChI=1S/C8H14N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h3-6,13-15H,1-2H2,(H3,9,10,11,16)/t3-,4-,5-,6-/m1/s1","5,6-dihydro-5-azacytidine","2´-deoxy-5,6-dihydro-5-azacytidine - a less toxic alternative of 2´-deoxy-5-azacytidine: a comparative study of hypomethylating potential.",49312,C8H14N4O5,246.22,247.22
775,"InChI=1S/C8H15N4O14P3/c9-5-1-2-11(8(15)10-5)12-7(14)6(13)4(24-12)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-7,13-14H,3H2,(H,19,20)(H,21,22)(H2,9,10,15)(H2,16,17,18)/t4-,6-,7-/m1/s1",azacytidine triphosphate,Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.,8911,C8H15N4O14P3,484.14,485.14
776,"InChI=1S/C8H16N2O3/c11-6-5-9-1-3-10(4-2-9)7-8(12)13/h11H,1-7H2,(H,12,13)","2,2-difluoro-2-deoxyuridine","Development of a sensitive and selective LC-MS/MS method for simultaneous determination of gemcitabine and 2,2-difluoro-2-deoxyuridine in human plasma.",59253,C8H16N2O3,188.22,189.22
777,InChI=1S/C8H6ClNO2/c9-8-4-2-1-3-7(8)5-6-10(11)12/h1-6H/b6-5+,5-N-methylcarboxamidoadenosine,Stimulatory effects of adenosine on prolactin secretion in the pituitary gland of the rat.,95035,C8H6ClNO2,183.59,184.59
778,"InChI=1S/C9H10F2N2O5/c10-6-7(11)13(9(17)12-8(6)16)5-1-3(15)4(2-14)18-5/h3-5,14-15H,1-2H2,(H,12,16,17)/t3-,4+,5+/m0/s1
InChI=1S/C9H10F2N2O5/c10-6-7(11)13(9(17)12-8(6)16)5-1-3(15)4(2-14)18-5/h3-5,14-15H,1-2H2,(H,12,16,17)",difluorodeoxyuridine,"Sensitive liquid chromatography mass spectrometry (LC-MS) assay reveals novel insights on DNA methylation and incorporation of gemcitabine, its metabolite difluorodeoxyuridine, deoxyuridine, and RX-3117 into DNA.",20462,C9H10F2N2O5,264.18,265.18
779,"InChI=1S/C9H10F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h1-2,4,6-7,14,16H,3H2,(H,12,15,17)/t4-,6-,7-/m1/s1","2',2'-difluorodeoxyuridine","A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies.",12518,C9H10F2N2O5,264.18,265.18
780,"InChI=1S/C9H10F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h1-2,4,6-7,14,16H,3H2,(H,12,15,17)/t4-,6-,7-/m1/s1
InChI=1S/C9H10F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h1-2,4,6-7,14,16H,3H2,(H,12,15,17)
InChI=1S/C9H10F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h1-2,4,6-7,14,16H,3H2,(H,12,15,17)/t4-,6-,7?/m1/s1","2',2'-difluoro-2'-deoxyuridine","LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.",2082,C9H10F2N2O5,264.18,265.18
781,"InChI=1S/C9H10FIN2O5/c10-5-6(15)4(2-14)18-8(5)13-1-3(11)7(16)12-9(13)17/h1,4-6,8,14-15H,2H2,(H,12,16,17)/t4-,5+,6-,8-/m1/s1",Fialuridine,[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.,23160,C9H10FIN2O5,372.09,373.09
782,"InChI=1S/C9H10FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h1-3,5,7,14H,4H2,(H2,11,12,15)/t5-,7+/m0/s1","2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine",Potent antiviral effect of reverset in HIV-1-infected adults following a single oral dose.,84213,C9H10FN3O3,227.19,228.19
783,"InChI=1S/C9H10FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h1-3,5,7,14H,4H2,(H2,11,12,15)/t5-,7+/m1/s1","beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine","Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and beta-D-arabinofuranosylcytosine).",76814,C9H10FN3O3,227.19,228.19
784,"InChI=1S/C9H10FN5O4/c10-4-2-15(9(18)12-8(4)17)7-1-5(13-14-11)6(3-16)19-7/h2,5-7,16H,1,3H2,(H,12,17,18)/t5-,6+,7+/m0/s1","3'-azido-2',3'-dideoxy-5-fluorouridine",Synthesis and biological activity of salinomycin conjugates with floxuridine.,29638,C9H10FN5O4,271.21,272.21
785,"InChI=1S/C9H10N2O4/c12-5-6-1-2-8(15-6)11-4-3-7(13)10-9(11)14/h1-4,6,8,12H,5H2,(H,10,13,14)/t6-,8+/m0/s1","2',3'-didehydro-2',3'-dideoxyuridine",Complete conformational space of the potential HIV-1 reverse transcriptase inhibitors d4U and d4C. A quantum chemical study.,44380,C9H10N2O4,210.19,211.19
786,"InChI=1S/C9H10N2O5/c12-3-4-6(14)7-8(15-4)11-2-1-5(13)10-9(11)16-7/h1-2,4,6-8,12,14H,3H2/t4-,6-,7+,8-/m1/s1","2,2'-anhydrouridine",Influence of conformationally restricted pyrimidines on the activity of 10-23 DNAzymes.,44540,C9H10N2O5,226.19,227.19
787,"InChI=1S/C9H10N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-4,6-8,14-15H,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",uridine 5'-aldehyde,Synthesis of tunicaminyluracil derivatives.,86802,C9H10N2O6,242.19,243.19
788,"InChI=1S/C9H11BrN2O4S/c10-4-2-12(9(15)11-8(4)17)7-1-5(14)6(3-13)16-7/h2,5-7,13-14H,1,3H2,(H,11,15,17)/t5-,6+,7+/m0/s1",5-Bromo-4-thio-2'-deoxyuridine,Study on Interaction between 5-Bromo-4-thio-2'-deoxyuridine and human serum albumin by spectroscopy and molecular docking.,30449,C9H11BrN2O4S,323.16,324.16
789,"InChI=1S/C9H11BrN2O5/c10-12-7(15)1-2-11(9(12)16)8-3-5(14)6(4-13)17-8/h1-2,5-6,8,13-14H,3-4H2/t5-,6+,8+/m0/s1",bromo-2-deoxyuridine,Multiparametric cell cycle analysis by automated microscopy.,74693,C9H11BrN2O5,307.1,308.1
790,"InChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-Bromo-2'-Deoxyuridine,Survey of bromodeoxyuridine uptake among environmental bacteria and variation in uptake rates in a taxonomically diverse set of bacterial isolates.,48877,C9H11BrN2O5,307.1,308.1
791,"InChI=1S/C9H11BrN2O5/c10-5-2-12(9(16)11-7(5)15)8-6(14)1-4(3-13)17-8/h2,4,6,8,13-14H,1,3H2,(H,11,15,16)/t4-,6+,8+/m0/s1",5-bromo-3'-deoxyuridine,Neurogenesis and gliogenesis in the spinal cord of turtles.,94052,C9H11BrN2O5,307.1,308.1
792,"InChI=1S/C9H11BrN2O5/c10-7(15)5-3-4(13)8(17-5)12-2-1-6(14)11-9(12)16/h1-2,4-5,7-8,13,15H,3H2,(H,11,14,16)/t4-,5+,7?,8-/m1/s1",5'-bromo-3'-deoxyuridine,Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.,93326,C9H11BrN2O5,307.1,308.1
793,"InChI=1S/C9H11BrN2O5/c10-8(15)7-4(13)3-6(17-7)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8?/m0/s1",5'-Bromo-2'-deoxyuridine,[Antidepressant activities of flavonoids from Glycyrrhiza uralensis and its neurogenesis protective effect in rats].,37081,C9H11BrN2O5,307.1,308.1
794,"InChI=1S/C9H11BrN2O5/c10-9(3-5(14)6(4-13)17-9)12-2-1-7(15)11-8(12)16/h1-2,5-6,13-14H,3-4H2,(H,11,15,16)/t5-,6+,9-/m0/s1",Bromo-deoxyuridine,Detecting Hematopoietic Stem Cell Proliferation Using BrdU Incorporation.,16525,C9H11BrN2O5,307.1,308.1
795,"InChI=1S/C9H11BrN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1",5-Bromouridine,Visualization of Mitochondrial RNA Granules in Cultured Cells Using 5-Bromouridine Labeling.,3313,C9H11BrN2O6,323.1,324.1
796,"InChI=1S/C9H11BrN2O6/c10-7(16)6-4(14)5(15)8(18-6)12-2-1-3(13)11-9(12)17/h1-2,4-8,14-16H,(H,11,13,17)/t4-,5+,6-,7?,8+/m0/s1",5'-bromo-uridine,BRIC-seq: a genome-wide approach for determining RNA stability in mammalian cells.,35005,C9H11BrN2O6,323.1,324.1
797,"InChI=1S/C9H11BrN2O8/c10-20-19-9(7(16)6(15)4(3-13)18-9)12-2-1-5(14)11-8(12)17/h1-2,4,6-7,13,15-16H,3H2,(H,11,14,17)/t4-,6-,7-,9+/m1/s1",Bromodioxyuridine,Cell proliferation and apoptosis in rat mammary cancer after electrochemical treatment (EChT).,87208,C9H11BrN2O8,355.1,356.1
798,"InChI=1S/C9H11ClN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-Chlorodeoxyuridine,Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells.,95336,C9H11ClN2O5,262.65,263.65
799,"InChI=1S/C9H11ClN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
InChI=1S/C9H11ClN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)
InChI=1S/C9H11ClN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6-,7-/m1/s1",5-Chloro-2'-deoxyuridine,The 5-chlorouracil:7-deazaadenine base pair as an alternative to the dT:dA base pair.,20398,C9H11ClN2O5,262.65,263.65
800,"InChI=1S/C9H11ClN2O5S/c10-3-1-12(9(16)11-7(3)18)8-6(15)5(14)4(2-13)17-8/h1,4-6,8,13-15H,2H2,(H,11,16,18)/t4-,5-,6-,8-/m1/s1",5-chloro-4-thiouridine,Photoinduced fluorescent cross-linking of 5-chloro- and 5-fluoro-4-thiouridines with thymidine.,56494,C9H11ClN2O5S,294.71,295.71
801,"InChI=1S/C9H11ClN2O6/c10-9(7(16)6(15)4(3-13)18-9)12-2-1-5(14)11-8(12)17/h1-2,4,6-7,13,15-16H,3H2,(H,11,14,17)/t4-,6-,7-,9+/m1/s1",chlorouridine,Use of halogenated precursors for simultaneous DNA and RNA detection by means of immunoelectron and immunofluorescence microscopy.,68220,C9H11ClN2O6,278.65,279.65
802,"InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1
InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1","2'-deoxy-2',2'-difluorocytidine monohydrochloride",High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model.,91282,C9H12ClF2N3O4,299.66,300.66
803,"InChI=1S/C9H11F2N3O4/c10-6-7(11)14(9(17)13-8(6)12)5-1-3(16)4(2-15)18-5/h3-5,15-16H,1-2H2,(H2,12,13,17)/t3-,4+,5+/m0/s1
InChI=1S/C9H11F2N3O4/c10-6-7(11)14(9(17)13-8(6)12)5-1-3(16)4(2-15)18-5/h3-5,15-16H,1-2H2,(H2,12,13,17)",difluorodeoxycytidine,In vivo kinetics of the genotoxic and cytotoxic activities of cladribine and clofarabine.,5184,C9H11F2N3O4,263.2,264.2
804,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1","2',2'-Difluorodeoxycytidine","Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells.",65691,C9H11F2N3O4,263.2,264.2
805,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1
InChI=1S/C9H11F2N3O4.ClH/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17;/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17);1H/t4-,6-,7-;/m1./s1","2',2'-Difluoro-2'-deoxycytidine","Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.",30016,C9H11F2N3O4,263.2,264.2
806,"InChI=1S/C9H11FN2O4/c10-5-3-8(16-6(5)4-13)12-2-1-7(14)11-9(12)15/h1-2,5-6,8,13H,3-4H2,(H,11,14,15)/t5-,6+,8+/m0/s1","2',3'-dideoxy-3'-fluorouridine","Synthesis, solution conformation and anti-HIV activity of novel 3'-substituted-2',3'-dideoxy-5-hydroxymethyluridines and their 4,5-substituted analogues.",89382,C9H11FN2O4,230.19,231.19
807,"InChI=1S/C9H11FN2O5/c1-3-5(13)6(14)8(17-3)12-2-4(10)7(15)11-9(12)16/h2-3,5-6,8,13-14H,1H3,(H,11,15,16)/t3-,5-,6-,8-/m1/s1",5'-Deoxy-5-fluorouridine,The relationship between clinicopathological factors and the reduction of pyrimidine nucleoside phosphorylase activity after preoperative administration of 5'-deoxy-5-fluorouridine.,52539,C9H11FN2O5,246.19,247.19
808,"InChI=1S/C9H11FN2O5/c10-3-4-6(14)7(15)8(17-4)12-2-1-5(13)11-9(12)16/h1-2,4,6-8,14-15H,3H2,(H,11,13,16)/t4-,6-,7-,8-/m1/s1",5'-deoxy-5'-fluorouridine,Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.,109388,C9H11FN2O5,246.19,247.19
809,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)",5-fluoro 2'-deoxyuridine,"Coupling of 5-fluoro 2'-deoxyuridine to lactosaminated poly-l-lysine: an approach to a regional, non-invasive chemotherapy of liver micrometastases.",101514,C9H11FN2O5,246.19,247.19
810,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",2'-deoxy-5-fluorouridine,dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.,3547,C9H11FN2O5,246.19,247.19
811,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)
InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5?,6-,7-/m1/s1
InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7?/m0/s1
InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m1/s1",5-Fluoro-2'-deoxyuridine,Effects of 5'-fluoro-2-deoxyuridine on mitochondrial biology in Caenorhabditis elegans.,43065,C9H11FN2O5,246.19,247.19
812,"InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1",2'-deoxy-2'-fluorouridine,The effect on quadruplex stability of North-nucleoside derivatives in the loops of the thrombin-binding aptamer.,40862,C9H11FN2O5,246.19,247.19
813,"InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1
InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6?,7?,8-/m0/s1
InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6?,7+,8-/m0/s1",2'-deoxy-2'-fluoro-l-uridine,Synthesis and Structural Characterization of 2'-Deoxy-2'-fluoro-l-uridine Nucleic Acids.,1212,C9H11FN2O5,246.19,247.19
814,"InChI=1S/C9H11FN2O5/c10-8(15)7-4(13)3-6(17-7)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8?/m0/s1",5'-Fluorodeoxyuridine,Thymidine kinases share a conserved function for nucleotide salvage and play an essential role in Arabidopsis thaliana growth and development.,27340,C9H11FN2O5,246.19,247.19
815,"InChI=1S/C9H11FN2O5S/c10-3-1-12(9(16)11-7(3)18)8-6(15)5(14)4(2-13)17-8/h1,4-6,8,13-15H,2H2,(H,11,16,18)/t4-,5-,6-,8-/m1/s1",5-Fluoro-4-thiouridine,Photoinduced fluorescent cross-linking of 5-chloro- and 5-fluoro-4-thiouridines with thymidine.,56494,C9H11FN2O5S,278.26,279.26
816,"InChI=1S/C9H11FN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1",5-Fluorouridine,The role of hydration effects in 5-fluorouridine binding to SOD1: insight from a new 3D-RISM-KH based protocol for including structural water in docking simulations.,7850,C9H11FN2O6,262.19,263.19
817,"InChI=1S/C9H11FN2O6/c10-7(16)6-4(14)5(15)8(18-6)12-2-1-3(13)11-9(12)17/h1-2,4-8,14-16H,(H,11,13,17)/t4-,5+,6-,7?,8+/m0/s1",5'-Fluorouridine,Nuclear organization and dynamics of transcription sites in rat sensory ganglia neurons detected by incorporation of 5'-fluorouridine into nascent RNA.,76246,C9H11FN2O6,262.19,263.19
818,"InChI=1S/C9H11FN2O6/c10-9(17)6(15)4(3-13)18-7(9)12-2-1-5(14)11-8(12)16/h1-2,4,6-7,13,15,17H,3H2,(H,11,14,16)/t4-,6-,7-,9-/m1/s1",2'-fluorouridine,Quantification of 2'-fluoro-2'-deoxyuridine and 2'-fluoro-2'-deoxycytidine in DNA and RNA isolated from rats and woodchucks using LC/MS/MS.,95135,C9H11FN2O6,262.19,263.19
819,"InChI=1S/C9H11FN2O6/c10-9(3-13)6(16)5(15)7(18-9)12-2-1-4(14)11-8(12)17/h1-2,5-7,13,15-16H,3H2,(H,11,14,17)/t5-,6+,7-,9-/m1/s1",4'-fluorouridine,[Synthesis and biological properties of pyrimidine 4'-fluoro nucleosides and 4'-fluoro uridine 5'-O-triphospate].,52812,C9H11FN2O6,262.19,263.19
820,"InChI=1S/C9H11FN6O4/c10-5-6(18)9(3-17,14-15-12)20-7(5)16-2-1-4(11)13-8(16)19/h1-2,5-7,12,17-18H,3H2,(H-,11,13,19)/p+1/t5-,6-,7+,9+/m0/s1",2'-deoxy-2'-beta-fluoro-4'-azidocytidine,2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.,67835,C9H12FN6O4+,288.24,289.24
821,"InChI=1S/C9H11IN2O4S/c10-4-2-12(9(15)11-8(4)17)7-1-5(14)6(3-13)16-7/h2,5-7,13-14H,1,3H2,(H,11,15,17)/t5-,6+,7+/m0/s1",5-iodo-4-thio-2'-deoxyuridine,Why Does the Type of Halogen Atom Matter for the Radiosensitizing Properties of 5-Halogen Substituted 4-Thio-2'-Deoxyuridines?,8888,C9H11IN2O4S,370.17,371.17
822,"InChI=1S/C9H11IN2O4S/c10-4-2-12(9(17)11-8(4)15)7-1-5(14)6(3-13)16-7/h2,5-7,13-14H,1,3H2,(H,11,15,17)/t5-,6+,7+/m0/s1",2'-deoxy-5-iodo-2-thiouridine,Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro.,107465,C9H11IN2O4S,370.17,371.17
823,"InChI=1S/C9H11IN2O5/c10-3-4-6(14)7(15)8(17-4)12-2-1-5(13)11-9(12)16/h1-2,4,6-8,14-15H,3H2,(H,11,13,16)/t4-,6-,7-,8-/m1/s1",5'-deoxy-5'-iodouridine,Lithiation at the 6-position of uridine with lithium hexamethyldisilazide: crucial role of temporary silylation.,86012,C9H11IN2O5,354.1,355.1
824,"InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)",Iododeoxyuridine,Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.,9039,C9H11IN2O5,354.1,355.1
825,"InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)
InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-iodo-deoxyuridine,Rapid quantitation of plasma 2'-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients.,81083,C9H11IN2O5,354.1,355.1
826,"InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",2'-deoxy-5-iodouridine,Modification of oligodeoxynucleotides by on-column Suzuki cross-coupling reactions.,13630,C9H11IN2O5,354.1,355.1
827,"InChI=1S/C9H11IN2O5/c10-8(15)7-4(13)3-6(17-7)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8?/m0/s1",5'-iodo-2'-deoxyuridine,Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys.,49427,C9H11IN2O5,354.1,355.1
828,"InChI=1S/C9H11IN2O5/c10-8(15)7-4(13)3-6(17-7)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8?/m0/s1
InChI=1S/C9H11IN2O5/c10-8(15)7-4(13)3-6(17-7)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)",5'-iododeoxyuridine,Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.,109963,C9H11IN2O5,354.1,355.1
829,"InChI=1S/C9H11IN2O6/c10-3-1-12(9(17)11-7(3)16)8-6(15)5(14)4(2-13)18-8/h1,4-6,8,13-15H,2H2,(H,11,16,17)/t4-,5-,6-,8-/m1/s1",5-iodouridine,Fluorous-assisted synthesis of (E)-5-[3-aminoallyl]-uridine-5'-O-triphosphate.,29078,C9H11IN2O6,370.1,371.1
830,"InChI=1S/C9H11IN2O6/c10-4-1-5(14)11-9(17)12(4)8-7(16)6(15)3(2-13)18-8/h1,3,6-8,13,15-16H,2H2,(H,11,14,17)/t3-,6-,7-,8-/m1/s1",6-Iodouridine,Antimalarial activities of 6-iodouridine and its prodrugs and potential for combination therapy.,37323,C9H11IN2O6,370.1,371.1
831,"InChI=1S/C9H11N2O5Se/c12-3-4-6(14)7(15)8(16-4)11-2-1-5(13)10-9(11)17/h1-2,4,6-8,12,14-15H,3H2/t4-,6-,7-,8-/m1/s1",2-selenouridine,Escherichia coli tRNA 2-selenouridine synthase (SelU) converts S2U-RNA to Se2U-RNA via S-geranylated-intermediate.,13943,C9H11N2O5Se,306.15,307.15
832,"InChI=1S/C9H11N2O8P/c12-3-4-6-7(19-20(15,16)18-6)8(17-4)11-2-1-5(13)10-9(11)14/h1-2,4,6-8,12H,3H2,(H,15,16)(H,10,13,14)/t4-,6-,7-,8-/m1/s1","uridine 2',3'-cyclic phosphate","Cleavage of the phosphodiester bond of uridylyl-(3',5')-8-carboxymethylaminoadenosine by hydronium, hydroxide and zinc(II) ions: a model study aimed at elucidating the potential of a carboxylate function as an intramolecular catalyst.",101673,C9H11N2O8P,306.17,307.17
833,"InChI=1S/C9H11N2O8P/c12-5-1-2-11(9(14)10-5)8-6(13)7-4(18-8)3-17-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H,10,12,14)/p-1/t4-,6-,7-,8-/m1/s1","uridine 3',5'-cyclic monophosphate",Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.,26002,C9H10N2O8P,305.16,306.16
834,"InChI=1S/C9H11N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h1-4,6,8,13H,5H2,(H2,10,11,14)/t6-,8+/m0/s1","2',3'-didehydro-2',3'-dideoxycytidine",Complete conformational space of the potential HIV-1 reverse transcriptase inhibitors d4U and d4C. A quantum chemical study.,44380,C9H11N3O3,209.2,210.2
835,"InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1",Cyclocytidine hydrochloride,"Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.",5438,C9H12ClN3O4,261.66,262.66
836,"InChI=1S/C9H11N3O4/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8/h1-2,4,6-8,10,13-14H,3H2/t4-,6-,7+,8-/m1/s1
InChI=1S/C9H11N3O4.ClH/c10-5-1-2-12-8-7(16-9(12)11-5)6(14)4(3-13)15-8;/h1-2,4,6-8,10,13-14H,3H2;1H/t4-,6-,7+,8-;/m1./s1",Cyclocytidine,Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration.,113138,C9H11N3O4,225.2,226.2
837,"InChI=1S/C9H11N3O7/c13-3-6-5(14)1-7(19-6)11-2-4(12(17)18)8(15)10-9(11)16/h2,5-7,13-14H,1,3H2,(H,10,15,16)/t5-,6+,7+/m0/s1",2'-deoxy-5-nitrouridine,Nucleoside phosphonic acids in thymidine phosphorylase inhibition: structure-activity relationship.,63230,C9H11N3O7,273.2,274.2
838,"InChI=1S/C9H11N5O4/c10-13-12-5-3-8(18-6(5)4-15)14-2-1-7(16)11-9(14)17/h1-2,5-6,8,15H,3-4H2,(H,11,16,17)/t5-,6+,8+/m0/s1
InChI=1S/C9H11N5O4/c10-13-12-5-3-8(18-6(5)4-15)14-2-1-7(16)11-9(14)17/h1-2,5-6,8,15H,3-4H2,(H,11,16,17)/t5-,6-,8-/m1/s1
InChI=1S/C9H11N5O4/c10-13-12-5-3-8(18-6(5)4-15)14-2-1-7(16)11-9(14)17/h1-2,5-6,8,15H,3-4H2,(H,11,16,17)
InChI=1S/C9H11N5O4/c10-13-12-5-3-8(18-6(5)4-15)14-2-1-7(16)11-9(14)17/h1-2,5-6,8,15H,3-4H2,(H,11,16,17)/t5?,6-,8-/m1/s1","3'-Azido-2',3'-dideoxyuridine","Simultaneous determination of 3'-azido-2',3'-dideoxyuridine and novel prodrugs in rat plasma by liquid chromatography.",89376,C9H11N5O4,253.22,254.22
839,"InChI=1S/C9H11N5O4/c10-9-12-7-6(8(16)13-9)11-3-14(7)4-2-17-5(1-15)18-4/h3-5,15H,1-2H2,(H3,10,12,13,16)/t4-,5-/m1/s1",(-)-beta-D-dioxolane guanosine,"Dioxolane guanosine, the active form of the prodrug diaminopurine dioxolane, is a potent inhibitor of drug-resistant HIV-1 isolates from patients for whom standard nucleoside therapy fails.",97389,C9H11N5O4,253.22,254.22
840,"InChI=1S/C9H11N5O5/c10-13-12-4-2-14(9(18)11-8(4)17)7-1-5(16)6(3-15)19-7/h2,5-7,15-16H,1,3H2,(H,11,17,18)/t5-,6+,7+/m0/s1",5-azido-2'-deoxyuridine,Strain Promoted Click Chemistry of 2- or 8-Azidopurine and 5-Azidopyrimidine Nucleosides and 8-Azidoadenosine Triphosphate with Cyclooctynes. Application to Living Cell Fluorescent Imaging.,27562,C9H11N5O5,269.21,270.21
841,"InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6-,7-,8-/m1/s1
InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)
InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6?,7-,8-/m1/s1
InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6?,7+,8-/m1/s1
InChI=1S/C9H11N5O5/c10-13-12-6-7(17)4(3-15)19-8(6)14-2-1-5(16)11-9(14)18/h1-2,4,6-8,15,17H,3H2,(H,11,16,18)/t4-,6?,7-,8?/m1/s1",2'-Azido-2'-deoxyuridine,Biological activity and phosphorylation of 2'-azido-2'-deoxyuridine and 2'-azido-2'-deoxycytidine.,111269,C9H11N5O5,269.21,270.21
842,"InChI=1S/C9H11N5O6/c10-13-12-3-1-14(9(19)11-7(3)18)8-6(17)5(16)4(2-15)20-8/h1,4-6,8,15-17H,2H2,(H,11,18,19)/t4-,5-,6-,8-/m1/s1",5-azidouridine,Strain Promoted Click Chemistry of 2- or 8-Azidopurine and 5-Azidopyrimidine Nucleosides and 8-Azidoadenosine Triphosphate with Cyclooctynes. Application to Living Cell Fluorescent Imaging.,27562,C9H11N5O6,285.21,286.21
843,"InChI=1S/C9H11N5O6/c10-13-12-9(19)6(17)4(3-15)20-7(9)14-2-1-5(16)11-8(14)18/h1-2,4,6-7,15,17,19H,3H2,(H,11,16,18)/t4-,6-,7-,9-/m1/s1",2'-azidouridine,An optimized chemical-genetic method for cell-specific metabolic labeling of RNA.,6822,C9H11N5O6,285.21,286.21
844,"InChI=1S/C9H11N5O6/c10-13-12-9(3-15)6(18)5(17)7(20-9)14-2-1-4(16)11-8(14)19/h1-2,5-7,15,17-18H,3H2,(H,11,16,19)/t5-,6+,7-,9-/m1/s1",4'-Azidouridine,Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.,71228,C9H11N5O6,285.21,286.21
845,"InChI=1S/C9H12BrN2O8P/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(20-7)3-19-21(16,17)18/h2,5-7,13H,1,3H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1",5-Bromo-2'-deoxyuridine-5'-monophosphate,Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.,110966,C9H12BrN2O8P,387.08,388.08
846,"InChI=1S/C9H12BrN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h3,5,7,14H,1-2,4H2,(H2,11,12,15)/t5-,7+/m0/s1","5-bromo-2',3'-dideoxycytidine","Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.",69099,C9H12BrN3O3,290.11,291.11
847,"InChI=1S/C9H12BrN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1",5-bromo-2'-deoxycytidine,5-Bromo-2'-deoxycytidine-a potential DNA photosensitizer.,21333,C9H12BrN3O4,306.11,307.11
848,"InChI=1S/C9H12BrN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
InChI=1S/C9H12BrN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)",5-bromodeoxycytidine,Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.,21250,C9H12BrN3O4,306.11,307.11
849,"InChI=1S/C9H12BrN3O4/c10-6-2-7(11)12-9(16)13(6)8-1-4(15)5(3-14)17-8/h2,4-5,8,14-15H,1,3H2,(H2,11,12,16)/t4-,5+,8+/m0/s1",6-bromo-2'-deoxycytidine,The radiosensitivity of 5- and 6-bromocytidine derivatives--electron induced DNA degradation.,32084,C9H12BrN3O4,306.11,307.11
850,"InChI=1S/C9H12BrN3O5/c10-3-1-13(9(17)12-7(3)11)8-6(16)5(15)4(2-14)18-8/h1,4-6,8,14-16H,2H2,(H2,11,12,17)/t4-,5-,6-,8-/m1/s1",5-bromocytidine,Intramolecular Charge Transfer in 5-Halogen Cytidines Revealed by Femtosecond Time-Resolved Spectroscopy.,6375,C9H12BrN3O5,322.11,323.11
851,"InChI=1S/C9H12BrN3O5/c10-9(7(16)6(15)4(3-14)18-9)13-2-1-5(11)12-8(13)17/h1-2,4,6-7,14-16H,3H2,(H2,11,12,17)/t4-,6-,7-,9+/m1/s1",bromocytidine,The radiosensitivity of 5- and 6-bromocytidine derivatives--electron induced DNA degradation.,32084,C9H12BrN3O5,322.11,323.11
852,"InChI=1S/C9H12BrNO5/c12-4-6-5(13)3-7(16-6)10-2-1-8(14)11-9(10)15/h1-2,5-7,12-13H,3-4H2,(H,11,14,15)/t5-,6+,7?/m0/s1",bromdeoxyuridine,"[(18)F]FLT-PET imaging does not always ""light up"" proliferating tumor cells.",46004,C9H12BrNO5,294.1,295.1
853,"InChI=1S/C9H12ClN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1",5-Chloro-2'-deoxycytidine,Analytical and pharmacokinetic studies with 5-chloro-2'-deoxycytidine.,93723,C9H12ClN3O4,261.66,262.66
854,"InChI=1S/C9H12ClN3O5/c10-3-1-13(9(17)12-7(3)11)8-6(16)5(15)4(2-14)18-8/h1,4-6,8,14-16H,2H2,(H2,11,12,17)/t4-,5-,6-,8-/m1/s1",5-chloro-cytidine,A Role for Chlorinated Nucleosides in the Perturbation of Macrophage Function and Promotion of Inflammation.,9968,C9H12ClN3O5,277.66,278.66
855,"InChI=1S/C9H12FN2O8P/c10-4-2-12(9(15)11-8(4)14)7-1-5(13)6(20-7)3-19-21(16,17)18/h2,5-7,13H,1,3H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,7+/m0/s1",5-fluoro-2'-deoxyuridine 5'-monophosphate,Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment.,24890,C9H12FN2O8P,326.17,327.17
856,"InChI=1S/C9H12FN2O8P/c10-8(20-21(16,17)18)7-4(13)3-6(19-7)12-2-1-5(14)11-9(12)15/h1-2,4,6-8,13H,3H2,(H,11,14,15)(H2,16,17,18)/t4-,6+,7-,8?/m0/s1
InChI=1S/C9H12FN2O8P/c10-8(20-21(16,17)18)7-4(13)3-6(19-7)12-2-1-5(14)11-9(12)15/h1-2,4,6-8,13H,3H2,(H,11,14,15)(H2,16,17,18)",5'-fluoro-2'-deoxyuridine monophosphate,"MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine.",91198,C9H12FN2O8P,326.17,327.17
857,"InChI=1S/C9H12FN2O8P/c10-9(12-2-1-7(14)11-8(12)15)3-5(13)6(20-9)4-19-21(16,17)18/h1-2,5-6,13H,3-4H2,(H,11,14,15)(H2,16,17,18)/t5-,6+,9-/m0/s1
InChI=1S/C9H12FN2O8P/c10-9(12-2-1-7(14)11-8(12)15)3-5(13)6(20-9)4-19-21(16,17)18/h1-2,5-6,13H,3-4H2,(H,11,14,15)(H2,16,17,18)",fluorodeoxyuridine monophosphate,Combined in silico and 19F NMR analysis of 5-fluorouracil metabolism in yeast at low ATP conditions.,7680,C9H12FN2O8P,326.17,327.17
858,"InChI=1S/C9H12FN2O9P/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(21-8)2-20-22(17,18)19/h1,4-6,8,13-14H,2H2,(H,11,15,16)(H2,17,18,19)/p-2/t4-,5-,6-,8-/m1/s1",5-fluorouridine-5'-monophosphate,Dietary serine-microbiota interaction enhances chemotherapeutic toxicity without altering drug conversion.,5533,C9H10FN2O9P,340.16,341.16
859,"InChI=1S/C9H12FN2O9P/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(21-8)2-20-22(17,18)19/h1,4-6,8,13-14H,2H2,(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1
InChI=1S/C9H12FN2O9P/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(21-8)2-20-22(17,18)19/h1,4-6,8,13-14H,2H2,(H,11,15,16)(H2,17,18,19)/p-2/t4-,5-,6-,8-/m1/s1",5-fluorouridine 5'-monophosphate,"Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.",103844,C9H12FN2O9P,342.17,343.17
860,"InChI=1S/C9H12FN3O3/c10-6-3-13(9(15)12-8(6)11)7-2-1-5(4-14)16-7/h3,5,7,14H,1-2,4H2,(H2,11,12,15)/t5-,7+/m0/s1","beta-L-2',3'-Dideoxy-5-fluorocytidine","Pharmacokinetics of beta-L-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.",109174,C9H12FN3O3,229.21,230.21
861,"InChI=1S/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1",5'-deoxy-5-fluorocytidine,Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR).,1775,C9H12FN3O4,245.21,246.21
862,"InChI=1S/C9H12FN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1",2'-deoxy-5-fluorocytidine,"In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.",47400,C9H12FN3O4,245.21,246.21
863,"InChI=1S/C9H12FN3O4/c10-6-7(15)4(3-14)17-8(6)13-2-1-5(11)12-9(13)16/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16)/t4-,6-,7-,8-/m1/s1",2'-Deoxy-2'-fluorocytidine,Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine.,87675,C9H12FN3O4,245.21,246.21
864,"InChI=1S/C9H12FN3O4/c10-6-7(16)4(3-14)17-8(6)13-2-1-5(15)12-9(13)11/h1-2,4,6-8,14,16H,3H2,(H2,11,12,15)/t4-,6-,7-,8-/m1/s1",2'-deoxy-2'-fluoroisocytidine,"Duplex DNA and DNA-RNA hybrids with parallel strand orientation: 2'-deoxy-2'-fluoroisocytidine, 2'-deoxy-2'-fluoroisoguanosine, and canonical nucleosides with 2'-fluoro substituents cause unexpected changes on the double helix stability.",29151,C9H12FN3O4,245.21,246.21
865,"InChI=1S/C9H12FN3O5/c10-3-1-13(9(17)12-7(3)11)8-6(16)5(15)4(2-14)18-8/h1,4-6,8,14-16H,2H2,(H2,11,12,17)/t4-,5-,6-,8-/m1/s1",5-fluorocytidine,Intramolecular Charge Transfer in 5-Halogen Cytidines Revealed by Femtosecond Time-Resolved Spectroscopy.,6375,C9H12FN3O5,261.21,262.21
866,"InChI=1S/C9H12FN3O5/c10-9(17)6(15)4(3-14)18-7(9)13-2-1-5(11)12-8(13)16/h1-2,4,6-7,14-15,17H,3H2,(H2,11,12,16)/t4-,6-,7-,9-/m1/s1",2'-fluorocytidine,Quantification of 2'-fluoro-2'-deoxyuridine and 2'-fluoro-2'-deoxycytidine in DNA and RNA isolated from rats and woodchucks using LC/MS/MS.,95135,C9H12FN3O5,261.21,262.21
867,"InChI=1S/C9H12FN3O5/c10-9(3-14)6(16)5(15)7(18-9)13-2-1-4(11)12-8(13)17/h1-2,5-7,14-16H,3H2,(H2,11,12,17)/t5-,6+,7-,9-/m1/s1",4'-fluorocytidine,[Synthesis and biological properties of pyrimidine 4'-fluoro nucleosides and 4'-fluoro uridine 5'-O-triphospate].,52812,C9H12FN3O5,261.21,262.21
868,"InChI=1S/C9H12IN2O9P/c10-4-1-5(13)11-9(16)12(4)8-7(15)6(14)3(21-8)2-20-22(17,18)19/h1,3,6-8,14-15H,2H2,(H,11,13,16)(H2,17,18,19)/t3-,6-,7-,8-/m1/s1",6-Iodouridine 5'-monophosphate,"A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.",71783,C9H12IN2O9P,450.08,451.08
869,"InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1",2'-deoxy-5-iodocytidine,"X-ray analyses of d(GCGAAAGC) and d(GXGAAAGCT), where X = 2'-deoxy-5-iodocytidine.",90667,C9H12IN3O4,353.11,354.11
870,"InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)",5-iododeoxycytidine,Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.,21250,C9H12IN3O4,353.11,354.11
871,"InChI=1S/C9H12IN3O4/c10-8(15)7-4(14)3-6(17-7)13-2-1-5(11)12-9(13)16/h1-2,4,6-8,14-15H,3H2,(H2,11,12,16)/t4-,6+,7-,8?/m0/s1",5'-iodo-2'-deoxycytidine,(E)-5-(2'-bromovinyl)-2'-deoxyuridine inhibition of macropodid herpesvirus 1 in vitro.,111059,C9H12IN3O4,353.11,354.11
872,"InChI=1S/C9H12IN3O5/c10-3-1-13(9(17)12-7(3)11)8-6(16)5(15)4(2-14)18-8/h1,4-6,8,14-16H,2H2,(H2,11,12,17)/t4-,5-,6-,8-/m1/s1",5-iodo-cytidine,Practical synthesis of cytidine-5-carboxamide-modified nucleotide reagents.,29336,C9H12IN3O5,369.11,370.11
873,"InChI=1S/C9H12N2O3S/c12-5-6-1-2-8(14-6)11-4-3-7(15)10-9(11)13/h3-4,6,8,12H,1-2,5H2,(H,10,13,15)/t6-,8+/m0/s1","2',3'-dideoxy-4-thiouridine","Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells.",106107,C9H12N2O3S,228.27,229.27
874,"InChI=1S/C9H12N2O4/c12-5-6-1-2-8(15-6)11-4-3-7(13)10-9(11)14/h3-4,6,8,12H,1-2,5H2,(H,10,13,14)/t6-,8+/m0/s1","2',3'-Dideoxyuridine","Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.",69099,C9H12N2O4,212.2,213.2
875,"InChI=1S/C9H12N2O4S/c12-4-6-5(13)3-8(15-6)11-2-1-7(14)10-9(11)16/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,16)/t5-,6+,8+/m0/s1",2'-Deoxy-2-thiouridine,Prebiotic phosphorylation of 2-thiouridine provides either nucleotides or DNA building blocks via photoreduction.,10355,C9H12N2O4S,244.27,245.27
876,"InChI=1S/C9H12N2O4S/c12-4-6-5(13)3-8(15-6)11-2-1-7(16)10-9(11)14/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,16)/t5-,6+,8+/m0/s1",4-Thio-2'-deoxyuridine,Covalent cross-linking of duplex DNA using 4-thio-2'-deoxyuridine as a readily modifiable platform for introduction of reactive functionality into oligonucleotides.,113266,C9H12N2O4S,244.27,245.27
877,"InChI=1S/C9H12N2O4S/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1","2'-deoxy-5,6-dihydro-4-thiouridine","beta-Selective synthesis of 2'-deoxy-5,6-dihydro-4-thiouridine, a precursor of the unstable nucleoside product of ionising radiation damage 2'-deoxy-5,6-dihydrocytidine.",81150,C9H12N2O4S,244.27,245.27
878,"InChI=1S/C9H12N2O5/c1-4-6(13)7(14)8(16-4)11-3-2-5(12)10-9(11)15/h2-4,6-8,13-14H,1H3,(H,10,12,15)/t4-,6-,7-,8-/m1/s1",5'-deoxyuridine,Stereoselective synthesis of uridine-derived nucleosyl amino acids.,46682,C9H12N2O5,228.2,229.2
879,"InChI=1S/C9H12N2O5/c12-3-7-5(13)1-6(16-7)4-2-10-9(15)11-8(4)14/h2,5-7,12-13H,1,3H2,(H2,10,11,14,15)/t5-,6+,7+/m0/s1",2'-Deoxypseudouridine,Synthesis of oligodeoxyribonucleotides containing 2'-deoxypseudouridine: inhibition of uracil-DNA glycosylase.,90128,C9H12N2O5,228.2,229.2
880,"InChI=1S/C9H12N2O5/c12-4-5-3-6(13)8(16-5)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",3'-deoxyuridine,"Pac13 is a Small, Monomeric Dehydratase that Mediates the Formation of the 3'-Deoxy Nucleoside of Pacidamycins.",17277,C9H12N2O5,228.2,229.2
881,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",2'-Deoxyuridine,Effects of sodium cationization versus protonation on the conformations and N-glycosidic bond stabilities of sodium cationized Urd and dUrd: solution conformation of [Urd+Na],17719,C9H12N2O5,228.2,229.2
882,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1
InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)
InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8?/m0/s1",2'-desoxyuridine,Control of Energy Transfer Between Pyrene- and Perylene-Nucleosides by the Sequence of DNA-Templated Supramolecular Assemblies.,6077,C9H12N2O5,228.2,229.2
883,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1
InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)
InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8?/m0/s1
InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6-,8-/m1/s1",2-deoxyuridine,Early hepatic insulin resistance in mice: a metabolomics analysis.,55918,C9H12N2O5,228.2,229.2
884,"InChI=1S/C9H12N2O5S/c10-5-1-2-11(9(15)17-5)8-7(14)6(13)4(3-12)16-8/h1-2,4,6-8,10,12-14H,3H2/t4-,6-,7-,8-/m1/s1
InChI=1S/C9H12N2O5S/c10-5-1-2-11(9(15)17-5)8-7(14)6(13)4(3-12)16-8/h1-2,4,6-8,10,12-14H,3H2",3-thiacytidine,Antiviral effects of PNA in duck hepatitis B virus infection model.,68546,C9H12N2O5S,260.27,261.27
885,"InChI=1S/C9H12N2O5S/c12-3-4-6(13)7(14)8(16-4)11-2-1-5(17)10-9(11)15/h1-2,4,6-8,12-14H,3H2,(H,10,15,17)/t4-,6-,7-,8-/m1/s1",4-Thiouridine,"Local administration of 4-Thiouridine, a novel molecule with potent anti-inflammatory properties, protects against experimental colitis and arthritis.",5542,C9H12N2O5S,260.27,261.27
886,"InChI=1S/C9H12N2O5S/c12-3-4-6(14)7(15)8(16-4)11-2-1-5(13)10-9(11)17/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,17)/t4-,6-,7-,8-/m1/s1",2-Thiouridine,"Synthesis, base pairing and structure studies of geranylated RNA.",22637,C9H12N2O5S,260.27,261.27
887,"InChI=1S/C9H12N2O5S/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",4'-Thiouridine,A novel method for the synthesis of 4'-thiopyrimidine nucleosides using hypervalent iodine compounds.,88353,C9H12N2O5S,260.27,261.27
888,"InChI=1S/C9H12N2O5Se/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",4'-Selenouridine,Synthesis and properties of oligonucleotides containing 4'-selenoribonucleosides.,63306,C9H12N2O5Se,307.16,308.16
889,"InChI=1S/C9H12N2O6/c12-2-4-5(13)6(14)7(17-4)3-1-10-9(16)11-8(3)15/h1,4-7,12-14H,2H2,(H2,10,11,15,16)/t4-,5-,6-,7+/m1/s1",Pseudouridine,Pseudouridine site assignment by high-throughput in vitro RNA pseudouridylation and sequencing.,527,C9H12N2O6,244.2,245.2
890,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6+,7+,8-/m1/s1",ara-uridine,Hydrogermylation of 5-ethynyluracil nucleosides: formation of 5-(2-germylvinyl)uracil and 5-(2-germylacetyl)uracil nucleosides.,36187,C9H12N2O6,244.2,245.2
891,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1",spongouridine,Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold.,1353,C9H12N2O6,244.2,245.2
892,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m0/s1",L-uridine,Thermodynamic study of hybridization properties of heterochiral nucleic acids.,89843,C9H12N2O6,244.2,245.2
893,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",D-uridine,Synthesis and anti-HIV activity of D- and L-thietanose nucleosides.,76616,C9H12N2O6,244.2,245.2
894,"InChI=1S/C9H12N2O6/c12-3-6-4(13)1-7(17-6)11-2-5(14)8(15)10-9(11)16/h2,4,6-7,12-14H,1,3H2,(H,10,15,16)/t4-,6+,7+/m0/s1",5-hydroxy-2'-deoxyuridine,Human NEIL3 is mainly a monofunctional DNA glycosylase removing spiroimindiohydantoin and guanidinohydantoin.,35584,C9H12N2O6,244.2,245.2
895,"InChI=1S/C9H12N2O7/c12-2-4-5(14)6(15)8(18-4)11-1-3(13)7(16)10-9(11)17/h1,4-6,8,12-15H,2H2,(H,10,16,17)/t4-,5-,6-,8-/m1/s1",5-Hydroxyuridine,Synthesis and base pairing properties of DNA-RNA heteroduplex containing 5-hydroxyuridine.,59181,C9H12N2O7,260.2,261.2
896,"InChI=1S/C9H12N2O8/c12-1-2-3(13)4(14)8(19-2)11-7(17)5(15)6(16)10-9(11)18/h2-4,8,12-15,17H,1H2,(H,10,16,18)/t2-,3-,4-,8-/m1/s1","5,6-dihydroxyuridine",Parallel multiplex thermodynamic analysis of coaxial base stacking in DNA duplexes by oligodeoxyribonucleotide microchips.,100211,C9H12N2O8,276.2,277.2
897,"InChI=1S/C9H12N3O7P/c10-5-1-2-12(9(14)11-5)8-6(13)7-4(18-8)3-17-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H2,10,11,14)/t4-,6-,7-,8-/m1/s1","cytidine 3',5'-cyclic monophosphate",Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.,26002,C9H12N3O7P,305.18,306.18
898,"InChI=1S/C9H12N3O7P/c10-5-1-2-12(9(14)11-5)8-7-6(4(3-13)17-8)18-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H2,10,11,14)/t4-,6-,7-,8?/m1/s1","cytidine-2',3'-cyclophosphate",Synthesis of cytidine ribonucleotides by stepwise assembly of the heterocycle on a sugar phosphate.,90992,C9H12N3O7P,305.18,306.18
899,"InChI=1S/C9H12N3O7P/c10-5-1-2-12(9(14)11-5)8-7-6(4(3-13)17-8)18-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H2,10,11,14)/t4-,6-,7-,8?/m1/s1
InChI=1S/C9H12N3O7P/c10-5-1-2-12(9(14)11-5)8-7-6(4(3-13)17-8)18-20(15,16)19-7/h1-2,4,6-8,13H,3H2,(H,15,16)(H2,10,11,14)/t4-,6?,7+,8-/m1/s1","cytidine 2',3'-cyclic monophosphate",3'-N-Alkylamino-3'-deoxy-ara-uridines: a new class of potential inhibitors of ribonuclease A and angiogenin.,78769,C9H12N3O7P,305.18,306.18
900,"InChI=1S/C9H12N4O4/c1-4-7(15)5(3-14)17-8(4)13-9(16)12-6(10)2-11-13/h2,5,7-8,14-15H,1,3H2,(H2,10,12,16)/t5-,7+,8-/m1/s1",2'-deoxy-2'-methylene-6-azacytidine,"Synthesis of 2'-methylene-substituted 5-azapyrimidine, 6-azapyrimidine, and 3-deazaguanine nucleoside analogues as potential antitumor/antiviral agents.",109524,C9H12N4O4,240.22,241.22
901,"InChI=1S/C9H12N4O7/c10-7-3(13(18)19)1-12(9(17)11-7)8-6(16)5(15)4(2-14)20-8/h1,4-6,8,14-16H,2H2,(H2,10,11,17)/t4-,5-,6-,8-/m1/s1",5-nitrocytidine,Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases.,73559,C9H12N4O7,288.21,289.21
902,"InChI=1S/C9H12N6O3/c10-7-1-2-15(9(17)12-7)8-3-5(13-14-11)6(4-16)18-8/h1-2,5-6,8,16H,3-4H2,(H2,10,12,17)/t5-,6+,8+/m0/s1","3'-azido-2',3'-dideoxycytidine","The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.",48947,C9H12N6O3,252.23,253.23
903,"InChI=1S/C9H12N6O3/c10-8-7-9(12-3-11-8)15(14-13-7)6-1-4(17)5(2-16)18-6/h3-6,16-17H,1-2H2,(H2,10,11,12)/t4-,5+,6+/m0/s1",8-aza-2'-deoxyadenosine,Enhancement of nucleoside cytotoxicity through nucleotide prodrugs.,94287,C9H12N6O3,252.23,253.23
904,"InChI=1S/C9H12N6O4/c10-5-1-2-15(9(18)12-5)8-6(13-14-11)7(17)4(3-16)19-8/h1-2,4,6-8,16-17H,3H2,(H2,10,12,18)/t4-,6-,7-,8-/m1/s1",2'-azido-2'-deoxycytidine,Synthesis and biological activity of bis(pivaloyloxymethyl) ester of 2'-azido-2'-deoxyuridine 5'-monophosphate.,111268,C9H12N6O4,268.23,269.23
905,"InChI=1S/C9H12N6O4/c10-7-3-1-11-15(8(3)13-14-12-7)9-6(18)5(17)4(2-16)19-9/h1,4-6,9,16-18H,2H2,(H2,10,12,13)/t4-,5-,6-,9-/m1/s1","7-deaza-2,8-diazaadenosine","1,N6-Etheno-7-deaza-2,8-diazaadenosine: syntheses, properties and conversion to 7-deaza-2,8-diazaadenosine.",81149,C9H12N6O4,268.23,269.23
906,"InChI=1S/C9H12N6O4/c10-7-4-8(12-2-11-7)15(14-13-4)9-6(18)5(17)3(1-16)19-9/h2-3,5-6,9,16-18H,1H2,(H2,10,11,12)/t3-,5-,6-,9-/m1/s1",8-aza-adenosine,Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors.,51523,C9H12N6O4,268.23,269.23
907,"InChI=1S/C9H12N6O5/c10-4-1-2-15(8(19)12-4)7-5(17)6(18)9(3-16,20-7)13-14-11/h1-2,5-7,16-18H,3H2,(H2,10,12,19)/t5-,6+,7-,9-/m1/s1",4'-Azidocytidine,"The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.",62080,C9H12N6O5,284.23,285.23
908,"InChI=1S/C9H12N6O5/c10-9-11-6-3(7(19)12-9)13-14-15(6)8-5(18)4(17)2(1-16)20-8/h2,4-5,8,16-18H,1H2,(H3,10,11,12,19)/t2-,4-,5-,8-/m1/s1",8-azaguanosine,Interactions of calf spleen purine nucleoside phosphorylase with formycin B and its aglycone - spectroscopic and kinetic studies.,67220,C9H12N6O5,284.23,285.23
909,"InChI=1S/C9H13N2O7P/c12-7-3-4-11(9(13)10-7)8-2-1-6(18-8)5-17-19(14,15)16/h3-4,6,8H,1-2,5H2,(H,10,12,13)(H2,14,15,16)/t6-,8+/m0/s1","2',3'-dideoxyuridine 5'-monophosphate","Bis(carbamoyloxymethyl) esters of 2',3'-dideoxyuridine 5'-monophosphate (ddUMP) as potential ddUMP prodrugs.",81298,C9H13N2O7P,292.18,293.18
910,"InChI=1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",2'-deoxyuridine-5'-monophosphate,Inhibition of thymidylate synthase affects neural tube development in mice.,15703,C9H13N2O8P,308.18,309.18
911,"InChI=1S/C9H13N2O9P/c12-3-4-6(14)7(20-21(16,17)18)8(19-4)11-2-1-5(13)10-9(11)15/h1-2,4,6-8,12,14H,3H2,(H,10,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 2'-monophosphate,Structural basis for substrate specificity of the human mitochondrial deoxyribonucleotidase.,80124,C9H13N2O9P,324.18,325.18
912,"InChI=1S/C9H13N2O9P/c12-3-4-7(20-21(16,17)18)6(14)8(19-4)11-2-1-5(13)10-9(11)15/h1-2,4,6-8,12,14H,3H2,(H,10,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 3'-phosphate,Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.,58689,C9H13N2O9P,324.18,325.18
913,"InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 5'-monophosphate,Improvement of uridine production of Bacillus subtilis by atmospheric and room temperature plasma mutagenesis and high-throughput screening.,18433,C9H13N2O9P,324.18,325.18
914,"InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)",pseudouridine 5'-monophosphate,Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase.,16763,C9H13N2O9P,324.18,325.18
915,"InChI=1S/C9H13N2O9P/c12-5-4(2-19-21(16,17)18)20-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1",pseudouridine-5'-phosphate,Molecular identification of pseudouridine-metabolizing enzymes.,64338,C9H13N2O9P,324.18,325.18
916,"InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1","2',3'-Dideoxycytidine","Determination of 2',3'-dideoxycytidine in maternal plasma, amniotic fluid, placental and fetal tissues by high-performance liquid chromatography.",83732,C9H13N3O3,211.22,212.22
917,"InChI=1S/C9H13N3O3S/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",2'-deoxy-4'-thiocytidine,Practical synthesis of 2'-deoxy-4'-thioribonucleosides: substrates for the synthesis of 4'-thioDNA.,78815,C9H13N3O3S,243.28,244.28
918,"InChI=1S/C9H13N3O4/c1-4-6(13)7(14)8(16-4)12-3-2-5(10)11-9(12)15/h2-4,6-8,13-14H,1H3,(H2,10,11,15)/t4-,6-,7-,8-/m1/s1",5'-deoxycytidine,Analysis of urinary nucleosides. III. Identification of 5'-deoxycytidine in urine of a patient with head and neck cancer.,91144,C9H13N3O4,227.22,228.22
919,"InChI=1S/C9H13N3O4/c1-9(5-13)15-4-7(16-9)12-3-2-6(10)11-8(12)14/h2-3,7,13H,4-5H2,1H3,(H2,10,11,14)/t7-,9-/m1/s1","2',3'-dideoxy-4'-C-methyl-3'-oxacytidine","Synthesis and biological evaluation of L- and D-configurations of 2',3'-dideoxy-4'-C-methyl-3'-oxacytidine analogues.",99106,C9H13N3O4,227.22,228.22
920,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)",3H-deoxycytidine,Concomitant quantification of targeted drug delivery and biological response in individual cells.,69122,C9H13N3O4,227.22,228.22
921,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",2'-Deoxycytidine,2'-Deoxycytidine decreases the anti-tumor effects of 5-fluorouracil on mouse myeloma cells.,54273,C9H13N3O4,227.22,228.22
922,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m1/s1",L-2'-deoxycytidine,Inhibition of pre-mRNA splicing by synthetic branched nucleic acids.,88838,C9H13N3O4,227.22,228.22
923,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-6(14)3-5(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",3'-deoxycytidine,Synthesis of beta-enantiomers of N4-hydroxy-3'-deoxypyrimidine nucleosides and their evaluation against bovine viral diarrhoea virus and hepatitis C virus in cell culture.,86558,C9H13N3O4,227.22,228.22
924,"InChI=1S/C9H13N3O4/c10-9-11-2-4(8(15)12-9)6-1-5(14)7(3-13)16-6/h2,5-7,13-14H,1,3H2,(H3,10,11,12,15)/t5-,6+,7+/m0/s1",2'-deoxypseudoisocytidine,"A short, efficient synthesis of 2'-deoxypseudoisocytidine based on Heck-chemistry.",88605,C9H13N3O4,227.22,228.22
925,"InChI=1S/C9H13N3O4/c10-9-11-7(15)1-2-12(9)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",2'-deoxyisocytidine,"6-aza-2'-deoxyisocytidine: synthesis, properties of oligonucleotides, and base-pair stability adjustment of DNA with parallel strand orientation.",92831,C9H13N3O4,227.22,228.22
926,"InChI=1S/C9H13N3O4S/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1",4'-thiocytidine,[Development of highly nuclease-resistant chemically-modified oligonucleotides].,50699,C9H13N3O4S,259.28,260.28
927,"InChI=1S/C9H13N3O4S/c10-5-1-2-12(9(17)11-5)8-7(15)6(14)4(3-13)16-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,17)/t4-,6-,7-,8-/m1/s1",2-thiocytidine,"Biosynthesis of Sulfur-Containing tRNA Modifications: A Comparison of Bacterial, Archaeal, and Eukaryotic Pathways.",19098,C9H13N3O4S,259.28,260.28
928,"InChI=1S/C9H13N3O5/c10-3-4-6(14)7(15)8(17-4)12-2-1-5(13)11-9(12)16/h1-2,4,6-8,14-15H,3,10H2,(H,11,13,16)/t4-,6-,7-,8-/m1/s1",5'-amino-5'-deoxyuridine,"Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.",5043,C9H13N3O5,243.22,244.22
929,"InChI=1S/C9H13N3O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3,10H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-Amino-2'-deoxyuridine,"5-amino-2'-deoxyuridine, a novel thymidine analogue for high-resolution footprinting of protein-DNA complexes.",92398,C9H13N3O5,243.22,244.22
930,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",ara-cytidine,"Bisphosphonate derivatives of nucleoside antimetabolites: hydrolytic stability and hydroxyapatite adsorption of 5'-beta,gamma-methylene and 5'-beta,gamma-(1-hydroxyethylidene) triphosphates of 5-fluorouridine and ara-cytidine.",65017,C9H13N3O5,243.22,244.22
931,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8?/m1/s1",aracytidine,Controlling DNA Fragmentation in MALDI-MS by Chemical Modification.,115562,C9H13N3O5,243.22,244.22
932,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m0/s1",L-cytidine,Synthesis and anti-HIV activity of D- and L-thietanose nucleosides.,76616,C9H13N3O5,243.22,244.22
933,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1",3H-cytidine,RNA and DNA synthesis of epidermal basal cells after wounding. Comparison of vital and postmortem investigations.,114197,C9H13N3O5,243.22,244.22
934,"InChI=1S/C9H13N3O5/c10-6-4(3-13)17-8(7(6)15)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3,10H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1",3'-amino-3'-deoxyuridine,"Hydrolytic reactions of diribonucleoside 3',5'-(3'-N-phosphoramidates): kinetics and mechanisms for the P-O and P-N bond cleavage of 3'-amino-3'-deoxyuridylyl-3',5'-uridine.",93407,C9H13N3O5,243.22,244.22
935,"InChI=1S/C9H13N3O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3,10H2,(H,11,14,16)/t4-,6-,7-,8-/m1/s1",2'-amino-2'-deoxyuridine,A direct comparison of azide and nitrile vibrational probes.,50500,C9H13N3O5,243.22,244.22
936,"InChI=1S/C9H13N3O5/c10-8-5(15)2-12(9(16)11-8)7-1-4(14)6(3-13)17-7/h2,4,6-7,13-15H,1,3H2,(H2,10,11,16)/t4-,6+,7+/m0/s1",5-hydroxy-2'-deoxycytidine,Human NEIL3 is mainly a monofunctional DNA glycosylase removing spiroimindiohydantoin and guanidinohydantoin.,35584,C9H13N3O5,243.22,244.22
937,"InChI=1S/C9H13N3O5/c10-9-11-1-3(8(16)12-9)7-6(15)5(14)4(2-13)17-7/h1,4-7,13-15H,2H2,(H3,10,11,12,16)/t4-,5-,6-,7+/m1/s1",Pseudoisocytidine,"A unique unnatural base pair between a C analogue, pseudoisocytosine, and an A analogue, 6-methoxypurine, in replication.",95971,C9H13N3O5,243.22,244.22
938,"InChI=1S/C9H13N3O5/c10-9-11-5(14)1-2-12(9)8-7(16)6(15)4(3-13)17-8/h1-2,4,6-8,13,15-16H,3H2,(H2,10,11,14)/t4-,6-,7-,8-/m1/s1",isocytidine,"2'-O-Methyl- and 2'-O-propargyl-5-methylisocytidine: synthesis, properties and impact on the isoCd-dG and the isoCd-isoGd base pairing in nucleic acids with parallel and antiparallel strand orientation.",22917,C9H13N3O5,243.22,244.22
939,"InChI=1S/C9H13N3O6/c10-4-1-5(14)12(9(17)11-4)8-7(16)6(15)3(2-13)18-8/h1,3,6-8,13,15-16H,2,10H2,(H,11,17)/t3-,6-,7-,8-/m1/s1",6-hydroxycytidine,Accurate micro- and macro- gas phase basicities of hydroxyl-radical-modified pyrimidines estimated by advanced quantum chemistry methods.,61874,C9H13N3O6,259.22,260.22
940,"InChI=1S/C9H13N3O6/c10-7-3(14)1-12(9(17)11-7)8-6(16)5(15)4(2-13)18-8/h1,4-6,8,13-16H,2H2,(H2,10,11,17)/t4-,5-,6-,8-/m1/s1",5-hydroxycytidine,Thermodynamic signature of DNA damage: characterization of DNA with a 5-hydroxy-2'-deoxycytidine·2'-deoxyguanosine base pair.,45082,C9H13N3O6,259.22,260.22
941,"InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1",Beta-D-N4-hydroxycytidine,Metabolism of the anti-hepatitis C virus nucleoside beta-D-N4-hydroxycytidine in different liver cells.,83400,C9H13N3O6,259.22,260.22
942,"InChI=1S/C9H13N3O7/c10-6-5(16)7(17)12(9(18)11-6)8-4(15)3(14)2(1-13)19-8/h2-4,8,13-16H,1,10H2,(H,11,18)/t2-,3-,4-,8-/m1/s1","5,6-dihydroxycytidine",Accurate micro- and macro- gas phase basicities of hydroxyl-radical-modified pyrimidines estimated by advanced quantum chemistry methods.,61874,C9H13N3O7,275.22,276.22
943,"InChI=1S/C9H13N5O11P2/c10-13-12-6-7(16)4(3-23-27(21,22)25-26(18,19)20)24-8(6)14-2-1-5(15)11-9(14)17/h1-2,4,6-8,16H,3H2,(H,21,22)(H,11,15,17)(H2,18,19,20)/t4-,6-,7-,8?/m1/s1
InChI=1S/C9H13N5O11P2/c10-13-12-6-7(16)4(3-23-27(21,22)25-26(18,19)20)24-8(6)14-2-1-5(15)11-9(14)17/h1-2,4,6-8,16H,3H2,(H,21,22)(H,11,15,17)(H2,18,19,20)/t4-,6-,7-,8-/m1/s1",2'-azido-2'-deoxyuridine 5'-diphosphate,Synthesis and biological activity of bis(pivaloyloxymethyl) ester of 2'-azido-2'-deoxyuridine 5'-monophosphate.,111268,C9H13N5O11P2,429.17,430.17
944,"InChI=1S/C9H14BrN2O15P3/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(25-8)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h1,4-6,8,13-14H,2H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1",5-bromouridine triphosphate,Inhibition of transcription at radiation-induced nuclear foci of phosphorylated histone H2AX in mammalian cells.,68620,C9H14BrN2O15P3,563.04,564.04
945,"InChI=1S/C9H14BrN2O15P3/c10-9(12-2-1-5(13)11-8(12)14)7(27-30(21,22)23)6(26-29(18,19)20)4(25-9)3-24-28(15,16)17/h1-2,4,6-7H,3H2,(H,11,13,14)(H2,15,16,17)(H2,18,19,20)(H2,21,22,23)/t4-,6-,7-,9+/m1/s1",bromouridine tri-phosphate,Histographic recording of human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev and nuclear factors.,112513,C9H14BrN2O15P3,563.04,564.04
946,"InChI=1S/C9H14BrN2O15P3/c10-9(12-2-1-5(13)11-8(12)16)7(15)6(14)4(25-9)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,4,6-7,14-15H,3H2,(H,20,21)(H,22,23)(H,11,13,16)(H2,17,18,19)/t4-,6-,7-,9+/m1/s1",bromouridine-triphosphate,In situ fluorescence visualization of bromouridine incorporated into newly transcribed nucleolar RNA.,105400,C9H14BrN2O15P3,563.04,564.04
947,"InChI=1S/C9H14F2N2O5/c10-9(11)6(16)4(3-14)18-7(9)13-2-1-5(15)12-8(13)17/h4-7,14-16H,1-3H2,(H,12,17)/t4-,5-,6-,7-/m1/s1","(4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine","Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase.",43851,C9H14F2N2O5,268.22,269.22
948,"InChI=1S/C9H14F2N3O13P3/c10-6-7(11)14(9(16)13-8(6)12)5-1-3(15)4(25-5)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-5,15H,1-2H2,(H,20,21)(H,22,23)(H2,12,13,16)(H2,17,18,19)/t3-,4+,5+/m0/s1
InChI=1S/C9H14F2N3O13P3/c10-6-7(11)14(9(16)13-8(6)12)5-1-3(15)4(25-5)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-5,15H,1-2H2,(H,20,21)(H,22,23)(H2,12,13,16)(H2,17,18,19)",difluorodeoxycytidine triphosphate,A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.,82121,C9H14F2N3O13P3,503.14,504.14
949,"InChI=1S/C9H14F2N3O13P3/c10-9(11)6(15)4(25-7(9)14-2-1-5(12)13-8(14)16)3-24-29(20,21)27-30(22,23)26-28(17,18)19/h1-2,4,6-7,15H,3H2,(H,20,21)(H,22,23)(H2,12,13,16)(H2,17,18,19)/t4-,6-,7-/m1/s1","2',2'-difluorodeoxycytidine 5'-triphosphate",Pharmacokinetics of gemcitabine and its primary metabolite in dogs after intravenous infusion.,76566,C9H14F2N3O13P3,503.14,504.14
950,"InChI=1S/C9H14FN2O15P3/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(25-8)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h1,4-6,8,13-14H,2H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1",5-fluorouridine 5'-triphosphate,Population Pharmacokinetics of Intracellular 5-Fluorouridine 5'-Triphosphate and its Relationship with Hand-and-Foot Syndrome in Patients Treated with Capecitabine.,2850,C9H14FN2O15P3,502.13,503.13
951,"InChI=1S/C9H14IN2O15P3/c10-3-1-12(9(16)11-7(3)15)8-6(14)5(13)4(25-8)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h1,4-6,8,13-14H,2H2,(H,20,21)(H,22,23)(H,11,15,16)(H2,17,18,19)/t4-,5-,6-,8-/m1/s1",5-Iodouridine triphosphate,Post-transcriptional labeling by using Suzuki-Miyaura cross-coupling generates functional RNA probes.,14703,C9H14IN2O15P3,610.04,611.04
952,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 5'-diphosphate,Hair cell specific NTPDase6 immunolocalisation in vestibular end organs: potential role of purinergic signaling in vestibular sensory transduction.,37859,C9H14N2O12P2,404.16,405.16
953,"InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1
InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)
InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)/t5-,6-,8-/m1/s1","5,6-dihydro-2'-deoxyuridine",Reactivity of damaged pyrimidines: formation of a Schiff base intermediate at the glycosidic bond of saturated dihydrouridine.,29527,C9H14N2O5,230.22,231.22
954,"InChI=1S/C9H14N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h5-6,8,12-13H,1-4H2,(H,10,14,15)/t5-,6+,8-/m0/s1",tetrahydrodeoxyuridine,Accumulation of arabinosyluracil 5'-triphosphate during arabinosylcytosine therapy in circulating blasts of patients with acute myelogenous leukemia.,111510,C9H14N2O5,230.22,231.22
955,"InChI=1S/C9H14N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4,6-8,12,14-15H,1-3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1","3,4-dihydrouridine",Site-bound water and the shortcomings of a less than perfect transition state analogue.,98904,C9H14N2O6,246.22,247.22
956,"InChI=1S/C9H14N2O6/c12-3-5-4(13)1-8(17-5)11-7(15)2-6(14)10-9(11)16/h4-5,7-8,12-13,15H,1-3H2,(H,10,14,16)/t4-,5+,7?,8+/m0/s1","5,6-dihydro-6-hydroxy-2'-deoxyuridine",Characterization and mechanism of formation of tandem lesions in DNA by a nucleobase peroxyl radical.,71444,C9H14N2O6,246.22,247.22
957,"InChI=1S/C9H14N3O6P/c10-7-3-4-12(9(13)11-7)8-2-1-6(18-8)5-17-19(14,15)16/h3-4,6,8H,1-2,5H2,(H2,10,11,13)(H2,14,15,16)/t6-,8+/m0/s1","2',3'-dideoxycytidine-5'-monophosphate",Multidrug-resistant HIV-1 reverse transcriptase: involvement of ribonucleotide-dependent phosphorolysis in cross-resistance to nucleoside analogue inhibitors.,93993,C9H14N3O6P,291.2,292.2
958,"InChI=1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",2'-deoxycytidine 5'-monophosphate,Ultrafast IR spectroscopy of the short-lived transients formed by UV excitation of cytosine derivatives.,70236,C9H14N3O7P,307.2,308.2
959,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-6(14)7(4(3-13)19-8)20-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",cytidine 3'-phosphate,Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.,58689,C9H14N3O8P,323.2,324.2
960,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",cytidine 5'-monophosphate,Kinetico-Mechanistic Studies of Nucleoside and Nucleotide Substitution Reactions of Co(III) Complexes of Fully Alkylated Cyclen.,28174,C9H14N3O8P,323.2,324.2
961,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(20-21(16,17)18)6(14)4(3-13)19-8/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",cytidine 2'-monophosphate,A microfabrication-based approach to quantitative isothermal titration calorimetry.,25167,C9H14N3O8P,323.2,324.2
962,"InChI=1S/C9H14N3O8P/c10-6-7(14)4(3-19-21(16,17)18)20-8(6)12-2-1-5(13)11-9(12)15/h1-2,4,6-8,14H,3,10H2,(H,11,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",2'-aminouridine,Synthesis of 2'-aminouridine derivatives as an organocatalyst for Diels-Alder reaction.,8966,C9H14N3O8P,323.2,324.2
963,"InChI=1S/C9H14N4O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3,10H2,(H2,11,12,16)/t5-,6+,7+/m0/s1",5-amino-2'-deoxycytidine,Rigid 5'-6-locked phenanthroline-derived nucleosides chelated to ruthenium and europium ions.,38583,C9H14N4O4,242.23,243.23
964,"InChI=1S/C9H14N4O4/c10-5-1-2-13(9(16)12-5)8-6(11)7(15)4(3-14)17-8/h1-2,4,6-8,14-15H,3,11H2,(H2,10,12,16)/t4-,6-,7-,8-/m1/s1",2'-amino-2'-deoxycytidine,[Monomers for oligonucleotide synthesis with linkers carrying reactive residues: II. Synthesis of phosphoamidites based of uridine and cytosine and containing a linker with methoxyoxalamide groups in position 2'].,84615,C9H14N4O4,242.23,243.23
965,"InChI=1S/C9H14N4O5/c10-12-5-1-2-13(9(17)11-5)8-7(16)6(15)4(3-14)18-8/h1-2,4,6-8,14-16H,3,10H2,(H,11,12,17)/t4-,6-,7-,8-/m1/s1",N(4)-aminocytidine,A comparison of mutation spectra detected by the Escherichia coli lac(+) reversion assay and the Salmonella typhimurium his(+) reversion assay.,104154,C9H14N4O5,258.23,259.23
966,"InChI=1S/C9H14N4O5/c10-12-5-1-2-13(9(17)11-5)8-7(16)6(15)4(3-14)18-8/h1-2,4,6-8,14-16H,3,10H2,(H,11,12,17)/t4-,6-,7-,8-/m1/s1
InChI=1S/C9H14N4O5/c10-12-5-1-2-13(9(17)11-5)8-7(16)6(15)4(3-14)18-8/h1-2,4,6-8,14-16H,3,10H2,(H,11,12,17)
InChI=1S/C9H14N4O5/c10-12-5-1-2-13(9(17)11-5)8-7(16)6(15)4(3-14)18-8/h1-2,4,6-8,14-16H,3,10H2,(H,11,12,17)/t4-,6+,7?,8-/m1/s1",N4-aminocytidine,"Binding specificities of the mismatch binding protein, MutS, to oligonucleotides containing modified bases.",90664,C9H14N4O5,258.23,259.23
967,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/p-4/t5-,6+,8+/m0/s1",deoxyuridine-triphosphate,Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.,28381,C9H11N2O14P3,464.11,465.11
968,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",2'-Deoxyuridine triphosphate,Modified 5'-trityl nucleosides as inhibitors of Plasmodium falciparum dUTPase.,50965,C9H15N2O14P3,468.14,469.14
969,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/p-4/t4-,6-,7-,8-/m1/s1",uridine-triphosphate,Attenuated purinergic receptor function in patients with type 2 diabetes.,57734,C9H11N2O15P3,480.11,481.11
970,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 5'-triphosphate,New Insights in Purinergic Therapy: Novel Antagonists for Uridine 5'-Triphosphate-Activated P2Y Receptors from Brazilian Flora.,11781,C9H15N2O15P3,484.14,485.14
971,"InChI=1S/C9H15N2O15P3/c12-5-4(2-23-28(19,20)26-29(21,22)25-27(16,17)18)24-7(6(5)13)3-1-10-9(15)11-8(3)14/h1,4-7,12-13H,2H2,(H,19,20)(H,21,22)(H2,16,17,18)(H2,10,11,14,15)/t4-,5-,6-,7+/m1/s1",pseudouridine-5'-triphosphate,An Efficient Protection-Free One-Pot Chemical Synthesis of Modified Nucleoside-5'-Triphosphates.,23113,C9H15N2O15P3,484.14,485.14
972,"InChI=1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",cytidine diphosphate,Efficient synthesis of cytidine diphosphate choline (CDP-choline) and its analogs.,28081,C9H15N3O11P2,403.18,404.18
973,"InChI=1S/C9H15N3O4/c10-6-1-2-12(4-11-6)9-8(15)7(14)5(3-13)16-9/h1-2,5,7-9,13-15H,3-4H2,(H2,10,11)/t5-,7?,8-,9?/m1/s1",(deoxy)cytidine,Validation of a sensitive LC/MSMS method for chloronucleoside analysis in biological matrixes and its applications.,23130,C9H15N3O4,229.23,230.23
974,"InChI=1S/C9H15N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h4,6-8,13-15H,1-3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1","5,6-dihydrocytidine","Catalysis by entropic effects: the action of cytidine deaminase on 5,6-dihydrocytidine.",96550,C9H15N3O5,245.23,246.23
975,"InChI=1S/C9H16N2O18P4/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(26-8)3-25-31(19,20)28-33(23,24)29-32(21,22)27-30(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,23,24)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",uridine 5'-tetraphosphate,Uridine 5'-polyphosphates (p4U and p5U) and uridine(5')polyphospho(5')nucleosides (Up(n)Ns) can be synthesized by UTP:glucose-1-phosphate uridylyltransferase from Saccharomyces cerevisiae.,87045,C9H16N2O18P4,564.12,565.12
976,"InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8-/m1/s1","3,4,5,6-Tetrahydrouridine","Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and bioavailability in mice by 3,4,5,6-tetrahydrouridine.",64732,C9H16N2O6,248.23,249.23
977,"InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8-/m1/s1
InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5-,6-,7-,8-/m1/s1
InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)
InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8?/m1/s1
InChI=1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5+,6-,7-,8-/m1/s1",Tetrahydrouridine,Rapid Homogeneous Immunoassay to Quantify Gemcitabine in Plasma for Therapeutic Drug Monitoring.,18341,C9H16N2O6,248.23,249.23
978,"InChI=1S/C9H16N3O12P3/c10-7-3-4-12(9(13)11-7)8-2-1-6(22-8)5-21-26(17,18)24-27(19,20)23-25(14,15)16/h3-4,6,8H,1-2,5H2,(H,17,18)(H,19,20)(H2,10,11,13)(H2,14,15,16)/t6-,8+/m0/s1","2',3'-dideoxycytidine 5'-triphosphate","Effects of 2',3'-dideoxycytidine and 2',3'-dideoxycytidine 5'-triphosphate on phospholipid metabolism in permeabilized rat hepatocytes.",113974,C9H16N3O12P3,451.16,452.16
979,"InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1",Deoxycytidine triphosphate,Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.,96414,C9H16N3O13P3,467.16,468.16
980,"InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/t5-,6+,8+/m0/s1
InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/p-4/t5-,6+,8+/m0/s1
InChI=1S/C9H16N3O13P3.Li/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17;/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17);/q;+1/p-1/t5-,6+,8+;/m0./s1",2'-deoxycytidine-5'-triphosphate,The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.,102188,C9H16N3O13P3,467.16,468.16
981,"InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",cytidine 5'-triphosphate,Single cytidine units-templated syntheses of multi-colored water-soluble Au nanoclusters.,32220,C9H16N3O14P3,483.16,484.16
982,"InChI=1S/C9H16N3O14P3/c10-8-5(14)2-12(9(15)11-8)7-1-4(13)6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h2,4,6-7,13-14H,1,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6+,7+/m0/s1",5-hydroxy-2'-deoxycytidine 5'-triphosphate,"The mutations induced by oxidatively damaged nucleotides, 5-formyl-dUTP and 5-hydroxy-dCTP,in Escherichia coli.",110879,C9H16N3O14P3,483.16,484.16
983,"InChI=1S/C9H9IN2O4/c10-6-3-12(9(15)11-8(6)14)7-2-1-5(4-13)16-7/h1-3,5,7,13H,4H2,(H,11,14,15)/t5-,7+/m0/s1","2',3'-didehydro-2',3'-dideoxy-5-iodouridine",Synthesis and evaluation of cis-1-[4-(hydroxymethyl)-2-cyclopenten-1-yl]-5-[(124)I]iodouracil: a new potential PET imaging agent for HSV1-tk expression.,68074,C9H9IN2O4,336.08,337.08
